BH : Annual Report 2005 by Bumrungrad Hospital Public Company Limited

Annual Report 2005

“√∫— ≠ / Table of Contents 2

“ πå®“°ª√–∏“π°√√¡°“√ / Message from Chairman “ πå®“°ºŸÕâ ”π«¬°“√¥â“π∫√‘À“√ - °≈ÿ¡à ¿Ÿ¡¿‘ “§ / Message from Group Chief Executive Officer ∏ÿ√°‘®¢Õß∫”√ÿß√“…Æ√å / Bumrungradûs Business ¢âÕ¡Ÿ≈∑“ß°“√‡ß‘π ë ¢âÕ¡Ÿ≈∑“ß°“√‡ß‘π‚¥¬ √ÿª ë §”Õ∏‘∫“¬·≈–°“√«‘‡§√“–Àå∞“π–°“√‡ß‘π·≈–º≈°“√¥”‡π‘π°“√ ë √“¬ß“π¢Õß§≥–°√√¡°“√µ√«® Õ∫ ë √“¬ß“π§«“¡√—∫º‘¥™Õ∫¢Õß§≥–°√√¡°“√µàÕ√“¬ß“π°“√‡ß‘π ë ß∫°“√‡ß‘π √ÿª “√– π‡∑»∑’ Ë ”§—≠ ë ¢âÕ¡Ÿ≈∑—«Ë ‰ª ë ≈—°…≥–°“√ª√–°Õ∫∏ÿ√°‘® ë ªí®®—¬§«“¡‡ ’¬Ë ß ë ‚§√ß √â“ß°“√∂◊ÕÀÿπâ ·≈–°“√®—¥°“√ ë °“√°—∫°—∫¥Ÿ·≈°‘®°“√ ë √“¬°“√√–À«à“ß°—π

4 6 17 19 20 22 23 24 61 63 65 68 70 82 88

Financial Information

ë ë ë ë ë

Financial Highlights

Management Discussion and Analysis

Report of the Audit Committee

Report of the Accountability of the Board of Directors to the Company‘s Financial Reports

Financial Statements

Other Important Information

ë ë ë ë ë ë

129

General Information

131

Company Profile

132

Risk Factors

136

Shareholding Structure & Management

137

Corporate Governance

144

Related Parties Transactions

148

Bumrungrad Hospital Public Company Limited

√“¬ß“πª√–®”ªï 2548

“ πå®“°ª√–∏“π°√√¡°“√ ªï 2548 ‡ªìπªï∑’Ë ”§—≠„πª√–«—µ‘»“ µ√å¢Õß∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π) ´÷ßË ‰¥â©≈Õß§√∫√Õ∫ 25 ªï¢Õß‚√ßæ¬“∫“≈ ‡¡◊ÕË ¡Õß¬âÕπ°≈—∫‰ª ‡√“‰¥â‡¥‘π∑“ß¡“ Õ¬à“ß‰¡àπ“à ‡™◊ÕË ‡√‘¡Ë ®“°‚√ßæ¬“∫“≈∑—«Ë ‰ª¢π“¥°≈“ß¥â«¬®”π«π‡µ’¬ß 200 ‡µ’¬ß„πªï 2523 ®π‡ªìπÀπ÷Ëß„π‚√ßæ¬“∫“≈∑’Ë¡’™◊ËÕ‡ ’¬ß∑’Ë ÿ¥¢Õß‚≈°„πªí®®ÿ∫—π „Àâ∫√‘°“√√—°…“ºŸâªÉ«¬ªï≈– °«à“≈â“π§π ®“°°«à“ 190 ª√–‡∑» §ÿ≥ ¡∫—µ‘ ”§—≠∑’Ë∑”„Àâ‡√“ª√– ∫§«“¡ ”‡√Á®Õ¬à“ß¬‘Ëß„π∑ÿ°«—ππ’È §◊Õ§≥–·æ∑¬å·≈–æπ—° ß“π∑’¬Ë Õ¥‡¬’¬Ë ¡ ‡æ√“–∏ÿ√°‘®°“√·æ∑¬åππ—È ∑’ Ë ¥ÿ ·≈â«°Á§Õ◊ ∏ÿ√°‘®°“√„Àâ∫√‘°“√π—πË ‡Õß ·≈–™◊ÕË ‡ ’¬ß¢Õß‡√“∑“ß¥â“π°“√∫√‘°“√·≈–°“√·æ∑¬å∑’Ë‡ªìπ‡≈‘»‰¥â∑”„Àâ∫”√ÿß√“…Æ√å‡ªìπ§«“¡¿Ÿ¡‘„® ¢Õß«ß°“√∏ÿ√°‘®·æ∑¬å‰∑¬ ¥â«¬§ÿ≥ ¡∫—µÀ‘ ≈—°¥—ß°≈à“« ·≈–∑’¡ß“π∫√‘À“√π“π“™“µ‘∑‡’Ë ¢â¡ ·¢Áß∑”„Àâ∫”√ÿß√“…Æ√å “¡“√∂µÕ∫ πÕß§«“¡µâÕß°“√¢ÕßºŸâªÉ«¬·≈–‡ªÑ“ª√– ß§å¢ÕßºŸâ∂◊Õ Àÿπâ ‰¥âÕ¬à“ßµàÕ‡π◊ÕË ß ¡ÕßÕÕ°‰ª¢â“ßÀπâ“ ∫”√ÿß√“…Æ√å®–°”Àπ¥Õπ“§µ‚¥¬°“√‡√‘Ë¡¥”‡π‘πß“πµ—ßÈ ·µà«—ππ’È æ◊πÈ ∑’Ë „π°“√√Õß√— ∫ ºŸâ ªÉ « ¬¢Õß‚√ßæ¬“∫“≈∫”√ÿ ß √“…Æ√å ∑Ë’ ° √ÿ ß ‡∑æ¡À“π§√®–‡æ‘Ë ¡ ‡ªì π Õß‡∑à“ °“√∑àÕß‡∑’¬Ë «‡æ◊ÕË √—°…“æ¬“∫“≈ (Medical Tourism) ®–™à«¬„ÀâºªŸâ «É ¬µà“ß™“µ‘¢Õß‡√“‡æ‘¡Ë ¢÷πÈ ·≈–‡§√◊Õ¢à“¬‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å®– §√Õ∫§≈ÿ¡µ—ßÈ ·µà‡Õ‡™’¬µ–«—πµ°®π∂÷ß‡Õ‡™’¬µ–«—πÕÕ° √Ÿª·∫∫°“√¥”‡π‘π∏ÿ√°‘®∫√‘°“√∑“ß°“√·æ∑¬å¢Õß∫”√ÿß√“…Æ√å®–‡ªìπ∑’¬Ë Õ¡√—∫«à“‡ªìπ√Ÿª·∫∫∑’Ë “¡“√∂µÕ∫ πÕß ‘ßË ∑’∑Ë «—Ë ‚≈°µâÕß°“√¡“°∑’ Ë ÿ¥ §◊Õ ∫√‘°“√∑’¡Ë ’§≥ÿ ¿“æ·≈–‡¢â“∂÷ß‰¥âß“à ¬ ¥â«¬√“§“∑’§Ë ¡ÿâ §à“ „πÕπ“§µ 25 ªï¢“â ßÀπâ“ ®–µâÕß¡’°“√‡ª≈’¬Ë π·ª≈ß‡°‘¥¢÷ÈπÕ’°¡“°¡“¬ ·µà„π°“√‡ª≈’¬Ë π·ª≈ß∑—ÈßÀ¡¥π—πÈ ®–¡’ ß‘Ë Àπ÷Ëß∑’®Ë –‡À¡◊Õπ‡¥‘¡ π—πË §◊Õ §”¡—πË —≠≠“¢Õß‡√“ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ∑’®Ë –„Àâ∫√‘°“√√—°…“æ¬“∫“≈¥â«¬«‘∑¬“°“√·æ∑¬å∑≈’Ë È”Àπâ“·≈–°“√∫√‘°“√¡“µ√∞“π “°≈ ‡æ◊ÕË ºŸªâ «É ¬¢Õß‡√“ ·µà≈–∑à“π

π“¬™—¬ ‚ ¿≥æπ‘™ ª√–∏“π°√√¡°“√

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

Annual Report 2005

Message from the Chairman 2005 was a milestone year, as Bumrungrad Hospital PCL celebrated its 25th Anniversary. Looking back, we have taken an incredible journey, starting in 1980 with a modest 200-bed general hospital to one of the most recognized healthcare brand names in the world, serving over one million patients annually from over 190 countries. We attribute our success in no small part to our exceptional employees and physicians. Healthcare is, after all, a service business, and our reputation for outstanding service and medical excellence has made Bumrungrad the pride of Thai healthcare. Those core attributes and a strong multinational management team continue to meet the needs of our patients and the goals of our shareholders year after year. Looking forward, Bumrungrad is positioning itself for future by acting today. Clinical capacity at our Bangkok campus will double, medical tourism will drive our international patient volume, and the Bumrungrad hospital network will span from the Middle East to the Far East. The Bumrungrad model of healthcare will become recognized for delivering what people around the world want most: quality, access, and affordability. Our next twenty five years will undoubtedly see many more changes, but throughout it all one thing will remain the same â&#x20AC;&#x201C; our commitment to deliver world class medicine and world class service one patient at a time.

Mr. Chai Sophonpanich Chairman

Bumrungrad Hospital Public Company Limited

√“¬ß“πª√–®”ªï 2548

“ πå®“°ºŸÕâ ”π«¬°“√¥â“π∫√‘À“√ - °≈ÿ¡à ¿Ÿ¡¿‘ “§ ªí®®—¬„¥∑’∑Ë ”„Àâ∫”√ÿß√“…Æ√åª√– ∫§«“¡ ”‡√Á® ·≈–‡√“®–‡®√‘≠‡µ‘∫‚µµàÕ‰ª„πÕπ“§µÕ¬à“ß‰√? §◊Õ§”∂“¡∑’πË —°≈ß∑ÿπ ºŸ â Õ◊Ë ¢à“« ·≈–ºŸ∂â Õ◊ Àÿâπ∂“¡‡√“∫àÕ¬∑’Ë ¥ÿ ·≈–¥â«¬ 12 ªï∑’Ë‰¥â∫√‘À“√ ∫”√ÿß√“…Æ√å Õ‘π‡µÕ√å‡π™—πË ·π≈ ¢â“æ‡®â“ “¡“√∂°≈à“«‰¥âÕ¬à“ß™—¥‡®π«à“ ‡√“ª√– ∫§«“¡ ”‡√Á® ‡π◊ËÕß®“°‡√“„Àâ∫√‘°“√∑“ß°“√·æ∑¬å∑’Ë¡’§ÿ≥¿“æ ‚¥¬¡◊ÕÕ“™’æ∑’Ë∑ÿà¡‡∑·≈–Àà«ß„¬ ·≈–„Àâ§«“¡ ”§—≠µàÕºŸªâ «É ¬‡ªìπÕ—π¥—∫·√° Õ¬à“ß‰√°Á¥’ ªí®®—¬∑’Ë∑”„Àâ∫”√ÿß√“…Æ√å Õ‘π‡µÕ√å‡π™—Ëπ·π≈¡’‡Õ°≈—°…≥å·µ°µà“ß®“°§Ÿà·¢àß §◊Õ§«“¡ “¡“√∂„π°“√ √â“ß§«“¡‰¥â‡ª√’¬∫®“°°“√‡ªìπºŸ√â ‡‘ √‘¡Ë (First moverûs advantage) „πµ≈“¥ ”§—≠¡“°¡“¬ ‡√“‡ªìπºŸ√â ‡‘ √‘¡Ë „π°“√ÕÕ°·∫∫‚√ßæ¬“∫“≈ °“√æ—≤π“√–∫∫ “√ π‡∑» °“√√—∫√Õß§ÿ≥¿“æ¡“µ√∞“π “°≈ ·≈–°“√∑àÕß‡∑’¬Ë «‡æ◊ÕË √—°…“æ¬“∫“≈ (Medical Tourism) „π·µà≈–¥â“ππ—Èπ ∫”√ÿß√“…Æ√å‡ªìπºŸâπ”µ≈“¥ ‡æ√“–‡√“µÕ∫ πÕßµàÕ ‘ßË ∑â“∑“¬ À√◊Õ‚Õ°“ ¥â«¬·π«∑“ß∑’·Ë ª≈°„À¡àÀ√◊Õ¥â«¬π«—µ°√√¡∑’ Ë √â“ß √√§å • „πªï 2540 ∑à“¡°≈“ß°“√·¢àß¢—π∑’√Ë πÿ ·√ß„π∏ÿ√°‘®‚√ßæ¬“∫“≈‡Õ°™π ∫”√ÿß√“…Æ√å Õ‘π‡µÕ√å‡π™—πË ·π≈ ‰¥â°”Àπ¥¡“µ√∞“π„À¡à„π°“√ÕÕ°·∫∫ ‚√ßæ¬“∫“≈ ¥â«¬°“√ √â“ß ¿“æ·«¥≈âÕ¡¢Õß‚√ßæ¬“∫“≈„Àâ·µ°µà“ß®“°‚√ßæ¬“∫“≈Õ◊πË Ê Õ¬à“ß ‘πÈ ‡™‘ß • „πªï 2543 ∫”√ÿß√“…Æ√å Õ‘π‡µÕ√å‡π™—Ëπ·π≈ ‡≈‘°∑’Ë®–‡ªìπºŸâµ“¡·≈–‡√‘Ë¡‡ªìπºŸâπ”¥â“π‡∑§‚π‚≈¬’ ‚¥¬°“√π”√–∫∫‡°Á∫¢âÕ¡Ÿ≈∫—π∑÷°ª√–«—µ‘ §π‰¢â·≈–¢âÕ¡Ÿ≈√–∫∫√—ß ’«‘∑¬“„π√Ÿª·∫∫Õ‘‡≈Á°∑√Õπ‘° å‰¥âÕ¬à“ß ¡∫Ÿ√≥å§√∫∂â«π „π¢≥–∑’Ë ‚√ßæ¬“∫“≈ à«π„À≠à„π‚≈°¬—ß„™â√–∫∫„π√Ÿª·∫∫ ‡Õ° “√Õ¬Ÿà • „πªï 2544 ∫”√ÿß√“…Æ√å Õ‘π‡µÕ√å‡π™—πË ·π≈ ‡ªìπ‚√ßæ¬“∫“≈·Ààß·√°„π‡Õ‡™’¬∑’Ë‰¥â√∫— √Õß§ÿ≥¿“æ¢Õß‚√ßæ¬“∫“≈√–¥—∫ “°≈ ®“° ∂“∫—π Joint Commission International Accreditation ´÷Ëß‡ªìπ°“√· ¥ß„Àâ‡ÀÁπ∂÷ß§«“¡‡ªìπºŸâπ”¥â“π§ÿ≥¿“æ ∑—¥‡∑’¬¡°—∫»Ÿπ¬å°“√·æ∑¬å∑’Ë¥’∑’Ë ÿ¥„π À√—∞Õ‡¡√‘°“·≈–¬ÿ‚√ª • «‘°ƒµ°“√≥å∑“ß‡»√…∞°‘® ‡Àµÿ°“√≥åµ°÷ ∂≈à¡ 9/11 ·≈–°“√√–∫“¥¢Õß‚√§ SARS ‰¥â∑”„Àâ∏√ÿ °‘®À≈“¬·Ààß„π¿Ÿ¡¿‘ “§À¬ÿ¥™–ß—° ·µà∫”√ÿß√“…Æ√å Õ‘π‡µÕ√å‡π™—πË ·π≈ ‰¥â„™â«°‘ ƒµ°“√≥å¥ß— °≈à“«„Àâ‡ªìπ‚Õ°“ „π°“√¢¬“¬∏ÿ√°‘®„πµ≈“¥µà“ßª√–‡∑»„À¡àÊ „πªí®®ÿ∫π— ∫”√ÿß√“…Æ√å Õ‘π‡µÕ√å‡π™—πË ·π≈ ‰¥â√—∫°“√¬°¬àÕß„Àâ‡ªìπºŸâ√‘‡√‘Ë¡∫ÿ°‡∫‘°°“√∑àÕß‡∑’Ë¬«‡æ◊ËÕ√—°…“æ¬“∫“≈ (Medical Tourism) ·≈–‡ªìπ‚√ßæ¬“∫“≈∑’Ë‡ªìπ®ÿ¥À¡“¬Õ—π¥—∫Àπ÷Ëß ¢Õß‚≈°‡æ◊ÕË °“√¥Ÿ·≈√—°…“ ÿ¢¿“æ √–∫∫°“√∫√‘°“√¥Ÿ·≈√—°…“ ÿ¢¿“æ∑—«Ë ‚≈°°”≈—ß‡ª≈’¬Ë π·ª≈ßÕ¬à“ß√«¥‡√Á« ·≈–°“√‡ª≈’¬Ë π·ª≈ßÀ≈“¬Ê à«π®–‡ªìπ‰ª„π≈—°…≥–ªØ‘√ªŸ ... ‰¡à‰¥â‡ªìπ ‰ª„π≈—°…≥–«‘«≤— π“°“√Õ¬à“ß™â“Ê ‡√“ ∫”√ÿß√“…Æ√å Õ‘π‡µÕ√å‡π™—πË ·π≈Õ¬Ÿà„πµ”·Àπàß∑’Ë‰¡à‡À¡◊Õπ„§√∑’æË √âÕ¡∑’®Ë –‡µ‘∫‚µµàÕ‰ª„πÕπ“§µ ‡æ√“–‡√“ ®–¡ÿßà √â“ß √√§å ‘Ëß„À¡àÊ Õ¬à“ßµàÕ‡π◊ËÕß ‡æ◊ÕË µÕ∫√—∫°—∫ ‘ßË ∑â“∑“¬·≈–‚Õ°“ ∑’‡Ë °‘¥¢÷πÈ ∫π‚≈°∑’Ë "√“∫" „∫π’È

π“¬ ‡§Õ√åµ ‘ ‡® ™‚√‡¥Õ√å ºŸÕâ ”π«¬°“√¥â“π∫√‘À“√ - °≈ÿ¡à ¿Ÿ¡¿‘ “§ 4

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

Annual Report 2005

Message from Group Chief Executive Officer What is the key to Bumrungrad’s success and how will you generate growth going forward?

This is the question I am asked most often by investors, journalists and shareholders, and after 12 years at the helm of Bumrungrad International, I can unequivocally say we succeed because we consistently deliver quality medical services by committed and caring professionals who put the patient first. But what makes Bumrungrad International unique, however, is our ability to create first mover’s advantage in so many key market segments.We are a first mover in hospital design, information technology, quality accreditation and medical tourism. In each of these areas, Bumrungrad is a market leader because we responded to a challenge or opportunity with a novel approach or innovative solution. •

In 1997 amid rising competition in the private hospital sector, Bumrungrad International set a new standard in hospital design by creating a hospital environment that was distinctly different from anything else in the market.

•

In 2000, Bumrungrad International stopped being a technology follower and started being a technology leader by implementing a fully integrated electronic medical record and digital radiology system while most of the world’s hospitals are still using paper based systems.

•

In 2001, Bumrungrad International was the first hospital in Asia to receive JCI Accreditation, and in doing so established itself as a leader in quality on par with the best medical centers in the USA and Europe.

•

The Asian economic crisis, 9/11 and SARS crippled many businesses regionally, but Bumrungrad International used these events to expand into new overseas markets. Today, Bumrungrad International is regarded as the pioneer in medical tourism and the world’s #1 international destination for healthcare.

Healthcare delivery systems worldwide are changing, and many of these changes will be revolutionary…not evolutionary. Bumrungrad International is uniquely positioned for growth, because we continue to innovate to meet the challenges and opportunities in a ‘flat’ world.

Mr. Curtis J. Schroeder Group Chief Executive Officer

Bumrungrad Hospital Public Company Limited

√“¬ß“πª√–®”ªï 2548

∑ÿ°§«“¡‡™’¬Ë «™“≠¢Õß‡√“... ‡æ◊ÕË §ÿ≥ ∑‘»∑“ß°“√µ≈“¥„À¡à¢Õß∫”√ÿß√“…Æ√å Õ‘π‡µÕ√å‡π™—Ëπ·π≈ ®–‡πâπ®ÿ¥·¢Áß¢Õß‡√“ §◊Õ °“√√—°…“‡©æ“–∑“ß§√Õ∫§≈ÿ¡ ∑ÿ° “¢“ ‚¥¬¡’ºªŸâ «É ¬‡ªìπ»Ÿπ¬å°≈“ß ¥â«¬§≥–·æ∑¬åº‡Ÿâ ™’¬Ë «™“≠‡©æ“–∑“ß´÷ßË ºà“π°“√Õ∫√¡®“°µà“ßª√–‡∑»°«à“ 700 §π „π∑ÿ° “¢“«‘™“°“√·æ∑¬å ∫”√ÿß√“…Æ√å®÷ß‡ªìπ‚√ßæ¬“∫“≈∑’Ë √â“ß§«“¡·µ°µà“ß ‚¥¬‡πâπ∫√‘°“√∑’Ë¡’§ÿ≥¿“æ∑’Ë‡ªìπ‡≈‘»·≈– §≥–·æ∑¬åº‡Ÿâ ™’¬Ë «™“≠‡©æ“–∑“ß∑’§Ë √Õ∫§≈ÿ¡„π∑ÿ°Ê¥â“π...‡æ◊ÕË ºŸªâ «É ¬¢Õß‡√“ ·µà≈–∑à“π

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

Annual Report 2005

Our Specialty is You Bumrungrad Internationalâ&#x20AC;&#x2122;s new marketing campaign emphasizes our core strength â&#x20AC;&#x201C; patient centered specialty care. With over 700 internationally trained specialists in all fields of medicine, Bumrungrad International differentiates itself by delivering high quality, integrated specialty careâ&#x20AC;Śone patient at a time.

Bumrungrad Hospital Public Company Limited

Annual Report 2005

æ◊πÈ ∑’ Ë ”À√—∫°“√‡µ‘∫‚µ ¥â«¬Õ“§“√„À¡à´ß÷Ë ¡’æπ◊È ∑’√Ë «¡°«à“ 25,000 µ“√“ß‡¡µ√ ∫”√ÿß√“…Æ√å Õ‘π‡µÕ√å‡π™—πË ·π≈ ®–¢¬“¬æ◊πÈ ∑’Ë„Àâ∫√‘°“√ ºŸâªÉ«¬πÕ°¢Õß‚√ßæ¬“∫“≈„Àâ “¡“√∂√Õß√—∫ºŸâªÉ«¬πÕ°‰¥â∂÷ß 5,500 §πµàÕ«—π ´÷Ëß®–∑”„Àâ∫”√ÿß√“…Æ√å Õ‘π‡µÕ√å‡π™—πË ·π≈ ‡ªìπÀπ÷ßË „π‚√ßæ¬“∫“≈∑’Ë¡§’ ≈’π§‘ ºŸªâ «É ¬πÕ°∑’Ë„À≠à∑ ’Ë ¥ÿ „π‚≈° °“√ÕÕ°·∫∫∑’ Ë «¬ß“¡ ◊ÕË ∂÷ß æ◊πÈ ∑’∑Ë °’Ë «â“ß¢«“ß ·≈–§«“¡ –¥«° ∫“¬ ·≈–®–‡ªìπ°“√æ—≤π“ª√—∫‡ª≈’¬Ë πª√– ∫°“√≥å„π‚√ßæ¬“∫“≈„Àâ¥¬’ ß‘Ë ¢÷πÈ ·°à§π‰¢â¢Õß‡√“

Room to Grow Bumrungrad International’s new 25,000 sq. meter outpatient clinic will expand total outpatient capacity to 5,500 patients per day, making Bumrungrad International one of the largest outpatient clinics in the world. The striking new design communicates spaciousness and comfort, and re-defines the hospital experience for our patients.

Bumrungrad Hospital Public Company Limited

Annual Report 2005

°“√¢¬“¬‡§√◊Õ¢à“¬„πµà“ßª√–‡∑» °≈¬ÿ∑∏å „π°“√¢¬“¬∏ÿ√°‘®¢Õß∫”√ÿß√“…Æ√å Õ‘π‡µÕ√å‡π™—Ëπ·π≈ ®–¡ÿàßæ—≤π“‡§√◊Õ¢à“¬‚√ßæ¬“∫“≈„π¿Ÿ¡‘¿“§ ‚¥¬‡πâπµ≈“¥∑’¡Ë °’ “√‡µ‘∫‚µ¢Õß§«“¡µâÕß°“√∫√‘°“√∑“ß°“√·æ∑¬å∑’Ë ßŸ ∑’ Ë ÿ¥„π‚≈° ‚§√ß°“√‚√ßæ¬“∫“≈„À¡à„π ª√–‡∑»¥Ÿ‰∫¢Õß∫”√ÿß√“…Æ√å™à«¬ √â“ß§«“¡ ¡∫Ÿ√≥å¢Õß‡§√◊Õ¢à“¬¢Õß‡√“À≈—ß®“°∑’Ë‰¥â‡¢â“´◊ÈÕ‚√ßæ¬“∫“≈‡Õ‡™’¬π ŒÕ ªîµÕ≈ „π°√ÿß¡–π‘≈“‡¡◊ÕË °àÕπÀπâ“π’È ·≈–®–™à«¬ √â“ß∞“π„π°“√‡æ‘¡Ë §«“¡À≈“°À≈“¬·≈–‡µ‘∫‚µ¢Õß‡§√◊Õ ¢à“¬∫”√ÿß√“…Ø√å„πÕπ“§µ

Spreading our Wings Bumrungrad International’s expansion strategy involves developing a regional network of hospitals in some of the world’s fastest growing healthcare markets. Bumrungrad’s new hospital project in Dubai complements our earlier acquisition of Asian Hospital in Manila and paves the way for future diversification and growth.

Bumrungrad Hospital Public Company Limited

Annual Report 2005

‚√ßæ¬“∫“≈∑’∑Ë «—Ë ‚≈°¡“‡æ◊ÕË °“√√—°…“ ÿ¢¿“æ ∫”√ÿß√“…Æ√å Õ‘π‡µÕ√å‡π™—Ëπ·π≈ ‡ªìπºŸ∫â °ÿ ‡∫‘°°“√∑àÕß‡∑’¬Ë «‡æ◊ËÕ√—°…“æ¬“∫“≈ (Medical Tourism) ·≈–ªí®®ÿ∫π— ‡√“‰¥â√°— …“§π‰¢â™“«µà“ß™“µ‘°«à“ 400,000 §π®“° 190 ª√–‡∑»„π·µà≈–ªï ´÷ßË ∑”„Àâ‡√“‡ªìπ®ÿ¥À¡“¬ª≈“¬∑“ß Õ—π¥—∫Àπ÷Ëß„π‚≈°¢Õß°“√∑àÕß‡∑’Ë¬«‡æ◊ËÕ√—°…“æ¬“∫“≈ Ÿµ√·Ààß§«“¡ ”‡√Á®¢Õß‡√“ßà“¬·≈–™—¥‡®π §◊Õ °“√ „Àâ∫√‘°“√∑“ß°“√·æ∑¬å∑’Ë‰¥â¡“µ√∞“π “°≈ Õ¬à“ß§ÿ¡â √“§“ ¥â«¬¡◊ÕÕ“™’æ∑’‡Ë ™◊ËÕ∂◊Õ‰¥â „π ‘ßË ·«¥≈âÕ¡√–¥—∫Àâ“¥“« ‚¥¬∫√‘°“√∑’√Ë «¥‡√Á«‰¡àµÕâ ß√Õ

Where the World Comes for Healthcare Bumrungrad International pioneered medical tourism and now treats 400,000 international patients from 190 countries annually, making us the world’s number one medical tourism destination. Our formula is simple: deliver world class, affordable healthcare by trusted professionals in a five-star setting with no waiting.

Bumrungrad Hospital Public Company Limited

Annual Report 2005

°“√ √â“ß™◊ËÕ ç∫”√ÿß√“…Æ√åé „Àâ‡ªìπ∑’Ë√Ÿâ®—°·≈–‡™◊ËÕ¡—Ëπ√–¥—∫‚≈° ∫”√ÿß√“…Æ√å Õ‘π‡µÕ√å‡π™—πË ·π≈ ‡ªìπ™◊ÕË ∑’‡Ë ªìπ∑’√Ë ®Ÿâ °— „π·«¥«ß°“√√—°…“æ¬“∫“≈Õ¬à“ß√«¥‡√Á« ∫√‘…∑— ‡∑§‚π‚≈¬’ ™—πÈ π”¢Õß‚≈° §◊Õ Õ‘π‡∑≈ §Õ√åªªÕ‡√™—πË ·Ààß À√—∞Õ‡¡√‘°“ ‰¥â„Àâ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å‡ªìπµ—«Õ¬à“ß°“√ ‡ªìπºŸ â √â“ß √√§å π«—µ°√√¡„π¥â“π°“√√—°…“æ¬“∫“≈„π°“√‚¶…≥“∑—«Ë ‚≈°¢Õß Õ‘π‡∑≈ ¬‘ßË °«à“π—πÈ §π¥ŸÀ≈“¬ ≈â“π§π∑—«Ë ‚≈°‰¥â‡ÀÁπ§«“¡‡ªìπºŸπâ ”¥â“π°“√√—°…“æ¬“∫“≈√–¥—∫ “°≈¢Õß∫”√ÿß√“…Æ√å „π√“¬°“√ "60 Minutes" ´÷ßË ‡ªìπ√“¬°“√∑’Ë‰¥â√∫— §«“¡π‘¬¡Õ¬à“ß Ÿß¢Õß ∂“π’ ‚∑√∑—»πå CBS

Brand Building Bumrungrad International is fast becoming one of the most recognized names in healthcare. Intel Corporation showcased Bumrungrad as a healthcare innovator in its worldwide advertising campaign, and millions of viewers around the world tuned in to watch Bumrungrad featured on CBS’ award winning program 60 Minutes.

Bumrungrad Hospital Public Company Limited

¢âÕ¡Ÿ≈∑“ß°“√‡ß‘π

√“¬ß“πª√–®”ªï 2548

¢âÕ¡Ÿ≈∑“ß°“√‡ß‘π‚¥¬ √ÿª º≈°“√¥”‡π‘π°“√√«¡ (æ—π∫“∑) ‘π∑√—æ¬åÀ¡ÿπ‡«’¬π√«¡ ‘π∑√—æ¬å√«¡ Àπ’ È π‘ À¡ÿπ‡«’¬π√«¡ Àπ’ È π‘ √«¡ à«π¢ÕßºŸ∂â Õ◊ Àÿπâ √“¬‰¥â√«¡ °”‰√ ÿ∑∏‘ ”À√—∫ªï °”‰√µàÕÀÿπâ ¢—πÈ æ◊πÈ ∞“π °”‰√µàÕÀÿπâ ª√—∫≈¥ ¡Ÿ≈§à“µ“¡∫—≠™’¢—Èπæ◊Èπ∞“π ¡Ÿ≈§à“µ“¡∫—≠™’ª√—∫≈¥ ‡ß‘πªíπº≈µàÕÀÿπâ Õ—µ√“ à«π∑“ß°“√‡ß‘π Õ—µ√“ à«π ¿“æ§≈àÕß (‡∑à“) √–¬–‡«≈“‡°Á∫Àπ’‡È ©≈’¬Ë («—π) √–¬–‡«≈“¢“¬ ‘π§â“‡©≈’¬Ë («—π) √–¬–‡«≈“™”√–Àπ’È («—π) Õ—µ√“°”‰√¢—πÈ µâπ (%) Õ—µ√“°”‰√°àÕπÀ—°¥Õ°‡∫’¬È ¿“…’ §à“‡ ◊ÕË ¡√“§“ ·≈–§à“µ—¥®”Àπà“¬ (EBITDA Margin) Õ—µ√“°”‰√ ÿ∑∏‘ (%) Õ—µ√“ à«π°“√‡µ‘∫‚µ¢Õß√“¬‰¥â®“°°‘®°“√‚√ßæ¬“∫“≈ (%) Õ—µ√“ à«π°“√‡µ‘∫‚µ¢Õß°”‰√ ÿ∑∏‘ (%) Õ—µ√“º≈µÕ∫·∑π®“° ‘π∑√—æ¬å (%) Õ—µ√“ à«πÀπ’ È ‘πµàÕ à«π¢ÕßºŸ∂â Õ◊ Àÿπâ (‡∑à“) Õ—µ√“§«“¡ “¡“√∂™”√–¥Õ°‡∫’¬È (‡∑à“) Õ—µ√“§«“¡ “¡“√∂™”√–¿“√–ºŸ°æ—π (Cash Basis) (‡∑à“)

2548

2547

2546

1,103,842 5,727,518 1,580,758 3,031,729 2,695,789 6,806,775 1,052,739 1.45 1.21 3.59 3.01 0.75

1,503,740 5,021,086 1,181,395 2,960,888 2,060,198 5,809,299 934,547 1.36 1.08 3.00 2.39 0.70

1,635,878 4,456,285 824,743 3,196,780 1,259,505 4,620,311 666,488 1.34 0.78 2.48 1.44 -

0.70 13.99 11.04 38.98 37.6%

1.27 16.36 9.73 39.88 35.6%

1.98 16.34 10.04 41.49 34.6%

24.5% 15.5% 16.9% 12.6% 19.6% 1.16 12.94 3.72

23.4% 16.1% 26.6% 40.2% 19.7% 1.44 9.54 3.03

22.3% 14.4% 25.4% 194.5% 16.6% 2.58 6.66 5.47

* °”‰√µàÕÀÿπâ ¢—Èπæ◊πÈ ∞“π·≈–°”‰√µàÕÀÿπâ ª√—∫≈¥ ”À√—∫ªï π‘È ÿ¥ 31 ∏—π«“§¡ 2546 ‰¥âª√—∫ª√ÿß∂◊Õ‡ ¡◊Õπ«à“°“√·µ°Àÿπâ ‰¥â‡°‘¥¢÷πÈ µ—ßÈ ·µà«π— ‡√‘¡Ë µâπ¢Õßß«¥∑’‡Ë πÕ√“¬ß“π

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

§”Õ∏‘∫“¬·≈–°“√«‘‡§√“–Àå∞“π–°“√‡ß‘π·≈–º≈°“√¥”‡π‘πß“π 1. √“¬‰¥â·≈–§à“„™â®“à ¬ ∫√‘…∑— œ ¡’√“¬‰¥â√«¡ 6,807 ≈â“π∫“∑„πªï 2548 ‡æ‘¡Ë ¢÷πÈ ®“°ªï 2547 ®”π«π 998 ≈â“π∫“∑ §‘¥‡ªìπ√âÕ¬≈– 17 (‰¡à√«¡√“¬‰¥â®“°√“¬°“√ æ‘‡»…®”π«π 64 ≈â“π∫“∑„πªï 2547) ‡π◊ÕË ß®“°°“√‡µ‘∫‚µÕ¬à“ßµàÕ‡π◊ÕË ß¢Õß°‘®°“√‚√ßæ¬“∫“≈„πªï 2548 ‚¥¬¡’√“¬‰¥â‡æ‘¡Ë ¢÷πÈ ®“°ºŸªâ «É ¬„π „πÕ—µ√“√âÕ¬≈– 13 ·≈– ºŸªâ «É ¬πÕ°„πÕ—µ√“√âÕ¬≈– 17 ”À√—∫ªï 2548 ∫√‘…—∑œ ¡’§à“„™â®“à ¬ 5,760 ≈â“π∫“∑ ‡æ‘¡Ë ¢÷πÈ ®“°ªï 2547 ®”π«π 829 ≈â“π∫“∑ §‘¥‡ªìπ√âÕ¬≈– 17 ´÷ßË ‡ªìπ‰ªµ“¡°“√ ¢¬“¬µ—«¢Õß∏ÿ√°‘®‚√ßæ¬“∫“≈ µâπ∑ÿπ°‘®°“√‚√ßæ¬“∫“≈·≈–§à“„™â®à“¬„π°“√∫√‘À“√Õ¬Ÿà„πÕ—µ√“∑’Ë Õ¥§≈âÕß°—∫√“¬‰¥â∑’Ë‡æ‘Ë¡¡“°¢÷Èπ „πªï 2548 ∫√‘…∑— œ¡’¿“…’‡ß‘π‰¥âπµ‘ ‘∫§ÿ §≈‡æ‘Ë¡¢÷πÈ 89 ≈â“π∫“∑ §‘¥‡ªìπ√âÕ¬≈– 69 ‡π◊ËÕß®“°∫√‘…∑— œ‰¥â„™âº≈¢“¥∑ÿπ∑“ß¿“…’®“°ªï°Õà πÊÀ¡¥·≈â« ·≈–‡√‘¡Ë ®à“¬¿“…’„πªï 2548 2. °”‰√ ÿ∑∏‘·≈–√“¬°“√æ‘‡»… ∫√‘…∑— œ ¡’°”‰√ ÿ∑∏‘„πªï 2548 ®”π«π 1,053 ≈â“π∫“∑ ‡æ‘¡Ë ¢÷πÈ √âÕ¬≈– 21 ®“°°”‰√ ÿ∑∏‘ 871 ≈â“π∫“∑„πªï 2547 (‰¡à√«¡√“¬‰¥â®“° √“¬°“√æ‘‡»…®”π«π 64 ≈â“π∫“∑„πªï 2547) ‡π◊ÕË ß®“°√“¬‰¥â¢Õß°‘®°“√‚√ßæ¬“∫“≈∑’‡Ë æ‘¡Ë ¢÷πÈ Õ¬à“ßµàÕ‡π◊ÕË ß ∫√‘…∑— œ¡’°”‰√µàÕÀÿπâ ¢—πÈ æ◊πÈ ∞“π ‡∑à“°—∫ 1.45 ∫“∑µàÕÀÿâπ ‡æ‘¡Ë ¢÷πÈ √âÕ¬≈– 14 ®“° 1.27 ∫“∑µàÕÀÿπâ „πªï 2547 (‰¡à√«¡√“¬°“√æ‘‡»…) ‡™àπ‡¥’¬«°—π °”‰√µàÕÀÿπâ ·∫∫ª√—∫≈¥ ‡æ‘¡Ë √âÕ¬≈– 20 ®“° 1.01 ∫“∑µàÕÀÿπâ „πªï 2547 ‡ªìπ 1.21 ∫“∑µàÕÀÿπâ „πªï 2548 „πªï 2547 ∫√‘…∑— œ¡’°”‰√®“°°“√∑’∫Ë √‘…∑— °√ÿß‡∑æª√–°—π¿—¬ ®”°—¥ (¡À“™π) ·ª≈ß ¿“æÀÿπâ °Ÿ‡â ªìπÀÿπâ “¡—≠®”π«π 64 ≈â“π∫“∑ ®“°¥Õ° ‡∫’¬È §â“ß®à“¬‡µÁ¡®”π«π∑—ßÈ 12 ªï¢ÕßÀÿπâ °Ÿ®â ”π«π 96 ≈â“π∫“∑ ∫√‘…∑— œ‰¥â∑”°“√∫—π∑÷°¥Õ°‡∫’¬È Àÿπâ °Ÿ§â “â ß®à“¬ ´÷ßË §ß‡À≈◊ÕÕ¬Ÿ®à ”π«π 64 ≈â“π∫“∑‡ªìπ°”‰√®“°°“√·ª≈ß ¿“æÀÿπâ °Ÿâ ‡¡◊ÕË ∫√‘…∑— °√ÿß‡∑æª√–°—π¿—¬ ®”°—¥ (¡À“™π) ºŸ∂â Õ◊ Àÿπâ °Ÿâ ‰¥â„™â ∑‘ ∏‘·ª≈ß ¿“æÀÿπâ °Ÿ‡â ªìπÀÿπâ “¡—≠„π«—π∑’Ë 25 ‘ßÀ“§¡ 2547 ‚¥¬∑’√Ë “¬°“√¥—ß°≈à“«· ¥ß‡ªìπ√“¬°“√æ‘‡»…„πß∫°”‰√¢“¥∑ÿπ„πªï 2547

2548 √“¬‰¥â√«¡ °”‰√¢—πÈ µâπ °”‰√°àÕπ√“¬°“√æ‘‡»… √“¬°“√æ‘‡»… °”‰√ ÿ∑∏‘

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

6,807 2,501 1,053 1,053

(Àπà«¬: ≈â“π∫“∑) 2547 5,809 2,020 870 64 935

√“¬ß“πª√–®”ªï 2548

3. ß∫¥ÿ≈ ≥ «—π∑’Ë 31 ∏—π«“§¡ 2548 ∫√‘…—∑œ ¡’ ‘π∑√—æ¬å√«¡ 5,728 ≈â“π∫“∑ ‡æ‘¡Ë ¢÷πÈ ®“° 5,021 ≈â“π∫“∑ ≥ «—π∑’Ë 31 ∏—π«“§¡ 2547 ´÷ßË ‡ªìπº≈ ®“°°“√‡æ‘¡Ë ¢÷πÈ ¢Õß∑’¥Ë π‘ Õ“§“√·≈–Õÿª°√≥å ®“°°“√ √â“ßÕ“§“√‚√ßæ¬“∫“≈„À¡à ·≈–°“√≈ß∑ÿπ„π∫√‘…∑— ‡Õ‡™’¬π ŒÕ æ‘∑Õ≈ Õ‘ß§å„π ª√–‡∑»øî≈ª‘ ªîπ å à«πÕ—µ√“ à«πÀπ’ È π‘ ÿ∑∏‘µÕà ∑ÿπ (Net debt to equity) ≥ «—π∑’Ë 31 ∏—π«“§¡ 2548 Õ¬Ÿà„π√–¥—∫∑’Ë„°≈â‡§’¬ß°—∫ªï∑º’Ë “à π¡“ ∑’Ë 0.37 ‡∑à“ à«πºŸ∂â Õ◊ Àÿπâ ≥ «—π∑’Ë 31 ∏—π«“§¡ 2548 Õ¬Ÿà∑’Ë 2,615 ≈â“π∫“∑ ‡æ‘¡Ë ¢÷Èπ®“° 2,060 ≈â“π∫“∑ ≥ «—π∑’Ë 31 ∏—π«“§¡ 2547 ®“° °”‰√ ÿ∑∏‘¢Õßªï 2548 à«πÀπ’ È π‘ ¢Õß∫√‘…∑— ≥ «—π∑’Ë 31 ∏—π«“§¡ 2548 ‡∑à“°—∫ 3,032 ≈â“π∫“∑ „°≈â‡§’¬ß°—∫ 2,960 ≈â“π∫“∑ „πªï 2547 4. ¿“æ§≈àÕß ∫√‘…∑— œ¡’°√–· ‡ß‘π ¥®“°°‘®°√√¡¥”‡π‘πß“π ®”π«π 1,513 ≈â“π∫“∑ „πªï 2548 ‡∑’¬∫°—∫ 1,238 ≈â“π∫“∑„πªï 2547 °“√‡æ‘¡Ë ¢÷πÈ ¥—ß°≈à“« ‡π◊ÕË ß¡“®“°º≈°”‰√°àÕπÀ—°¿“…’∑¥’Ë ¢’ π÷È ¢Õß∫√‘…∑— œ °√–· ‡ß‘π ¥„™â‰ª„π°‘®°√√¡≈ß∑ÿπ≈¥≈ß‡ªìπ 859 ≈â“π∫“∑ „πªï 2548 ®“° 1,268 ≈â“π∫“∑ „πªï 2547 ‡π◊ÕË ß®“°°“√≈¥≈ß¢Õß‡ß‘πΩ“° ∂“∫—π°“√‡ß‘π´÷ßË ∂÷ß°”Àπ¥®à“¬§◊π‡°‘π°«à“ 3 ‡¥◊Õπ ‡ß‘π ¥ ÿ∑∏‘„™â‰ª„π°‘®°√√¡®—¥À“ ‡ß‘π‡æ‘¡Ë ¢÷πÈ ‡ªìπ 857 ≈â“π∫“∑ „πªï 2548 ®“° 273 ≈â“π∫“∑„πªï 2547 ‡π◊ÕË ß®“°∫√‘…∑— œ¡’°“√™”√–§◊π‡ß‘π°Ÿâ·≈–®à“¬‡ß‘πªíπº≈„π ªï 2548 ‡ªìπº≈„Àâ∫√‘…—∑¡’‡ß‘π ¥·≈–√“¬°“√‡∑’¬∫‡∑à“‡ß‘π ¥ª≈“¬ªï≈¥≈ß‡ªìπ 544 ≈â“π∫“∑„πªï 2548 ®“° 723 ≈â“π∫“∑„πªï 2547 Õ—µ√“ à«π ¿“æ§≈àÕßÕ¬Ÿ∑à ’Ë√–¥—∫ 0.70 ‡∑à“„πªï 2548 ‡∑’¬∫°—∫ 1.27 ‡∑à“„πªï 2547 ‡π◊ËÕß®“°°“√≈¥≈ß¢Õß‡ß‘π ¥·≈–‡ß‘π≈ß∑ÿπ™—«Ë §√“« „π¢≥–∑’ÀË π’È π‘ À¡ÿπ‡«’¬π‡æ‘Ë¡¢÷πÈ ®“°¿“…’‡ß‘π‰¥âπµ‘ ∫‘ ÿ§§≈§â“ß®à“¬∑’‡Ë æ‘¡Ë ¢÷Èπ ¥—ßπ—πÈ Õ—µ√“ à«π ¿“æ§≈àÕßÀ¡ÿπ‡√Á« ®÷ß≈¥≈ß‡™àπ°—π ‡ªìπ 0.65 ‡∑à“„πªï 2548 ®“° 1.15 ‡∑à“„πªï 2547

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

√“¬ß“π¢Õß§≥–°√√¡°“√µ√«® Õ∫ ‡√’¬π ∑à“πºŸ∂â Õ◊ Àÿπâ ∫√‘…∑— ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å®”°—¥ (¡À“™π) ‡¡◊ÕË «—π∑’Ë 28 °ÿ¡¿“æ—π∏å 2548 §≥–°√√¡°“√µ√«® Õ∫´÷ßË §√∫«“√–°“√¥”√ßµ”·Àπàß ‰¥â√∫— °“√·µàßµ—ßÈ ‚¥¬¡µ‘∑ª’Ë √–™ÿ¡§≥–°√√¡°“√∫√‘…∑— ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π) „Àâ°≈—∫‡¢â“¥”√ßµ”·ÀπàßµàÕ‰ªÕ’°«“√–Àπ÷ßË ¡’√–¬–‡«≈“ 3 ªï §◊Õ æ.». 2548 - 2550 §≥– °√√¡°“√µ√«® Õ∫ ª√–°Õ∫¥â«¬°√√¡°“√∫√‘…∑— ∑’‡Ë ªìπÕ‘ √–®“°°“√∫√‘À“√ß“π ‰¥â·°à π“ß “« ‚ ¿“«¥’ Õÿµµ‚¡∫≈ ‡ªìπª√–∏“π°√√¡°“√ µ√«® Õ∫ π“¬∫ÿ≠ª°√≥å ‚™§«—≤π“ ·≈–π“¬ √¥‘… «‘≠≠√—µπå ‡ªìπ°√√¡°“√µ√«® Õ∫ „πªï æ.». 2548 §≥–°√√¡°“√µ√«® Õ∫ ¡’°“√ª√–™ÿ¡ ∑—ßÈ À¡¥ 4 §√—ßÈ ‡æ◊ËÕ¥”‡π‘πß“πµ“¡§«“¡√—∫º‘¥™Õ∫∑’Ë‰¥â√∫— ¡Õ∫À¡“¬ ‚¥¬¡’ ª√–‡¥Áπ∑’‡Ë ªìπ “√– ”§—≠§◊Õ 1. Õ∫∑“πß∫°“√‡ß‘π¢Õß∫√‘…—∑·≈–∫√‘…—∑¬àÕ¬°àÕππ”‡ πÕµàÕ§≥–°√√¡°“√∫√‘…—∑ ®“°°“√ Õ∫∑“π·≈–øíß§”™’È·®ß®“°ºŸâµ√«® Õ∫∫—≠™’·≈–ΩÉ“¬∫√‘À“√ §≥–°√√¡°“√µ√«® Õ∫¡’§«“¡‡ÀÁπ«à“ ‡™◊ËÕ‰¥â«“à ß∫°“√‡ß‘π¥—ß°≈à“«‰¥â®¥— ∑”‚¥¬¡’°“√‡ªî¥‡º¬¢âÕ¡Ÿ≈∑’Ë ”§—≠Õ¬à“ß∂Ÿ°µâÕß·≈–‡æ’¬ßæÕ 2. æ‘®“√≥“‡ πÕ·π–°“√·µàßµ—ÈßºŸâ Õ∫∫—≠™’·≈–§à“µ√«® Õ∫∫—≠™’ª√–®”ªïµàÕ§≥–°√√¡°“√∫√‘…—∑ ‡æ◊ËÕ‡ πÕµàÕ∑’ªË √–™ÿ¡ºŸ∂â Õ◊ Àÿπâ æ‘®“√≥“Õπÿ¡µ— ‘ 3. æ‘®“√≥“·≈–√—∫øíß§”™’È·®ß√“¬ß“πº≈°“√µ√«® Õ∫¿“¬„π®“°ºŸâµ√«® Õ∫¿“¬„π¢Õß∫√‘…—∑ ‡°’Ë¬«°—∫ª√– ‘∑∏‘¿“æ·≈–§«“¡ ‡æ’¬ßæÕ„π°“√ª√–‡¡‘π§«“¡‡ ’Ë¬ß¢Õß·µà≈–Àπà«¬ß“π¢Õß∫√‘…—∑ §≥–°√√¡°“√¡’§«“¡‡ÀÁπ«à“√–∫∫°“√§«∫§ÿ¡¿“¬„π¡’§«“¡ ‡À¡“– ¡·≈–‡æ’¬ßæÕ°—∫°“√ªÑÕß°—π§«“¡‡ ’¬Ë ß®“°°“√¥”‡π‘πß“π¢Õß∫√‘…∑— §≥–°√√¡°“√µ√«® Õ∫‰¥âªØ‘∫—µ‘Àπâ“∑’Ëµ“¡∑’Ë ‰¥â√—∫¡Õ∫À¡“¬¥â«¬§«“¡√–¡—¥√–«—ß·≈–Õ¬à“ß‡µÁ¡§«“¡ “¡“√∂ ‡æ◊ËÕª√–‚¬™πå¢Õß∫√‘…—∑ ºŸ∂â Õ◊ Àÿπâ ·≈–ºŸ¡â ’ «à π‰¥â‡ ’¬∑—ßÈ ª«ß

π“ß “«‚ ¿“«¥’ Õÿµµ‚¡∫≈ ª√–∏“π°√√¡°“√µ√«® Õ∫ «—π∑’Ë 3 ¡’π“§¡ 2549

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

√“¬ß“π§«“¡√—∫º‘¥™Õ∫¢Õß§≥–°√√¡°“√µàÕ√“¬ß“π°“√‡ß‘π §≥–°√√¡°“√∫√‘…∑— ‡ªìπºŸ√â ∫— º‘¥™Õ∫µàÕß∫°“√‡ß‘π√«¡¢Õß∫√‘…∑— ·≈–∫√‘…∑— ¬àÕ¬ ·≈– “√ π‡∑»∑’ªË √“°Ø„π√“¬ß“πª√–®”ªï ß∫°“√‡ß‘π¥—ß °≈à“«®–®—¥∑”¢÷πÈ µ“¡¡“µ√∞“π°“√∫—≠™’∑√’Ë ∫— √Õß∑—«Ë ‰ª‚¥¬‡≈◊Õ°„™âπ‚¬∫“¬°“√∫—≠™’∑‡’Ë À¡“– ¡·≈–∂◊ÕªØ‘∫µ— Õ‘ ¬à“ß ¡Ë”‡ ¡Õ ‚¥¬®—¥∑”¢÷πÈ Õ¬à“ß√–¡—¥√–«—ßµ≈Õ¥®πª√–‡¡‘π∂÷ß§«“¡‡À¡“– ¡¢Õß°“√· ¥ß√“¬°“√∑’Ëπ”‡ πÕ„πß∫°“√‡ß‘π‚¥¬√«¡ √«¡∑—Èß¡’°“√‡ªî¥‡º¬¢âÕ¡Ÿ≈Õ¬à“ß ‡æ’¬ßæÕ„πÀ¡“¬‡Àµÿª√–°Õ∫ß∫°“√‡ß‘π §≥–°√√¡°“√∫√‘…—∑‰¥â®—¥„Àâ¡’√–∫∫°“√§«∫§ÿ¡¿“¬„π∑’Ë¡’ª√– ‘∑∏‘¿“æ·≈–ª√– ‘∑∏‘º≈ ‡æ◊ËÕ„Àâ¡—Ëπ„®«à“¢âÕ¡Ÿ≈∑“ß∫—≠™’¡’°“√∫—π∑÷°Õ¬à“ß §√∫∂â«π ∂Ÿ°µâÕß ·≈–¡’√–∫∫°“√®—¥‡°Á∫√—°…“∑√—æ¬å π‘ ‡æ◊ÕË ªÑÕß°—π°“√∑ÿ®√‘µÀ√◊Õ‡ ’¬À“¬Õ¬à“ß¡’ “√– ”§—≠ §≥–°√√¡°“√¡’§«“¡‡ÀÁπ«à“ √–∫∫§«∫§ÿ¡¿“¬„π¢Õß∫√‘…∑— ‚¥¬√«¡Õ¬Ÿà„π√–¥—∫∑’πË “à æÕ„® ·≈– “¡“√∂ √â“ß§«“¡‡™◊ÕË ¡—πË µàÕ§«“¡‡™◊ÕË ∂◊Õ ‰¥â¢Õßß∫°“√‡ß‘π¢Õß∫√‘…∑— ·≈–∫√‘…∑— ¬àÕ¬ ≥ «—π∑’Ë 31 ∏—π«“§¡ 2548

π“¬™—¬ ‚ ¿≥æπ‘™ ª√–∏“π°√√¡°“√

π“ß≈‘π¥“ ≈’ À–ªí≠≠“ °√√¡°“√ºŸ®â ¥— °“√

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

√“¬ß“π¢ÕßºŸâ Õ∫∫—≠™’√—∫Õπÿ≠“µ ‡ πÕµàÕºŸ∂â Õ◊ Àÿπâ ·≈–§≥–°√√¡°“√¢Õß ∫√‘…∑— ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π) ¢â“æ‡®â“‰¥âµ√«® Õ∫ß∫¥ÿ≈√«¡ ≥ «—π∑’Ë 31 ∏—π«“§¡ 2548 ·≈– 2547 ß∫°”‰√¢“¥∑ÿπ√«¡ ß∫· ¥ß°“√‡ª≈’¬Ë π·ª≈ß à«π¢ÕßºŸ∂â Õ◊ Àÿπâ √«¡ ·≈–ß∫°√–· ‡ß‘π ¥√«¡ ”À√—∫ªï π‘È ÿ¥«—π‡¥’¬«°—π¢Õß·µà≈–ªï¢Õß∫√‘…∑— ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π) ·≈–∫√‘…∑— ¬àÕ¬ ·≈– ‰¥âµ√«® Õ∫ß∫°“√‡ß‘π‡©æ“–¢Õß∫√‘…∑— ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π) ¥â«¬‡™àπ°—π ´÷ßË ºŸ∫â √‘À“√¢Õß°‘®°“√‡ªìπºŸ√â ∫— º‘¥™Õ∫µàÕ §«“¡∂Ÿ°µâÕß·≈–§√∫∂â«π¢Õß¢âÕ¡Ÿ≈„πß∫°“√‡ß‘π‡À≈à“π’È à«π¢â“æ‡®â“‡ªìπºŸâ√—∫º‘¥™Õ∫„π°“√· ¥ß§«“¡‡ÀÁπµàÕß∫°“√‡ß‘π¥—ß°≈à“«®“°º≈ °“√µ√«® Õ∫¢Õß¢â“æ‡®â“ ¢â“æ‡®â“‰¥âªØ‘∫—µ‘ß“πµ√«® Õ∫µ“¡¡“µ√∞“π°“√ Õ∫∫—≠™’∑’Ë√—∫√Õß∑—Ë«‰ª ´÷Ëß°”Àπ¥„Àâ¢â“æ‡®â“µâÕß«“ß·ºπ·≈–ªØ‘∫—µ‘ß“π‡æ◊ËÕ„Àâ‰¥â§«“¡ ‡™◊ËÕ¡—ËπÕ¬à“ß¡’‡Àµÿº≈«à“ß∫°“√‡ß‘π· ¥ß¢âÕ¡Ÿ≈∑’Ë¢—¥µàÕ¢âÕ‡∑Á®®√‘ßÕ—π‡ªìπ “√– ”§—≠À√◊Õ‰¡à °“√µ√«® Õ∫√«¡∂÷ß°“√„™â«‘∏’°“√∑¥ Õ∫À≈—° ∞“πª√–°Õ∫√“¬°“√∑—Èß∑’Ë‡ªìπ®”π«π‡ß‘π·≈–°“√‡ªî¥‡º¬¢âÕ¡Ÿ≈„πß∫°“√‡ß‘π °“√ª√–‡¡‘π§«“¡‡À¡“– ¡¢ÕßÀ≈—°°“√∫—≠™’∑’Ë°‘®°“√„™â·≈– ª√–¡“≥°“√‡°’¬Ë «°—∫√“¬°“√∑“ß°“√‡ß‘π∑’‡Ë ªìπ “√– ”§—≠ ´÷ßË ºŸ∫â √‘À“√‡ªìπºŸ®â ¥— ∑”¢÷πÈ µ≈Õ¥®π°“√ª√–‡¡‘π∂÷ß§«“¡‡À¡“– ¡¢Õß°“√· ¥ß √“¬°“√∑’πË ”‡ πÕ„πß∫°“√‡ß‘π‚¥¬√«¡ ¢â“æ‡®â“‡™◊ÕË «à“°“√µ√«® Õ∫¥—ß°≈à“«„Àâ¢Õâ √ÿª∑’‡Ë ªìπ‡°≥±åÕ¬à“ß‡À¡“– ¡„π°“√· ¥ß§«“¡‡ÀÁπ¢Õß ¢â“æ‡®â“ ¢â“æ‡®â“‡ÀÁπ«à“ ß∫°“√‡ß‘π¢â“ßµâππ’È· ¥ß∞“π–°“√‡ß‘π ≥ «—π∑’Ë 31 ∏—π«“§¡ 2548 ·≈– 2547 º≈°“√¥”‡π‘πß“π·≈–°√–· ‡ß‘π ¥ ”À√—∫ ªï π‘È ÿ¥«—π‡¥’¬«°—π¢Õß·µà≈–ªï¢Õß∫√‘…∑— ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π) ·≈–∫√‘…∑— ¬àÕ¬·≈–‡©æ“–¢Õß∫√‘…∑— ‚√ßæ¬“∫“≈ ∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π) ‚¥¬∂Ÿ°µâÕßµ“¡∑’§Ë «√„π “√– ”§—≠µ“¡À≈—°°“√∫—≠™’∑√’Ë ∫— √Õß∑—«Ë ‰ª

ÿ¡“≈’ √’«√“∫—≥±‘µ ºŸ â Õ∫∫—≠™’√∫— Õπÿ≠“µ ‡≈¢∑–‡∫’¬π 3970

∫√‘…∑— ”π—°ß“π ‡Õ‘π å∑ ·Õπ¥å ¬—ß ®”°—¥ °√ÿß‡∑æœ: 28 °ÿ¡¿“æ—π∏å 2549

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

∫√‘…∑— ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π) ·≈–∫√‘…∑— ¬àÕ¬ ß∫¥ÿ≈ ≥ «—π∑’Ë 31 ∏—π«“§¡ 2548 ·≈– 2547

ß∫°“√‡ß‘π√«¡ À¡“¬‡Àµÿ ‘π∑√—æ¬å ‘π∑√—æ¬åÀ¡ÿπ‡«’¬π ‡ß‘π ¥·≈–√“¬°“√‡∑’¬∫‡∑à“‡ß‘π ¥ ‡ß‘π≈ß∑ÿπ™—«Ë §√“« - ‡ß‘πΩ“°ª√–®”°—∫ ∂“∫—π°“√‡ß‘π ≈Ÿ°Àπ’°È “√§â“ - ÿ∑∏‘ 5, 6 ‡ß‘π∑¥√Õß·°àæπ—°ß“π·≈–°√√¡°“√ ‡ß‘π„Àâ°¬Ÿâ ¡◊ √–¬– —πÈ ·≈–¥Õ°‡∫’¬È §â“ß√—∫ - °‘®°“√∑’‡Ë °’¬Ë «¢âÕß°—π 6 ‘π§â“§ß‡À≈◊Õ 7 §à“„™â®“à ¬®à“¬≈à«ßÀπâ“ ‘π∑√—æ¬åÀ¡ÿπ‡«’¬πÕ◊πË √«¡ ‘π∑√—æ¬åÀ¡ÿπ‡«’¬π ‘π∑√—æ¬å‰¡àÀ¡ÿπ‡«’¬π ‡ß‘πΩ“°ª√–®”°—∫ ∂“∫—π°“√‡ß‘π∑’πË ”‰ª§È”ª√–°—π 4 ‡ß‘π≈ß∑ÿπ´÷ßË ∫—π∑÷°‚¥¬«‘∏ ’ «à π‰¥â‡ ’¬ 8 ‡ß‘π≈ß∑ÿπ√–¬–¬“«Õ◊πË - ÿ∑∏‘ 9 ‡ß‘π„Àâ°¬Ÿâ ¡◊ √–¬–¬“«·≈–¥Õ°‡∫’¬È §â“ß√—∫ - °‘®°“√∑’‡Ë °’¬Ë «¢âÕß°—π 6 ∑’¥Ë π‘ Õ“§“√·≈–Õÿª°√≥å - ÿ∑∏‘ 10 ‘π∑√—æ¬å‰¡à¡µ’ «— µπ - ÿ∑∏‘ 11 ‘π∑√—æ¬å‰¡àÀ¡ÿπ‡«’¬πÕ◊πË √«¡ ‘π∑√—æ¬å‰¡àÀ¡ÿπ‡«’¬π √«¡ ‘π∑√—æ¬å

2548

2547

(Àπà«¬: ∫“∑) ß∫°“√‡ß‘π‡©æ“–∫√‘…∑— œ 2548 2547

523,506,119 20,000,000 339,475,021 10,014,019 1,383,764 149,895,896 49,969,718 9,597,054 1,103,841,591

652,881,941 470,000,000 234,958,035 5,533,291 430,028 104,451,057 30,277,597 5,208,217 1,503,740,166

362,385,685 20,000,000 314,651,484 9,523,442 21,039,663 147,181,909 26,073,426 1,245,248 902,100,857

516,300,167 233,885,989 5,436,879 25,172,581 102,027,734 29,378,850 765,330 912,967,530

229,883,845 481,415,370 2,047,213 3,269,654,875 624,219,061 16,456,303 4,623,676,667 5,727,518,258

229,827,772 209,354 2,047,213 2,801,618,198 476,127,798 7,515,561 3,517,345,896 5,021,086,062

221,250,972 1,492,256,552 2,047,213 22,603,851 2,153,355,063 692,026,413 19,456,303 4,602,996,367 5,505,097,224

221,250,880 885,171,148 2,047,213 25,022,369 1,618,024,805 661,016,711 7,515,561 3,420,048,687 4,333,016,217

À¡“¬‡Àµÿª√–°Õ∫ß∫°“√‡ß‘π‡ªìπ à«πÀπ÷ßË ¢Õßß∫°“√‡ß‘ππ’È

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

∫√‘…∑— ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π) ·≈–∫√‘…∑— ¬àÕ¬ ß∫¥ÿ≈ (µàÕ) ≥ «—π∑’Ë 31 ∏—π«“§¡ 2548 ·≈– 2547

À¡“¬‡Àµÿ Àπ’ È π‘ ·≈– à«π¢ÕßºŸ∂â Õ◊ Àÿπâ Àπ’ È π‘ À¡ÿπ‡«’¬π ‡®â“Àπ’°È “√§â“ ‡ß‘π°Ÿ¬â ¡◊ √–¬–¬“«∑’∂Ë ß÷ °”Àπ¥™”√–¿“¬„πÀπ÷ßË ªï ‡ß‘π°Ÿ¬â ¡◊ √–¬– —πÈ ·≈–¥Õ°‡∫’¬È §â“ß®à“¬ - °‘®°“√∑’‡Ë °’¬Ë «¢âÕß°—π §à“∏√√¡‡π’¬¡·æ∑¬å§“â ß®à“¬ ¥Õ°‡∫’¬È §â“ß®à“¬ ¥Õ°‡∫’¬È §â“ß®à“¬ - Àÿπâ °Ÿ·â ª≈ß ¿“æ∑’Ë∂Õ◊ ‡ªìπµ√“ “√∑ÿπ ¿“…’‡ß‘π‰¥âπµ‘ ∫‘ §ÿ §≈§â“ß®à“¬ §à“„™â®“à ¬§â“ß®à“¬ ‡®â“Àπ’ÕÈ π◊Ë √“¬‰¥â√∫— ≈à«ßÀπâ“ Àπ’ È π‘ À¡ÿπ‡«’¬πÕ◊πË √«¡Àπ’ È π‘ À¡ÿπ‡«’¬π Àπ’ È π‘ ‰¡àÀ¡ÿπ‡«’¬π ‡ß‘π°Ÿ¬â ¡◊ √–¬–¬“« §à“‡º◊ÕË º≈¢“¥∑ÿπ∑’‡Ë °‘π°«à“‡ß‘π≈ß∑ÿπ„π∫√‘…∑— ¬àÕ¬ √«¡Àπ’ È π‘ ‰¡àÀ¡ÿπ‡«’¬π √«¡Àπ’ È π‘

À¡“¬‡Àµÿª√–°Õ∫ß∫°“√‡ß‘π‡ªìπ à«πÀπ÷ßË ¢Õßß∫°“√‡ß‘ππ’È

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

12 6

6 6

12 8

ß∫°“√‡ß‘π√«¡ 2548

2547

(Àπà«¬: ∫“∑) ß∫°“√‡ß‘π‡©æ“–∫√‘…∑— œ 2548 2547

484,362,198 328,521,802 213,240,714 585,039 6,232,877 205,622,400 203,357,059 71,126,079 34,131,272 33,578,559 1,580,757,999

413,412,878 482,523,293 328,521,802 1,704,315,348 167,001,668 213,049,372 6,232,877 6,232,877 60,893,372 204,543,949 136,153,589 171,015,278 47,862,449 67,173,381 21,316,501 32,445,898 1,181,395,136 2,881,299,396

412,139,998 1,470,826,509 166,377,045 6,232,877 134,068,672 40,064,828 19,994,446 2,249,704,375

1,450,971,293 1,450,971,293 3,031,729,292

1,779,493,095 8,561,836 1,779,493,095 8,561,836 2,960,888,231 2,889,861,232

23,114,011 23,114,011 2,272,818,386

√“¬ß“πª√–®”ªï 2548

2548

2547

(Àπà«¬: ∫“∑) ß∫°“√‡ß‘π‡©æ“–∫√‘…∑— œ 2548 2547

920,341,835

920,009,835

920,341,835

920,009,835

2,360,850

2,692,850

2,360,850

2,692,850

727,691,372

727,359,372

727,691,372

727,359,372

2,360,850 285,568,300 30,828,437 550,000,000 (192,661,558)

2,692,850 285,568,300 550,000,000 (192,661,558)

2,360,850 285,568,300 30,828,437 550,000,000 (192,661,558)

2,692,850 285,568,300 550,000,000 (192,661,558)

92,275,000 1,119,173,591 2,615,235,992 80,552,974 2,695,788,966 5,727,518,258

46,500,000 640,738,867 2,060,197,831 2,060,197,831 5,021,086,062

92,275,000 1,119,173,591 2,615,235,992 2,615,235,992 5,505,097,224

46,500,000 640,738,867 2,060,197,831 2,060,197,831 4,333,016,217

ß∫°“√‡ß‘π√«¡ À¡“¬‡Àµÿ à«π¢ÕßºŸ∂â Õ◊ Àÿπâ ∑ÿπ‡√◊ÕπÀÿâπ 14 ∑ÿπ®¥∑–‡∫’¬π Àÿπâ “¡—≠ 920,341,835 Àÿâπ ¡Ÿ≈§à“Àÿπâ ≈– 1 ∫“∑ (2547: Àÿπâ “¡—≠ 920,009,835 Àÿπâ ¡Ÿ≈§à“Àÿπâ ≈– 1 ∫“∑) Àÿπâ ∫ÿ√¡‘ ‘∑∏‘ 2,360,850 Àÿâπ ¡Ÿ≈§à“Àÿπâ ≈– 1 ∫“∑ (2547: Àÿπâ ∫ÿ√¡‘ ‘∑∏‘ 2,692,850 Àÿπâ ¡Ÿ≈§à“Àÿπâ ≈– 1 ∫“∑) ∑ÿπ∑’ÕË Õ°·≈–™”√–·≈â« Àÿπâ “¡—≠ 727,691,372 Àÿπâ ¡Ÿ≈§à“Àÿâπ≈– 1 ∫“∑ (2547: Àÿπâ “¡—≠ 727,359,372 Àÿπâ ¡Ÿ≈§à“Àÿπâ ≈– 1 ∫“∑) Àÿπâ ∫ÿ√‘¡ ‘∑∏‘ 2,360,850 Àÿπâ ¡Ÿ≈§à“Àÿâπ≈– 1 ∫“∑ (2547: Àÿπâ ∫ÿ√¡‘ ‘∑∏‘ 2,692,850 Àÿπâ ¡Ÿ≈§à“Àÿπâ ≈– 1 ∫“∑) à«π‡°‘π¡Ÿ≈§à“Àÿπâ “¡—≠ º≈µà“ß®“°°“√·ª≈ß§à“ß∫°“√‡ß‘π Àÿπâ °Ÿ·â ª≈ß ¿“æ∑’∂Ë Õ◊ ‡ªìπµ√“ “√∑ÿπ 13 à«π‡°‘π¡Ÿ≈§à“‡ß‘π≈ß∑ÿπ∑’ Ë ßŸ °«à“¡Ÿ≈§à“µ“¡∫—≠™’¢Õß∫√‘…∑— ¬àÕ¬ 8 °”‰√ – ¡ ®—¥ √√·≈â« - ”√Õßµ“¡°ÆÀ¡“¬ 15 ¬—ß‰¡à‰¥â®¥— √√ √«¡ à«π¢ÕßºŸ∂â Õ◊ Àÿπâ ¢Õß∫√‘…∑— œ à«π¢ÕßºŸ∂â Õ◊ Àÿπâ à«ππâÕ¬¢Õß∫√‘…∑— ¬àÕ¬ √«¡ à«π¢ÕßºŸ∂â Õ◊ Àÿπâ √«¡Àπ’ È π‘ ·≈– à«π¢ÕßºŸ∂â Õ◊ Àÿπâ À¡“¬‡Àµÿª√–°Õ∫ß∫°“√‡ß‘π‡ªìπ à«πÀπ÷ßË ¢Õßß∫°“√‡ß‘ππ’È

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

∫√‘…∑— ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π) ·≈–∫√‘…∑— ¬àÕ¬ ß∫°”‰√¢“¥∑ÿπ ”À√—∫ªï π‘È ÿ¥«—π∑’Ë 31 ∏—π«“§¡ 2548 ·≈– 2547

ß∫°“√‡ß‘π√«¡ À¡“¬‡Àµÿ √“¬‰¥â √“¬‰¥â®“°°‘®°“√‚√ßæ¬“∫“≈ √“¬‰¥â§“à ‡™à“ √“¬‰¥â§“à ∏√√¡‡π’¬¡™¥‡™¬°“√‡ ’¬‚Õ°“ ∑“ß∏ÿ√°‘® ¥Õ°‡∫’¬È √—∫ °”‰√®“°Õ—µ√“·≈°‡ª≈’¬Ë π √“¬‰¥âÕπ◊Ë à«π·∫àß°”‰√®“°‡ß‘π≈ß∑ÿπµ“¡«‘∏ ’ «à π‰¥â‡ ’¬ √«¡√“¬‰¥â §à“„™â®“à ¬ µâπ∑ÿπ°‘®°“√‚√ßæ¬“∫“≈ §à“‡ ◊ÕË ¡√“§“·≈–µ—¥®”Àπà“¬ §à“„™â®“à ¬„π°“√∫√‘À“√ §à“µÕ∫·∑π°√√¡°“√ §à“§«“¡π‘¬¡µ—¥®”Àπà“¬ §à“‡º◊ÕË °“√¥âÕ¬§à“¢Õß ‘π∑√—æ¬å∂“«√ à«π·∫àß¢“¥∑ÿπ®“°‡ß‘π≈ß∑ÿπµ“¡«‘∏ ’ «à π‰¥â‡ ’¬ √«¡§à“„™â®“à ¬ °”‰√°àÕπ¥Õ°‡∫’¬È ®à“¬·≈–¿“…’‡ß‘π‰¥â ¥Õ°‡∫’¬È ®à“¬ ¿“…’‡ß‘π‰¥âπµ‘ ∫‘ §ÿ §≈ °”‰√°àÕπ à«π¢ÕßºŸ∂â Õ◊ Àÿπâ à«ππâÕ¬ à«π¢ÕßºŸ∂â Õ◊ Àÿπâ à«ππâÕ¬ °”‰√®“°°“√¥”‡π‘πß“πª°µ‘ √“¬°“√æ‘‡»… - °”‰√®“°°“√·ª≈ß ¿“æÀÿπâ °Ÿ‡â ªìπÀÿπâ “¡—≠ °”‰√ ÿ∑∏‘ ”À√—∫ªï

À¡“¬‡Àµÿª√–°Õ∫ß∫°“√‡ß‘π‡ªìπ à«πÀπ÷ßË ¢Õßß∫°“√‡ß‘ππ’È

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

6 6 6 6

10, 11 6 16 2.3 10

6 17

(Àπà«¬: ∫“∑) ß∫°“√‡ß‘π‡©æ“–∫√‘…∑— œ 2548 2547

2548

2547

6,646,518,382 89,087,699 8,414,581 25,216,037 34,378,394 3,160,025 6,806,775,118

5,686,055,350 53,074,334 25,434,212 16,099,062 28,636,062 5,809,299,020

6,595,730,218 114,204,008 8,402,714 24,467,416 36,903,233 29,804,599 6,809,512,188

2,482,255,106 85,599,024 25,500,000 15,524,216 6,718,329 57,489,213 328,668,699 3,001,754,587

4,145,590,150 291,816,213 981,990,496 4,105,000 11,430,248 5,434,932,107 1,371,843,011 (106,867,549) (217,907,995) 1,047,067,467 5,671,812 1,052,739,279 1,052,739,279

3,665,606,435 242,004,565 763,153,919 4,365,000 (1,366,162) 9,000,000 4,682,763,757 1,126,535,263 (118,886,083) (128,636,071) 879,013,109 (8,444,076) 870,569,033 63,978,082 934,547,115

4,127,593,520 251,605,807 1,002,171,837 4,105,000 11,430,248 37,995,459 5,434,901,871 1,374,610,317 (101,549,396) (220,321,642) 1,052,739,279 1,052,739,279 1,052,739,279

1,591,582,497 80,313,675 409,534,019 4,365,000 9,000,000 10,334,336 2,105,129,527 896,625,060 (26,056,027) 870,569,033 870,569,033 63,978,082 934,547,115

√“¬ß“πª√–®”ªï 2548

∫√‘…∑— ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π) ·≈–∫√‘…∑— ¬àÕ¬ ß∫°”‰√¢“¥∑ÿπ (µàÕ) ”À√—∫ªï π‘È ÿ¥«—π∑’Ë 31 ∏—π«“§¡ 2548 ·≈– 2547 ß∫°“√‡ß‘π√«¡ À¡“¬‡Àµÿ °”‰√µàÕÀÿπâ ¢—πÈ æ◊πÈ ∞“π °”‰√®“°°“√¥”‡π‘πß“πª°µ‘ √“¬°“√æ‘‡»… °”‰√ ÿ∑∏‘ ®”π«πÀÿπâ “¡—≠∂—«‡©≈’¬Ë ∂à«ßπÈ”Àπ—° (Àÿπâ ) °”‰√µàÕÀÿπâ ª√—∫≈¥ °”‰√®“°°“√¥”‡π‘πß“πª°µ‘ √“¬°“√æ‘‡»… °”‰√ ÿ∑∏‘ ®”π«πÀÿπâ “¡—≠∂—«‡©≈’¬Ë ∂à«ßπÈ”Àπ—° (Àÿπâ )

2548

2547

(Àπà«¬: ∫“∑) ß∫°“√‡ß‘π‡©æ“–∫√‘…∑— œ 2548 2547

18 1.45 1.45 727,630,430

1.27 0.09 1.36 686,003,287

1.45 1.45 727,630,430

1.27 0.09 1.36 686,003,287

18 1.21 1.21 867,414,859

1.01 0.07 1.08 863,080,160

1.21 1.21 867,414,859

1.01 0.07 1.08 863,080,160

À¡“¬‡Àµÿª√–°Õ∫ß∫°“√‡ß‘π‡ªìπ à«πÀπ÷ßË ¢Õßß∫°“√‡ß‘ππ’È

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

À¡“¬‡Àµÿª√–°Õ∫°“√‡ß‘π‡ªìπ à«πÀπ÷ßË ¢Õßß∫°“√‡ß‘ππ’È

¬Õ¥§ß‡À≈◊Õµâπªï 2547 ·ª≈ßÀÿπâ ∫ÿ√¡‘ ‘∑∏‘‡ªìπÀÿπâ “¡—≠ ≈¥¡Ÿ≈§à“∑’µË √“‰«â¢ÕßÀÿπâ ‡æ◊ÕË ≈¥¢“¥∑ÿπ – ¡ Àÿπâ “¡—≠∑’ÕË Õ°‡æ‘¡Ë „π√–À«à“ßªï ·ª≈ßÀÿπâ °Ÿ·â ª≈ß ¿“æ‡ªìπÀÿπâ “¡—≠ ¥Õ°‡∫’¬È ®à“¬ ”À√—∫Àÿπâ °Ÿ·â ª≈ß ¿“æ ∑’∂Ë Õ◊ ‡ªìπµ√“ “√∑ÿπ ‚Õπ‰ª ”√Õßµ“¡°ÆÀ¡“¬ °”‰√ ÿ∑∏‘ ”À√—∫ªï 2547 ‡ß‘πªíπº≈®à“¬ à«π¢ÕßºŸ∂â Õ◊ Àÿπà à«ππâÕ¬ ”À√—∫ªï 2547 ´◊ÕÈ ‡ß‘π≈ß∑ÿπ„π∫√‘…∑— ¬àÕ¬®“°ºŸ∂â Õ◊ Àÿπâ à«ππâÕ¬ ¬Õ¥§ß‡À≈◊Õª≈“¬ªï 2547 ·ª≈ßÀÿπâ ∫ÿ√¡‘ ‘∑∏‘‡ªìπÀÿπâ “¡—≠ ‡ß‘π≈ß∑ÿπ à«π¢ÕßºŸ∂â Õ◊ Àÿπâ à«ππâÕ¬ ≥ «—π∑’´Ë Õ◊È ‡ß‘π≈ß∑ÿπ„π∫√‘…∑— ¬àÕ¬ º≈µà“ß®“°°“√·ª≈ß§à“ß∫°“√‡ß‘π ¥Õ°‡∫’¬È ®à“¬ ”À√—∫Àÿπâ °Ÿ·â ª≈ß ¿“æ ∑’∂Ë Õ◊ ‡ªìπµ√“ “√∑ÿπ ‚Õπ‰ª ”√Õßµ“¡°ÆÀ¡“¬ °”‰√ ÿ∑∏‘ ”À√—∫ªï 2548 ‡ß‘πªíπº≈®à“¬ à«π¢ÕßºŸ∂â Õ◊ Àÿπâ à«ππâÕ¬ ”À√—∫ªï 2548 ¬Õ¥§ß‡À≈◊Õª≈“¬ªï 2548

13 15

14 14 14 13 2,692,850 (332,000) 2,360,850

727,691,372

5,590,700 (205,000) (2,692,850) -

727,359,372 332,000

1,321,228,030 205,000 (660,716,515) 9,500,000 57,142,857

285,568,300

285,568,300 -

101,111,673 184,456,627

∑ÿπ‡√◊ÕπÀÿπâ ∑’ÕË Õ°·≈–™”√–·≈â« à«π‡°‘π À¡“¬‡Àµÿ Àÿπâ “¡—≠ Àÿπâ ∫ÿ√¡‘ ‘∑∏‘ ¡Ÿ≈§à“Àÿπâ “¡—≠

ß∫°“√‡ß‘π√«¡

30,828,437 30,828,437

41,599,484 (41,599,484)

550,000,000

550,000,000 -

(192,661,558)

(192,661,558) (192,661,558) -

45,775,000 92,275,000

46,500,000 46,500,000 -

(17,500,000) (45,775,000) 1,052,739,279 (511,029,555) 1,119,173,591

(12,671,233) (46,500,000) 934,547,115 (219,015,667) 640,738,867 -

(679,030,713) 663,409,365 -

√«¡

(Àπà«¬: ∫“∑)

78,323,511 78,323,511 7,901,275 38,729,712 (17,500,000) 1,052,739,279 (511,029,555) (5,671,812) (5,671,812) 80,552,974 2,695,788,966

(12,671,233) 934,547,115 (219,015,667) 8,444,076 8,444,076 (28,561,788) (221,223,346) 2,060,197,831 -

20,117,712 1,259,505,213 110,611,673 200,000,000

º≈µà“ß®“°°“√ à«π‡°‘π¡Ÿ≈§à“‡ß‘π≈ß∑ÿπ °”‰√ – ¡ ·ª≈ß§à“ ‘∑∏‘‡≈◊Õ° Àÿπâ °Ÿ·â ª≈ß ¿“æ ∑’ Ë ßŸ °«à“¡Ÿ≈§à“µ“¡ ®—¥ √√·≈â« ¬—ß‰¡à‰¥â®¥— √√ à«π¢ÕßºŸ∂â Õ◊ Àÿπâ ß∫°“√‡ß‘π ·ª≈ß ¿“æ ∑’∂Ë Õ◊ ‡ªìπµ√“ “√∑ÿπ ∫—≠™’¢Õß∫√‘…∑— ¬àÕ¬ ”√Õßµ“¡°ÆÀ¡“¬ (¢“¥∑ÿπ) à«ππâÕ¬

∫√‘…∑— ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å (¡À“™π) ·≈–∫√‘…∑— ¬àÕ¬ ß∫· ¥ß°“√‡ª≈’¬Ë π·ª≈ß à«π¢ÕßºŸ∂â Õ◊ Àÿπâ ”À√—∫ªïô ‘Èπ ÿ¥«—π∑’Ë 31 ∏—π«“§¡ 2548 ·≈– 2547

√“¬ß“πª√–®”ªï 2548

À¡“¬‡Àµÿª√–°Õ∫°“√‡ß‘π‡ªìπ à«πÀπ÷ßË ¢Õßß∫°“√‡ß‘ππ’È

¬Õ¥§ß‡À≈◊Õµâπªï 2547 ·ª≈ßÀÿπâ ∫ÿ√¡‘ ‘∑∏‘‡ªìπÀÿπâ “¡—≠ ≈¥¡Ÿ≈§à“∑’µË √“‰«â¢ÕßÀÿπâ ‡æ◊ÕË ≈¥¢“¥∑ÿπ – ¡ Àÿπâ “¡—≠∑’ÕË Õ°‡æ‘¡Ë „π√–À«à“ßªï ·ª≈ßÀÿπâ °Ÿ·â ª≈ß ¿“æ‡ªìπÀÿπâ “¡—≠ ¥Õ°‡∫’¬È ®à“¬ ”À√—∫Àÿπâ °Ÿ·â ª≈ß ¿“æ∑’∂Ë Õ◊ ‡ªìπµ√“ “√∑ÿπ ‚Õπ‰ª ”√Õßµ“¡°ÆÀ¡“¬ °”‰√ ÿ∑∏‘ ”À√—∫ªï 2547 ‡ß‘πªíπº≈®à“¬ ´◊ÕÈ ‡ß‘π≈ß∑ÿπ„π∫√‘…∑— ¬àÕ¬®“°ºŸ∂â Õ◊ Àÿπâ à«ππâÕ¬ ¬Õ¥§ß‡À≈◊Õª≈“¬ªï 2547 ·ª≈ßÀÿπâ ∫ÿ√¡‘ ‘∑∏‘‡ªìπÀÿπâ “¡—≠ º≈µà“ß®“°°“√·ª≈ß§à“ß∫°“√‡ß‘π ¥Õ°‡∫’¬È ®à“¬ ”À√—∫Àÿπâ °Ÿ·â ª≈ß ¿“æ∑’∂Ë Õ◊ ‡ªìπµ√“ “√∑ÿπ ‚Õπ‰ª ”√Õßµ“¡°ÆÀ¡“¬ °”‰√ ÿ∑∏‘ ”À√—∫ªï 2548 ‡ß‘πªíπº≈®à“¬ ¬Õ¥§ß‡À≈◊Õª≈“¬ªï 2548

13 15

14 14 14 13 13 15

À¡“¬‡Àµÿ

1,321,228,030 205,000 (660,716,515) 9,500,000 57,142,857 727,359,372 332,000 727,691,372

5,590,700 (205,000) (2,692,850) 2,692,850 (332,000) 2,360,850

∑ÿπ‡√◊ÕπÀÿπâ ∑’ÕË Õ°·≈–™”√–·≈â« Àÿπâ “¡—≠ Àÿπâ ∫ÿ√¡‘ ‘∑∏‘

101,111,673 184,456,627 285,568,300 285,568,300

30,828,437 30,828,437

41,599,484 (41,599,484) -

à«π‡°‘π º≈µà“ß®“°°“√ ‘∑∏‘ ¡Ÿ≈§à“Àÿπâ “¡—≠ ·ª≈ß§à“ß∫°“√‡ß‘π ‡≈◊Õ°·ª≈ß ¿“æ

550,000,000 550,000,000 550,000,000

(192,661,558) (192,661,558) (192,661,558)

46,500,000 46,500,000 45,775,000 92,275,000

(679,030,713) 663,409,365 (12,671,233) (46,500,000) 934,547,115 (219,015,667) 640,738,867 (17,500,000) (45,775,000) 1,052,739,279 (511,029,555) 1,119,173,591

à«π‡°‘π¡Ÿ≈§à“‡ß‘π≈ß∑ÿπ °”‰√ – ¡ Àÿπâ °Ÿ·â ª≈ß ¿“æ ∑’ Ë ßŸ °«à“¡Ÿ≈§à“µ“¡ ®—¥ √√·≈â« ¬—ß‰¡à‰¥â®¥— √√ ∑’Ë∂Õ◊ ‡ªìπµ√“ “√∑ÿπ ∫—≠™’¢Õß∫√‘…∑— ¬àÕ¬ ”√Õßµ“¡°ÆÀ¡“¬ (¢“¥∑ÿπ)

ß∫°“√‡ß‘π‡©æ“–∫√‘…∑— œ

∫√‘…∑— ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å (¡À“™π) ·≈–∫√‘…∑— ¬àÕ¬ ß∫· ¥ß°“√‡ª≈’Ë¬π·ª≈ß à«π¢ÕßºŸâ∂◊ÕÀÿπâ (µàÕ) ”À√—∫ªïô ‘Èπ ÿ¥«—π∑’Ë 31 ∏—π«“§¡ 2548 ·≈– 2547

1,239,387,501 110,611,673 200,000,000 (12,671,233) 934,547,115 (219,015,667) (192,661,558) 2,060,197,831 30,828,437 (17,500,000) 1,052,739,279 (511,029,555) 2,615,235,992

√«¡

(Àπà«¬: ∫“∑)

√“¬ß“πª√–®”ªï 2548

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

∫√‘…∑— ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π) ·≈–∫√‘…∑— ¬àÕ¬ ß∫°√–· ‡ß‘π ¥ ”À√—∫ªï π‘È ÿ¥«—π∑’Ë 31 ∏—π«“§¡ 2548 ·≈– 2547

ß∫°“√‡ß‘π√«¡ 2548 2547 °√–· ‡ß‘π ¥®“° („™â‰ª„π) °‘®°√√¡¥”‡π‘πß“π °”‰√ ÿ∑∏‘ √“¬°“√ª√—∫°√–∑∫°”‰√ ÿ∑∏‘ ‡ªìπ‡ß‘π ¥√—∫ (®à“¬) ®“°°‘®°√√¡¥”‡π‘πß“π: §à“‡ ◊ÕË ¡√“§“·≈–µ—¥®”Àπà“¬ §à“‡º◊ÕË °“√¥âÕ¬§à“¢Õß ‘π∑√—æ¬å∂“«√ Àπ’ È ≠Ÿ ·≈–Àπ’ È ß —¬®– Ÿ≠ §à“§«“¡π‘¬¡µ—¥®”Àπà“¬ à«π·∫àß¢“¥∑ÿπ (°”‰√) ®“°‡ß‘π≈ß∑ÿπµ“¡«‘∏ ’ «à π‰¥â‡ ’¬ à«π¢ÕßºŸ∂â Õ◊ Àÿπâ à«ππâÕ¬„π°”‰√ ÿ∑∏‘ ”À√—∫ªï ¢“¥∑ÿπ®“°°“√®”Àπà“¬ ‘π∑√—æ¬å∂“«√ ‘π∑√—æ¬å¥”‡π‘πß“π≈¥≈ß (‡æ‘¡Ë ¢÷πÈ ) ≈Ÿ°Àπ’°È “√§â“ ‘π§â“§ß‡À≈◊Õ ‘π∑√—æ¬åÀ¡ÿπ‡«’¬πÕ◊πË Àπ’ È π‘ ¥”‡π‘πß“π‡æ‘¡Ë ¢÷πÈ (≈¥≈ß) ‡®â“Àπ’°È “√§â“ §à“∏√√¡‡π’¬¡·æ∑¬å§“â ß®à“¬ ¥Õ°‡∫’¬È §â“ß®à“¬ ¿“…’‡ß‘π‰¥âπµ‘ ∫‘ §ÿ §≈§â“ß®à“¬ §à“„™â®“à ¬§â“ß®à“¬ ‡®â“Àπ’ÕÈ π◊Ë √“¬‰¥â√∫— ≈à«ßÀπâ“ Àπ’ È π‘ À¡ÿπ‡«’¬πÕ◊πË ‡ß‘π ¥ ÿ∑∏‘®“°°‘®°√√¡¥”‡π‘πß“π À¡“¬‡Àµÿª√–°Õ∫ß∫°“√‡ß‘π‡ªìπ à«πÀπ÷ßË ¢Õßß∫°“√‡ß‘ππ’È

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

(Àπà«¬: ∫“∑) ß∫°“√‡ß‘π‡©æ“–∫√‘…∑— œ 2548 2547

1,052,739,279

934,547,115

1,052,739,279

934,547,115

291,816,213 11,430,248 14,264,748 (3,160,025) (5,671,812) 2,694,621 1,364,113,272

242,004,565 9,000,000 25,401,693 (1,366,162) 8,444,076 12,634,832 1,230,666,119

251,605,807 11,430,248 12,776,194 8,190,860 3,073,072 1,339,815,460

80,313,675 9,000,000 20,629,906 (318,334,363) 75,989 726,232,322

(118,781,734) (45,444,839) (24,080,958)

(27,367,348) (10,937,761) (24,880,633)

(93,541,690) (45,154,175) 2,825,506

(233,476,034) (102,027,734) (29,108,734)

8,523,531 46,239,046 585,039 144,729,028 67,203,470 23,263,630 34,131,272 12,262,058 1,512,742,815

(29,705,824) 23,109,224 60,893,372 (1,400,477) 2,359,624 15,337,486 1,238,073,782

7,957,506 46,672,327 204,543,949 36,946,606 27,108,553 12,451,452 1,539,625,494

366,589,082 166,377,045 127,974,511 785,282 18,668,832 1,042,014,572

√“¬ß“πª√–®”ªï 2548

∫√‘…∑— ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π) ·≈–∫√‘…∑— ¬àÕ¬ ß∫°√–· ‡ß‘π ¥ (µàÕ) ”À√—∫ªï π‘È ÿ¥«—π∑’Ë 31 ∏—π«“§¡ 2548 ·≈– 2547

À¡“¬‡Àµÿ °√–· ‡ß‘π ¥®“° („™â‰ª„π) °‘®°√√¡≈ß∑ÿπ ‡ß‘πΩ“° ∂“∫—π°“√‡ß‘π´÷ßË ∂÷ß°”Àπ¥®à“¬§◊π‡°‘π°«à“ 3 ‡¥◊Õπ ·≈–∑’πË ”‰ª§È”ª√–°—π≈¥≈ß (‡æ‘¡Ë ¢÷πÈ ) ‡ß‘π∑¥√Õß·°àæπ—°ß“π·≈–°√√¡°“√≈¥≈ß (‡æ‘¡Ë ¢÷πÈ ) ‡ß‘π„Àâ°¬Ÿâ ¡◊ √–¬– —πÈ ·≈–¥Õ°‡∫’¬È §â“ß√—∫ - °‘®°“√ ∑’‡Ë °’¬Ë «¢âÕß°—π≈¥≈ß (‡æ‘¡Ë ¢÷πÈ ) ‡ß‘π„Àâ°¬Ÿâ ¡◊ √–¬–¬“«·≈–¥Õ°‡∫’¬È §â“ß√—∫ - °‘®°“√ ∑’‡Ë °’¬Ë «¢âÕß°—π≈¥≈ß ´◊ÕÈ ‡ß‘π≈ß∑ÿπ„π∫√‘…∑— ¬àÕ¬·≈–∫√‘…∑— √à«¡ ´◊ÕÈ ‡ß‘π≈ß∑ÿπ„π∫√‘…∑— Õ◊πË ‡ß‘πªíπº≈√—∫ Õ“§“√·≈–Õÿª°√≥å‡æ‘¡Ë ¢÷πÈ ‘π∑√—æ¬å‰¡àÀ¡ÿπ‡«’¬πÕ◊πË ‡æ‘¡Ë ¢÷πÈ ‡ß‘π ¥ ÿ∑∏‘„™â‰ª„π°‘®°√√¡≈ß∑ÿπ °√–· ‡ß‘π ¥®“° („™â‰ª„π) °‘®°√√¡®—¥À“‡ß‘π ‡ß‘π°Ÿ¬â ¡◊ √–¬– —πÈ ·≈–¥Õ°‡∫’¬È §â“ß®à“¬ - °‘®°“√∑’‡Ë °’¬Ë «¢âÕß°—π‡æ‘¡Ë ¢÷πÈ ‡ß‘π°Ÿ¬â ¡◊ √–¬–¬“«≈¥≈ß ‡ß‘π ¥√—∫®“°°“√ÕÕ°Àÿπâ “¡—≠ ‡ß‘πªíπº≈®à“¬ Àπ’ È π‘ µ“¡ —≠≠“°“√ª√—∫‚§√ß √â“ßÀπ’≈È ¥≈ß®“°¥Õ°‡∫’¬È ®à“¬ ¥Õ°‡∫’¬È ®à“¬ ”À√—∫Àÿπâ °Ÿ·â ª≈ß ¿“æ∑’∂Ë Õ◊ ‡ªìπµ√“ “√∑ÿπ ‡ß‘π ¥ ÿ∑∏‘®“° („™â‰ª„π) °‘®°√√¡®—¥À“‡ß‘π°àÕπ√“¬°“√æ‘‡»… √“¬°“√æ‘‡»… - °”‰√®“°°“√·ª≈ß ¿“æÀÿπâ °Ÿ‡â ªìπÀÿπâ “¡—≠ ‡ß‘π ¥ ÿ∑∏‘®“° („™â‰ª„π) °‘®°√√¡®—¥À“‡ß‘π ‡ß‘π ¥·≈–√“¬°“√‡∑’¬∫‡∑à“‡ß‘π ¥‡æ‘¡Ë ¢÷πÈ (≈¥≈ß) ÿ∑∏‘ º≈µà“ß®“°°“√·ª≈ß§à“ß∫°“√‡ß‘π ‡ß‘π ¥·≈–√“¬°“√‡∑’¬∫‡∑à“‡ß‘π ¥µâπªï ‡ß‘π ¥·≈–√“¬°“√‡∑’¬∫‡∑à“‡ß‘π ¥ª≈“¬ªï 20

2548

ß∫°“√‡ß‘π√«¡ 2547

(Àπà«¬: ∫“∑) ß∫°“√‡ß‘π‡©æ“–∫√‘…∑— œ 2548 2547

399,943,927 (4,480,728)

(390,029,286) 4,271,126

(92) (4,086,563)

(219,944,991) (5,357,699)

(953,736)

(135,412,365)

4,132,918

(250,334,202)

7,791,506 2,418,518 (221,223,346) (599,000,000) (347,213) (508,207,993) (665,176,119) (25,072,229) (116,787,922) (1,268,229,800) (1,378,499,260)

6,285,039 (221,223,346) (347,213) 239,738,300 (1,140,670,600) (28,990,053) (1,620,844,765)

(385,002,855) (653,109,053) (215,474,922) (859,077,367) (328,521,802) (511,029,555) (17,500,000) (857,051,357) (857,051,357) (203,385,909) 24,010,087 722,881,941 543,506,119

(82,130,450) 110,611,673 (219,015,667) (8,043,836) (10,000,000) (208,578,280) (63,978,082) (272,556,362) (302,712,380) 1,025,594,321 722,881,941

233,488,839 (511,029,555) (17,500,000) (295,040,716) (295,040,716) (133,914,482) 516,300,167 382,385,685

1,214,280,376 110,611,673 (219,015,667) (8,043,836) (10,000,000) 1,087,832,546 (63,978,082) 1,023,854,464 445,024,271 71,275,896 516,300,167

À¡“¬‡Àµÿª√–°Õ∫ß∫°“√‡ß‘π‡ªìπ à«πÀπ÷ßË ¢Õßß∫°“√‡ß‘ππ’È

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

∫√‘…∑— ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π) ·≈–∫√‘…∑— ¬àÕ¬ ß∫°√–· ‡ß‘π ¥ (µàÕ) ”À√—∫ªï π‘È ÿ¥«—π∑’Ë 31 ∏—π«“§¡ 2548 ·≈– 2547 ß∫°“√‡ß‘π√«¡ 2548 2547 ¢âÕ¡Ÿ≈°√–· ‡ß‘π ¥‡ªî¥‡º¬‡æ‘¡Ë ‡µ‘¡ ‡ß‘π ¥®à“¬„π√–À«à“ßªï ”À√—∫ ¥Õ°‡∫’¬È ®à“¬ ¿“…’‡ß‘π‰¥âπµ‘ ∫‘ §ÿ §≈ √“¬°“√∑’¡Ë ‘„™à‡ß‘π ¥ ·ª≈ßÀÿπâ °Ÿ·â ª≈ß ¿“æ‡ªìπÀÿπâ “¡—≠ ‘π∑√—æ¬å∑’Ë‰¥â¡“®“°°“√À—°°≈∫Àπ’È ‘π∑√—æ¬å ∑ÿ ∏‘∑’Ë‰¥â¡“®“°°“√√—∫‚Õπ°‘®°“√∑’¬Ë ß— ¡‘‰¥â®“à ¬™”√–

À¡“¬‡Àµÿª√–°Õ∫ß∫°“√‡ß‘π‡ªìπ à«πÀπ÷ßË ¢Õßß∫°“√‡ß‘ππ’È

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

106,270,888 73,178,967 -

126,959,087 78,214,628 200,000,000 390,900,014 -

(Àπà«¬: ∫“∑) ß∫°“√‡ß‘π‡©æ“–∫√‘…∑— œ 2548 2547

106,930,038 15,777,693 -

28,719,220 10,471,929 200,000,000 390,900,014 772,236,429

√“¬ß“πª√–®”ªï 2548

∫√‘…∑— ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π) ·≈–∫√‘…∑— ¬àÕ¬ À¡“¬‡Àµÿª√–°Õ∫ß∫°“√‡ß‘π ”À√—∫ªï π‘È ÿ¥«—π∑’Ë 31 ∏—π«“§¡ 2548 ·≈– 2547 1. ¢âÕ¡Ÿ≈∑—«Ë ‰ª ∫√‘…∑— ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π) ‰¥â®¥∑–‡∫’¬π‡ªìπ∫√‘…∑— ¡À“™π®”°—¥µ“¡°ÆÀ¡“¬‰∑¬·≈–ª√–°Õ∫°‘®°“√„πª√–‡∑»‰∑¬ ‚¥¬¥”‡π‘π∏ÿ√°‘®À≈—°§◊Õ °‘®°“√‚√ßæ¬“∫“≈ °“√≈ß∑ÿπ„π∫√‘…∑— Õ◊πË ·≈–„Àâ‡™à“Õ —ßÀ“√‘¡∑√—æ¬å ‡¡◊ÕË «—π∑’Ë 8 ¡‘∂πÿ “¬π 2547 ∑’ªË √–™ÿ¡§≥–°√√¡°“√∫√‘…∑— œ‰¥â¡¡’ µ‘„Àâ∫√‘…∑— œ¬â“¬ ”π—°ß“π®“°‡≈¢∑’Ë 210 ´Õ¬ 1 (´Õ¬√◊πË ƒ¥’) ∂ππ ÿ¢¡ÿ «‘∑ ·¢«ß§≈Õß‡µ¬‡Àπ◊Õ ‡¢µ«—≤π“ °√ÿß‡∑æ¡À“π§√ ‡ªìπ 33 ´Õ¬ ÿ¢ÿ¡«‘∑ 3 (π“π“‡Àπ◊Õ) ∂ππ ÿ¢¡ÿ «‘∑ ·¢«ß§≈Õß‡µ¬‡Àπ◊Õ ‡¢µ«—≤π“ °√ÿß‡∑æ¡À“π§√ ∫√‘…∑— œ‰¥â¥”‡π‘π°“√®¥∑–‡∫’¬π°“√¬â“¬ ”π—°ß“π¥—ß°≈à“«µàÕ°√–∑√«ßæ“≥‘™¬å·≈–°√¡ √√æ“°√‡¡◊ÕË «—π∑’Ë 1 °√°Æ“§¡ 2547 ·≈– 11 ¡‘∂πÿ “¬π 2547 µ“¡≈”¥—∫ ‡¡◊ËÕ«—π∑’Ë 15 ¡‘∂ÿπ“¬π 2547 ∑’Ëª√–™ÿ¡«‘ “¡—≠ºŸâ∂◊ÕÀÿâπ¢Õß∫√‘…—∑œ‰¥â¡’¡µ‘Õπÿ¡—µ‘„Àâ´◊ÈÕ°‘®°“√ ‚√ßæ¬“∫“≈®“°∫√‘…—∑¬àÕ¬ (∫√‘…—∑ ∫”√ÿß√“…Æ√å ‡¡¥‘§Õ≈ ‡´Áπ‡µÕ√å ®”°—¥) ·≈–Õπÿ¡µ— ‘„Àâ§≥–°√√¡°“√∫√‘…∑— œ‡ªìπºŸæâ ®‘ “√≥“§à“µÕ∫·∑π ∑—ßÈ π’È ∫√‘…∑— œ®–´◊ÕÈ —ßÀ“√‘¡∑√—æ¬å √«¡∑—ßÈ √—∫‚Õπ„∫Õπÿ≠“µ∑’Ë‡°’¬Ë «¢âÕß √—∫‚Õπ ‘∑∏‘Àπâ“∑’µË “¡ —≠≠“µà“ß Ê ·≈–√—∫‚Õπæπ—°ß“π∑—ÈßÀ¡¥∑’‡Ë °’¬Ë «¢âÕß°—∫°‘®°“√‚√ßæ¬“∫“≈ °“√ ´◊ÕÈ °‘®°“√¥—ß°≈à“«¥”‡π‘π°“√‡ √Á®‡√’¬∫√âÕ¬·≈–∫—π∑÷°√“¬°“√∫—≠™’·≈â« ‚¥¬¡’§“à µÕ∫·∑π„π°“√´◊ÕÈ °‘®°“√‡ªìπ®”π«π‡ß‘π 772.2 ≈â“π∫“∑ πÕ°®“°π’È ∫√‘…∑— œ‡™à“Õ“§“√‚√ßæ¬“∫“≈¢Õß∫√‘…∑— ∫”√ÿß√“…Æ√å ‡¡¥‘§Õ≈ ‡´Áπ‡µÕ√å ®”°—¥ ‡æ◊ÕË „™â„π°“√¥”‡π‘π°‘®°“√‚√ßæ¬“∫“≈µàÕ‰ª ∑’ªË √–™ÿ¡§≥–°√√¡°“√∫√‘…∑— œ§√—ßÈ ∑’Ë 2/2548 ‡¡◊ÕË «—π∑’Ë 28 °ÿ¡¿“æ—π∏å 2548 ‰¥â¡¡’ µ‘Õπÿ¡µ— ‘°“√≈ß∑ÿπ„πÀÿπâ √âÕ¬≈– 49 ¢Õß∫√‘…—∑∑’®Ë –®—¥µ—ßÈ ¢÷πÈ „À¡à„π‡¡◊Õß¥Ÿ‰∫ À√—∞Õ“À√—∫‡Õ¡‘‡√ µå ‡æ◊ÕË ª√–°Õ∫°‘®°“√‚√ßæ¬“∫“≈‚¥¬¡’¡≈Ÿ §à“°“√≈ß∑ÿπ®”π«π‡ß‘π 388 ≈â“π∫“∑ §“¥«à“°“√≈ß∑ÿπ à«π·√°®–‡√‘¡Ë „πªï 2549 - 2550 ∑—Èßπ’È ∫√‘…∑— ¬àÕ¬ (∫√‘…∑— ∫”√ÿß√“…Æ√å Õ‘π‡µÕ√å‡π™—πË ·π≈ ®”°—¥) ‰¥â‡¢â“∑”∫—π∑÷°¢âÕµ°≈ß°—∫§Ÿ à —≠≠“ ‡¡◊ÕË «—π∑’Ë 16 ¡’π“§¡ 2548 ‡¡◊ÕË «—π∑’Ë 21 °—π¬“¬π 2548 ∑’ªË √–™ÿ¡«‘ “¡—≠ºŸâ∂Õ◊ Àÿâπ§√—ßÈ ∑’Ë 1/2548 ‰¥â¡¡’ µ‘Õπÿ¡—µ‘„ÀâÕÕ°·≈–‡ πÕ¢“¬ Àÿπâ °Ÿâ„π«ß‡ß‘π®”π«π‰¡à‡°‘π 2,500 ≈â“π∫“∑ Õ“¬ÿ‰¡à‡°‘π 10 ªï π—∫®“°«—π∑’ÕË Õ°Àÿπâ °Ÿâ ‡æ◊ÕË „™â„π°“√™”√–Àπ’È ¥”‡π‘π∏ÿ√°‘® ·≈–¢¬“¬∏ÿ√°‘®¢Õß∫√‘…∑— œ ∑—ßÈ π’È „Àâ§≥–Õπÿ°√√¡°“√ °“√≈ß∑ÿπ¢Õß∫√‘…∑— œÀ√◊Õ∫ÿ§§≈∑’§Ë ≥–Õπÿ°√√¡°“√°“√≈ß∑ÿπ¢Õß∫√‘…∑— œ¡Õ∫À¡“¬ ¡’Õ”π“®„π°“√æ‘®“√≥“°”Àπ¥À√◊Õ‡ª≈’¬Ë π·ª≈ß‡«≈“ „π°“√ÕÕ°Àÿπâ °Ÿ·â µà≈–§√—ßÈ √«¡∑—ßÈ √“¬≈–‡Õ’¬¥·≈–‡ß◊ÕË π‰¢Õ◊πË Ê„π°“√ÕÕ°·≈–‡ πÕ¢“¬Àÿπâ °Ÿ·â µà≈–§√—ßÈ ‚¥¬‡¡◊ÕË «—π∑’Ë 25 æƒ»®‘°“¬π 2548 ∫√‘…—∑œ‰¥â√—∫Õπÿ≠“µ®“° ”π—°ß“π§≥–°√√¡°“√°”°—∫À≈—°∑√—æ¬å·≈–µ≈“¥À≈—°∑√—æ¬å„Àâ‡ πÕ¢“¬Àÿâπ°Ÿâ„π°√≥’∑—Ë«‰ª‰¥â ‚¥¬¡’°”Àπ¥√–¬– ‡«≈“ 1 ªï

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

2. À≈—°‡°≥±å„π°“√®—¥∑”ß∫°“√‡ß‘π√«¡ 2.1 ß∫°“√‡ß‘π√«¡π’È‰¥â®—¥∑”¢÷πÈ ‚¥¬√«¡ß∫°“√‡ß‘π ”À√—∫ªï π‘È ÿ¥«—π∑’Ë 31 ∏—π«“§¡ 2548 ·≈– 2547 ¢Õß∫√‘…∑— ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π) (ç∫√‘…∑— œé) ·≈–∫√‘…∑— ¬àÕ¬¥—ßµàÕ‰ªπ’:È -

∫√‘…∑— ¬àÕ¬ ∫√‘…∑— ¬àÕ¬∑’∂Ë Õ◊ Àÿπâ ‚¥¬∫√‘…∑— œ ∫√‘…∑— ∫”√ÿß√“…Æ√å ‡¡¥‘§Õ≈ ‡´Áπ‡µÕ√å ®”°—¥ ∫√‘…∑— ∫”√ÿß√“…Æ√å Õ‘π‡µÕ√å‡π™—Ëπ·π≈ ®”°—¥ ∫√‘…∑— ‰«∑—≈‰≈øá ®”°—¥ ∫√‘…∑— ¬àÕ¬∑’∂Ë Õ◊ Àÿπâ ‚¥¬∫√‘…∑— ¬àÕ¬ ∫√‘…∑— ∫”√ÿß√“…Æ√å Õ‘π‡µÕ√å‡π™—πË ·π≈ øî≈‘ªªîπ å Õ‘ß§å ∫√‘…∑— ‡πª®Ÿπ µ√Õ¬°â“ ‚Œ≈¥‘ß§å Õ‘ß§å

Õ—µ√“√âÕ¬≈– ¢Õß°“√∂◊ÕÀÿπâ ‚¥¬∫√‘…∑— œ 2548 2547 100.00

100.00

40.00

100.00

≈—°…≥– ¢Õß∏ÿ√°‘®

„Àâ‡™à“Õ“§“√ ≈ß∑ÿπ„π∫√‘…∑— Õ◊πË »Ÿπ¬å¥·Ÿ ≈ ÿ¢¿“æ ∫√‘À“√°‘®°“√ ‚√ßæ¬“∫“≈ ≈ß∑ÿπ„π∫√‘…∑— Õ◊πË

Õ—µ√“√âÕ¬≈–¢Õß Õ—µ√“√âÕ¬≈–¢Õß ‘π∑√—æ¬å√«¡„π √“¬‰¥â√«¡„π ß∫°“√‡ß‘π√«¡ ß∫°“√‡ß‘π√«¡ 2548 2547 2548 2547 20

Bumrungrad International Holdings (Hong Kong) Limited Bumrungrad International Management (Hong Kong) Limited

≈ß∑ÿπ„π∫√‘…∑— Õ◊πË ∫√‘À“√°‘®°“√ ‚√ßæ¬“∫“≈

2.2 ¬Õ¥§ß§â“ß·≈–√“¬°“√√–À«à“ß°—π∑’‡Ë ªìπ “√– ”§—≠¢Õß∫√‘…∑— œ·≈–∫√‘…∑— ¬àÕ¬ ‡ß‘π≈ß∑ÿπ„π∫√‘…∑— ¬àÕ¬µ“¡∫—≠™’¢Õß∫√‘…∑— œ·≈– à«π ¢ÕßºŸ∂â Õ◊ Àÿπâ ¢Õß∫√‘…∑— ¬àÕ¬‰¥âµ¥— ÕÕ°®“°ß∫°“√‡ß‘π√«¡π’·È ≈â« 2.3 º≈µà“ß¢Õßµâπ∑ÿπ¢Õß‡ß‘π≈ß∑ÿπ∑’‡Ë °‘π°«à“À√◊ÕµË”°«à“¡Ÿ≈§à“ ‘π∑√—æ¬å ∑ÿ ∏‘¢Õß∫√‘…∑— ¬àÕ¬ ≥ «—π´◊ÕÈ Àÿπâ ‰¥â· ¥ß¿“¬„µâÀ«— ¢âÕ ç§à“§«“¡ π‘¬¡„π°“√√«¡°‘®°“√é „πß∫¥ÿ≈√«¡·≈–µ—¥®”Àπà“¬¿“¬„π√–¬–‡«≈“ 5 ªï ·≈– 10 ªï 2.4 „π‡¥◊Õπ°ÿ¡¿“æ—π∏å 2548 ∫√‘…∑— ¬àÕ¬·ÀàßÀπ÷ßË (∫√‘…∑— ∫”√ÿß√“…Æ√å Õ‘π‡µÕ√å‡π™—πË ·π≈ ®”°—¥) ‰¥â≈ß∑ÿπ„π∫√‘…∑— ∫”√ÿß√“…Æ√å Õ‘π‡µÕ√å‡π™—πË ·π≈ øî≈ª‘ ªîπ å Õ‘ß§å (BIPI ‡¥‘¡™◊ÕË ç∫√‘…∑— «‘ µâ“ ‡¡¥‘§Õ≈ ·¡‡π®‡¡âπ∑å Õ‘ß§åé) ´÷ßË ‡ªìπ∫√‘…—∑∑’®Ë —¥µ—ßÈ „πª√–‡∑» øî≈ª‘ ªîπ å „πÕ—µ√“√âÕ¬≈– 100 2.5 „π‡¥◊Õπ°ÿ¡¿“æ—π∏å 2548 ∫√‘…∑— ¬àÕ¬·ÀàßÀπ÷ßË (∫√‘…∑— ∫”√ÿß√“…Æ√å Õ‘π‡µÕ√å‡π™—πË ·π≈ ®”°—¥) ‰¥â≈ß∑ÿπ„π∫√‘…∑— ‡πª®Ÿπ µ√Õ¬°â“ ‚Œ≈¥‘ßÈ Õ‘ß§å (‡πª®Ÿπ) ´÷ßË ‡ªìπ∫√‘…∑— ∑’®Ë ¥— µ—ßÈ „πª√–‡∑»øî≈ª‘ ªîπ å „πÕ—µ√“√âÕ¬≈– 40 ß∫°“√‡ß‘π¢Õß∫√‘…∑— ‡πª®Ÿπ‰¥â√«¡Õ¬Ÿà „πß∫°“√‡ß‘π√«¡π’∂È ß÷ ·¡â«“à ∫√‘…∑— ¬àÕ¬®–∂◊ÕÀÿπâ √âÕ¬≈– 40 ‡π◊ÕË ß®“°∫√‘…∑— ¬àÕ¬¡’Õ”π“®§«∫§ÿ¡°“√∫√‘À“√ß“π¢Õß∫√‘…∑— ¥—ß°≈à“« 2.6 „π‡¥◊Õπ∏—π«“§¡ 2548 ∫√‘…∑— ¬àÕ¬·ÀàßÀπ÷ßË (∫√‘…∑— ∫”√ÿß√“…Æ√å Õ‘π‡µÕ√å‡π™—πË ·π≈ ®”°—¥) ‰¥â≈ß∑ÿπ„π Bumrungrad International Holdings (Hong Kong) Limited (BIH (HK)) ´÷ßË ‡ªìπ∫√‘…∑— ∑’®Ë ¥— µ—ßÈ „πŒàÕß°ß „πÕ—µ√“√âÕ¬≈– 100

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

2.7 „π‡¥◊Õπ∏—π«“§¡ 2548 ∫√‘…∑— ¬àÕ¬·ÀàßÀπ÷ßË (∫√‘…∑— ∫”√ÿß√“…Æ√å Õ‘π‡µÕ√å‡π™—πË ·π≈ ®”°—¥) ‰¥â≈ß∑ÿπ„π Bumrungrad International Management (Hong Kong) Limited (BIM (HK)) ´÷ßË ‡ªìπ∫√‘…∑— ∑’®Ë ¥— µ—ßÈ „πŒàÕß°ß „πÕ—µ√“√âÕ¬≈– 100 2.8 „π‡¥◊Õπ¡‘∂ÿπ“¬π 2547 ∫√‘…—∑œ‰¥â´Õ◊È ‡ß‘π≈ß∑ÿπ„π∫√‘…∑— ∫”√ÿß√“…Æ√å ‡¡¥‘§Õ≈ ‡´Áπ‡µÕ√å ®”°—¥ ‡æ‘¡Ë ‡µ‘¡®“°ºŸ∂â ◊ÕÀÿπâ ‡¥‘¡ ∑”„Àâ —¥ à«π°“√∂◊ÕÀÿπâ ¢Õß∫√‘…∑— œ„π∫√‘…∑— ¬àÕ¬·Ààßπ’‡È æ‘¡Ë ¢÷πÈ ®“°√âÕ¬≈– 97.45 ‡ªìπ√âÕ¬≈– 100 2.9 „π‡¥◊Õπæƒ»®‘°“¬π 2547 ∫√‘…∑— ∫”√ÿß√“…Æ√å Õ‘π‡µÕ√å‡π™—πË ·π≈ ®”°—¥ ‰¥â∑”°“√‡æ‘¡Ë ∑ÿπ‚¥¬∫√‘…∑— œ‡¢â“´◊ÈÕÀÿπâ ∑’‡Ë æ‘¡Ë ¢÷πÈ ∑—ÈßÀ¡¥ ∑”„Àâ ¥— à«π°“√∂◊ÕÀÿπâ ¢Õß∫√‘…∑— œ„π∫√‘…∑— ¬àÕ¬·Ààßπ’‡È æ‘¡Ë ¢÷πÈ ®“°√âÕ¬≈– 99.94 ‡ªìπ√âÕ¬≈– 100 2.10 ß∫°“√‡ß‘π¢Õß∫√‘…—∑¬àÕ¬„πµà“ßª√–‡∑»·ª≈ß§à“‡ªìπ‡ß‘π∫“∑‚¥¬„™âÕ—µ√“·≈°‡ª≈’Ë¬π ≥ «—π∑’Ë„πß∫¥ÿ≈ ”À√—∫√“¬°“√ ‘π∑√—æ¬å·≈– Àπ’ È π‘ ·≈–Õ—µ√“∂—«‡©≈’¬Ë ”À√—∫√“¬°“√∑’‡Ë ªìπ√“¬‰¥â·≈–§à“„™â®“à ¬ º≈µà“ß´÷ßË ‡°‘¥¢÷πÈ ®“°°“√·ª≈ß§à“¥—ß°≈à“«‰¥â· ¥ß‰«â‡ªìπ√“¬°“√ çº≈µà“ß®“°°“√·ª≈ß§à“ß∫°“√‡ß‘πé „π à«π¢ÕßºŸ∂â Õ◊ Àÿπâ

3. π‚¬∫“¬°“√∫—≠™’∑ ’Ë ”§—≠ ß∫°“√‡ß‘ππ’®È ¥— ∑”¢÷πÈ µ“¡¡“µ√∞“π°“√∫—≠™’¿“¬„µâæ√–√“™∫—≠≠—µ«‘ ™‘ “™’æ∫—≠™’ æ.». 2547 ß∫°“√‡ß‘π¢Õß∫√‘…∑— œ·≈–∫√‘…∑— ¬àÕ¬‰¥â®¥— ∑” ¢÷πÈ µ“¡À≈—°√“§“∑ÿπ‡¥‘¡ π‚¬∫“¬°“√∫—≠™’∑ ’Ë ”§—≠¢Õß∫√‘…∑— œ·≈–∫√‘…∑— ¬àÕ¬‚¥¬ √ÿª¡’¥ß— µàÕ‰ªπ’:È 3.1 °“√√—∫√Ÿ√â “¬‰¥â·≈–§à“„™â®“à ¬ √“¬‰¥â®“°°“√ª√–°Õ∫°‘®°“√‚√ßæ¬“∫“≈‚¥¬ à«π„À≠àª√–°Õ∫¥â«¬√“¬‰¥â§“à √—°…“æ¬“∫“≈ √“¬‰¥â‡¡◊ÕË ‰¥â„Àâ∫√‘°“√À√◊Õ®”Àπà“¬·≈â«

§à“ÀâÕßæ—° §à“¬“ ‚¥¬®–∫—π∑÷°‡ªìπ

√“¬‰¥â§“à ‡™à“ √“¬‰¥â§“à ∑’ªË √÷°…“·≈–°“√®—¥°“√ ¥Õ°‡∫’¬È √—∫ ·≈–§à“„™â®“à ¬∫—π∑÷°µ“¡‡°≥±å§ß§â“ß 3.2 ‡ß‘π ¥·≈–√“¬°“√‡∑’¬∫‡∑à“‡ß‘π ¥ ‡ß‘π ¥·≈–√“¬°“√‡∑’¬∫‡∑à“‡ß‘π ¥ À¡“¬∂÷ß ‡ß‘π ¥·≈–‡ß‘πΩ“° ∂“∫—π°“√‡ß‘π ´÷ßË ∂÷ß°”Àπ¥®à“¬§◊π¿“¬„π√–¬–‡«≈“‰¡à‡°‘π 3 ‡¥◊Õπ π—∫·µà«π— ∑’ΩË “°·≈–ª√“»®“°¿“√–ºŸ°æ—π 3.3 ≈Ÿ°Àπ’°È “√§â“·≈–§à“‡º◊ÕË Àπ’ È ß —¬®– Ÿ≠ ≈Ÿ°Àπ’°È “√§â“· ¥ßµ“¡¡Ÿ≈§à“ ÿ∑∏‘∑®’Ë –‰¥â√∫— ∫√‘…∑— œ·≈–∫√‘…∑— ¬àÕ¬∫—π∑÷°§à“‡º◊ÕË Àπ’ È ß —¬®– Ÿ≠ ”À√—∫º≈¢“¥∑ÿπ‚¥¬ª√–¡“≥∑’§Ë “¥ «à“®–‡°‘¥¢÷Èπ®“°Àπ’È∑’Ë‡√’¬°‡°Á∫‰¡à ‰¥â ∫√‘…—∑œ·≈–∫√‘…—∑¬àÕ¬ æ‘®“√≥“§«“¡‡æ’¬ßæÕ¢Õß§à“‡º◊ËÕÀπ’È ß —¬®– Ÿ≠‚¥¬æ‘®“√≥“∞“π– ªí®®ÿ∫π— ¢Õß≈Ÿ°Àπ’‡È ªìπ‡°≥±å Àπ’ È ≠Ÿ ®–∂Ÿ°µ—¥®”Àπà“¬‡¡◊ÕË ‰¡à “¡“√∂‡√’¬°‡°Á∫‡ß‘π‰¥â 3.4 ‘π§â“§ß‡À≈◊Õ ‘π§â“§ß‡À≈◊Õ· ¥ß¡Ÿ≈§à“µ“¡√“§“∑ÿπ («‘∏∂’ «— ‡©≈’¬Ë ) À√◊Õ¡Ÿ≈§à“ ÿ∑∏‘∑®’Ë –‰¥â√∫— ·≈â«·µàÕ¬à“ß„¥®– µË”°«à“

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

3.5 ∑’¥Ë π‘ Õ“§“√·≈–Õÿª°√≥å/§à“‡ ◊ÕË ¡√“§“ ∑’Ë¥‘π· ¥ß¡Ÿ≈§à“µ“¡√“§“∑ÿπ Õ“§“√·≈–Õÿª°√≥å· ¥ß¡Ÿ≈§à“µ“¡√“§“∑ÿπÀ—°§à“‡ ◊ËÕ¡√“§“ – ¡ §à“‡ ◊ËÕ¡√“§“¢ÕßÕ“§“√·≈– Õÿª°√≥å§”π«≥®“°√“§“∑ÿπ¢Õß ‘π∑√—æ¬å ‚¥¬«‘∏‡’ âπµ√ßµ“¡Õ“¬ÿ°“√„™âß“π‚¥¬ª√–¡“≥¢Õß ‘π∑√—æ¬å¥ß— µàÕ‰ªπ’:È ‘∑∏‘°“√‡™à“ à«πª√—∫ª√ÿß∑’¥Ë π‘ Õ“§“√·≈– ‘ßË ª≈Ÿ° √â“ß ‡§√◊ÕË ßÕÿª°√≥å√–∫∫Õ”π«¬§«“¡ –Õ“¥ ‡§√◊ÕË ß¡◊Õ·æ∑¬å Õÿª°√≥å ‚√ßæ¬“∫“≈ ‡§√◊ÕË ß„™â·≈–‡§√◊ÕË ßµ°·µàß ¬“πæ“Àπ–

µ“¡Õ“¬ÿ ≠— ≠“‡™à“ (30 ªï) 3 ªï ·≈– 30 ªï 8 - 30 ªï 5 - 20 ªï 5 - 15 ªï 3 - 15 ªï 5 - 15 ªï 5 - 10 ªï

‰¡à¡°’ “√§‘¥§à“‡ ◊ÕË ¡√“§“ ”À√—∫∑’¥Ë π‘ ·≈– ‘π∑√—æ¬å√–À«à“ß°àÕ √â“ß·≈–µ‘¥µ—ßÈ 3.6 °“√¥âÕ¬§à“¢Õß ‘π∑√—æ¬å ∫√‘…∑— œ·≈–∫√‘…∑— ¬àÕ¬ Õ∫∑“π°“√¥âÕ¬§à“¢Õß ‘π∑√—æ¬å‡¡◊ÕË ¡’¢Õâ ∫àß™’«È “à √“§“µ“¡∫—≠™’¢Õß ‘π∑√—æ¬å¡’¡≈Ÿ §à“ Ÿß°«à“¡Ÿ≈§à“∑’§Ë “¥«à“®– ‰¥â√∫— §◊π ´÷ßË ¡Ÿ≈§à“∑’§Ë “¥«à“®–‰¥â√∫— §◊π¥—ß°≈à“«¡“®“°°“√ª√–¡“≥°“√¢ÕßΩÉ“¬∫√‘À“√ „π°√≥’∑’Ë√“§“µ“¡∫—≠™’¢Õß ‘π∑√—æ¬å Ÿß°«à“¡Ÿ≈§à“∑’Ë§“¥«à“®–‰¥â√—∫§◊π ∫√‘…—∑œ·≈–∫√‘…—∑¬àÕ¬®–√—∫√Ÿâ¢“¥∑ÿπ®“°°“√¥âÕ¬§à“¢Õß ‘π∑√—æ¬å„πß∫°”‰√¢“¥∑ÿπ ·≈–®–∫—π∑÷°°≈—∫√“¬°“√¢“¥∑ÿπ®“°°“√¥âÕ¬§à“¢Õß ‘π∑√—æ¬å‡¡◊ËÕ¡’¢âÕ∫àß™’È«à“°“√≈¥¡Ÿ≈§à“¥—ß°≈à“«‰¡à¡’ Õ¬ŸÕà °’ µàÕ‰ªÀ√◊Õ¬—ß§ß¡’Õ¬Ÿ·à µà‡ªìπ‰ª„π∑“ß∑’≈Ë ¥≈ß‚¥¬∫—π∑÷°„π∫—≠™’√“¬‰¥âÕπ◊Ë 3.7 §à“µ—¥®”Àπà“¬ ‘π∑√—æ¬å‰¡à¡µ’ «— µπµ—¥®”Àπà“¬‚¥¬«‘∏’‡ âπµ√ß‡ªìπ‡«≈“ 5 ªï ·≈– 10 ªï 3.8 ‡ß‘π≈ß∑ÿπ ‡ß‘π≈ß∑ÿπ„π∫√‘…∑— ¬àÕ¬ („πß∫°“√‡ß‘π‡©æ“–¢Õß∫√‘…∑— œ) ·≈–∫√‘…∑— √à«¡· ¥ß¡Ÿ≈§à“µ“¡«‘∏ ’ «à π‰¥â‡ ’¬ ´÷ßË °“√∫—π∑÷°‡ß‘π≈ß∑ÿπµ“¡«‘∏’ à«π‰¥â‡ ’¬π’È‡ß‘π≈ß∑ÿπ®–∂Ÿ°∫—π∑÷°§√—Èß·√°„π√“§“∑ÿπ∑’Ë´◊ÈÕ¡“·≈–∂Ÿ°ª√—∫¥â«¬ à«π‰¥â‡ ’¬¢Õß∫√‘…—∑œ„πº≈°“√¥”‡π‘πß“π¢Õß∫√‘…—∑ ¬àÕ¬·≈–∫√‘…—∑√à«¡„π·µà≈–ªï º≈¢“¥∑ÿπ à«π∑’Ë‡°‘π°«à“¡Ÿ≈§à“‡ß‘π≈ß∑ÿπ„π∫√‘…—∑¬àÕ¬®–· ¥ß‡ªìπÀπ’È ‘π‰¡àÀ¡ÿπ‡«’¬π¿“¬„µâÀ—«¢âÕ ç§à“‡º◊ÕË º≈¢“¥∑ÿπ∑’‡Ë °‘π°«à“‡ß‘π≈ß∑ÿπ„π∫√‘…∑— ¬àÕ¬é ‡ß‘π≈ß∑ÿπ√–¬–¬“«Õ◊πË ∑’‡Ë ªìπµ√“ “√∑ÿπ∑’Ë‰¡àÕ¬Ÿà„π§«“¡µâÕß°“√¢Õßµ≈“¥ ´÷ßË ∫√‘…∑— œ∂◊Õ‡ªìπ ‡ß‘π≈ß∑ÿπ∑—Ë«‰ª· ¥ß¡Ÿ≈§à“µ“¡√“§“∑ÿπ ∫√‘…∑— œ®–∫—π∑÷°¢“¥∑ÿπ®“°°“√¥âÕ¬§à“ (∂â“¡’) ¢Õß‡ß‘π≈ß∑ÿπ ∑—«Ë ‰ª„πß∫°”‰√¢“¥∑ÿπ 3.9 ‡ß‘πµ√“µà“ßª√–‡∑» √“¬°“√∑’‡Ë ªìπ‡ß‘πµ√“µà“ßª√–‡∑»´÷ßË ‡°‘¥¢÷Èπ√–À«à“ßªï·ª≈ß§à“‡ªìπ‡ß‘π∫“∑‚¥¬„™âÕ—µ√“·≈°‡ª≈’¬Ë π ≥ «—π∑’Ë∑‡’Ë °‘¥√“¬°“√ ‘π∑√—æ¬å·≈– Àπ’È ‘π∑’Ë‡ªìπµ—«‡ß‘π∑’Ë‡ªìπ‡ß‘πµ√“µà“ßª√–‡∑»§ß‡À≈◊Õ ≥ «—π∑’Ë„πß∫¥ÿ≈·ª≈ß§à“‡ªìπ‡ß‘π∫“∑‚¥¬„™âÕµ— √“·≈°‡ª≈’¬Ë π ≥ «—π∑’Ë„πß∫¥ÿ≈ °”‰√·≈–¢“¥∑ÿπ∑’‡Ë °‘¥®“°°“√‡ª≈’¬Ë π·ª≈ß„πÕ—µ√“·≈°‡ª≈’¬Ë π‰¥â√«¡Õ¬Ÿà„π°“√§”π«≥º≈°“√¥”‡π‘πß“π 38

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

3.10 ‡§√◊ÕË ß¡◊Õ∑“ß°“√‡ß‘π ∫√‘…∑— œ·≈–∫√‘…∑— ¬àÕ¬‰¡à¡π’ ‚¬∫“¬∑’®Ë –ª√–°Õ∫∏ÿ√°√√¡µ√“ “√Õπÿæπ— ∏å∑“ß°“√‡ß‘ππÕ°ß∫¥ÿ≈‡æ◊ÕË °“√‡°Áß°”‰√À√◊Õ‡æ◊ÕË °“√§â“ ‡§√◊ÕË ß¡◊Õ∑“ß°“√‡ß‘π∑’·Ë ¥ß„πß∫¥ÿ≈ª√–°Õ∫¥â«¬‡ß‘π ¥·≈–‡ß‘πΩ“° ∂“∫—π°“√‡ß‘π ‡ß‘π≈ß∑ÿπ ≈Ÿ°Àπ’°È “√§â“ ‡®â“Àπ’È°“√§â“ ‡ß‘π„Àâ °Ÿ¬â ¡◊ ·≈–‡ß‘π°Ÿ¬â ¡◊ ´÷ßË π‚¬∫“¬°“√∫—≠™’‡©æ“– ”À√—∫√“¬°“√·µà≈–√“¬°“√‰¥â‡ªî¥‡º¬·¬°‰«â„π·µà≈–À—«¢âÕ∑’‡Ë °’¬Ë «¢âÕß 3.11 °“√„™âª√–¡“≥°“√∑“ß∫—≠™’ „π°“√®—¥∑”ß∫°“√‡ß‘πµ“¡À≈—°°“√∫—≠™’∑’Ë√—∫√Õß∑—Ë«‰ª „π∫“ß°√≥’ΩÉ“¬∫√‘À“√Õ“®µâÕß„™â °“√ª√–¡“≥°“√√“¬°“√∫—≠™’∫“ß √“¬°“√ ´÷ßË ¡’º≈°√–∑∫µàÕ®”π«π‡ß‘π∑’·Ë ¥ß„πß∫°“√‡ß‘π·≈–À¡“¬‡Àµÿª√–°Õ∫ß∫°“√‡ß‘π ¥â«¬‡Àµÿπº’È ≈∑’‡Ë °‘¥¢÷πÈ ®√‘ß„π¿“¬À≈—ß ®÷ßÕ“®·µ°µà“ß‰ª®“°®”π«π∑’ªË √–¡“≥‰«â 3.12 º≈ª√–‚¬™πåæπ—°ß“π ∫√‘…—∑œ·≈–∫√‘…—∑¬àÕ¬·≈–æπ—°ß“π‰¥â√à«¡°—π®¥∑–‡∫’¬π®—¥µ—Èß°Õß∑ÿπ ”√Õß‡≈’È¬ß™’æµ“¡æ√–√“™∫—≠≠—µ‘°Õß∑ÿπ ”√Õß‡≈’È¬ß™’æ æ.». 2530 ´÷ßË ª√–°Õ∫¥â«¬‡ß‘π∑’æË π—°ß“π®à“¬ – ¡·≈–‡ß‘π∑’∫Ë √‘…∑— œ·≈–∫√‘…∑— ¬àÕ¬®à“¬ ¡∑∫„Àâ‡ªìπ√“¬‡¥◊Õπ„πÕ—µ√“√âÕ¬≈– 5 ·≈–√âÕ¬≈– 5 - 7 ¢Õß‡ß‘π‡¥◊Õπæπ—°ß“πµ“¡≈”¥—∫ °Õß∑ÿπ ”√Õß‡≈’È¬ß™’æπ’∫È √‘À“√ ‚¥¬∫√‘…∑— À≈—°∑√—æ¬å®¥— °“√°Õß∑ÿπøîππ— ´à“ ®”°—¥ ·≈–®–®à“¬§◊π„Àâ·°àæπ—°ß“π„π°√≥’∑Õ’Ë Õ°®“°ß“πµ“¡√–‡∫’¬∫¢Õß°Õß∑ÿπœ „π√–À«à“ßªï 2548 ∫√‘…∑— œ·≈–∫√‘…∑— ¬àÕ¬‰¥â ®à“¬‡ß‘π ¡∑∫‡¢â“°Õß∑ÿπœ·≈–∫—π∑÷°‡ªìπ§à“„™â®“à ¬‡ªìπ®”π«π‡ß‘π 21.9 ≈â“π∫“∑ (2547: 17.1 ≈â“π∫“∑) 3.13 ¿“…’‡ß‘π‰¥âπµ‘ ∫‘ §ÿ §≈ ¿“…’‡ß‘π‰¥âπµ‘ ∫‘ §ÿ §≈§”π«≥¢÷πÈ ®“°°”‰√ ÿ∑∏‘À≈—ß®“°∫«°°≈—∫¥â«¬§à“„™â®“à ¬µà“ß Ê ∑’Ë‰¡àÕπÿ≠“µ„Àâ∂Õ◊ ‡ªìπ√“¬®à“¬„π°“√§”π«≥ ¿“…’·≈–À—°º≈¢“¥∑ÿπ – ¡∑“ß¿“…’¬°¡“®“°ªï°Õà π (∂â“¡’) ·≈–‰¡à√«¡ à«π·∫àß°”‰√¢“¥∑ÿπ®“°‡ß‘π≈ß∑ÿπµ“¡«‘∏ ’ «à π‰¥â‡ ’¬·≈– ‡ß‘πªíπº≈√—∫®“°∫√‘…∑— ¬àÕ¬ 3.14 °”‰√µàÕÀÿπâ °”‰√µàÕÀÿπâ ¢—πÈ æ◊πÈ ∞“π§”π«≥‚¥¬°“√À“√°”‰√ ÿ∑∏‘ ”À√—∫ªï¥«â ¬®”π«π∂—«‡©≈’¬Ë ∂à«ßπÈ”Àπ—°¢ÕßÀÿπâ “¡—≠∑’ÕË Õ°Õ¬Ÿà„π√–À«à“ßªï °”‰√µàÕÀÿâπª√—∫≈¥§”π«≥‚¥¬°“√À“√°”‰√ ÿ∑∏‘ ”À√—∫ªïÀ≈—ß®“°ª√—∫ª√ÿßº≈°√–∑∫¢Õß√“¬°“√∑’Ë‡°’Ë¬«°—∫Àÿâπ “¡—≠‡∑’¬∫‡∑à“ª√—∫ ≈¥¥â«¬º≈√«¡¢Õß®”π«π∂—«‡©≈’Ë¬∂à«ßπÈ”Àπ—°¢ÕßÀÿâπ “¡—≠∑’ËÕÕ°Õ¬Ÿà „π√–À«à“ßªï°—∫®”π«π∂—«‡©≈’Ë¬∂à«ßπÈ”Àπ—°¢ÕßÀÿâπ “¡—≠∑’Ë ∫√‘…∑— œÕ“®µâÕßÕÕ°‡æ◊ÕË ·ª≈ßÀÿπâ “¡—≠‡∑’¬∫‡∑à“ª√—∫≈¥∑—ßÈ ‘πÈ „Àâ‡ªìπÀÿπâ “¡—≠

4. ‡ß‘πΩ“°ª√–®”°—∫ ∂“∫—π°“√‡ß‘π∑’πË ”‰ª§È”ª√–°—π ≥ «—π∑’Ë 31 ∏—π«“§¡ 2548 ‡ß‘πΩ“°°—∫ ∂“∫—π°“√‡ß‘π®”π«π 9.9 ≈â“π∫“∑ (2547: 9.8 ≈â“π∫“∑) ‰¥âπ”‰ª«“ß‰«â°∫— ∏π“§“√‡æ◊ÕË ‡ªìπ À≈—°ª√–°—π ”À√—∫Àπ—ß ◊Õ§È”ª√–°—π∑’Ë∏π“§“√ÕÕ°„Àâ „ππ“¡¢Õß∫√‘…—∑œ·≈–∫√‘…—∑¬àÕ¬·ÀàßÀπ÷Ëß (∫√‘…—∑ ∫”√ÿß√“…Æ√å ‡¡¥‘§Õ≈ ‡´Áπ‡µÕ√å ®”°—¥) ·≈–‡ß‘πΩ“°ª√–®”®”π«π 220 ≈â“π∫“∑ (2547: 220 ≈â“π∫“∑) „™â‡ªìπÀ≈—°ª√–°—π ”À√—∫ —≠≠“‡ß‘π°Ÿ¬â ◊¡√–¬–¬“« ¢Õß∫√‘…∑— ¬àÕ¬·Ààß‡¥’¬«°—πµ“¡∑’°Ë ≈à“«„π À¡“¬‡Àµÿ 12 ∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

5. ≈Ÿ°Àπ’°È “√§â“ ≈Ÿ°Àπ’°È “√§â“ ≥ «—π∑’Ë 31 ∏—π«“§¡ 2548 ·≈– 2547 ®”·π°µ“¡Õ“¬ÿÀπ’È∑§’Ë “â ß™”√–‰¥â¥ß— π’:È -

√–¬–‡«≈“§â“ß™”√– ¬—ß‰¡à∂ß÷ °”Àπ¥™”√– ‡°‘π°”Àπ¥ 1 - 30 «—π 31 - 60 «—π 61 - 90 «—π 91 - 180 «—π 181 - 365 «—π ¡“°°«à“ 365 «—π √«¡ À—°: §à“‡º◊ÕË Àπ’ È ß —¬®– Ÿ≠ ÿ∑∏‘

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

ß∫°“√‡ß‘π√«¡ 2548 2547 209,272,336 136,767,440

(Àπà«¬: ∫“∑) ß∫°“√‡ß‘π‡©æ“–∫√‘…∑— œ 2548 2547 186,997,648 136,417,029

67,190,268 24,610,224 15,250,749 22,180,489 15,347,076 28,688,726 382,539,868 (43,064,847) 339,475,021

65,560,381 24,016,496 14,244,873 22,038,206 14,690,543 28,679,631 356,227,778 (41,576,294) 314,651,484

64,123,228 20,727,678 6,726,545 8,740,767 11,208,297 17,035,150 265,329,105 (30,371,070) 234,958,035

63,970,698 20,454,501 6,623,260 8,618,016 11,138,405 17,035,150 264,257,059 (30,371,070) 233,885,989

√“¬ß“πª√–®”ªï 2548

6. √“¬°“√∏ÿ√°‘®°—∫°‘®°“√∑’‡Ë °’¬Ë «¢âÕß°—π „π√–À«à“ßªï ∫√‘…∑— œ¡’√“¬°“√∏ÿ√°‘®∑’ Ë ”§—≠°—∫∫√‘…∑— ¬àÕ¬·≈–∫√‘…∑— ∑’‡Ë °’¬Ë «¢âÕß°—π ´÷ßË ‡°’¬Ë «¢âÕß°—π‚¥¬ °“√∂◊ÕÀÿπâ À√◊Õ°“√¡’º∂Ÿâ Õ◊ Àÿπâ À√◊Õ °√√¡°“√∫“ß à«π√à«¡°—π √“¬°“√∏ÿ√°‘®¥—ß°≈à“«‡ªìπ‰ªµ“¡‡ß◊ËÕπ‰¢·≈–‡°≥±åµ“¡ —≠≠“∑’Ëµ°≈ß√à«¡°—π√–À«à“ß∫√‘…—∑œ·≈–∫√‘…—∑‡À≈à“ π—πÈ ‚¥¬ “¡“√∂ √ÿª‰¥â¥ß— π’È: -

ß∫°“√‡ß‘π‡©æ“–∫√‘…∑— œ 2548 2547

(Àπà«¬: ≈â“π∫“∑) π‚¬∫“¬°”Àπ¥√“§“

√“¬°“√∏ÿ√°‘®°—∫∫√‘…∑— ¬àÕ¬ √“¬‰¥â§“à ‡™à“ √“¬‰¥â§“à ∏√√¡‡π’¬¡™¥‡™¬°“√‡ ’¬‚Õ°“ ∑“ß∏ÿ√°‘® ¥Õ°‡∫’¬È √—∫

25.1 2.4

40.6 25.5 2.0

√“¬‰¥â§“à ∫√‘°“√∑“ß°“√·æ∑¬å √“¬‰¥â§“à ∑’ªË √÷°…“ ‡ß‘πªíπº≈√—∫ √“¬‰¥âÕπ◊Ë §à“‡™à“®à“¬ ¥Õ°‡∫’¬È ®à“¬ ®à“¬§à“µÕ∫·∑π„π°“√´◊ÕÈ °‘®°“√‚√ßæ¬“∫“≈ ÿ∑∏‘ ´◊ÕÈ Õÿª°√≥å ¢“¬Õÿª°√≥å

10.6 9.9 84.0 101.5 8.5 0.7

3.3 24.8 239.7 35.0 26.0 772.2 -

µ“¡ —≠≠“ °) µ“¡ —≠≠“ ¢) Õ—µ√“ MLR ≈∫Õ—µ√“√âÕ¬≈– 0.5 µàÕªï (2547: √âÕ¬≈– 11 µàÕªï ·≈–Õ—µ√“ MLR ≈∫Õ—µ√“√âÕ¬≈– 0.5 µàÕªï) √“§“∑ÿπ∫«°°”‰√ à«π‡æ‘¡Ë µ“¡ —≠≠“ §) Àÿâπ≈– 2 ∫“∑ µ“¡∑’®Ë “à ¬®√‘ß µ“¡ —≠≠“ ß) Õ—µ√“ MLR ≈∫Õ—µ√“√âÕ¬≈– 0.45 µàÕªï √“§“µ“¡∫—≠™’∫«°°”‰√ √“§“µ“¡∫—≠™’∫«°°”‰√ √“§“µ“¡∫—≠™’

√“¬°“√∏ÿ√°‘®°—∫∫√‘…∑— ∑’‡Ë °’¬Ë «¢âÕß°—π √“¬‰¥â§“à ∫√‘°“√∑“ß°“√·æ∑¬å √“¬‰¥â§“à ‡™à“ ¥Õ°‡∫’¬È √—∫ §à“‡™à“®à“¬ §à“∫√‘®“§®à“¬ ´◊ÕÈ ‚ª√·°√¡§Õ¡æ‘«‡µÕ√å §à“‡∫’¬È ª√–°—π®à“¬

12.4 1.3 20.1 11.6 64.2 15.6

1.0 1.9 12.9 19.6 0.6 415.2 0.9

√“§“∑ÿπ∫«°°”‰√ à«π‡æ‘¡Ë µ“¡ —≠≠“ ®) Õ—µ√“ MLR µàÕªï µ“¡ —≠≠“ ©) µ“¡ —≠≠“ ™) µ“¡∑’√Ë –∫ÿ„π°√¡∏√√¡åª√–°—π¿—¬

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

ß∫°“√‡ß‘π√«¡ 2548 2547 √“¬°“√∏ÿ√°‘®°—∫∫√‘…∑— ¬àÕ¬ (µ—¥ÕÕ°®“°ß∫°“√‡ß‘π√«¡·≈â«) ¥Õ°‡∫’¬È √—∫ √“¬°“√∏ÿ√°‘®°—∫∫√‘…∑— ∑’‡Ë °’¬Ë «¢âÕß°—π √“¬‰¥â§“à ∫√‘°“√∑“ß°“√·æ∑¬å √“¬‰¥â§“à ∫√‘°“√µ‘¥µ—ßÈ √–∫∫ √“¬‰¥â§“à ≈‘¢ ‘∑∏‘Ï ‚ª√·°√¡§Õ¡æ‘«‡µÕ√å √“¬‰¥â§“à ‡™à“ √“¬‰¥â§“à ∏√√¡‡π’¬¡°“√®—¥°“√ ¥Õ°‡∫’¬È √—∫ §à“‡™à“®à“¬ §à“∫√‘®“§®à“¬ §à“∫√‘°“√¥Ÿ·≈√—°…“‚ª√·°√¡§Õ¡æ‘«‡µÕ√å ´◊ÕÈ ‚ª√·°√¡§Õ¡æ‘«‡µÕ√å ¢“¬Õÿª°√≥å §à“∫√‘°“√µ‘¥µ—ßÈ √–∫∫®à“¬ §à“‡∫’¬È ª√–°—π®à“¬

1.9

12.4 6.8 5.7 1.3 23.1 20.1 11.6 164.2 7.7 4.1 15.7

13.8 1.9 17.5 19.6 8.2 7.7 415.2 7.4

(Àπà«¬: ≈â“π∫“∑) π‚¬∫“¬°”Àπ¥√“§“

√âÕ¬≈– 10 µàÕªï √“§“∑ÿπ∫«°°”‰√ à«π‡æ‘¡Ë µ“¡ —≠≠“ ´) µ“¡ —≠≠“ ¨) µ“¡ —≠≠“ ®) µ“¡ —≠≠“ ≠) Õ—µ√“ MLR µàÕªï µ“¡ —≠≠“ ©) µ“¡¢âÕ ™) µ“¡ —≠≠“ ™) µ“¡¢âÕ ™) µ“¡ —≠≠“ ´) µ“¡∑’√Ë –∫ÿ„π°√¡∏√√¡åª√–°—π¿—¬

°) ∫√‘…∑— ¬àÕ¬ (∫√‘…∑— ∫”√ÿß√“…Æ√å ‡¡¥‘§Õ≈ ‡´Áπ‡µÕ√å ®”°—¥) ‰¥â∑” —≠≠“‡™à“∑’¥Ë π‘ Õ“§“√·≈–ÀÕæ—°æ¬“∫“≈ °—∫∫√‘…∑— œ ‡æ◊ÕË ª√–°Õ∫ ∏ÿ√°‘®‚√ßæ¬“∫“≈‡ªìπ√–¬–‡«≈“ 30 ªï ‡√‘¡Ë µ—ßÈ ·µàªï 2539 §à“‡™à“¥—ß°≈à“«§‘¥‡ªìπ®”π«π‡ß‘πªï≈– 40.1 ≈â“π∫“∑ ´÷ßË ‰¡à√«¡§à“‡™à“∫’‡Õ™ ‡√ ´‘‡¥π´å ‡¡◊ÕË «—π∑’Ë 1 ‘ßÀ“§¡ 2547 ∫√‘…∑— ¬àÕ¬‰¥â¬°‡≈‘° —≠≠“‡™à“Õ“§“√ ÀÕæ—°æ¬“∫“≈·≈–Õ“§“√∫’‡Õ™ ‡√ ´‘‡¥π´å°∫— ∫√‘…∑— œ ∫√‘…∑— ¬àÕ¬®÷ß‰¡à¡¿’ “√–∑’µË Õâ ß®à“¬§à“‡™à“¥—ß°≈à“«Õ’°µàÕ‰ª ∫√‘…∑— ¬àÕ¬ (∫√‘…∑— ‰«∑—≈‰≈øá ®”°—¥) ‰¥â∑” —≠≠“‡™à“Õ“§“√°—∫∫√‘…∑— œ‡æ◊ÕË ª√–°Õ∫∏ÿ√°‘®‡ªìπ√–¬–‡«≈“ 11 ªï ‡√‘¡Ë µ—ßÈ ·µàªï 2544 §à“‡™à“ Õ“§“√¥—ß°≈à“«§‘¥‡ªìπ®”π«π‡ß‘πªï≈– 3 ≈â“π∫“∑ ‡¡◊ÕË «—π∑’Ë 1 °√°Æ“§¡ 2547 ∫√‘…∑— œ·≈–∫√‘…∑— ¬àÕ¬‰¥â∑”∫—π∑÷°·°â‰¢‡æ‘¡Ë ‡µ‘¡µàÕ ∑â“¬ —≠≠“‡™à“ ‚¥¬∫√‘…∑— ¬àÕ¬µâÕß®à“¬§à“‡™à“„πÕ—µ√“√âÕ¬≈– 5 ¢Õß√“¬‰¥â√«¡¿“…’¡≈Ÿ §à“‡æ‘¡Ë ·µà‰¡àπÕâ ¬°«à“‡¥◊Õπ≈– 238,200 ∫“∑ ¢) ∫√‘…∑— ¬àÕ¬ (∫√‘…∑— ∫”√ÿß√“…Æ√å ‡¡¥‘§Õ≈ ‡´Áπ‡µÕ√å ®”°—¥) ‰¥â∑” —≠≠“°—∫∫√‘…∑— œ‚¥¬¡’«µ— ∂ÿª√– ß§å‡æ◊ÕË ¡‘„Àâ∫√‘…∑— œ¥”‡π‘π∏ÿ√°‘® ‚√ßæ¬“∫“≈„πæ◊πÈ ∑’Ë„°≈â‡§’¬ß —≠≠“¥—ß°≈à“«¡’°”Àπ¥ 30 ªï ‡√‘¡Ë ®“°ªï 2540 ¿“¬„µâ‡ß◊ÕË π‰¢∑’√Ë –∫ÿ„π —≠≠“ ∫√‘…—∑¬àÕ¬¡’¿“√– §à“∏√√¡‡π’¬¡∑’µË Õâ ß®à“¬¿“¬„π‡«≈“ 9 ªï §‘¥‡ªìπ®”π«π√«¡∑—ßÈ ‘πÈ 255 ≈â“π∫“∑ ‚¥¬‡√‘¡Ë ∫—π∑÷°¿“√–„πªï 2540 ®”π«π 51 ≈â“π∫“∑ ·≈–ªï∂¥— ‰ªÕ’° 8 ªï ‚¥¬¡’¿“√–§à“∏√√¡‡π’¬¡ªï≈– 25.5 ≈â“π∫“∑ πÕ°®“°π’È ∫√‘…∑— œ§‘¥¥Õ°‡∫’¬È ”À√—∫§à“∏√√¡‡π’¬¡∑’¬Ë ß— ‰¡à‰¥â√∫— ™”√– „πÕ—µ√“√âÕ¬≈– 11 µàÕªï ∑—ßÈ π’¿È “¬À≈—ß®“°°“√¢“¬°‘®°“√‚√ßæ¬“∫“≈„Àâ·°à∫√‘…∑— œ ∫√‘…∑— ¬àÕ¬®÷ß ‰¡à¡¿’ “√–∑’µË Õâ ß®à“¬§à“∏√√¡‡π’¬¡ ¥—ß°≈à“«Õ’°µàÕ‰ª §) ∫√‘…∑— œ‰¥â∑” —≠≠“„Àâ∫√‘°“√‡°’¬Ë «°—∫°“√®—¥°“√·°à∫√‘…∑— ‰«∑—≈‰≈øá ®”°—¥ ´÷ßË —≠≠“°”Àπ¥„Àâ∫√‘…∑— ‰«∑—≈‰≈øá ®”°—¥ µâÕß®à“¬ §à“∏√√¡‡π’¬¡°“√®—¥°“√„Àâ·°à∫√‘…—∑œ„πÕ—µ√“√âÕ¬≈– 3.5 ¢Õß√“¬‰¥â ‚¥¬„π‡¥◊Õπ°—π¬“¬π 2547 ∑—Èß Õß∫√‘…—∑µ°≈ß√à«¡°—π„π °“√¬°‡≈‘° —≠≠“¥—ß°≈à“« 42

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

∫√‘…∑— œ‰¥â∑” —≠≠“„Àâ∫√‘°“√¥â“π°“√„Àâ§”·π–π”·≈–ª√÷°…“·°à∫√‘…∑— ∫”√ÿß√“…Æ√å ‡¡¥‘§Õ≈ ‡´Áπ‡µÕ√å ®”°—¥ ‚¥¬§‘¥§à“∏√√¡‡π’¬¡∑’Ë ª√÷°…“ ”À√—∫‡¥◊Õπ ‘ßÀ“§¡∂÷ß∏—π«“§¡ 2547 ‡ªìπ®”π«π∑—ßÈ ‘πÈ 24 ≈â“π∫“∑ ß) ∫√‘…∑— œ‰¥â∑” —≠≠“‡™à“Õ“§“√‚√ßæ¬“∫“≈°—∫∫√‘…∑— ∫”√ÿß√“…Æ√å ‡¡¥‘§Õ≈ ‡´Áπ‡µÕ√å ®”°—¥ ‡æ◊ÕË ¥”‡π‘π°‘®°“√‚√ßæ¬“∫“≈‡ªìπ√–¬– ‡«≈“ 3 ªï ‡√‘¡Ë µ—Èß·µà‡¥◊Õπ ‘ßÀ“§¡ 2547 §à“‡™à“Õ“§“√¥—ß°≈à“«§‘¥‡ªìπ®”π«π‡ß‘πªï≈– 84 ≈â“π∫“∑ ®) ∫√‘…∑— ‚°≈‡∫‘≈ ·§√å ‚´≈Ÿ™π—Ë (ª√–‡∑»‰∑¬) ®”°—¥ ‰¥â∑” —≠≠“‡™à“æ◊πÈ ∑’ÕË “§“√°—∫∫√‘…∑— œ‡æ◊ÕË ª√–°Õ∫∏ÿ√°‘®‡ªìπ√–¬–‡«≈“ 3 ªï ‡√‘¡Ë µ—ßÈ ·µàªï 2544 ·≈– “¡“√∂µàÕÕ“¬ÿ —≠≠“‰¥âÕ’° 3 ªï §à“‡™à“Õ“§“√¥—ß°≈à“« §‘¥‡ªìπ®”π«π‡ß‘πªï≈– 1 ≈â“π∫“∑ ´÷ßË ‰¡à√«¡§à“‡™à“ÀâÕßæ—° Õ“§“√∫’‡Õ™ ‡√ ´‘‡¥π´å ©) ∫√‘…∑— œ‰¥â∑” —≠≠“‡™à“∑’¥Ë π‘ æ√âÕ¡ ‘ßË ª≈Ÿ° √â“ß (Õ“§“√∫’‡Õ™∑“«‡«Õ√å) °—∫∏π“§“√°√ÿß‡∑æ ®”°—¥ (¡À“™π) ‡ªìπ√–¬–‡«≈“ 3 ªï ‡√‘¡Ë µ—ßÈ ·µà‡¥◊Õπ ‘ßÀ“§¡ 2543 §à“‡™à“®à“¬®”π«π¥—ß°≈à“«§”π«≥¢÷πÈ „πÕ—µ√“√âÕ¬≈– 75 ¢Õß√“¬‰¥â ∑ÿ ∏‘ (√“¬√—∫√«¡À—°√“¬®à“¬√«¡) ®“°°“√„Àâ‡™à“™à«ß ·µà‰¡àπÕâ ¬°«à“ªï≈– 8 ≈â“π∫“∑ ‡¡◊ÕË «—π∑’Ë 11 æƒ»®‘°“¬π 2548 ∏π“§“√‰¥âÕπÿ¡µ— ‘„Àâ∫√‘…∑— œµàÕ —≠≠“‡™à“ ´÷Ëß‡√‘¡Ë µ—ßÈ ·µà«π— ∑’Ë 29 ‘ßÀ“§¡ 2548 ∂÷ß«—π∑’Ë 28 ‘ßÀ“§¡ 2549 ‚¥¬Õ—µ√“§à“‡™à“·≈–‡ß◊ÕË π‰¢Õ◊Ëπ„Àâ‡ªìπ‰ªµ“¡ —≠≠“‡™à“‡¥‘¡ §à“‡™à“§â“ß®à“¬ ≥ «—π∑’Ë 31 ∏—π«“§¡ 2548 ¡’®”π«π 3.3 ≈â“π∫“∑ (2547: 4.3 ≈â“π∫“∑) ‰¥â∫π— ∑÷°√«¡Õ¬Ÿà„π∫—≠™’‡®â“Àπ’ÕÈ π◊Ë „πß∫¥ÿ≈ ™) „π‡¥◊Õπ∏—π«“§¡ 2547 ∫√‘…∑— œ‰¥â∑” —≠≠“°—∫∫√‘…∑— ‚°≈‡∫‘≈ ·§√å ‚´≈Ÿ™π—Ë (ª√–‡∑»‰∑¬) ®”°—¥ ‡æ◊ÕË ´◊ÕÈ ‚ª√·°√¡§Õ¡æ‘«‡µÕ√å‡ªìπ ®”π«π∑—ßÈ ‘πÈ 10.3 ≈â“π‡À√’¬≠ À√—∞œ (‰¡à√«¡¿“…’¡≈Ÿ §à“‡æ‘¡Ë ) ´÷ßË ∫√‘…∑— œ‰¥â™”√–§à“‚ª√·°√¡§Õ¡æ‘«‡µÕ√å¥ß— °≈à“«·≈â«∑—ßÈ ®”π«π „π‡¥◊Õπ¡°√“§¡ 2548 ∫√‘…∑— œ‰¥â∑” —≠≠“°—∫∫√‘…∑— ‚°≈‡∫‘≈ ·§√å ‚´≈Ÿ™π—Ë (ª√–‡∑»‰∑¬) ®”°—¥ ‡æ◊ÕË ´◊ÕÈ ‚ª√·°√¡§Õ¡æ‘«‡µÕ√å‡æ‘¡Ë ‡µ‘¡ ‡ªìπ®”π«π∑—ßÈ ‘πÈ 1.5 ≈â“π‡À√’¬≠ À√—∞œ (‰¡à√«¡¿“…’¡≈Ÿ §à“‡æ‘¡Ë ) ‚¥¬„π‰µ√¡“ ∑’ÀË π÷ßË ¢Õßªï 2548 ∫√‘…∑— œ‰¥â™”√–§à“‚ª√·°√¡ §Õ¡æ‘«‡µÕ√å¥ß— °≈à“«·≈â«∑—ßÈ ®”π«π ∫√‘…∑— ¬àÕ¬ (∫√‘…∑— ∫”√ÿß√“…Æ√å Õ‘π‡µÕ√å‡π™—πË ·π≈ ®”°—¥) ‰¥â∑” —≠≠“´◊ÕÈ ≈‘¢ ‘∑∏‘Ï ‚ª√·°√¡§Õ¡æ‘«‡µÕ√å°—∫∫√‘…∑— ‚°≈‡∫‘≈ ·§√å ‚´≈Ÿ™π—Ë (ª√–‡∑»‰∑¬) ®”°—¥ „π‡¥◊Õπ¡°√“§¡ 2548 ‡æ◊ÕË „™â„π°“√ª√–°Õ∫∏ÿ√°‘®‡°’¬Ë «°—∫°“√„Àâ∫√‘°“√°“√®—¥°“√∏ÿ√°‘®‚√ßæ¬“∫“≈„πµà“ß ª√–‡∑» ∑—ßÈ π’È ∫√‘…∑— ¬àÕ¬‰¥â®“à ¬™”√–§à“∏√√¡‡π’¬¡¢—πÈ µË”®”π«π 2.5 ≈â“π‡À√’¬≠ À√—∞œ ·≈â«„π‰µ√¡“ ∑’ Ë Õß¢Õßªï 2548 „π‡¥◊Õπ¡°√“§¡ 2548 ∫√‘…∑— ¬àÕ¬ (∫√‘…∑— ∫”√ÿß√“…Æ√å ‡¡¥‘§Õ≈ ‡´Áπ‡µÕ√å ®”°—¥) ‰¥â¢“¬Õÿª°√≥å„Àâ∫√‘…∑— ‚°≈‡∫‘≈ ·§√å ‚´≈Ÿ™π—Ë (ª√–‡∑»‰∑¬) ®”°—¥ ®”π«π‡ß‘π 7.7 ≈â“π∫“∑ „π√“§“µ“¡∫—≠™’∫«°°”‰√ à«π‡æ‘¡Ë ·≈–‰¥â√∫— ™”√–‡ß‘π‡√’¬∫√âÕ¬·≈â« ∫√‘…∑— ∫”√ÿß√“…Æ√å ‡¡¥‘§Õ≈ ‡´Áπ‡µÕ√å ®”°—¥µâÕß®à“¬§à“∫√‘°“√„π°“√¥Ÿ·≈√—°…“‚ª√·°√¡§Õ¡æ‘«‡µÕ√å„Àâ·°à∫√‘…∑— ‚°≈‡∫‘≈ ·§√å ‚´≈Ÿ™π—Ë (ª√–‡∑»‰∑¬) ®”°—¥ §à“∫√‘°“√§â“ß®à“¬ ≥ «—π∑’Ë 31 ∏—π«“§¡ 2547 ¡’®”π«π 7.7 ≈â“π∫“∑ ‰¥â∫π— ∑÷°√«¡Õ¬Ÿà„π∫—≠™’‡®â“Àπ’ÕÈ π◊Ë „πß∫°“√‡ß‘π√«¡ ∫√‘…∑— ‰¥â®“à ¬™”√–§à“∫√‘°“√¥—ß°≈à“«·≈â«„π√–À«à“ßªï 2548 ´) „π‡¥◊Õπ‡¡…“¬π 2548 ∫√‘…∑— ¬àÕ¬ (∫√‘…∑— ∫”√ÿß√“…Æ√å Õ‘π‡µÕ√å‡π™—πË ·π≈ ®”°—¥) ‰¥â∑” —≠≠“°—∫ ∫√‘…∑— ‚°≈‡∫‘≈ ·§√å ‚´≈Ÿ™π—Ë (ª√–‡∑»‰∑¬) ®”°—¥ ‡°’¬Ë «°—∫°“√„Àâ∫√‘°“√µ‘¥µ—ßÈ ‚ª√·°√¡§Õ¡æ‘«‡µÕ√å„Àâ·°à∫√‘…∑— ‡Õ‡™’¬π ŒÕ æ‘∑Õ≈ Õ‘ß§å (AHI) ‡æ◊ÕË „™â„π °“√ª√–°Õ∫∏ÿ√°‘®‚√ßæ¬“∫“≈„πµà“ßª√–‡∑» §à“∫√‘°“√¥—ß°≈à“«§‘¥‡ªìπ®”π«π‡ß‘π∑—ßÈ ‘πÈ 200,000 ‡À√’¬≠ À√—∞œ ‚¥¬„πªï 2548 ∫√‘…∑— ¬àÕ¬‰¥â∫π— ∑÷°§à“∫√‘°“√µ‘¥µ—ßÈ ‚ª√·°√¡§Õ¡æ‘«‡µÕ√å¥ß— °≈à“«·≈â«‡ªìπ®”π«π 103,000 ‡À√’¬≠ À√—∞œ ∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

∑—Èßπ’È ∫√‘…—∑¬àÕ¬‰¥â∑” —≠≠“‡°’Ë¬«°—∫∫√‘°“√µ‘¥µ—Èß‚ª√·°√¡§Õ¡æ‘«‡µÕ√å¥—ß°≈à“«¢â“ßµâπ°—∫ AHI ‚¥¬§‘¥§à“∫√‘°“√‡ªìπ®”π«π‡ß‘π ∑—ßÈ ‘πÈ 350,000 ‡À√’¬≠ À√—∞œ ‚¥¬„πªï 2548 ∫√‘…∑— ¬àÕ¬‰¥â√∫— ™”√–§à“∫√‘°“√µ‘¥µ—ßÈ ‚ª√·°√¡§Õ¡æ‘«‡µÕ√å¥ß— °≈à“«·≈â«‡ªìπ®”π«π 175,000 ‡À√’¬≠ À√—∞œ ¨) ∫√‘…—∑¬àÕ¬ (∫√‘…—∑ ∫”√ÿß√“…Æ√å Õ‘π‡µÕ√å‡π™—Ëπ·π≈ ®”°—¥) ‰¥â∑” —≠≠“¢“¬≈‘¢ ‘∑∏‘Ï ‚ª√·°√¡§Õ¡æ‘«‡µÕ√å°—∫∫√‘…—∑ ‡Õ‡™’¬π ŒÕ æ‘∑Õ≈ Õ‘ß§å (AHI) „π‡¥◊Õπ°ÿ¡¿“æ—π∏å 2548 ‚¥¬ AHI ‰¥â®“à ¬™”√–§à“≈‘¢ ‘∑∏‘‡Ï ªìπ®”π«π 52,676,342 ‡ª‚´·≈â«„πªï 2548 ∑—ßÈ π’È ∫√‘…∑— ¬àÕ¬®–∑¬Õ¬√—∫√Ÿ§â “à ≈‘¢ ‘∑∏‘¥Ï ß— °≈à“«‡ªìπ√“¬‰¥âµ“¡√–¬–‡«≈“∑’°Ë ”Àπ¥„π —≠≠“ §à“≈‘¢ ‘∑∏‘∑Ï ¬’Ë ß— ‰¡à√∫— √Ÿ‡â ªìπ√“¬‰¥â ≥ «—π∑’Ë 31 ∏—π«“§¡ 2548 ¡’®”π«π 32.6 ≈â“π∫“∑ ‰¥â∫π— ∑÷°√«¡Õ¬Ÿà„π∫—≠™’√“¬‰¥â√∫— ≈à«ßÀπâ“„πß∫¥ÿ≈ ≠) ∫√‘…∑— ¬àÕ¬ (∫√‘…∑— ∫”√ÿß√“…Æ√å Õ‘π‡µÕ√å‡π™—πË ·π≈ øî≈ª‘ ªîπ å Õ‘ß§å) (BIPI) ‰¥â∑” —≠≠“„Àâ∫√‘°“√°“√®—¥°“√·°à∫√‘…∑— ‡Õ‡™’¬π ŒÕ æ‘∑Õ≈ Õ‘ß§å (AHI) ´÷ßË —≠≠“°”Àπ¥„Àâ AHI µâÕß®à“¬§à“∏√√¡‡π’¬¡°“√®—¥°“√„Àâ·°à∫√‘…∑— ¬àÕ¬µ“¡Õ—µ√“√âÕ¬≈–¢Õß√“¬‰¥â ∑ÿ ∏‘·≈– °”‰√°àÕπ¥Õ°‡∫’È¬®à“¬ ¿“…’‡ß‘π‰¥â §à“‡ ◊ËÕ¡√“§“·≈–§à“µ—¥®”Àπà“¬ ‚¥¬§à“∏√√¡‡π’¬¡¥—ß°≈à“«®–®à“¬‡ªìπ‡ß‘π ¥®π∂÷ß¬Õ¥§ß∑’Ë ®”π«πÀπ÷ßË à«π‡°‘π¬Õ¥§ß∑’¥Ë ß— °≈à“«®–®à“¬‡ªìπÀÿπâ ¢Õß AHI ®π∂÷ß√âÕ¬≈– 10 ¢Õß®”π«πÀÿπâ ∑’ÕË Õ°·≈–‡√’¬°™”√–·≈â«¢Õß AHI («‘∏ª’ √—∫≈¥) —≠≠“¡’√–¬–‡«≈“ 5 ªï ‘πÈ ÿ¥ªï 2553 ·≈– “¡“√∂µàÕÕ“¬ÿ ≠— ≠“‰¥â §à“∏√√¡‡π’¬¡°“√®—¥°“√∑’¬Ë ß— ‰¡à‰¥â√—∫™”√– ≥ «—π∑’Ë 31 ∏—π«“§¡ 2548 ¡’®”π«π 22.8 ≈â“π∫“∑ ‰¥â∫π— ∑÷°√«¡Õ¬Ÿà„π∫—≠™’≈°Ÿ Àπ’°È “√§â“„πß∫°“√‡ß‘π√«¡ ¬Õ¥§ß§â“ß¢Õß√“¬°“√¢â“ßµâπ (πÕ°‡Àπ◊Õ®“°¢âÕ ©), ™), ¨) ·≈– ≠)) ‰¥â· ¥ß·¬°µà“ßÀ“°„πß∫¥ÿ≈ ¥—ßπ’:È ß∫°“√‡ß‘π√«¡ 2548 2547 ‡ß‘π„Àâ°¬Ÿâ ¡◊ √–¬– —πÈ ·≈–¥Õ°‡∫’¬È §â“ß√—∫ - °‘®°“√∑’‡Ë °’¬Ë «¢âÕß°—π Õ¥’µ∫√‘…∑— ¬àÕ¬ ∫√‘…∑— ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å√–¬Õß ®”°—¥ À—°: §à“‡º◊ÕË Àπ’ È ß —¬®– Ÿ≠ ∫√‘…∑— ¬àÕ¬ ∫√‘…∑— ∫”√ÿß√“…Æ√å Õ‘π‡µÕ√å‡π™—πË ·π≈ ®”°—¥ ∫√‘…∑— ‰«∑—≈‰≈øá ®”°—¥ ∫√‘…∑— √à«¡ ∫√‘…∑— ‡Õ‡™’¬π ŒÕ æ‘∑Õ≈ Õ‘ß§å ∫√‘…∑— ·Õ≈ ‡Õ §≈‘ππ‘ßË ®”°—¥ ∫√‘…∑— ∑’‡Ë °’¬Ë «¢âÕß°—π ∫√‘…∑— ‚°≈‡∫‘≈ ·§√å ‚´≈Ÿ™π—Ë (ª√–‡∑»‰∑¬) ®”°—¥ ¡Ÿ≈π‘∏‘ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å √«¡

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

(Àπà«¬: ∫“∑) ß∫°“√‡ß‘π‡©æ“–∫√‘…∑— œ 2548 2547

39,431,842

(39,431,842)

5,878

20,744,994

1,094,973

24,742,553

105

150

105

150

138,547

217,648

138,547

217,648

150,139

212,230

150,139

212,230

1,383,764

430,028

21,039,663

25,172,581

√“¬ß“πª√–®”ªï 2548

ß∫°“√‡ß‘π√«¡ 2548 2547 ‡ß‘π„Àâ°¬Ÿâ ¡◊ √–¬–¬“«·≈–¥Õ°‡∫’¬È §â“ß√—∫ › °‘®°“√∑’‡Ë °’¬Ë «¢âÕß°—π ∫√‘…∑— ¬àÕ¬ ∫√‘…∑— ∫”√ÿß√“…Æ√å Õ‘π‡µÕ√å‡π™—Ëπ·π≈ ®”°—¥ ∫√‘…∑— ‰«∑—≈‰≈øá ®”°—¥ √«¡

‡ß‘π°Ÿ¬â ¡◊ √–¬– —πÈ ·≈–¥Õ°‡∫’¬È §â“ß®à“¬ › °‘®°“√∑’‡Ë °’¬Ë «¢âÕß°—π ∫√‘…∑— ¬àÕ¬ ∫√‘…∑— ∫”√ÿß√“…Æ√å ‡¡¥‘§Õ≈ ‡´Áπ‡µÕ√å ®”°—¥

(Àπà«¬:∫“∑) ß∫°“√‡ß‘π‡©æ“–∫√‘…∑— œ 2548 2547

22,603,851 22,603,851

733,104 24,289,265 25,022,369

1,704,315,348 1,470,826,509

‡ß‘π„Àâ°¬Ÿâ ¡◊ √–¬– —πÈ ·≈–√–¬–¬“«·°à∫√‘…∑— ‰«∑—≈‰≈øá ®”°—¥ §‘¥¥Õ°‡∫’¬È „πÕ—µ√“ MLR ≈∫¥â«¬Õ—µ√“ √âÕ¬≈– 0.5 µàÕªï ∫√‘…∑— œ‰¡à¡°’ “√§‘¥¥Õ°‡∫’¬È ”À√—∫‡ß‘π„Àâ°¬Ÿâ ¡◊ √–¬– —πÈ ·°à°®‘ °“√∑’‡Ë °’¬Ë «¢âÕß°—πÕ◊πË ∫√‘…∑— ∫”√ÿß√“…Æ√å Õ‘π‡µÕ√å‡π™—πË ·π≈ ®”°—¥ „Àâ‡ß‘π°Ÿ¬â ¡◊ √–¬–¬“«·°à∫√‘…∑— ‡πª®Ÿπ µ√Õ¬°â“ ‚Œ≈¥‘ßÈ Õ‘ß§å ®”π«π 30 ≈â“π‡ª‚´ §‘¥¥Õ°‡∫’¬È „πÕ—µ√“√âÕ¬≈– 10 µàÕªï ‚¥¬§√∫°”Àπ¥™”√–„π‡«≈“ 7 ªï (¿“¬„π ªï 2555) ‡ß‘π„Àâ°¬Ÿâ ¡◊ ¥—ß°≈à“«§È”ª√–°—π‚¥¬Àÿπâ ¢Õß ∫√‘…∑— ¥—ß°≈à“«´÷ßË ‡ªìπ¢Õß Mr. Augusto G. Gan ‡ß‘π°Ÿ¬â ¡◊ √–¬– —πÈ ®“°∫√‘…∑— ∫”√ÿß√“…Æ√å ‡¡¥‘§Õ≈ ‡´Áπ‡µÕ√å ®”°—¥ §‘¥¥Õ°‡∫’¬È „πÕ—µ√“ MLR ≈∫¥â«¬Õ—µ√“√âÕ¬≈– 0.45 µàÕªï

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

√“¬°“√‡§≈◊ÕË π‰À«¢Õß‡ß‘π„Àâ°¬Ÿâ ¡◊ ·≈–‡ß‘π°Ÿ¬â ¡◊ „π√–À«à“ßªï “¡“√∂ √ÿª‰¥â¥ß— π’È 31 ∏—π«“§¡ 2547

‡æ‘¡Ë ¢÷πÈ

≈¥≈ß

(Àπà«¬:∫“∑) 31 ∏—π«“§¡ 2548

‡ß‘π„Àâ°¬Ÿâ ¡◊ √–¬– —πÈ ·≈–¥Õ°‡∫’¬È §â“ß√—∫ - °‘®°“√∑’‡Ë °’¬Ë «¢âÕß°—π ∫√‘…∑— ¬àÕ¬ ∫√‘…∑— ∫”√ÿß√“…Æ√å Õ‘π‡µÕ√å‡π™—πË ·π≈ ®”°—¥ 16,685,753 16,679,875 5,878 ∫√‘…∑— ‰«∑—≈‰≈øá ®”°—¥ ‡ß‘πµâπ 23,572,320 29,440,842 32,365,839 20,647,323 ¥Õ°‡∫’¬È §â“ß√—∫ 1,170,233 1,051,870 2,124,432 97,671 ∫√‘…∑— √à«¡ ∫√‘…∑— ‡Õ‡™’¬π ŒÕ æ‘∑Õ≈ Õ‘ß§å 9,779,374 8,684,401 1,094,973 ∫√‘…∑— ·Õ≈ ‡Õ §≈‘ππ‘Ëß ®”°—¥ 150 605 650 105 ∫√‘…∑— ∑’‡Ë °’¬Ë «¢âÕß°—π ∫√‘…∑— ‚°≈‡∫‘≈ ·§√å ‚´≈Ÿ™π—Ë (ª√–‡∑»‰∑¬) ®”°—¥ 217,648 10,541,377 10,620,478 138,547 ¡Ÿ≈π‘∏‘ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å 212,230 1,937,365 1,999,456 150,139 ‡ß‘π„Àâ°¬Ÿâ ¡◊ √–¬–¬“«·≈–¥Õ°‡∫’¬È §â“ß√—∫ - °‘®°“√∑’‡Ë °’¬Ë «¢âÕß°—π ∫√‘…∑— ¬àÕ¬ ∫√‘…∑— ∫”√ÿß√“…Æ√å Õ‘π‡µÕ√å‡π™—πË ·π≈ ®”°—¥ ‡ß‘πµâπ 538,300 538,300 ¥Õ°‡∫’¬È §â“ß√—∫ 194,804 194,804 ∫√‘…∑— ‰«∑—≈‰≈øá ®”°—¥ ‡ß‘πµâπ 22,494,000 22,494,000 ¥Õ°‡∫’¬È §â“ß√—∫ 1,795,265 1,210,054 2,895,468 109,851 ‡ß‘π„Àâ°¬Ÿâ ¡◊ √–¬– —πÈ ·≈–¥Õ°‡∫’¬È §â“ß®à“¬ - °‘®°“√∑’‡Ë °’¬Ë «¢âÕß°—π ∫√‘…∑— ¬àÕ¬ ∫√‘…∑— ∫”√ÿß√“…Æ√å ‡¡¥‘§Õ≈ ‡´Áπ‡µÕ√å ®”°—¥ ‡ß‘πµâπ 1,465,445,867 705,742,675 466,873,194 1,704,315,348 ¥Õ°‡∫’¬È §â“ß®à“¬ 5,380,642 101,641,785 107,022,427 -

7. ‘π§â“§ß‡À≈◊Õ

¬“ ‡«™¿—≥±å «— ¥ÿÕπ◊Ë √«¡

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

ß∫°“√‡ß‘π√«¡ 2548 2547 90,825,694 72,896,227 25,784,871 19,874,000 33,285,331 11,680,830 149,895,896 104,451,057

(Àπà«¬:∫“∑) ß∫°“√‡ß‘π√«¡ 2548 2547 88,111,707 70,472,904 25,784,871 19,874,000 33,285,331 11,680,830 147,181,909 102,027,734

√“¬ß“πª√–®”ªï 2548

8. ‡ß‘π≈ß∑ÿπ´÷ßË ∫—π∑÷°‚¥¬«‘∏ ’ «à π‰¥â‡ ’¬/§à“‡º◊ÕË º≈¢“¥∑ÿπ∑’‡Ë °‘π°«à“‡ß‘π≈ß∑ÿπ„π∫√‘…∑— ¬àÕ¬ ‡ß‘π≈ß∑ÿπ´÷ßË ∫—π∑÷°‚¥¬«‘∏ ’ «à π‰¥â‡ ’¬ª√–°Õ∫¥â«¬‡ß‘π≈ß∑ÿπ„πÀÿπâ “¡—≠¢Õß∫√‘…∑— ¥—ßµàÕ‰ªπ’:È ß∫°“√‡ß‘π√«¡ (Àπà«¬: ∫“∑) ‡ß‘π≈ß∑ÿπ ∫√‘…∑— ∫√‘…∑— √à«¡ ∫√‘…∑— ·Õ≈ ‡Õ §≈‘ππ‘ßË ®”°—¥ ∫√‘…∑— ‡Õ‡™’¬π ŒÕ æ‘∑Õ≈ Õ‘ß§å √«¡‡ß‘π≈ß∑ÿπ

∑ÿπ∑’™Ë ”√–·≈â« —¥ à«π‡ß‘π≈ß∑ÿπ 2548 2547 2548 2547 √âÕ¬≈– √âÕ¬≈– 1,250,000 1,409,179,552 ‡ª‚´

«‘∏√’ “§“∑ÿπ 2548

1,250,000 25.00 25.00 -

35.19

«‘∏ ’ «à π‰¥â‡ ’¬ 2548 2547

2547

312,500

209,354

‡ß‘πªíπº≈ 2548 2547

209,354

385,759,564

481,206,016

386,072,064

312,500

481,415,370

209,354

ß∫°“√‡ß‘π‡©æ“–∫√‘…∑— œ (Àπà«¬: ∫“∑) ‡ß‘π≈ß∑ÿπ ∫√‘…∑—

∑ÿπ∑’™Ë ”√–·≈â« 2548 2547

—¥ à«π‡ß‘π≈ß∑ÿπ 2548 2547 √âÕ¬≈– √âÕ¬≈–

«‘∏√’ “§“∑ÿπ 2548

2547

«‘∏ ’ «à π‰¥â‡ ’¬ 2548 2547

∫√‘…∑— ¬àÕ¬ ∫√‘…∑— ∫”√ÿß√“…Æ√å 958,953,608 958,953,608 100.00 100.00 1,691,902,972 1,691,902,972 1,092,852,182 1,077,599,756 ‡¡¥‘§Õ≈ ‡´Áπ‡µÕ√å ®”°—¥ ∫√‘…∑— ∫”√ÿß√“…Æ√å 600,000,000 1,000,000 100.00 100.00 599,999,400 999,400 591,856,574 23,596 Õ‘π‡µÕ√å‡π™—πË ·π≈ ®”°—¥ ∫√‘…∑— ‰«∑—≈‰≈øá ®”°—¥ 31,500,000 31,500,000 100.00 100.00 25,610,000 25,610,000 (8,561,836) (23,114,011) √«¡‡ß‘π≈ß∑ÿπ„π∫√‘…∑— ¬àÕ¬ 2,317,512,372 1,718,512,372 1,676,146,920 1,054,509,341 ∫√‘…∑— √à«¡ ∫√‘…∑— ·Õ≈ ‡Õ §≈‘πË π‘ßË ®”°—¥ 1,250,000 √«¡‡ß‘π≈ß∑ÿπ„π∫√‘…∑— √à«¡ √«¡‡ß‘π≈ß∑ÿπ

1,250,000 25.00 25.00

312,500 312,500 209,354 209,354 312,500 312,500 209,354 209,354 2,317,824,872 1,718,824,872 1,676,356,274 1,054,718,695

‡ß‘πªíπº≈ 2548 2547

239,738,300

(Àπà«¬: ∫“∑) ß∫°“√‡ß‘π‡©æ“–∫√‘…∑— œ 2548 2547 ¡Ÿ≈§à“‡ß‘π≈ß∑ÿπ ÿ∑∏‘ ‡ß‘π≈ß∑ÿπ´÷ßË ∫—π∑÷°‚¥¬«‘∏ ’ «à π‰¥â‡ ’¬ à«π‡°‘π¡Ÿ≈§à“‡ß‘π≈ß∑ÿπ∑’ Ë Ÿß°«à“¡Ÿ≈§à“µ“¡∫—≠™’¢Õß∫√‘…∑— ¬àÕ¬ §à“‡º◊ÕË º≈¢“¥∑ÿπ∑’‡Ë °‘π°«à“‡ß‘π≈ß∑ÿπ„π∫√‘…∑— ¬àÕ¬ √«¡

1,492,256,552 192,661,558 (8,561,836) 1,676,356,274

885,171,148 192,661,558 (23,114,011) 1,054,718,695

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

‡¡◊ÕË «—π∑’Ë 16 ¡‘∂πÿ “¬π 2547 ∫√‘…∑— œ‰¥â´Õ◊È Àÿπâ “¡—≠¢Õß∫√‘…∑— ∫”√ÿß√“…Æ√å ‡¡¥‘§Õ≈ ‡´Áπ‡µÕ√å ®”°—¥ ®”π«π 3,060,623 Àÿπâ ®“°∫√√…—∑ ‡ß‘π∑ÿπ√–À«à“ßª√–‡∑» „π√“§“Àÿπâ ≈– 72.28050 ∫“∑ (√“§“∑’∑Ë ’Ëª√÷°…“∑“ß°“√‡ß‘π¢Õß∫√‘…∑— œ„Àâ§«“¡‡ÀÁπ«à“‡ªìπ√“§“µ≈“¥) √«¡‡ªìπ‡ß‘π 221,223,346 ∫“∑ ∑”„Àâ ¥— à«π°“√∂◊ÕÀÿπâ ¢Õß∫√‘…∑— œ„π∫√‘…∑— ¥—ß°≈à“«‡æ‘¡Ë ¢÷πÈ ®“°√âÕ¬≈– 97.45 ‡ªìπ√âÕ¬≈– 100 à«πµà“ß¢Õß√“§“∑ÿπ¢Õß ‡ß‘π≈ß∑ÿπ∑’‡Ë °‘π°«à“¡Ÿ≈§à“ ‘π∑√—æ¬å ∑ÿ ∏‘¢Õß∫√‘…∑— ¬àÕ¬®”π«π 192.7 ≈â“π∫“∑ ‰¥â· ¥ß‰«â„π à«π¢ÕßºŸ∂â Õ◊ Àÿπâ „πß∫°“√‡ß‘π√«¡·≈–ß∫°“√‡ß‘π ‡©æ“–∫√‘…∑— œ ‡¡◊ÕË «—π∑’Ë 18 ‘ßÀ“§¡ 2547 ∑’ªË √–™ÿ¡§≥–°√√¡°“√¢Õß∫√‘…—∑ ∫”√ÿß√“…Æ√å ‡¡¥‘§Õ≈ ‡´Áπ‡µÕ√å ®”°—¥ ‰¥â¡¡’ µ‘Õπÿ¡µ— ‘„Àâ∫√‘…∑— ®à“¬ ‡ß‘πªíπº≈√–À«à“ß°“≈„Àâ·°àº∂Ÿâ Õ◊ Àÿâπ®“°º≈°“√¥”‡π‘πß“πµ—ßÈ ·µà«π— ∑’Ë 1 ¡°√“§¡ 2547 ∂÷ß«—π∑’Ë 30 ¡‘∂πÿ “¬π 2547 „πÕ—µ√“Àÿπâ ≈– 2 ∫“∑ ∫√‘…∑— œ‰¥â√∫— ‡ß‘πªíπº≈‡ªìπ®”π«π‡ß‘π∑—Èß ‘πÈ 239.7 ≈â“π∫“∑ „π‡¥◊Õπæƒ»®‘°“¬π 2547 ∫√‘…∑— ∫”√ÿß√“…Æ√å Õ‘π‡µÕ√å‡π™—πË ·π≈ ®”°—¥ ‰¥â∑”°“√‡æ‘¡Ë ∑ÿπ‚¥¬°“√ÕÕ° Àÿπâ “¡—≠„À¡à®”π«π 5,990,000 Àÿπâ ¡Ÿ≈§à“Àÿπâ ≈– 100 ∫“∑ ∑”„Àâ∑ÿπ®¥∑–‡∫’¬π¢Õß∫√‘…∑— ¬àÕ¬‡æ‘Ë¡®“° 1 ≈â“π∫“∑‡ªìπ 600 ≈â“π∫“∑ ∫√‘…∑— œ‡¢â“´◊ÕÈ Àÿπâ ∑’‡Ë æ‘¡Ë ¢÷Èπ∑—ßÈ À¡¥ ∑”„Àâ ¥— à«π°“√∂◊ÕÀÿπâ ¢Õß∫√‘…∑— œ„π∫√‘…∑— ¬àÕ¬·Ààßπ’‡È æ‘¡Ë ¢÷πÈ ®“°√âÕ¬≈– 99.94 ‡ªìπ√âÕ¬≈– 100 ‚¥¬∫√‘…∑— œ‰¥â®“à ¬™”√–§à“Àÿπâ ¥—ß°≈à“« ‡√’¬∫√âÕ¬·≈â«„π‰µ√¡“ ∑’ÀË π÷ßË ¢Õßªï 2548 ‡¡◊ÕË «—π∑’Ë 24 °ÿ¡¿“æ—π∏å 2548 ∫√‘…∑— ¬àÕ¬·ÀàßÀπ÷ßË (∫√‘…∑— ∫”√ÿß√“…Æ√å Õ‘π‡µÕ√å‡π™—πË ·π≈ ®”°—¥) ‰¥â´Õ◊È ‡ß‘π≈ß∑ÿπ„πÀÿπâ ∫ÿ√‘¡ ‘∑∏‘¢Õß∫√‘…∑— ‡πª®Ÿπ µ√Õ¬°â“ ‚Œ≈¥‘ßÈ Õ‘ß§å (‡πª®Ÿπ) ®”π«π 66,667 Àÿπâ √“§“µ√“‰«âÀπÿâ ≈– 1,000 ‡ª‚´ „π√“§“√«¡∑—ßÈ ‘πÈ 131,949,605.69 ∫“∑ (185 ≈â“π‡ª‚´) ∑—ßÈ π’È ∫√‘…∑— ¬àÕ¬¡’ ¥— à«π °“√∂◊ÕÀÿπâ „π∫√‘…∑— ¥—ß°≈à“«√âÕ¬≈– 40 πÕ°®“°π’È ∫√‘…∑— ¬àÕ¬‰¥â´Õ◊È ‡ß‘π≈ß∑ÿπ„π∫√‘…∑— ∫”√ÿß√“…Æ√å Õ‘π‡µÕ√å‡π™—πË ·π≈ øî≈ª‘ ªîπ å Õ‘ß§å (BIPI) ®”π«π 7,000,000 Àÿπâ √“§“µ√“‰«âÀπÿâ ≈– 1 ‡ª‚´ „π√“§“ 59,155,653.07 ∫“∑ ‚¥¬¡’ ¥— à«π °“√∂◊ÕÀÿπâ √âÕ¬≈– 100 ·≈–‡ß‘π≈ß∑ÿπ π—∫ πÿπ„π√Ÿª‡ß‘π„Àâ°¬Ÿâ ¡◊ ·°à BIPI ®”π«π 179,386,827.26 ∫“∑ (253,856,573.29 ‡ª‚´) ‡πª®Ÿπ ·≈– BIPI ‰¥â´◊ÈÕ‡ß‘π≈ß∑ÿπ„πÀÿâπ “¡—≠¢Õß∫√‘…∑— ‡Õ‡™’¬π ŒÕ æ‘∑Õ≈ Õ‘ß§å (AHI) „π√“§“ 215 ≈â“π‡ª‚´ (190,265,487 Àÿπâ ) ·≈– 283 ≈â“π‡ª‚´ (423,238,004 Àÿπâ ) µ“¡≈”¥—∫ ´÷ßË §‘¥‡ªìπ —¥ à«π√âÕ¬≈– 13.41 ·≈–√âÕ¬≈– 29.83 µ“¡≈”¥—∫ AHI ®¥∑–‡∫’¬π®—¥µ—ßÈ „π ª√–‡∑»øî≈ª‘ ªîπ å ‚¥¬ª√–°Õ∫°‘®°“√‚√ßæ¬“∫“≈ à«π·∫àß°”‰√/¢“¥∑ÿπ®“°°“√≈ß∑ÿπ„π∫√‘…∑— ·Õ≈ ‡Õ §≈‘ππ‘ßË ®”°—¥§”π«≥®“°ß∫°“√‡ß‘π∑’Ë‰¥â®¥— ∑”¢÷πÈ ‚¥¬ΩÉ“¬∫√‘À“√¢Õß∫√‘…∑— à«π·∫àß°”‰√/¢“¥∑ÿπ®“°°“√≈ß∑ÿπ„π AHI §”π«≥®“°ß∫°“√‡ß‘π∑’Ë‰¥â®—¥∑”¢÷Èπ‚¥¬ΩÉ“¬∫√‘À“√¢Õß∫√‘…—∑·≈–‰¥âºà“π°“√µ√«® Õ∫‚¥¬ ºŸ â Õ∫∫—≠™’¢Õß∫√‘…∑— ¥—ß°≈à“«„πµà“ßª√–‡∑»·≈â«

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

9. ‡ß‘π≈ß∑ÿπ√–¬–¬“«Õ◊πË (Àπà«¬: ∫“∑)

∫√‘…∑—

—¥ à«π‡ß‘π≈ß∑ÿπ ß∫°“√‡ß‘π√«¡ 2548 2547 2548 2547 √âÕ¬≈– √âÕ¬≈– ∫√‘…∑— ®—π∑∫ÿ√§’ π— ∑√’§≈—∫ ®”°—¥ 0.5 0.5 4,500,000 4,500,000 ∫√‘…∑— ‚°≈‡∫‘≈ ·§√å ‚´≈Ÿ™π—Ë ‡Õ .‡Õ. ®”°—¥ 14.0 14.0 347,213 347,213 √«¡ 4,847,213 4,847,213 À—°: §à“‡º◊ÕË °“√¥âÕ¬§à“¢Õß‡ß‘π≈ß∑ÿπ (2,800,000) (2,800,000) ÿ∑∏‘ 2,047,213 2,047,213

ß∫°“√‡ß‘π‡©æ“–∫√‘…∑— œ 2548 2547 4,500,000 347,213 4,847,213 (2,800,000) 2,047,213

4,500,000 347,213 4,847,213 (2,800,000) 2,047,213

∫√‘…∑— œ ª√–¡“≥§à“‡º◊ÕË °“√¥âÕ¬§à“¢Õß‡ß‘π≈ß∑ÿπ‚¥¬æ‘®“√≥“®“°ß∫°“√‡ß‘π≈à“ ÿ¥¢Õß∫√‘…∑— ∑’Ë‰ª≈ß∑ÿπ

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

∑’¥Ë π‘

ß∫°“√‡ß‘π√«¡ ‘π∑√—æ¬å Õÿª°√≥å ‡§√◊ÕË ß„™â·≈– √–À«à“ß°àÕ √â“ß ‚√ßæ¬“∫“≈ ‡§√◊ËÕßµ°·µàß ¬“πæ“Àπ– ·≈–µ‘¥µ—ßÈ

√«¡

(Àπà«¬: ∫“∑)

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

9,000,000 11,430,248 20,430,248

1,318,719,249 81,350,963 439,428,697 185,030,677 130,725,141 1,401,016,277 75,232,799 572,986,030 191,402,522 130,873,745

9,000,000 11,430,248 20,430,248

(8,139,391) 1,751,906,521

1,526,672,616 233,373,296

213,967,124 233,373,296

26,221,167 304,866,725 2,801,618,198 19,494,228 564,476,715 3,269,654,875

(356,836) (26,661) (5,343,071) (954,160) (307,135) (1,151,528) 557,246,549 48,816,645 601,328,364 334,833,558 167,165,714 30,945,859 -

26,283,456 5,813,931

487,521,905 41,800,823 520,304,049 287,839,523 152,456,048 70,081,480 7,042,483 86,367,386 47,948,195 15,016,801

1,806,241,154 123,151,786 968,732,746 472,870,200 283,181,189 52,504,623 304,866,725 4,337,290,814 36,189,015 1,008,938 241,043,269 58,896,758 16,414,125 2,620,000 381,434,030 737,606,135 (5,991,383) (111,280) (15,031,373) (5,530,878) (1,555,855) (4,684,536) (32,905,305) 121,824,040 (121,824,040) 1,958,262,826 124,049,444 1,194,744,642 526,236,080 298,039,459 50,440,087 564,476,715 5,041,991,644

‘∑∏‘°“√‡™à“ ‡§√◊ÕË ßÕÿª°√≥å ·≈– à«π Õ“§“√·≈– √–∫∫Õ”π«¬ ‡§√◊ÕË ß¡◊Õ ª√—∫ª√ÿß∑’¥Ë π‘ ‘ßË ª≈Ÿ° √â“ß §«“¡ –¥«° ·æ∑¬å

√“§“∑ÿπ 31 ∏—π«“§¡ 2547 290,861,482 34,880,909 ´◊ÕÈ ‡æ‘¡Ë ®”Àπà“¬ ‚Õπ 31 ∏—π«“§¡ 2548 290,861,482 34,880,909 §à“‡ ◊ÕË ¡√“§“ – ¡ 31 ∏—π«“§¡ 2547 10,466,812 §à“‡ ◊ÕË ¡√“§“ ”À√—∫ªï 1,103,020 §à“‡ ◊ÕË ¡√“§“ – ¡ ®”Àπà“¬ 31 ∏—π«“§¡ 2548 11,569,832 §à“‡º◊ÕË °“√¥âÕ¬§à“¢Õß ‘π∑√—æ¬å 31 ∏—π«“§¡ 2547 ‡æ‘¡Ë √–À«à“ßªï 31 ∏—π«“§¡ 2548 ¡Ÿ≈§à“ ÿ∑∏‘µ“¡∫—≠™’ 31 ∏—π«“§¡ 2547 290,861,482 24,414,097 31 ∏—π«“§¡ 2548 290,861,482 23,311,077 §à“‡ ◊ÕË ¡√“§“∑’√Ë «¡Õ¬Ÿà„πß∫°”‰√¢“¥∑ÿπ ”À√—∫ªï 2547 2548

10. ∑’¥Ë π‘ Õ“§“√·≈–Õÿª°√≥å

√“¬ß“πª√–®”ªï 2548

∑’¥Ë π‘ √“§“∑ÿπ 31 ∏—π«“§¡ 2547 290,861,482 15,563,340 ´◊ÕÈ ‡æ‘¡Ë ®”Àπà“¬ ‚Õπ 31 ∏—π«“§¡ 2548 290,861,482 15,563,340 §à“‡ ◊ÕË ¡√“§“ – ¡ 31 ∏—π«“§¡ 2547 6,394,139 §à“‡ ◊ÕË ¡√“§“ ”À√—∫ªï 459,101 §à“‡ ◊ÕË ¡√“§“ – ¡ ®”Àπà“¬ 31 ∏—π«“§¡ 2548 6,853,240 §à“‡º◊ÕË °“√¥âÕ¬§à“¢Õß ‘π∑√—æ¬å 31 ∏—π«“§¡ 2547 ‡æ‘¡Ë √–À«à“ßªï 31 ∏—π«“§¡ 2548 ¡Ÿ≈§à“ ÿ∑∏‘µ“¡∫—≠™’ 31 ∏—π«“§¡ 2547 290,861,482 9,169,201 31 ∏—π«“§¡ 2548 290,861,482 8,710,100 §à“‡ ◊ÕË ¡√“§“∑’√Ë «¡Õ¬Ÿà„πß∫°”‰√¢“¥∑ÿπ ”À√—∫ªï 2547 2548

‘π∑√—æ¬å Õÿª°√≥å ‡§√◊ÕË ß„™â·≈– √–À«à“ß°àÕ √â“ß ‚√ßæ¬“∫“≈ ‡§√◊ÕË ßµ°·µàß ¬“πæ“Àπ– ·≈–µ‘¥µ—ßÈ

√«¡

9,000,000 11,430,248 20,430,248

153,176,108 88,184,479 461,157,151 178,882,314 105,506,187 293,358,601 82,124,202 599,312,003 188,698,833 106,318,909

(234,367) 72,035,757

(143,156) (26,661) (855,674) (509,499) 59,677,436 17,114,390 134,021,932 111,181,677 -

57,837,517 14,432,607

46,486,603 65,185,390 88,391,003 46,505,786

44,554,668 10,241,074 15,265,924 6,899,977

26,221,158 19,494,219

(1,151,528) 8,510,111

3,847,708 5,813,931

9,000,000 11,430,248 20,430,248

(2,920,885) 409,394,543

234,547,099 177,768,329

69,624,253 177,768,329

304,866,725 1,618,024,805 564,476,714 2,153,355,063

197,730,776 98,425,553 516,643,754 244,067,704 163,343,704 30,068,866 304,866,725 1,861,571,904 34,605,395 924,319 241,043,270 57,462,952 16,138,217 2,620,000 381,434,029 734,228,182 (1,124,174) (111,280) (3,922,841) (1,650,146) (1,127,255) (4,684,536) (12,620,232) 121,824,040 (121,824,040) 353,036,037 99,238,592 753,764,183 299,880,510 178,354,666 28,004,330 564,476,714 2,583,179,854

‘∑∏‘°“√‡™à“ ‡§√◊ÕË ßÕÿª°√≥å ·≈– à«πª√—∫ª√ÿß Õ“§“√·≈– √–∫∫Õ”π«¬ ‡§√◊ÕË ß¡◊Õ ∑’¥Ë π‘ ‘ßË ª≈Ÿ° √â“ß §«“¡ –¥«° ·æ∑¬å

ß∫°“√‡ß‘π‡©æ“–∫√‘…∑— œ

(Àπà«¬:∫“∑)

√“¬ß“πª√–®”ªï 2548

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

∫√‘…∑— œ‰¥â®”πÕß∑’¥Ë π‘ ∑—ßÈ À¡¥´÷ßË ¡’¡≈Ÿ §à“µ“¡∫—≠™’®”π«π 290.9 ≈â“π∫“∑ (¡Ÿ≈§à“¬ÿµ∏‘ √√¡´÷ßË ª√–‡¡‘π‡¡◊ÕË «—π∑’Ë 12 æƒ»®‘°“¬π 2547 ‡∑à“°—∫ 581 ≈â“π∫“∑) °—∫∏π“§“√æ“≥‘™¬å·ÀàßÀπ÷ßË „π∞“π–ºŸ·â ∑πºŸ∂â ◊ÕÀÿâπ°Ÿ‡â æ◊ÕË ‡ªìπÀ≈—°ª√–°—π°“√ÕÕ°Àÿπâ °Ÿ·â ª≈ß ¿“æ¢Õß∫√‘…∑— œ µ“¡∑’°Ë ≈à“« „πÀ¡“¬‡Àµÿ 13 °) ·≈– 13 ¢) ∫√‘…—∑œ·≈–∫√‘…∑— ∫”√ÿß√“…Æ√å ‡¡¥‘§Õ≈ ‡´Áπ‡µÕ√å ®”°—¥ ‰¥â®¥®”πÕßÕ“§“√·≈–®”π”‡§√◊ÕË ß¡◊Õ·æ∑¬å·≈–Õÿª°√≥å ‚√ßæ¬“∫“≈´÷ßË ¡’ ¡Ÿ≈§à“ ÿ∑∏‘µ“¡∫—≠™’ ≥ «—π∑’Ë 31 ∏—π«“§¡ 2548 ®”π«π 1,285 ≈â“π∫“∑ (2547: 1,327 ≈â“π∫“∑) ‡æ◊ÕË §È”ª√–°—π‡ß‘π°Ÿ¬â ¡◊ √–¬–¬“«®“° ∏π“§“√æ“≥‘™¬å„πª√–‡∑»·ÀàßÀπ÷ßË µ“¡∑’°Ë ≈à“«„πÀ¡“¬‡Àµÿ 12 „π√–À«à“ßªï 2548 ∫√‘…∑— œ‰¥â∫π— ∑÷°§à“‡º◊ÕË °“√¥âÕ¬§à“¢ÕßÕÿª°√≥å ‚√ßæ¬“∫“≈®”π«π 11.4 ≈â“π∫“∑ (2547: 9 ≈â“π∫“∑) ‡π◊ÕË ß®“°¡’ ¢âÕ∫àß™’«È “à √“§“µ“¡∫—≠™’¢Õß ‘π∑√—æ¬å∫“ß√“¬°“√¡’¡≈Ÿ §à“ Ÿß°«à“¡Ÿ≈§à“∑’§Ë “¥«à“®–‰¥â√∫— §◊π ≥ «—π∑’Ë 31 ∏—π«“§¡ 2548 √“§“∑ÿπ¢ÕßÕÿª°√≥å¢Õß∫√‘…∑— œ·≈–∫√‘…∑— ¬àÕ¬´÷ßË À—°§à“‡ ◊ÕË ¡√“§“∑—ßÈ ®”π«π·≈â«·µà¬ß— §ß„™âß“πÕ¬Ÿ¡à ’®”π«π‡ß‘π 110 ≈â“π∫“∑ ·≈– 2.3 ≈â“π∫“∑ (2547: 6 ≈â“π∫“∑ ·≈– 4.5 ≈â“π∫“∑) µ“¡≈”¥—∫

11. ‘π∑√—æ¬å‰¡à¡µ’ «— µπ (Àπà«¬: ∫“∑)

‚ª√·°√¡§Õ¡æ‘«‡µÕ√å À—°: §à“µ—¥®”Àπà“¬ – ¡ ‚ª√·°√¡§Õ¡æ‘«‡µÕ√å - ÿ∑∏‘ §à“§«“¡π‘¬¡„π°“√´◊ÕÈ ∏ÿ√°‘® À—°: §à“µ—¥®”Àπà“¬ – ¡ §à“§«“¡π‘¬¡„π°“√´◊ÕÈ ∏ÿ√°‘® - ÿ∑∏‘ ‘π∑√—æ¬å‰¡à¡µ’ «— µπÕ◊πË À—°: §à“µ—¥®”Àπà“¬ – ¡ ‘π∑√—æ¬å‰¡à¡µ’ «— µπÕ◊πË - ÿ∑∏‘ √«¡ §à“µ—¥®”Àπà“¬∑’√Ë «¡Õ¬Ÿà„πß∫°”‰√¢“¥∑ÿπ ”À√—∫ªï

ß∫°“√‡ß‘π√«¡ 2548 2547 683,625,752 478,778,572 (61,065,496) (2,650,774) 622,560,256 476,127,798 1,687,000 (28,195) 1,658,805 624,219,061 476,127,798 58,442,917 28,037,441

ß∫°“√‡ß‘π‡©æ“–∫√‘…∑— œ 2548 2547 583,625,752 478,778,572 (57,195,496) (2,650,774) 526,430,256 476,127,798 192,927,561 192,927,561 (27,331,404) (8,038,648) 165,596,157 184,888,913 692,026,413 661,016,711 73,837,478 10,689,422

12. ‡ß‘π°Ÿ¬â ¡◊ √–¬–¬“« (Àπà«¬: ∫“∑) ß∫°“√‡ß‘π√«¡ ∫√‘…∑— ∫”√ÿß√“…Æ√å ‡¡¥‘§Õ≈ ‡´Áπ‡µÕ√å ®”°—¥ ‡ß‘π°Ÿ®â “°∏π“§“√æ“≥‘™¬å„πª√–‡∑» À—°: à«π∑’∂Ë ß÷ °”Àπ¥™”√–¿“¬„πÀπ÷ßË ªï à«π∑’∂Ë ß÷ °”Àπ¥™”√–‡°‘π°«à“Àπ÷ßË ªï

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

2548

2547

1,779,493,095 (328,521,802) 1,450,971,293

2,108,014,897 (328,521,802) 1,779,493,095

√“¬ß“πª√–®”ªï 2548

‡¡◊ËÕ«—π∑’Ë 16 °—π¬“¬π 2545 ∫√‘…—∑¬àÕ¬‰¥â‡¢â“∑” —≠≠“°Ÿâ¬◊¡‡ß‘π °ÿ≈∫“∑°—∫∏π“§“√æ“≥‘™¬å „πª√–‡∑»·ÀàßÀπ÷Ëß„π«ß‡ß‘π®”π«π 2,400,000,000 ∫“∑ ‡ß‘π°Ÿ¬â ¡◊ ¥—ß°≈à“«§‘¥¥Õ°‡∫’¬È „πÕ—µ√“√âÕ¬≈– 5.5 µàÕªï„πªï∑’Ë 1-2 À≈—ß®“°π—πÈ §‘¥¥Õ°‡∫’¬È „πÕ—µ√“ MLR ≈∫¥â«¬Õ—µ√“ √âÕ¬≈–§ß∑’µË àÕªï ‚¥¬¡’°”Àπ¥™”√–¥Õ°‡∫’¬È ∑ÿ° ‘Èπ‡¥◊Õπ·≈–¡’°”Àπ¥™”√–§◊π‡ß‘πµâπ∑ÿ° 3 ‡¥◊Õπ ®”π«π 24 ß«¥ ‡√‘Ë¡µ—ßÈ ·µà«π— ∑’Ë 30 ∏—π«“§¡ 2547 ‡ß‘π°Ÿâ¬◊¡π’È§È”ª√–°—π‚¥¬°“√®¥®”πÕßÕ“§“√·≈–®”π”‡§√◊ËÕß¡◊Õ·æ∑¬å·≈–Õÿª°√≥å ‚√ßæ¬“∫“≈·≈–‡ß‘πΩ“°ª√–®”µ“¡∑’Ë °≈à“«„π À¡“¬‡Àµÿ 10 ·≈–À¡“¬‡Àµÿ 4 „π‡¥◊Õπ°√°Æ“§¡ 2547 ∫√‘…∑— œ‰¥â‡¢â“∑” —≠≠“ Amendment Agreement ·≈– —≠≠“ Amended and Restated Facility Agreement °—∫∏π“§“√¥—ß°≈à“«‡æ◊ÕË √à«¡√—∫º‘¥™Õ∫Àπ’È π‘ —≠≠“°Ÿâ¬◊¡‡ß‘π‰¥â√–∫ÿ¢âÕªØ‘∫—µ‘·≈–¢âÕ®”°—¥∫“ßª√–°“√ ‡™àπ °“√¥”√ßÕ—µ√“ à«π∑“ß°“√‡ß‘π ¢âÕ®”°—¥‡°’Ë¬«°—∫°“√°àÕÀπ’È‡æ‘Ë¡·≈– °“√®à“¬‡ß‘πªíπº≈ ‡ªìπµâπ

13. Àÿâπ°Ÿâ·ª≈ß ¿“æ Àÿπâ °Ÿ·â ª≈ß ¿“æ ≥ «—π∑’Ë 31 ∏—π«“§¡ 2548 ·≈– 2547 ª√–°Õ∫¥â«¬: °) Àÿπâ °Ÿ·â ª≈ß ¿“æ¡’ª√–°—π∫“ß à«π®”π«π 300 ≈â“π∫“∑ √–¬–‡«≈“™”√–§◊π 12 ªï Õ—µ√“¥Õ°‡∫’¬È √âÕ¬≈– 2.5 µàÕªï„πªï∑’Ë 1 - 4 √âÕ¬≈– 5 µàÕªï„πªï∑’Ë 5 - 8 ·≈–√âÕ¬≈– 10 µàÕªï„πªï∑’Ë 9 - 12 ®à“¬™”√–∑ÿ° 6 ‡¥◊Õπ ‚¥¬¡’√“§“·ª≈ß ¿“æ ≥ ªí®®ÿ∫π— ‡∑à“°—∫ 4.55 ∫“∑µàÕ 1 Àÿπâ “¡—≠ ºŸ∂â Õ◊ Àÿâπ°Ÿ¡â ’ ∑‘ ∏‘‡≈◊Õ°·ª≈ß ¿“æ‡ªìπÀÿπâ “¡—≠‰¥âµ≈Õ¥Õ“¬ÿÀÿâπ°Ÿâ Àÿπâ °Ÿâ¡À’ ≈—°ª√–°—π‡ªìπ∑’¥Ë π‘ ¢Õß∫√‘…—∑œ ¢) Àÿπâ °Ÿ·â ª≈ß ¿“æ¡’ª√–°—π∫“ß à«π®”π«π 250 ≈â“π∫“∑ (¿“¬À≈—ß°“√„™â ∑‘ ∏‘·ª≈ß ¿“æ®”π«π 750 ≈â“π∫“∑ „πªï 2546) √–¬–‡«≈“™”√–§◊π 12 ªï Õ—µ√“¥Õ°‡∫’È¬√âÕ¬≈– 1 µàÕªï ®à“¬™”√–∑ÿ° 6 ‡¥◊Õπ ‚¥¬¡’√“§“·ª≈ß ¿“æ ≥ ªí®®ÿ∫π— ‡∑à“°—∫ 3.50 ∫“∑ µàÕ 1 Àÿπâ “¡—≠ ºŸ∂â Õ◊ Àÿπâ °Ÿ¡â ’ ∑‘ ∏‘‡≈◊Õ°·ª≈ß ¿“æ‡ªìπÀÿπâ “¡—≠‰¥âµ≈Õ¥Õ“¬ÿÀπÿâ °Ÿâ Àÿπâ °Ÿ¡â À’ ≈—°ª√–°—π‡ªìπ∑’¥Ë ‘π¢Õß∫√‘…—∑œ ‡¡◊ÕË «—π∑’Ë 24 æƒ»®‘°“¬π 2543 ∑’ªË √–™ÿ¡«‘ “¡—≠ºŸ∂â Õ◊ Àÿπâ ¢Õß∫√‘…∑— œ‰¥â¡’¡µ‘Õπÿ¡µ— ‘„Àâ·°â‰¢‡æ‘Ë¡‡µ‘¡ ¢âÕ°”Àπ¥«à“¥â«¬ ‘∑∏‘·≈–Àπâ“∑’¢Ë Õß ºŸÕâ Õ°Àÿπâ °Ÿ·â ≈–ºŸ∂â Õ◊ Àÿâπ°Ÿâ·ª≈ß ¿“æ ‚¥¬„Àâ ∑‘ ∏‘∫√‘…—∑œ‡≈◊Õ°∑’®Ë –‰∂à∂ÕπÀÿπâ °ŸÀâ √◊Õ·ª≈ß ¿“æÀÿπâ °Ÿ‡â ªìπÀÿâπ “¡—≠‡¡◊ÕË §√∫°”Àπ¥ ¿“¬„µâ¡“µ√∞“π°“√∫—≠™’©∫—∫∑’Ë 48 ç°“√· ¥ß√“¬°“√·≈–°“√‡ªî¥‡º¬¢âÕ¡Ÿ≈ ”À√—∫‡§√◊ËÕß¡◊Õ∑“ß°“√‡ß‘πé °“√„Àâ ∑‘ ∏‘∫√‘…∑— œ‡ªìπºŸ‡â ≈◊Õ°∑’Ë ®–‰∂à∂ÕπÀÿâπ°ŸâÀ√◊Õ·ª≈ß ¿“æÀÿâπ°Ÿâ‡ªìπÀÿâπ “¡—≠‡¡◊ËÕ§√∫°”Àπ¥·≈–®”π«πµ√“ “√∑ÿπ∑’Ë∫√‘…—∑œµâÕß àß¡Õ∫®–‰¡à‡ª≈’Ë¬π·ª≈ßµ“¡¡Ÿ≈§à“ ¬ÿµ∏‘ √√¡¢Õßµ√“ “√∑ÿππ—πÈ (‡π◊ÕË ß®“°∫√‘…∑— œ°”Àπ¥√“§“·ª≈ß ¿“æ∑’·Ë πàπÕπ‰«â·≈â«) ∑”„ÀâÀπÿâ °Ÿ·â ª≈ß ¿“æ¥—ß°≈à“«‰¡àÕ¬Ÿ¿à “¬„µâ§”®”°—¥ §«“¡¢ÕßÀπ’ È ‘π∑“ß°“√‡ß‘π·≈–∂◊Õ‡ªìπµ√“ “√∑ÿπ πÕ°®“°π’È ΩÉ“¬∫√‘À“√¢Õß∫√‘…—∑œ¡’§«“¡µ—Èß„®∑’®Ë –‡≈◊Õ°„™â ∑‘ ∏‘·ª≈ß ¿“æÀÿπâ °Ÿ‡â ªìπÀÿπâ “¡—≠‡¡◊ÕË §√∫°”Àπ¥ ¥—ßπ—Èπ Àÿπâ °Ÿ·â ª≈ß ¿“æ¥—ß°≈à“«∑—Èß®”π«π®÷ß‰¥â· ¥ß√«¡Õ¬Ÿà„π à«π¢ÕßºŸ∂â Õ◊ Àÿπâ ¢Õß∫√‘…∑— œ ·≈–¥Õ°‡∫’¬È „πÕπ“§µ ¢ÕßÀÿπâ °Ÿ¥â ß— °≈à“«®–∫—π∑÷°À—°°—∫ à«π¢ÕßºŸ∂â Õ◊ Àÿπâ ‚¥¬µ√ß ∫√‘…∑— œ‰¥â ”√ÕßÀÿπâ “¡—≠‰«â‡æ◊ÕË √Õß√—∫°“√„™â ∑‘ ∏‘·ª≈ß ¿“æÀÿπâ °Ÿ¥â ß— °≈à“«¢â“ßµâπ®”π«π 178,571,433 Àÿπâ ¥Õ°‡∫’¬È ®à“¬ ”À√—∫ªï 2548 ¢ÕßÀÿπâ °Ÿ·â ª≈ß ¿“æ¡’®”π«π 17.5 ≈â“π∫“∑ (2547: 12.7 ≈â“π∫“∑) ‚¥¬¥Õ°‡∫’¬È ¥—ß°≈à“«∫—π∑÷°‡ªìπ à«π∑’πË ” ‰ª≈¥°”‰√ – ¡

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

‡¡◊ÕË «—π∑’Ë 24 ‘ßÀ“§¡ 2547 ∫√‘…∑— °√ÿß‡∑æª√–°—π¿—¬ ®”°—¥ (¡À“™π) ´÷Ëß‡ªìπºŸ∂â Õ◊ Àÿπâ °Ÿ·â ª≈ß ¿“æ‰¡à¡’ª√–°—π™π‘¥‰¡à¡µ’ «— ·∑π ºŸ∂â Õ◊ Àÿπâ °Ÿ®â ”π«π 200 ≈â“π∫“∑ ‰¥â¢Õ„™â ∑‘ ∏‘·ª≈ß ¿“æÀÿâπ°Ÿâ∑ß—È ®”π«π‚¥¬„Àâ¡º’ ≈«—π∑’Ë 25 ‘ßÀ“§¡ 2547 ·≈–¡’√“¬≈–‡Õ’¬¥¢Õß °“√·ª≈ß ¿“æ¥—ßπ’:È ®”π«πÀÿπâ °Ÿ·â ª≈ß ¿“æ∑’ÕË Õ°®”Àπà“¬∑—ßÈ À¡¥ 20 Àπà«¬ ®”π«πÀÿπâ °Ÿ∑â ’Ë‰¥â¬π◊Ë ¢Õ·ª≈ß ¿“æ‰ª·≈â« Àπà«¬ ®”π«πÀÿπâ °Ÿ∑â ¬’Ë π◊Ë ¢Õ·ª≈ß ¿“æ§√—ßÈ π’È 20 Àπà«¬ ®”π«πÀÿπâ °Ÿ∑â ¬’Ë ß— ‰¡à·ª≈ß ¿“æ§ß‡À≈◊Õ Àπà«¬ ®”π«πÀÿπâ “¡—≠∑’¡Ë ’‰«â‡æ◊ÕË √Õß√—∫°“√·ª≈ß ¿“æ 75,000,000 Àÿπâ ®”π«πÀÿπâ “¡—≠∑’ºË ∂Ÿâ Õ◊ Àÿπâ °Ÿ¢â Õ∑”°“√·ª≈ß ¿“æ‰ª·≈â« Àÿπâ ®”π«πÀÿπâ “¡—≠∑’ºË ∂Ÿâ Õ◊ Àÿπâ °Ÿ¢â Õ∑”°“√·ª≈ß ¿“æ§√—ßÈ π’È 57,142,857 Àÿπâ ®”π«πÀÿπâ “¡—≠∑’√Ë Õß√—∫°“√·ª≈ß ¿“æ§ß‡À≈◊Õ 17,857,143 Àÿπâ °“√·ª≈ß ¿“æÀÿâπ°Ÿâ¥—ß°≈à“«¡’º≈„Àâ∫√‘…—∑œ‰¡à¡’¿“√–°“√®à“¬¥Õ°‡∫’È¬„πÕπ“§µ´÷Ëß∫√‘…—∑œ∫—π∑÷°‰«â „π∫—≠™’ çÀπ’È ‘πµ“¡ —≠≠“°“√ª√—∫ ‚§√ß √â“ßÀπ’éÈ Õ’°µàÕ‰ª ¥—ßπ—πÈ ∫√‘…—∑œ®÷ßª√—∫ª√ÿß¬Õ¥§ß‡À≈◊Õ¢ÕßÀπ’È π‘ µ“¡ —≠≠“°“√ª√—∫‚§√ß √â“ßÀπ’®È ”π«π 63,978,082 ∫“∑·≈– · ¥ß‡ªìπ√“¬°“√æ‘‡»…„πß∫°”‰√¢“¥∑ÿπ¿“¬„µâÀ«— ¢âÕ ç°”‰√®“°°“√·ª≈ß ¿“æÀÿπâ °Ÿ‡â ªìπÀÿπâ “¡—≠é ·≈–‚Õπ ç ‘∑∏‘‡≈◊Õ°·ª≈ß ¿“æé ®”π«π 41,599,484 ∫“∑‰ª¬—ß ç à«π‡°‘π¡Ÿ≈§à“Àÿπâ “¡—≠é

14. ∑ÿπ‡√◊ÕπÀÿâπ ºŸ∂â Õ◊ Àÿπâ ∫ÿ√¡‘ ‘∑∏‘¡ ’ ∑‘ ∏‘‡∑à“‡∑’¬¡°—∫Àÿπâ “¡—≠ ¬°‡«âπ ‘∑∏‘„π°“√√—∫‡ß‘πªíπº≈°àÕπ„πÕ—µ√“√âÕ¬≈– 15 ¢Õß∑ÿπ∑’‡Ë ªìπÀÿπâ ∫ÿ√¡‘ ‘∑∏‘ Àÿâπ∫ÿ√¡‘ ‘∑∏‘ ¥—ß°≈à“« “¡“√∂·ª≈ß ¿“æ‡ªìπÀÿπâ “¡—≠‰¥â „π‰µ√¡“ ∑’ÀË π÷ßË ¢Õßªï 2548 ¡’ºŸâ∂Õ◊ Àÿâπ∫ÿ√¡‘ ‘∑∏‘®”π«π 332,000 Àÿâπ (2547: 20,500 Àÿâπ) ¢Õ·ª≈ßÀÿπâ ∫ÿ√‘¡ ‘∑∏‘‡ªìπÀÿâπ “¡—≠„πÕ—µ√“ 1 Àÿπâ ∫ÿ√‘¡ ‘∑∏‘µàÕ 1 Àÿâπ “¡—≠ ‚¥¬∫√‘…—∑œ‰¥â¥”‡π‘π°“√®¥∑–‡∫’¬π°“√‡ª≈’Ë¬π·ª≈ß¥—ß°≈à“«°—∫°√–∑√«ßæ“≥‘™¬å‡√’¬∫√âÕ¬·≈â«‡¡◊ËÕ«—π∑’Ë 8 ¡’π“§¡ 2548 ‡¡◊ÕË «—π∑’Ë 18 ∏—π«“§¡ 2546 ∑’ªË √–™ÿ¡«‘ “¡—≠ºŸ∂â Õ◊ Àÿπâ ¢Õß∫√‘…—∑œ‰¥â¡¡’ µ‘Õπÿ¡µ— ‘„Àâ∫√‘…∑— œ≈¥∑ÿπ®¥∑–‡∫’¬π®”π«π 922,702,685 ∫“∑ ‚¥¬≈¥¡Ÿ≈§à“∑’µË √“‰«â¢ÕßÀÿπâ ®“°‡¥‘¡Àÿâπ≈– 10 ∫“∑ ‡ªìπÀÿπâ ≈– 5 ∫“∑ ´÷ßË ¡’º≈∑”„Àâ∑πÿ ™”√–·≈â«≈¥≈ß®”π«π 663,409,365 ∫“∑ ‡æ◊ÕË π” ‰ª≈¥¢“¥∑ÿπ – ¡¢Õß∫√‘…—∑œ ‚¥¬∫√‘…—∑œ‰¥â¥”‡π‘π°“√®¥∑–‡∫’¬π°“√‡ª≈’Ë¬π·ª≈ß¥—ß°≈à“«°—∫°√–∑√«ßæ“≥‘™¬å‡√’¬∫√âÕ¬·≈â«‡¡◊ËÕ«—π∑’Ë 8 ¡’π“§¡ 2547 ‡¡◊ÕË «—π∑’Ë 28 ‡¡…“¬π 2547 ∑’ªË √–™ÿ¡ “¡—≠ºŸâ∂Õ◊ Àÿâπ¢Õß∫√‘…∑— œ ‰¥â¡¡’ µ‘„Àâ‡ª≈’¬Ë π·ª≈ß¡Ÿ≈§à“Àÿâπ∑’µË √“‰«â¢Õß∫√‘…∑— œ®“°Àÿπâ ≈– 5 ∫“∑ ‡ªìπ Àÿπâ ≈– 1 ∫“∑ ·≈–·°â‰¢®”π«πÀÿπâ ¢Õß∑ÿπ®¥∑–‡∫’¬π¢Õß∫√‘…∑— œ®“° 184,540,537 Àÿπâ ¡Ÿ≈§à“Àÿπâ ≈– 5 ∫“∑ ‡ªìπ 922,702,685 Àÿπâ ¡Ÿ≈§à“ Àÿπâ ≈– 1 ∫“∑ ∫√‘…∑— œ‰¥â¥”‡π‘π°“√ ®¥∑–‡∫’¬π°“√‡ª≈’¬Ë π·ª≈ß¥—ß°≈à“«°—∫°√–∑√«ßæ“≥‘™¬å‡√’¬∫√âÕ¬·≈â«‡¡◊ÕË «—π∑’Ë 17 æƒ…¿“§¡ 2547 ‡¡◊ÕË «—π∑’Ë 16 ¡‘∂πÿ “¬π 2547 ∫√‘…∑— œ‰¥âÕÕ°Àÿπâ “¡—≠„Àâ·°à∫√√…—∑‡ß‘π∑ÿπ√–À«à“ßª√–‡∑»®”π«π 9,500,000 Àÿπâ ¡Ÿ≈§à“∑’µË √“‰«âÀÿâπ≈– 1 ∫“∑ „π√“§“¢“¬Àÿπâ ≈– 11.643334 ∫“∑ (√“§“°”Àπ¥®“°§à“‡©≈’¬Ë ¢Õß√“§“´◊ÕÈ ¢“¬Àÿπâ ¢Õß∫√‘…∑— œ„πµ≈“¥À≈—°∑√—æ¬å·Ààßª√–‡∑»‰∑¬) √«¡‡ªìπ¡Ÿ≈§à“∑—ßÈ ‘πÈ 110,611,673 ∫“∑ ¡’º≈„Àâ∫√‘…∑— œ¡’∑πÿ ™”√–·≈â«‡æ‘¡Ë ¢÷πÈ ®“° 663,409,365 ∫“∑ ‡ªìπ 672,909,365 ∫“∑ ·≈–¡’ «à π‡°‘π ¡Ÿ≈§à“Àÿπâ “¡—≠®”π«π 101,111,673 ∫“∑ ∫√‘…∑— œ‰¥â¥”‡π‘π°“√®¥∑–‡∫’¬π°“√‡ª≈’¬Ë π·ª≈ß¥—ß°≈à“«°—∫°√–∑√«ßæ“≥‘™¬å ‡√’¬∫√âÕ¬·≈â«‡¡◊ÕË «—π∑’Ë 18 ¡‘∂πÿ “¬π 2547 54

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

¿“¬À≈—ß°“√·ª≈ß ¿“æÀÿâπ°Ÿâ®”π«π 200 ≈â“π∫“∑ ‡¡◊ÕË «—π∑’Ë 25 ‘ßÀ“§¡ 2547 ¡’º≈„Àâ∫√‘…∑— œ¡’∑πÿ ™”√–·≈â«‡æ‘¡Ë ¢÷πÈ ®“° 672,909,365 ∫“∑ ‡ªìπ 730,052,222 ∫“∑ ¡’ «à π‡°‘π¡Ÿ≈§à“Àÿπâ “¡—≠‡æ‘¡Ë ¢÷πÈ ®“° 101,111,673 ∫“∑ ‡ªìπ 285,568,300 ∫“∑ ‚¥¬∫√‘…∑— œ‰¥â¥”‡π‘π°“√®¥ ∑–‡∫’¬π°“√‡ª≈’¬Ë π·ª≈ß¥—ß°≈à“«°—∫°√–∑√«ßæ“≥‘™¬å‡√’¬∫√âÕ¬·≈â«‡¡◊ÕË «—π∑’Ë 26 ‘ßÀ“§¡ 2547 ·≈–µ≈“¥À≈—°∑√—æ¬å·Ààßª√–‡∑»‰∑¬‰¥â√∫— Àÿπâ “¡—≠‡æ‘¡Ë ∑ÿπ¥—ß°≈à“«‡ªìπÀ≈—°∑√—æ¬å®¥∑–‡∫’¬π„πµ≈“¥À≈—°∑√—æ¬å·≈â«

15. ”√Õßµ“¡°ÆÀ¡“¬ µ“¡æ√–√“™∫—≠≠—µ∫‘ √‘…∑— ¡À“™π®”°—¥ æ.». 2535 ∫√‘…∑— œµâÕß®—¥ √√‡ß‘π ”√ÕßÕ¬à“ßπâÕ¬√âÕ¬≈– 5 ¢Õß°”‰√ ÿ∑∏‘ª√–®”ªïÀ≈—ß®“°À—° ¢“¥∑ÿπ – ¡¬°¡“ (∂â“¡’) ®π°«à“ ”√Õß¥—ß°≈à“«¡’®”π«π‡∑à“°—∫√âÕ¬≈– 10 ¢Õß∑ÿπ®¥∑–‡∫’¬π ”√Õßµ“¡°ÆÀ¡“¬¥—ß°≈à“«‰¡à “¡“√∂ π”‰ª®à“¬‡ªìπ‡ß‘πªíπº≈‰¥â „π√–À«à“ßªï 2548 ∫√‘…∑— œ‰¥â®¥— √√ ”√Õßµ“¡°ÆÀ¡“¬®”π«π 45.8 ≈â“π∫“∑ (2547: 46.5 ≈â“π∫“∑) ®“°°”‰√ ÿ∑∏‘ ”À√—∫ªï

16. §à“µÕ∫·∑π°√√¡°“√ §à“µÕ∫·∑π°√√¡°“√π’‡È ªìπº≈ª√–‚¬™πå∑®’Ë “à ¬„Àâ·°à°√√¡°“√¢Õß∫√‘…∑— œµ“¡¡“µ√“ 90 ¢Õßæ√–√“™∫—≠≠—µ∫‘ √‘…∑— ¡À“™π®”°—¥ ‚¥¬‰¡à√«¡ ‡ß‘π‡¥◊Õπ·≈–º≈ª√–‚¬™πå∑‡’Ë °’¬Ë «¢âÕß∑’®Ë “à ¬„Àâ·°à°√√¡°“√∫√‘À“√

17. ¿“…’‡ß‘π‰¥âπµ‘ ∫‘ ÿ§§≈ ¿“…’‡ß‘π‰¥âπµ‘ ‘∫§ÿ §≈ ”À√—∫ªï 2548 ¢Õß∫√‘…∑— œ §”π«≥¢÷πÈ „πÕ—µ√“√âÕ¬≈– 25 ¢Õß°”‰√ ÿ∑∏‘„π à«π∑’Ë‰¡à‡°‘π 300 ≈â“π∫“∑ ·≈–„πÕ—µ√“ √âÕ¬≈– 30 ¢Õß°”‰√ ÿ∑∏‘„π à«π∑’‡Ë °‘π 300 ≈â“π∫“∑ ∑—ßÈ π’È Õ—µ√“¥—ß°≈à“«‡ªìπ‰ªµ“¡æ√–√“™°ƒ…Æ’°“ ©∫—∫∑’Ë 387 (æ.». 2544) ≈ß«—π∑’Ë 28 ‘ßÀ“§¡ 2544 ÕÕ°µ“¡§«“¡„πª√–¡«≈√—…Æ“°√«à“¥â«¬°“√≈¥Õ—µ√“√—…Æ“°√ ¿“…’‡ß‘π‰¥âπµ‘ ∫‘ ÿ§§≈ ”À√—∫ªï 2548 ·≈– 2547 ¢Õß∫√‘…∑— ¬àÕ¬·ÀàßÀπ÷ßË (∫√‘…—∑ ∫”√ÿß√“…Æ√å ‡¡¥‘§Õ≈‡´Áπ‡µÕ√å ®”°—¥) §”π«≥¢÷Èπ„πÕ—µ√“ √âÕ¬≈– 30 ¢Õß°”‰√ ÿ∑∏‘∑“ß¿“…’ ∫√‘…∑— œ ‰¡à¡¿’ “√–¿“…’‡ß‘π‰¥âπµ‘ ∫‘ §ÿ §≈ ”À√—∫ªï 2547 ‡π◊ÕË ß®“°∫√‘…∑— œ¡’º≈¢“¥∑ÿπ∑“ß¿“…’®“°ªï°Õà πÊ¬°¡“¡“°°«à“°”‰√ ÿ∑∏‘ ”À√—∫ªï

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

18. °“√°√–∑∫¬Õ¥°”‰√µàÕÀÿπâ ª√—∫≈¥ (Àπà«¬: ∫“∑)

°”‰√ ÿ∑∏‘ 2548 2547

”À√—∫ªï ‘Èπ ÿ¥«—π∑’Ë 31 ∏—π«“§¡ ®”π«πÀÿπâ “¡—≠ ∂—«‡©≈’¬Ë ∂à«ßπÈ”Àπ—° 2548 2547 Àÿπâ Àÿπâ

°”‰√µàÕÀÿπâ ¢—πÈ æ◊πÈ ∞“π °”‰√ ÿ∑∏‘ 1,052,739,279 934,547,115 727,630,430 º≈°√–∑∫¢ÕßÀÿπâ “¡—≠‡∑’¬∫‡∑à“ª√—∫≈¥ Àÿπâ ∫ÿ√¡‘ ‘∑∏‘®”π«π 2,360,850 Àÿπâ (2547: 2,692,350 Àÿπâ ) 2,421,792 Àÿπâ °Ÿ·â ª≈ß ¿“æ®”π«π 55 Àÿπâ 137,362,637 °”‰√µàÕÀÿπâ ª√—∫≈¥ °”‰√∑’‡Ë ªìπ¢ÕßºŸ∂â Õ◊ Àÿπâ “¡—≠ ¡¡µ‘«“à ¡’°“√·ª≈ß‡ªìπÀÿπâ “¡—≠ 1,052,739,279 934,547,115 867,414,859

686,003,287

°”‰√µàÕÀÿπâ 2548 2547

1.45

1.36

1.21

1.08

2,711,894 174,364,979

863,080,160

19. ‡ß‘πªíπº≈®à“¬ ‡¡◊ÕË «—π∑’Ë 17 ‘ßÀ“§¡ 2548 ∑’ªË √–™ÿ¡§≥–°√√¡°“√¢Õß∫√‘…—∑œ‰¥â¡¡’ µ‘Õπÿ¡µ— ‘„Àâ∫√‘…∑— œ®à“¬‡ß‘πªíπº≈√–À«à“ß°“≈„Àâ·°àº∂Ÿâ Õ◊ Àÿπâ ®“°º≈°“√ ¥”‡π‘πß“πµ—ßÈ ·µà«—π∑’Ë 1 ¡°√“§¡ 2548 ∂÷ß«—π∑’Ë 30 ¡‘∂ÿπ“¬π 2548 „πÕ—µ√“Àÿâπ≈– 0.30 ∫“∑ √«¡‡ªìπ‡ß‘π 219 ≈â“π∫“∑ ‡¡◊ÕË «—π∑’Ë 27 ‡¡…“¬π 2548 ∑’ªË √–™ÿ¡ “¡—≠ª√–®”ªïº∂Ÿâ Õ◊ Àÿπâ ¢Õß∫√‘…∑— œ‰¥â¡’¡µ‘Õπÿ¡µ— ‘„Àâ∫√‘…∑— œ®à“¬‡ß‘πªíπº≈„Àâ·°àº∂Ÿâ Õ◊ Àÿπâ ®“°º≈°“√ ¥”‡π‘πß“π ”À√—∫ªï ‘Èπ ÿ¥«—π∑’Ë 31 ∏—π«“§¡ 2547 „πÕ—µ√“Àÿπâ ≈– 0.40 ∫“∑ √«¡‡ªìπ‡ß‘π 292 ≈â“π∫“∑ ·≈–¡’¡µ‘√∫— ∑√“∫°“√®à“¬‡ß‘πªíπº≈ √–À«à“ß°“≈„πÕ—µ√“Àÿπâ ≈– 0.30 ∫“∑ ‡¡◊ÕË «—π∑’Ë 18 ‘ßÀ“§¡ 2547 ∑’Ëª√–™ÿ¡§≥–°√√¡°“√¢Õß∫√‘…∑— œ‰¥â¡¡’ µ‘Õπÿ¡—µ‘„Àâ∫√‘…∑— œ®à“¬‡ß‘πªíπº≈√–À«à“ß°“≈„Àâ·°àº∂Ÿâ Õ◊ Àÿπâ ®“°º≈°“√ ¥”‡π‘πß“πµ—ßÈ ·µà«π— ∑’Ë 1 ¡°√“§¡ 2547 ∂÷ß«—π∑’Ë 30 ¡‘∂πÿ “¬π 2547 „πÕ—µ√“Àÿπâ ≈– 0.30 ∫“∑ √«¡‡ªìπ‡ß‘π 219 ≈â“π∫“∑

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

20. ß∫°√–· ‡ß‘π ¥ ‡ß‘π ¥·≈–√“¬°“√‡∑’¬∫‡∑à“‡ß‘π ¥µ“¡∑’·Ë ¥ßÕ¬Ÿà„πß∫°√–· ‡ß‘π ¥ª√–°Õ∫¥â«¬√“¬°“√¥—ßµàÕ‰ªπ’:È ß∫°“√‡ß‘π√«¡ 31 ∏—π«“§¡ 2548 2547 523,506,119 652,881,941 249,883,845 699,827,772 773,389,964 1,352,709,713

‡ß‘π ¥·≈–‡ß‘πΩ“° ∂“∫—π°“√‡ß‘π ‡ß‘πΩ“°ª√–®”°—∫ ∂“∫—π°“√‡ß‘π À—°: ‡ß‘πΩ“°´÷ßË ∂÷ß°”Àπ¥®à“¬§◊π‡°‘π°«à“ 3 ‡¥◊ÕπÀ√◊Õ∑’πË ”‰ª§È”ª√–°—π ‡ß‘π ¥·≈–√“¬°“√‡∑’¬∫‡∑à“‡ß‘π ¥

(Àπà«¬: ∫“∑) ß∫°“√‡ß‘π‡©æ“–∫√‘…∑— œ 31 ∏—π«“§¡ 2548 2547 362,385,685 516,300,167 241,250,972 221,250,880 603,636,657 737,551,047

(229,883,845) (629,827,772) (221,250,972) (221,250,880) 543,506,119 722,881,941 382,385,685 516,300,167

21. ®”π«π·≈–§à“„™â®“à ¬‡°’¬Ë «°—∫æπ—°ß“π

®”π«πæπ—°ß“π ≥ «—π ‘πÈ ªï §à“„™â®“à ¬‡°’¬Ë «°—∫æπ—°ß“π ”À√—∫ªï (æ—π∫“∑)

ß∫°“√‡ß‘π√«¡ 2548 2547 2,841 2,762 928,897 777,783

ß∫°“√‡ß‘π‡©æ“–∫√‘…∑— œ 2548 2547 2,809 2,729 916,257 333,575

22. ‡§√◊ËÕß¡◊Õ∑“ß°“√‡ß‘π 22.1 §«“¡‡ ’¬Ë ß®“°Õ—µ√“¥Õ°‡∫’¬È §«“¡‡ ’¬Ë ß®“°Õ—µ√“¥Õ°‡∫’¬È π’‡È °‘¥¢÷πÈ ®“°§«“¡º—πº«π¢ÕßÕ—µ√“¥Õ°‡∫’¬È „πµ≈“¥„πÕπ“§µ ´÷ßË ®– àßº≈°√–∑∫µàÕº≈°“√¥”‡π‘πß“π ·≈–°√–· ‡ß‘π ¥¢Õß∫√‘…—∑œ·≈–∫√‘…—∑¬àÕ¬ §«“¡‡ ’Ë¬ß®“°Õ—µ√“¥Õ°‡∫’È¬‡°’Ë¬«‡π◊ËÕß‚¥¬µ√ß°—∫∫—≠™’‡ß‘πΩ“°°—∫ ∂“∫—π°“√‡ß‘π ‡ß‘π„Àâ°¬Ÿâ ¡◊ ·°à°®‘ °“√∑’‡Ë °’¬Ë «¢âÕß°—π ‡ß‘π°Ÿ¬â ¡◊ ®“°°‘®°“√∑’‡Ë °’¬Ë «¢âÕß°—π ‡ß‘π°Ÿ¬â ¡◊ √–¬–¬“«·≈–Àÿπâ °Ÿ·â ª≈ß ¿“æ ∫√‘…∑— œ·≈–∫√‘…∑— ¬àÕ¬ ¡‘‰¥â„™âµ√“ “√Õπÿæπ— ∏å∑“ß°“√‡ß‘π‡æ◊ÕË ªÑÕß°—π§«“¡‡ ’¬Ë ß¥—ß°≈à“« √“¬≈–‡Õ’¬¥¢Õß‡ß‘π°Ÿ¬â ¡◊ √–¬–¬“«·≈–Àÿπâ °Ÿ·â ª≈ß ¿“æ‰¥â· ¥ß‰«â„π À¡“¬‡Àµÿ 12 ·≈– 13 µ“¡≈”¥—∫ 22.2 §«“¡‡ ’¬Ë ß®“°Õ—µ√“·≈°‡ª≈’¬Ë π ≥ «—π∑’Ë 31 ∏—π«“§¡ 2548 ∫√‘…∑— œ·≈–∫√‘…—∑¬àÕ¬¡’ ‘π∑√—æ¬å·≈–Àπ’ È ‘π∑’‡Ë ªìπ‡ß‘πµ√“µà“ßª√–‡∑» ´÷ßË ‰¡à‰¥â∑” —≠≠“ªÑÕß°—π§«“¡ ‡ ’¬Ë ß¥—ßπ’:È °ÿ≈‡ß‘π ‡À√’¬≠ À√—∞ ‡ª‚´

‘π∑√—æ¬å 32,818 29,380,522

Àπ’ È π‘ 4,601,749

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

22.3 §«“¡‡ ’¬Ë ß¥â“π°“√„Àâ ‘π‡™◊ÕË ∫√‘…∑— œ·≈–∫√‘…∑— ¬àÕ¬¡’§«“¡‡ ’¬Ë ß¥â“π°“√„Àâ π‘ ‡™◊ÕË ∑’‡Ë °’¬Ë «‡π◊ÕË ß°—∫∫—≠™’≈°Ÿ Àπ’°È “√§â“ Õ¬à“ß‰√°Áµ“¡ ‡π◊ÕË ß®“°∫√‘…∑— œ·≈–∫√‘…∑— ¬àÕ¬ ¡’∞“π¢Õß≈Ÿ°§â“∑’ËÀ≈“°À≈“¬·≈–¡’®”π«π¡“°√“¬ ¥—ßπ—Èπ ∫√‘…—∑œ·≈–∫√‘…—∑¬àÕ¬®÷ß‰¡à§“¥«à“®–‰¥â√—∫§«“¡‡ ’¬À“¬Õ¬à“ß‡ªìπ “√– ”§—≠®“°°“√‡°Á∫Àπ’®È “°≈Ÿ°Àπ’‡È À≈à“π—πÈ 22.4 ¡Ÿ≈§à“¬ÿµ∏‘ √√¡ ‡π◊ËÕß®“° ‘π∑√—æ¬å∑“ß°“√‡ß‘π à«π„À≠à®—¥Õ¬Ÿà „πª√–‡¿∑√–¬– —Èπ·≈–‡ß‘π°Ÿâ¬◊¡¡’Õ—µ√“¥Õ°‡∫’È¬ „°≈â‡§’¬ß°—∫Õ—µ√“¥Õ°‡∫’È¬„πµ≈“¥ ΩÉ“¬∫√‘À“√¢Õß∫√‘…—∑œ‡™◊ËÕ«à“¡Ÿ≈§à“¬ÿµ‘∏√√¡¢Õß ‘π∑√—æ¬å·≈–Àπ’È ‘π∑“ß°“√‡ß‘π¥—ß°≈à“«®–‰¡à·µ°µà“ßÕ¬à“ß‡ªìπ “√– ”§—≠°—∫¡Ÿ≈§à“ µ“¡∫—≠™’

23. ¿“√–ºŸ°æ—π ≥ «—π∑’Ë 31 ∏—π«“§¡ 2548 ∫√‘…∑— œ·≈–∫√‘…∑— ¬àÕ¬¡’¿“√–ºŸ°æ—π§ß‡À≈◊ÕÕ¬Ÿ¥à ß— µàÕ‰ªπ’È °) ∫√‘…—∑œ¡’¿“√–ºŸ°æ—π‡°’Ë¬«°—∫°“√®à“¬§à“∏√√¡‡π’¬¡„Àâ·°à∏π“§“√·ÀàßÀπ÷Ëß„π∞“π–ºŸâ·∑πºŸâ∂◊ÕÀÿâπ°Ÿâ·ª≈ß ¿“æ ‚¥¬ —≠≠“¥—ß°≈à“« ®– ‘πÈ ÿ¥„πªï 2555 ¬Õ¥§ß‡À≈◊Õ¢Õß¿“√–ºŸ°æ—πµ“¡ —≠≠“§‘¥‡ªìπ®”π«π‡ß‘π 1.7 ≈â“π∫“∑ (2547: 1.9 ≈â“π∫“∑) ¢) ∫√‘…∑— œ¡’¿“√–ºŸ°æ—πÕ—π‡°’¬Ë «‡π◊ÕË ß°—∫ —≠≠“°àÕ √â“ßÕ“§“√®”π«π 79.5 ≈â“π∫“∑ (2547: 263.6 ≈â“π∫“∑) ·≈–‡°’¬Ë «°—∫°“√ ´◊ÕÈ ‡§√◊ÕË ß¡◊Õ·æ∑¬å·≈–Õÿª°√≥å ‚√ßæ¬“∫“≈‡ªìπ®”π«π‡ß‘π 150.1 ≈â“π∫“∑ (2547: 71.5 ≈â“π∫“∑) §) ∫√‘…—∑œ¡’¿“√–ºŸ°æ—πÕ—π‡°’Ë¬«‡π◊ËÕß°—∫°“√®à“¬§à“‡™à“∑’Ë¥‘π‡æ◊ËÕ √â“ßÀÕæ—°æ¬“∫“≈®”π«π 91.7 ≈â“π∫“∑ ´÷Ëß —≠≠“¡’√–¬–‡«≈“ 30 ªï ‘Èπ ÿ¥ªï 2578 ·≈– “¡“√∂µàÕÕ“¬ÿ —≠≠“‡™à“‰¥âÕ°’ 20 ªï ß) ∫√‘…∑— œ¡’¿“√–ºŸ°æ—πÕ—π‡°’¬Ë «‡π◊ÕË ß°—∫°“√®à“¬§à“‡™à“Õÿª°√≥å°“√·æ∑¬å®”π«π 16.6 ≈â“π∫“∑ (2547: 36.6 ≈â“π∫“∑) ´÷ßË —≠≠“ ¡’√–¬–‡«≈“ 5 ªï ‘Èπ ÿ¥ªï 2549 ®) ∫√‘…∑— œ¡’¿“√–ºŸ°æ—πÕ—π‡°’¬Ë «‡π◊ÕË ß°—∫°“√®à“¬§à“‡™à“∑’¥Ë π‘ ·≈–Õ“§“√‡æ◊ÕË „Àâ∫√‘°“√ÀâÕßæ—°®”π«π 48 ≈â“π∫“∑ ´÷ßË —≠≠“¥—ß°≈à“« ¡’√–¬–‡«≈“ 3 ªï ‘Èπ ÿ¥ªï 2551 ·≈– “¡“√∂µàÕÕ“¬ÿ ≠— ≠“‡™à“‰¥âÕ’° 2 ªï ©) ∫√‘…—∑œ¡’¿“√–ºŸ°æ—πÕ—π‡°’Ë¬«‡π◊ËÕß°—∫°“√®à“¬§à“‡™à“Õ“§“√ÀÕæ—°æ¬“∫“≈·≈–∫√‘°“√∑’Ë‡°’Ë¬«¢âÕß®”π«π (2547: 17.4 ≈â“π∫“∑) ´÷ßË —≠≠“¥—ß°≈à“«¡’√–¬–‡«≈“ 3 ªï ‘πÈ ÿ¥ªï 2550 ·≈– “¡“√∂µàÕÕ“¬ÿ ≠— ≠“‰¥â

10.1

≈â“π∫“∑

™) ∫√‘…∑— œ¡’¿“√–ºŸ°æ—πÕ—π‡°’¬Ë «‡π◊ÕË ß°—∫°“√®à“¬§à“∫”√ÿß√—°…“Õÿª°√≥å°“√·æ∑¬å„πÕ—µ√“‡¥◊Õπ≈– 2.8 ≈â“π∫“∑ ´÷ßË —≠≠“¥—ß°≈à“« ¡’√–¬–‡«≈“ 5 ªï ‘πÈ ÿ¥ªï 2551 ·≈– “¡“√∂µàÕÕ“¬ÿ —≠≠“‰¥â ´) ∫√‘…∑— œ¡’¿“√–ºŸ°æ—πÕ—π‡°’¬Ë «‡π◊ÕË ß°—∫°“√®à“¬§à“∫√‘°“√√—°…“§«“¡ª≈Õ¥¿—¬„πÕ—µ√“‡¥◊Õπ≈– 0.8 ≈â“π∫“∑ ´÷ßË —≠≠“¥—ß°≈à“«¡’ √–¬–‡«≈“ 3 ªï ‘πÈ ÿ¥ªï 2548 ·≈– “¡“√∂µàÕÕ“¬ÿ —≠≠“‰¥â 58

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

¨) ∫√‘…∑— œ¡’¿“√–ºŸ°æ—πÕ—π‡°’¬Ë «‡π◊ÕË ß°—∫°“√®à“¬§à“∫√‘°“√∑”§«“¡ –Õ“¥„πÕ—µ√“‡¥◊Õπ≈– 1.9 ≈â“π∫“∑ ≠) ∫√‘…—∑œ¡’¿“√–ºŸ°æ—πÕ—π‡°’Ë¬«‡π◊ËÕß°—∫°“√®à“¬§à“‡™à“·≈–§à“∫”√ÿß√—°…“√∂¬πµå®”π«π 24.9 ≈â“π∫“∑ ´÷Ëß —≠≠“¥—ß°≈à“«¡’√–¬– ‡«≈“ 5 ªï ‘Èπ ÿ¥ªï 2552 Æ) ∫√‘…∑— ¬àÕ¬·ÀàßÀπ÷ßË (∫√‘…∑— ∫”√ÿß√“…Æ√å Õ‘π‡µÕ√å‡π™—πË ·π≈ ®”°—¥) ¡’¿“√–ºŸ°æ—πÕ—π‡°’¬Ë «‡π◊ÕË ß°—∫°“√®à“¬§à“∫√‘°“√∑’ªË √÷°…“„π Õ—µ√“ªï≈– 20,000 ‡À√’¬≠ À√—∞œ ´÷ßË —≠≠“¥—ß°≈à“«¡’√–¬–‡«≈“ 7 ªï ‘Èπ ÿ¥ªï 2555

24. Àπ—ß ◊Õ§È”ª√–°—π¢Õß∏π“§“√ ≥ «—π∑’Ë 31 ∏—π«“§¡ 2548 ¡’Àπ—ß ◊Õ§È”ª√–°—π∑’ÕË Õ°‚¥¬∏π“§“√„ππ“¡¢Õß∫√‘…∑— œ‡À≈◊ÕÕ¬Ÿ‡à ªìπ®”π«π‡ß‘π 1.9 ≈â“π∫“∑ (2547: 1.9 ≈â“π∫“∑) ·≈–„ππ“¡∫√‘…∑— ¬àÕ¬‡ªìπ®”π«π‡ß‘π 8.4 ≈â“π∫“∑ (2547: 8.4 ≈â“π∫“∑) ´÷ßË ‡°’¬Ë «‡π◊ÕË ß°—∫¿“√–ºŸ°æ—π∑“ßªØ‘∫µ— ∫‘ “ßª√–°“√µ“¡ ª°µ‘∏√ÿ °‘®

25. Àπ’ È π‘ ∑’ÕË “®®–‡°‘¥¢÷πÈ ‡¡◊ÕË «—π∑’Ë 4 µÿ≈“§¡ 2548 ∫√‘…∑— ‡Õ‡™’¬π ŒÕ æ‘∑Õ≈ Õ‘ß§å (AHI) ´÷ßË ‡ªìπ∫√‘…∑— √à«¡‰¥â√∫— ·®âßº≈„π‡∫◊ÕÈ ßµâπ®“° ”π—°ß“π √√æ“°√¢Õß ª√–‡∑»øî≈ª‘ ªîπ å«“à Õ“®®–¡’°“√™”√–¿“…’ ”À√—∫ªï π‘È ÿ¥«—π∑’Ë 31 ∏—π«“§¡ 2545 ‰¡à§√∫∂â«π ´÷ßË ºŸ∫â √‘À“√¢Õß∫√‘…∑— ‡™◊ÕË «à“º≈°“√µ√«® Õ∫¥—ß°≈à“«‰¡à¡¡’ ≈Ÿ ·≈–‰¥â ‚µâ·¬âß„π‡√◊ÕË ßπ’ÈÕ¬à“ßÀπ—°·πàπ ¥—ßπ—Èπ ∫√‘…∑— ®÷ß¡‘‰¥â∫π— ∑÷° ”√Õß‡º◊ÕË §«“¡‡ ’¬À“¬®“°°“√∂Ÿ°ª√–‡¡‘π¥—ß°≈à“« ‰«â„π∫—≠™’

26. °“√‡ πÕ¢âÕ¡Ÿ≈∑“ß°“√‡ß‘π®”·π°µ“¡ à«πß“π ∫√‘…—∑œ·≈–∫√‘…—∑¬àÕ¬¥”‡π‘π°‘®°“√„π à«πß“π∑“ß∏ÿ√°‘®À≈—°§◊Õ∏ÿ√°‘®‚√ßæ¬“∫“≈·≈–»Ÿπ¬å¥Ÿ·≈ ÿ¢¿“æ ·≈–¥”‡π‘π∏ÿ√°‘® à«π„À≠à„π à«π ß“π∑“ß¿Ÿ¡»‘ “ µ√å‡¥’¬«§◊Õ„πª√–‡∑»‰∑¬ ¥—ßπ—πÈ √“¬‰¥â °”‰√·≈– ‘π∑√—æ¬å ∑—ßÈ À¡¥∑’·Ë ¥ß„πß∫°“√‡ß‘π®÷ß‡°’¬Ë «¢âÕß°—∫ à«πß“π∏ÿ√°‘®·≈– à«πß“π∑“ß¿Ÿ¡»‘ “ µ√åµ“¡∑’°Ë ≈à“«‰«â¢“â ßµâπ „πªï 2548 ∫√‘…∑— œ·≈–∫√‘…∑— ¬àÕ¬¡’√“¬‰¥â®“°∏ÿ√°‘®‚√ßæ¬“∫“≈„πµà“ßª√–‡∑»‡ªìπ®”π«π‡ß‘π 43.0 ≈â“π∫“∑ (2547: 17.1 ≈â“π∫“∑)

27. °“√· ¥ß√“¬°“√„πß∫°“√‡ß‘π °“√· ¥ß√“¬°“√„πß∫°“√‡ß‘ππ’È‰¥â∑”¢÷πÈ ‡æ◊ÕË „Àâ‡ªìπ‰ªµ“¡¢âÕ°”Àπ¥„πª√–°“»°√¡æ—≤π“∏ÿ√°‘®°“√§â“≈ß«—π∑’Ë 14 °—π¬“¬π 2544 ÕÕ° µ“¡§«“¡„πæ√–√“™∫—≠≠—µ°‘ “√∫—≠™’ æ.». 2543 ∫√‘…∑— œ‰¥â®¥— ª√–‡¿∑√“¬°“√∫—≠™’∫“ß√“¬°“√„πß∫°“√‡ß‘π ”À√—∫ªï π‘È ÿ¥«—π∑’Ë 31 ∏—π«“§¡ 2547 „À¡à ‡æ◊ÕË „Àâ Õ¥§≈âÕß°—∫°“√®—¥ª√–‡¿∑ √“¬°“√∫—≠™’¢Õßªïª®í ®ÿ∫π— ´÷ßË ‰¡à¡’º≈°√–∑∫µàÕ°”‰√ ÿ∑∏‘À√◊Õ à«π¢ÕßºŸ∂â Õ◊ Àÿπâ µ“¡∑’Ë‰¥â√“¬ß“π‰ª·≈â«

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

28. ‡Àµÿ°“√≥å¿“¬À≈—ß«—π∑’Ë„πß∫°“√‡ß‘π ‡¡◊ÕË «—π∑’Ë 28 °ÿ¡¿“æ—π∏å 2549 ∑’ªË √–™ÿ¡§≥–°√√¡°“√∫√‘…∑— œ‰¥â¡’¡µ‘Õπÿ¡µ— ‘„Àâ∫√‘…∑— œ®à“¬‡ß‘πªíπº≈„Àâ·°àº∂Ÿâ Õ◊ Àÿπâ ®“°º≈°“√¥”‡π‘πß“π ”À√—∫ªï π‘È ÿ¥«—π∑’Ë 31 ∏—π«“§¡ 2548 „πÕ—µ√“Àÿπâ ≈– 0.45 ∫“∑ √«¡‡ªìπ‡ß‘π 329 ≈â“π∫“∑ ·≈–¡’¡µ‘√∫— ∑√“∫°“√®à“¬‡ß‘πªíπº≈√–À«à“ß °“≈µ“¡¡µ‘∑ª’Ë √–™ÿ¡§≥–°√√¡°“√∫√‘…—∑œ ‡¡◊ÕË «—π∑’Ë 17 ‘ßÀ“§¡ 2548 „πÕ—µ√“Àÿπâ ≈– 0.30 ∫“∑ √«¡‡ªìπ‡ß‘πªíπº≈ª√–®”ªï 2548 ∑—Èß ‘Èπ 0.75 ∫“∑µàÕÀÿπâ

29. °“√Õπÿ¡µ— ß‘ ∫°“√‡ß‘π ß∫°“√‡ß‘ππ’È‰¥â√∫— Õπÿ¡µ— ‘„Àâ‡º¬·æ√à®“°§≥–°√√¡°“√∫√‘…∑— œ „π«—π∑’Ë 28 °ÿ¡¿“æ—π∏å 2549

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√ÿª “√– π‡∑»∑’Ë ”§—≠

√“¬ß“πª√–®”ªï 2548

√ÿª “√ π‡∑»∑’ Ë ”§—≠ 1. ¢âÕ¡Ÿ≈∑—«Ë ‰ª 1.1 ¢âÕ¡Ÿ≈∫√‘…∑— ™◊ÕË : ª√–‡¿∑∏ÿ√°‘®: ∂“π∑’µË —Èß ”π—°ß“π„À≠à : ‡≈¢∑–‡∫’¬π∫√‘…∑— : Home page : E-mail address : ‚∑√»—æ∑å : ‚∑√ “√ : ∑ÿπ®¥∑–‡∫’¬π

∑ÿπ™”√–·≈â«

∫√‘…∑— ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π) (ç∫√‘…∑— œé) ‚√ßæ¬“∫“≈‡Õ°™π 33 ´Õ¬ ÿ¢¡ÿ «‘∑ 3 (π“π“‡Àπ◊Õ) ∂ππ ÿ¢¡ÿ «‘∑ ·¢«ß§≈Õß‡µ¬‡Àπ◊Õ ‡¢µ«—≤π“ °√ÿß‡∑æœ 10110 ∫¡®.173 http://www.bumrungrad.com info@bumrungrad.com 0 2667 1000 0 2667 2525 922,702,685 ∫“∑ ·∫àß‡ªìπ Àÿπâ “¡—≠ ®”π«π 920,341,835 Àÿπâ ¡Ÿ≈§à“Àÿâπ≈– 1 ∫“∑ Àÿπâ ∫ÿ√¡‘ ‘∑∏‘ ®”π«π 2,360,850 Àÿπâ ¡Ÿ≈§à“Àÿπâ ≈– 1 ∫“∑ 730,052,222 ∫“∑ ·∫àß‡ªìπ Àÿπâ “¡—≠ ®”π«π 727,691,372 Àÿπâ ¡Ÿ≈§à“Àÿπâ ≈– 1 ∫“∑ Àÿâπ∫ÿ√¡‘ ‘∑∏‘ ®”π«π 2,360,850 Àÿâπ ¡Ÿ≈§à“Àÿâπ≈– 1 ∫“∑

1.2 π‘µ∫‘ §ÿ §≈∑’∫Ë √‘…∑— œ∂◊ÕÀÿπâ µ—Èß·µà√Õâ ¬≈– 10 ¢÷πÈ ‰ª ∫√‘…∑—

ª√–‡¿∑∏ÿ√°‘®

1. ∫√‘…∑— ∫”√ÿß√“…Æ√å ‡¡¥‘§Õ≈ ‡´Áπ‡µÕ√å ®”°—¥

„Àâ‡™à“ Õ —ßÀ“√‘¡∑√—æ¬å

2. ∫√‘…∑— ‰«∑—≈‰≈øá ®”°—¥

»Ÿπ¬å ¢ÿ ¿“æ

3. ∫√‘…∑— ∫”√ÿß√“…Æ√å Õ‘π‡µÕ√å‡π™—Ëπ·π≈ ®”°—¥

°“√≈ß∑ÿπ „πµà“ßª√–‡∑»

∂“π∑’µË ß—È

‚∑√»—æ∑å

33/3 ÿ¢¡ÿ «‘∑ 3 ∂ππ ÿ¢¡ÿ «‘∑ ·¢«ß§≈Õß‡µ¬‡Àπ◊Õ ‡¢µ«—≤π“ °√ÿß‡∑æœ 10110 210 ÿ¢¡ÿ «‘∑ 1 ∂ππ ÿ¢¡ÿ «‘∑ ·¢«ß§≈Õß‡µ¬‡Àπ◊Õ ‡¢µ«—≤π“ °√ÿß‡∑æœ 10110 33 ÿ¢ÿ¡«‘∑ 3 ∂ππ ÿ¢¡ÿ «‘∑ ·¢«ß§≈Õß‡µ¬‡Àπ◊Õ ‡¢µ«—≤π“ °√ÿß‡∑æœ 10110

0 2667 1000

‚∑√ “√

®”π«πÀÿπâ “¡—≠ —¥ à«π ∑’®Ë ”Àπà“¬·≈â« °“√∂◊ÕÀÿπâ 0 2667 2525 119,869,201 100% Àÿπâ

0 2667 2340

0 2667 2341

315,000 Àÿπâ

100%

0 2667 1000

0 2667 2525

6,000,000 Àÿπâ

100%

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548 ∫√‘…∑—

ª√–‡¿∑∏ÿ√°‘®

4. ∫√‘…∑— ·Õ≈. ‡Õ §≈’ππ‘ßË ®”°—¥

∫√‘°“√´—°√’¥ ªí®®ÿ∫π— À¬ÿ¥ ¥”‡π‘π°‘®°“√

5. ∫√‘…∑— ‚°≈‡∫‘≈ ·§√å ‚´≈Ÿ™—Ëπ ‡Õ . ‡Õ. ®”°—¥

æ—≤π“√–∫∫ software ¢Õß‚√ßæ¬“∫“≈

∂“π∑’µË ß—È

‚∑√»—æ∑å

‚∑√ “√

®”π«πÀÿπâ “¡—≠ —¥ à«π ∑’®Ë ”Àπà“¬·≈â« °“√∂◊ÕÀÿπâ 0 2667 2525 12,500 25% Àÿπâ

68 ÿ¢¡ÿ «‘∑ 1 0 2667 1000 ∂ππ ÿ¢¡ÿ «‘∑ ·¢«ß§≈Õß‡µ¬‡Àπ◊Õ ‡¢µ«—≤π“ °√ÿß‡∑æœ 10110 9 Rue Schil er, 41 (76) 565 1533 41 (44) 496 6319 L-2519 Luxembourg

31,426 Àÿπâ

14%

1.3 ∫ÿ§§≈Õâ“ßÕ‘ß ∫√‘…∑— 1. ºŸ â Õ∫∫—≠™’

∫√‘…—∑ ”π—°ß“π ‡Õ‘π å∑ ·Õπ¥å ¬—ß ®”°—¥

2. ∑’ªË √÷°…“°ÆÀ¡“¬

∫√‘…∑— ∑’ªË √÷°…“‰∑¬ ®”°—¥

3. π“¬∑–‡∫’¬πÀ≈—°∑√—æ¬å

∫√‘…∑— »Ÿπ¬å√∫— Ω“°À≈—°∑√—æ¬å (ª√–‡∑»‰∑¬) ®”°—¥

4. π“¬∑–‡∫’¬π Àÿπâ °Ÿ·â ª≈ß ¿“æ

∫√‘…∑— ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

5. ºŸ·â ∑πºŸ∂â Õ◊ Àÿπâ °Ÿâ

∏π“§“√∑À“√‰∑¬ ®”°—¥ (¡À“™π)

2. ¢âÕ¡Ÿ≈∑“ß°“√‡ß‘π‚¥¬ √ÿª 2.1 ¢âÕ¡Ÿ≈®“°ß∫°“√‡ß‘π (Àπâ“ 19) 2.2 Õ—µ√“ à«π∑“ß°“√‡ß‘π (Àπâ“ 19)

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

∂“π∑’µË ß—È ™—πÈ 33 Õ“§“√‡≈§√—™¥“ ‡≈¢∑’Ë 193/136-137 ∂ππ√—™¥“¿‘‡…° °√ÿß‡∑æœ 10110 63 ´Õ¬ 8 (´Õ¬ª√’¥“) ∂ππ ÿ¢¡ÿ «‘∑ °√ÿß‡∑æœ 10110 62 Õ“§“√µ≈“¥À≈—°∑√—æ¬å ·Ààßª√–‡∑»‰∑¬ ™—πÈ 4, 6-7 ∂ππ√—™¥“¿‘‡…° ‡¢µ§≈Õß‡µ¬ °√ÿß‡∑æœ 10110 33 ´Õ¬ ÿ¢¡ÿ «‘∑ 3 (π“π“‡Àπ◊Õ) ∂ππ ÿ¢¡ÿ «‘∑ ·¢«ß§≈Õß‡µ¬‡Àπ◊Õ ‡¢µ«—≤π“ °√ÿß‡∑æœ 10110 3000 ∂ππæÀ≈‚¬∏‘π ®µÿ®°— √ °√ÿß‡∑æœ 10900

‚∑√»—æ∑å

‚∑√ “√

0 2264 0777

0 2264 0789-90

0 2255 2552

0 2653 1133

0 2229 2800

0 2359 1259

0 2667 2025

0 2667 2031

0 2299 1111, 0 2617 9111

02 299 1784

√“¬ß“πª√–®”ªï 2548

3. ≈—°…≥–°“√ª√–°Õ∫∏ÿ√°‘® 3.1 √ÿª “√– ”§—≠ ∫√‘…∑— ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π) (ç∫√‘…∑— œé) ª√–°Õ∫°‘®°“√‚√ßæ¬“∫“≈‡Õ°™π¢π“¥ 554 ‡µ’¬ß„π°√ÿß‡∑æ¡À“π§√ ·≈–‡ªìπÀπ÷Ëß„πºŸâπ”„π°“√„Àâ∫√‘°“√∑“ß°“√·æ∑¬å„πª√–‡∑»‰∑¬·≈–„π¿Ÿ¡‘¿“§‡Õ‡™’¬µ–«—πÕÕ°‡©’¬ß„µâ ‚¥¬¡’°“√„Àâ∫√‘°“√Õ¬à“ß§√∫ «ß®√∑—ßÈ °“√∫√‘°“√ºŸªâ «É ¬πÕ°·≈–°“√∫√‘°“√ºŸªâ «É ¬„π µ≈Õ¥√–¬–‡«≈“∑’Ëºà“π¡“‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å‰¥â„Àâ§«“¡ ”§—≠°—∫°“√√—°…“æ¬“∫“≈∑’Ë¡’§ÿ≥¿“æ·≈–§≥–·æ∑¬åºŸâ‡™’Ë¬«™“≠ ·≈– ‡ªìπ‚√ßæ¬“∫“≈·Ààß·√°„π‡Õ‡™’¬·≈–‚√ßæ¬“∫“≈‡¥’¬«„πª√–‡∑»‰∑¬∑’Ë‰¥â√∫— °“√√—∫√Õß§ÿ≥¿“æ‚√ßæ¬“∫“≈√–¥—∫ “°≈ (JCIA) µ“¡ ¡“µ√∞“π°“√√—∫√Õß¢Õß À√—∞Õ‡¡√‘°“ πÕ°®“°π’È ∫√‘…∑— œ‡ªìπ Holding Company ∂◊ÕÀÿπâ √âÕ¬≈– 100 „π∫√‘…∑— ∫”√ÿß√“…Æ√å ‡¡¥‘§Õ≈ ‡´Áπ‡µÕ√å ®”°—¥ ∫√‘…∑— ‰«∑—≈‰≈øá ®”°—¥ ·≈–∫√‘…∑— ∫”√ÿß√“…Æ√å Õ‘π‡µÕ√å‡π™—πË ·π≈ ®”°—¥ ∂◊ÕÀÿπâ √âÕ¬≈– 25 „π ∫√‘…∑— ·Õ≈ ‡Õ §≈’ππ‘ßË ®”°—¥ ·≈–∂◊ÕÀÿπâ √âÕ¬≈– 14 „π∫√‘…∑— ‚°≈‡∫‘≈ ·§√å ‚´≈Ÿ™π—Ë ‡Õ . ‡Õ. ®”°—¥ ‚§√ß √â“ß∫√‘…∑— ¡’√“¬≈–‡Õ’¬¥¥—ßµàÕ‰ªπ’È ∫√‘…∑— ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π) - ¥”‡π‘π∏ÿ√°‘®‚√ßæ¬“∫“≈‡Õ°™π„π°√ÿß‡∑æ¡À“π§√ - ¥”‡π‘π∏ÿ√°‘® Holding Company

100%

∫√‘…∑— ∫”√ÿß√“…Æ√å ‡¡¥‘§Õ≈ ‡´Áπ‡µÕ√å ®”°—¥

∫√‘…∑— ∫”√ÿß√“…Æ√å Õ‘π‡µÕ√å‡π™—Ëπ‡π≈ ®”°—¥

- ‡®â“¢ÕßÕ“§“√‚√ßæ¬“∫“≈ ´÷ßË „Àâ∫√‘…∑— ‚√ßæ¬“∫“≈ ∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π) ‡™à“

- ºŸ¥â ”‡π‘π°“√¥â“π °‘®°“√µà“ßª√–‡∑»

100% ∫√‘…∑— ‰«∑—≈‰≈øá ®”°—¥ - »Ÿπ¬å ßà ‡ √‘¡ ÿ¢¿“æ ·∫∫§√∫«ß®√

100% ∫√‘…∑— ·Õ≈ ‡Õ §≈’ππ‘ßË ®”°—¥

- À¬ÿ¥¥”‡π‘π°“√

14% ∫√‘…—∑ ‚°≈‡∫‘≈ ·§√å ‚´≈Ÿ™π—Ë ‡Õ . ‡Õ. ®”°—¥ - ºŸæâ ≤— π“√–∫∫‚ª√·°√¡ §Õ¡æ‘«‡µÕ√å ”À√—∫ ‚√ßæ¬“∫“≈

√“¬≈–‡Õ’¬¥¢Õß∫√‘…∑— ¬àÕ¬ ∫√‘…∑— √à«¡ ·≈–∫√‘…∑— ∑’‡Ë °’¬Ë «¢âÕß¢Õß∫√‘…∑— œ ¡’¥ß— µàÕ‰ªπ’È 1. ∫√‘…∑— ∫”√ÿß√“…Æ√å ‡¡¥‘§Õ≈ ‡´Áπ‡µÕ√å ®”°—¥ ‡ªìπ‡®â“¢ÕßÕ“§“√‚√ßæ¬“∫“≈ ´÷ßË „Àâ∫√‘…∑— ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π) ‡™à“ 2. ∫√‘…—∑ ∫”√ÿß√“…Æ√å Õ‘π‡µÕ√å‡π™—Ëπ·π≈ ®”°—¥ ‡ªìπºŸâ¥”‡π‘π°“√≈ß∑ÿπ·≈–√—∫®â“ß‡ªìπ∑’Ëª√÷°…“·≈–∫√‘À“√®—¥°“√‚√ßæ¬“∫“≈„π µà“ßª√–‡∑»¢Õß∫√‘…—∑œ ‚¥¬∑’Ëºà“π¡“ ∫√‘…—∑‰¥â√—∫®â“ß‡ªìπ∑’Ëª√÷°…“·≈–∫√‘À“√®—¥°“√‚√ßæ¬“∫“≈„πª√–‡∑»æ¡à“·≈–∫—ß§≈“‡∑» ´÷ßË —≠≠“¢Õß∑—ßÈ 2 ‚√ßæ¬“∫“≈π’È ‰¥â®∫·≈â«„πªï 2548 ·≈– 2549 µ“¡≈”¥—∫ πÕ°®“°π’È „πªï 2548 ∫√‘…—∑‰¥â‡¢â“∂◊ÕÀÿπâ 35% „π ‚√ßæ¬“∫“≈‡Õ‡™’¬π ŒÕ æ‘∑Õ≈ Õ‘ß§å„πª√–‡∑»øî≈ª‘ ªîπ å ·≈–‰¥â√∫— ®â“ß‡ªìπ∑’Ëª√÷°…“·≈–∫√‘À“√®—¥°“√‚√ßæ¬“∫“≈¥—ß°≈à“«¥â«¬ ·≈– „πªï 2548 ∫√‘…∑— ‰¥â≈ßπ“¡„π∫—π∑÷°§«“¡‡¢â“„®∑’®Ë –≈ß∑ÿπ √â“ß‚√ßæ¬“∫“≈„π¥Ÿ‰∫ √à«¡°—∫∫√‘…∑— Istithmar ·Ààßª√–‡∑» À√—∞Õ“À√—∫ ‡Õ¡‘‡√µ å √«¡∂÷ß‡ªìπºŸ√â ∫— º‘¥™Õ∫„π°“√∫√‘À“√‚√ßæ¬“∫“≈¥—ß°≈à“« ‚¥¬∑’§Ë “¥«à“‚√ßæ¬“∫“≈®– “¡“√∂‡ªî¥¥”‡π‘π°“√‰¥â„πªï 2551 ∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

3. ∫√‘…—∑ ‰«∑—≈‰≈øá ®”°—¥ ‡ªìπ»Ÿπ¬å àß‡ √‘¡ ÿ¢¿“æ·∫∫§√∫«ß®√ ‡™’Ë¬«™“≠∑“ß¥â“π°“√„Àâ∫√‘°“√ªÑÕß°—π·≈–√—°…“‡æ◊ËÕ™–≈Õ §«“¡‡ ◊ËÕ¡¢Õß√à“ß°“¬ ‚¥¬¡ÿàß‡πâπ°≈ÿà¡‡ªÑ“À¡“¬∑’Ë π„®°“√¥Ÿ·≈√—°…“ ÿ¢¿“æ‡ªìπæ‘‡»… ‰«∑—≈‰≈øá¡’°“√º ¡º “π√–À«à“ß §≥–·æ∑¬å¡Õ◊ Õ“™’æ∑’¡Ë §’ «“¡‡™’¬Ë «™“≠¥â“π‡«™»“ µ√å«¬— ¬ÿ«≤— πå ·≈–«‘∑¬“°“√¡“µ√∞“π√–¥—∫ “°≈ ‡æ◊ÕË ÕÕ°·∫∫‚ª√·°√¡ ÿ¢¿“æ ”À√—∫≈Ÿ°§â“·µà≈–√“¬‚¥¬‡©æ“– ´÷ßË ¡’∑ß—È ‚ª√·°√¡°“√ÕÕ°°”≈—ß°“¬ ‚ª√·°√¡‚¿™π“°“√ ·≈–‚ª√·°√¡Õ“À“√‡ √‘¡ ”À√—∫°“√¡’ ÿ¢¿“æ∑’¥Ë ’ 4. ∫√‘…∑— ·Õ≈ ‡Õ §≈’ππ‘ßË ®”°—¥ ªí®®ÿ∫π— À¬ÿ¥¥”‡π‘π°‘®°“√ 5. ∫√‘…∑— ‚°≈‡∫‘≈ ·§√å ‚´≈Ÿ™π—Ë ‡Õ . ‡Õ. ®”°—¥ ‡ªìπºŸæâ ≤— π“√–∫∫ software ”À√—∫‚√ßæ¬“∫“≈ ‚¥¬¡’ ”π—°ß“π„À≠àÕ¬Ÿ∑à ’Ë ª√–‡∑»≈—°‡´¡‡∫‘√°å 3.2 ‚§√ß √â“ß√“¬‰¥â Àπà«¬: ≈â“π∫“∑ °≈ÿ¡à ∏ÿ√°‘®

∏ÿ√°‘®°“√·æ∑¬å ∏ÿ√°‘®°“√·æ∑¬å ∏ÿ√°‘®°“√·æ∑¬å √«¡∏ÿ√°‘®°“√·æ∑¬å ∏ÿ√°‘®„Àâ‡™à“ ∏ÿ√°‘®„Àâ‡™à“ √«¡∏ÿ√°‘®„Àâ‡™à“ Õ◊πË Ê Õ◊πË Ê Õ◊πË Ê

¥”‡π‘π°“√‚¥¬

∫¡®. ‚√ßæ¬“∫“≈ ∫”√ÿß√“…Æ√å ∫®. ∫”√ÿß√“…Æ√å ‡¡¥‘§Õ≈‡´Áπ‡µÕ√å ∫®. ‰«∑—≈‰≈øá ∫¡®. ‚√ßæ¬“∫“≈ ∫”√ÿß√“…Æ√å ∫®. ∫”√ÿß√“…Æ√å ‡¡¥‘§Õ≈‡´Áπ‡µÕ√å ∫¡®. ‚√ßæ¬“∫“≈ ∫”√ÿß√“…Æ√å ∫®. ∫”√ÿß√“…Æ√å ‡¡¥‘§Õ≈‡´Áπ‡µÕ√å ∫®. ∫”√ÿß√“…Æ√å Õ‘π‡µÕ√å‡π™—Ëπ·π≈

√«¡Õ◊πË Ê √«¡

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

% °“√∂◊ÕÀÿπâ ¢Õß∫√‘…∑— œ -

2548 √“¬‰¥â√«¡ % 6,586

100.00

61 6,647 89

2547 √“¬‰¥â√«¡ %

2546 √“¬‰¥â√«¡ %

96.8

2,482

42.7

3,167

54.5

4,473

96.8

0.8 97.6 1.3

37 5,686 41

0.7 97.9 0.7

18 4,491 29

0.4 97.2 0.6

100.00

0.2

0.5

89 58

1.3 0.9

53 36

0.9 0.6

50 39

1.1 0.8

100.00

0.6

0.9

100.00

0.2

71 6,807

1.1 100.0

70 5,809

1.2 100.0

79 1.7 4,620 100.0

√“¬ß“πª√–®”ªï 2548

3.3 ≈—°…≥–°“√ª√–°Õ∫∏ÿ√°‘® ·≈–¿“«–°“√·¢àß¢—π ∫√‘…∑— ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π) ‡ªìπºŸ¥â ”‡π‘π°‘®°“√‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å„π°√ÿß‡∑æ¡À“π§√ ·≈–‡ªìπºŸ∑â ∑’Ë ”√“¬‰¥â À≈—° §‘¥‡ªìπ√âÕ¬≈– 97.6 ¢Õß√“¬‰¥â√«¡∑—ßÈ À¡¥ °“√∫√‘°“√¢Õß‚√ßæ¬“∫“≈ ´÷ßË ¥”‡π‘πß“π¥â«¬√–∫∫ “√ π‡∑»∑“ß°“√·æ∑¬å Hospital2000 ∑’∑Ë π— ¡—¬ “¡“√∂·∫àß‰¥â¥ß— µàÕ‰ªπ’È 1. °“√∫√‘°“√ºŸªâ «É ¬πÕ° ¡’§≈‘π°‘ µ√«®ºŸªâ «É ¬135 ÀâÕß ·≈–»Ÿπ¬å∫√‘°“√ºŸªâ «É ¬πÕ°®”π«π 33 »Ÿπ¬å “¡“√∂√Õß√—∫ºŸªâ «É ¬πÕ°‰¥â 3,500 §πµàÕ«—π 2. °“√∫√‘°“√ºŸªâ «É ¬„π ¡’®”π«π‡µ’¬ß 554 ‡µ’¬ß ‚¥¬∑’Ë ≥ «—π∑’Ë 31 ∏—π«“§¡ 2548 ‚√ßæ¬“∫“≈¡’‡µ’¬ßæ√âÕ¡„Àâ∫√‘°“√ ®”π«π 457 ‡µ’¬ß 3. °“√æ¬“∫“≈©ÿ°‡©‘π·≈–ÀâÕßºà“µ—¥ ¡’·ºπ°ºŸªâ «É ¬©ÿ°‡©‘π ´÷ßË ‡ªî¥∫√‘°“√µ≈Õ¥ 24 ™—Ë«‚¡ß æ√âÕ¡¥â«¬§≥–·æ∑¬å‡©æ“–∑“ß ·≈–¡’ÀÕâ ß ºà“µ—¥®”π«π 19 ÀâÕß ∑’‡Ë æ’¬∫æ√âÕ¡¥â«¬‡§√◊ÕË ß¡◊Õ·≈–Õÿª°√≥å∑∑’Ë —π ¡—¬ ∫√‘…∑— œ¡’·ºπ∑’®Ë –¢¬“¬æ◊πÈ ∑’°Ë “√„Àâ∫√‘°“√ ‡æ◊ËÕ√Õß√—∫ºŸªâ «É ¬∑’‡Ë æ‘¡Ë ¢÷Èπ ”À√—∫Õ’° 5-7 ªï¢â“ßÀπâ“ ‚¥¬∫√‘…—∑œÕ¬Ÿ√à –À«à“ß°“√°àÕ √â“ß Õ“§“√„À¡à ßŸ 22 ™—πÈ ´÷ßË ‡¡◊ÕË ‡ªî¥„Àâ∫√‘°“√‡µÁ¡∑’Ë ®– “¡“√∂√Õß√—∫ºŸªâ «É ¬πÕ°‰¥â∂ß÷ 5,500 §πµàÕ«—π „π¢≥–‡¥’¬«°—π ∫√‘…∑— œ®– “¡“√∂ ª√—∫æ◊πÈ ∑’∑Ë ’Ë„Àâ∫√‘°“√ ”À√—∫ºŸªâ «É ¬πÕ°ªí®®ÿ∫π— „πÕ“§“√‡¥‘¡ „Àâ‡ªìπæ◊πÈ ∑’ Ë ”À√—∫∫√‘°“√ºŸªâ «É ¬„π‰¥â ´÷ßË ®–∑”„Àâ∫√‘…∑— œ¡’®”π«π‡µ’¬ß„Àâ ∫√‘°“√∑—ßÈ ‘πÈ 700 ‡µ’¬ß ∫√‘…—∑œ ®–‡√‘Ë¡‡ªî¥∫√‘°“√µ÷°„À¡à∑≈’ –™—πÈ µ“¡§«“¡µâÕß°“√∑’‡Ë æ‘Ë¡¢÷πÈ ‚¥¬®–‡√‘¡Ë ‡ªî¥„Àâ∫√‘°“√„πªï 2549 „πªï 2548 ∫√‘…∑— œ‰¥â∑”°“√√—°…“ºŸªâ «É ¬∑—Èß ‘πÈ °«à“Àπ÷ßË ≈â“π§π ‚¥¬∑’Ë∞“π≈Ÿ°§â“¢Õß‚√ßæ¬“∫“≈ “¡“√∂·∫àß‰¥â 2 «‘∏’ ¥—ßµàÕ‰ªπ’È 1. ºŸªâ «É ¬„π·≈–ºŸªâ «É ¬πÕ° (% ¢Õß√“¬√—∫√«¡) ºŸªâ «É ¬„π 53% ºŸªâ «É ¬πÕ° 47% ¢âÕ¡Ÿ≈ ≥ «—π∑’Ë 31 ∏—π«“§¡ 2548

2. ºŸªâ «É ¬„πª√–‡∑»·≈–ºŸªâ «É ¬µà“ßª√–‡∑» „πªï 2548 ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å „π°√ÿß‡∑æ¡À“π§√‰¥â „Àâ∫√‘°“√√—°…“ºŸâªÉ«¬™“«µà“ß™“µ‘®“°°«à“ 190 ª√–‡∑» √«¡ 400,000 §π ‚¥¬∑’√Ë “¬√—∫¢Õß∫√‘…∑— œ “¡“√∂·∫àß‰¥â ¥—ßµàÕ‰ªπ’È (% ¢Õß√“¬√—∫√«¡) ºŸªâ «É ¬„πª√–‡∑» 47% ºŸªâ «É ¬µà“ßª√–‡∑» 53% ¢âÕ¡Ÿ≈ ≥ «—π∑’Ë 31 ∏—π«“§¡ 2548 ∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

¿“«–Õÿµ “À°√√¡·≈–°“√·¢àß¢—π ≥ ‘πÈ ªï 2546 ª√–‡∑»‰∑¬¡’ ‚√ßæ¬“∫“≈‡Õ°™π∑—ßÈ ‘πÈ 346 ·Ààß ‚¥¬∑’Ë 100 ·Ààß Õ¬Ÿà„π°√ÿß‡∑æ¡À“π§√ °“√„Àâ∫√‘°“√¢Õß∏ÿ√°‘®°“√ ·æ∑¬å„πª√–‡∑»¡’ª√‘¡“≥¡“°°«à“§«“¡µâÕß°“√¢ÕßºŸâªÉ«¬∑’Ë¡’Õ¬Ÿà ·¡â«à“ª√‘¡“≥§«“¡µâÕß°“√‰¥â‡æ‘Ë¡¡“°¢÷Èπµ“¡¿“«–‡»√…∞°‘®∑’Ëøóôπ µ—«¥’¢÷Èπµ“¡≈”¥—∫ „π¢≥–‡¥’¬«°—π ‚√ßæ¬“∫“≈‡Õ°™π„π°√ÿß‡∑æ¡À“π§√°Á¡’°“√ª√—∫ª√ÿßÕ¬à“ßµàÕ‡π◊ËÕß ∑—Èß„π¥â“π§ÿ≥¿“æ¢Õß °“√∫√‘°“√ ·≈–°“√µ°·µàß‚√ßæ¬“∫“≈ ‡æ◊ÕË ¬°√–¥—∫§«“¡ “¡“√∂„π°“√·¢àß¢—π¢Õßµπ‡Õß Õ¬à“ß‰√°Áµ“¡ Õÿµ “À°√√¡°“√·æ∑¬å ‡Õ°™π„πª√–‡∑»‰∑¬ ‡ªìπ°“√·¢àß¢—π·∫∫‰¡à ¡∫Ÿ√≥å (fragmented market) ·≈–¡’ ‚√ßæ¬“∫“≈‡Õ°™π‡æ’¬ß‰¡à°’Ë ‚√ßæ¬“∫“≈ ∑’Ë¡’ ∫√‘°“√∑“ß°“√·æ∑¬å§√∫∑ÿ° “¢“ ·≈– “¡“√∂µÕ∫ πÕß§«“¡µâÕß°“√¢Õß§π‰¢â™“«µà“ß™“µ‘‡™àπ‡¥’¬«°—∫∫√‘…∑— œ πÕ°®“°π’È ‡π◊ÕË ß®“°≈Ÿ°§â“™“«µà“ß™“µ‘¢Õß∫√‘…∑— œ ∑”√“¬‰¥â„Àâ°—∫∫√‘…∑— œ ª√–¡“≥§√÷ËßÀπ÷ßË ¢Õß√“¬‰¥â∑ß—È À¡¥ ¥—ßπ—πÈ ∫√‘…—∑œ ®÷ß ‰¡à‰¥â‡æ’¬ß·µà·¢àß¢—π°—∫‚√ßæ¬“∫“≈„πª√–‡∑»‰∑¬‡∑à“π—Èπ ·µà¬—ßµâÕß·¢àß¢—π°—∫‚√ßæ¬“∫“≈„πª√–‡∑»„π¿Ÿ¡‘¿“§π’È ‡™àπ ‘ß§å ‚ª√å ¡“‡≈‡´’¬ ·≈– Õ‘π‡¥’¬ ´÷ßË ·µà≈–ª√–‡∑» °Á¡°’ “√ª√—∫µ—«‡æ◊ËÕ°“√·¢àß¢—π∑’ Ë ßŸ ¢÷πÈ ‡™àπ°—π °≈¬ÿ∑∏å„π°“√·¢àß¢—π¢Õß∫√‘…∑— œ §◊Õ°“√√—°…“§ÿ≥¿“æ„π°“√∫√‘°“√∑’‡Ë ªìπ‡≈‘»·≈–·µ°µà“ß ´÷ßË √«¡∂÷ß°“√∑’Ë ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ‡ªìπ‚√ßæ¬“∫“≈·Ààß·√°„π‡Õ‡™’¬·≈–·Ààß‡¥’¬«„πª√–‡∑»‰∑¬∑’Ë‰¥â√—∫°“√√—∫√Õß§ÿ≥¿“æ‚√ßæ¬“∫“≈√–¥—∫ “°≈ (JCIA) πÕ°®“°π’È ∫√‘…∑— œ ¡’π‚¬∫“¬„π°“√°”Àπ¥√“§“Õ¬Ÿà„π√–¥—∫‡¥’¬«°—∫‚√ßæ¬“∫“≈‡Õ°™π™—πÈ π”„πª√–‡∑»·≈–¢≥–‡¥’¬«°—π‡ªìπ√“§“∑’·Ë ¢àß¢—π‰¥â„π ¿Ÿ¡¿‘ “§‡Õ‡™’¬ ”À√—∫°“√·¢àß¢—π„π√–¥—∫¿Ÿ¡‘¿“§ πÕ°®“°°“√√—°…“§ÿ≥¿“æ·≈–°“√°”Àπ¥√“§“¥—ß∑’Ë°≈à“«¢â“ßµâπ·≈â« ∫√‘…—∑œ¡’·ºπ∑’Ë®–√—°…“ §«“¡‡ªìπºŸâπ”„πÕÿµ “À°√√¡‚¥¬°“√¢¬“¬°“√„Àâ∫√‘°“√¢Õß‚√ßæ¬“∫“≈‰ª¬—ßµ≈“¥°≈ÿà¡‡ªÑ“À¡“¬Õ◊Ëπºà“π°“√≈ß∑ÿπ„π‚√ßæ¬“∫“≈„π µà“ßª√–‡∑» ´÷ßË ªí®®ÿ∫—π√«¡∂÷ßª√–‡∑» øî≈ª‘ ªîπ å ·≈–µ–«—πÕÕ°°≈“ß πÕ°®“°π’È ∫√‘…∑— œ‰¥âµß—È ”π—°ß“πµ—«·∑π„πµà“ßª√–‡∑» ·≈–¡’ °“√®—¥µ—Èß»Ÿπ¬å∫√‘°“√ºŸâªÉ«¬µà“ß™“µ‘Õ¬à“ß‡ªìπ∑“ß°“√ ‡æ◊ËÕÕ”π«¬§«“¡ –¥«°„Àâ·°à§π‰¢â™“«µà“ß™“µ‘ Õ’°∑—Èß‡ªìπ»Ÿπ¬å√—∫ºŸâªÉ«¬∑’Ë‰¥â √—∫§”·π–π”®“°·æ∑¬å ‚√ßæ¬“∫“≈Õ◊πË „Àâ¡“√—∫°“√√—°…“‡©æ“–∑“ß (Tertiary Referral Center) ®“°∑—ßÈ „π·≈–πÕ°ª√–‡∑» 4. ªí®®—¬§«“¡‡ ’¬Ë ß 1. º≈°√–∑∫®“°Õÿµ “À°√√¡°“√∑àÕß‡∑’¬Ë «∑’∂Ë ¥∂Õ¬ ∑’ºË “à π¡“Õÿµ “À°√√¡°“√∑àÕß‡∑’¬Ë «¿“¬„πª√–‡∑»‰¥â√—∫º≈°√–∑∫®“°À≈“¬ªí®®—¬ ‰¥â·°à °“√√–∫“¥¢Õß‚√§ SARS ‚√§‰¢âÀ«—¥π° ªí≠À“ºŸ°â Õà °“√√â“¬¢â“¡™“µ‘ §«“¡‰¡à ß∫„π¿Ÿ¡¿‘ “§µ–«—πÕÕ°°≈“ß √«¡∂÷ß‡Àµÿ°“√≥å§≈◊πË ¬—°…å π÷ “¡‘∑‡’Ë °‘¥¢÷πÈ „π¿“§„µâ¢Õßª√–‡∑» ‰∑¬ ´÷ËßÕ“®∑”„Àâ®”π«π™“«µà“ß™“µ‘∑’Ë‡¢â“¡“∑àÕß‡∑’Ë¬«≈¥πâÕ¬≈ß ·≈–¡’§«“¡‡ ’Ë¬ß∑’Ë®–°√–∑∫µàÕ√“¬‰¥â®“°ºŸâªÉ«¬™“«µà“ß™“µ‘ ¢Õß∫√‘…∑— œ ‡æ◊ËÕ‡ªìπ°“√≈¥§«“¡‡ ’Ë¬ß∑’ËÕ“®®–‡°‘¥¢÷Èπ ∫√‘…—∑œ ¡’°“√√—°…“ —¥ à«π®”π«πºŸâªÉ«¬™“«‰∑¬·≈–™“«µà“ß™“µ‘„Àâ¡’§«“¡ ¡¥ÿ≈°—π ‡æ◊ÕË ‰¡à„Àâ∫√‘…∑— œµâÕßæ÷ßË æ‘ß√“¬‰¥â®“°ºŸªâ «É ¬™“«µà“ß™“µ‘„π —¥ à«π∑’¡Ë “°‡°‘π‰ª

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

2. ¿“«–°“√·¢àß¢—π∑’√Ë πÿ ·√ß¢÷πÈ ¢Õß‚√ßæ¬“∫“≈‡Õ°™π™—πÈ π” „π ¿“«–ªí®®ÿ∫—π∑’Ëª√–™“™π¡’°”≈—ß´◊ÈÕ§àÕπ¢â“ß Ÿß §«“¡µâÕß°“√„π°“√„™â∫√‘°“√∑“ß°“√·æ∑¬å∑’Ë¡’§ÿ≥¿“æ∑’Ë¥’®“°‚√ßæ¬“∫“≈ ‡Õ°™π®÷ß¡’‡æ‘¡Ë ¡“°¢÷πÈ àßº≈„Àâ°“√·¢àß¢—π¢Õß‚√ßæ¬“∫“≈‡Õ°™π¡’§«“¡√ÿπ·√ß¡“°¢÷ÈπÕ¬à“ßµàÕ‡π◊ÕË ß §«“¡‡ ’Ë¬ß∑’∫Ë √‘…—∑œ ®– Ÿ≠ ‡ ’¬≈Ÿ°§â“‰ª„Àâ·°à ‚√ßæ¬“∫“≈Õ◊πË Ê ®÷ß¡’ ßŸ ¢÷πÈ µ“¡‰ª¥â«¬ ¥—ßπ—πÈ ‡æ◊ÕË §ß§«“¡‡ªìπ‚√ßæ¬“∫“≈™—Èππ”¢Õßª√–‡∑»·≈–¢Õß¿Ÿ¡¿‘ “§‡Õ‡™’¬·≈–≈¥§«“¡‡ ’¬Ë ß¥—ß°≈à“« ∫√‘…—∑œ ‰¥â≈ß∑ÿπ„πÕÿª°√≥å °“√·æ∑¬å∑∑’Ë π— ¡—¬ ·≈–¡’°“√æ—≤π“§ÿ≥¿“æ°“√√—°…“æ¬“∫“≈Õ¬à“ßµàÕ‡π◊ÕË ß ¥—ß®–‡ÀÁπ‰¥â®“°°“√∑’∫Ë √‘…∑— œ ‡ªìπ‚√ßæ¬“∫“≈ ·Ààß·√°„π‡Õ‡™’¬∑’Ë‰¥â√∫— °“√√—∫√Õß§ÿ≥¿“æ‚√ßæ¬“∫“≈√–¥—∫ “°≈ ®“° ∂“∫—π Joint Commission International Accreditation (JCIA) µ“¡¡“µ√∞“π°“√√—∫√Õß¢Õß À√—∞Õ‡¡√‘°“ ·≈–‡ªìπ‚√ßæ¬“∫“≈‡Õ°™π·Ààß·√°∑’Ë ‰¥â√—∫°“√√—∫√Õß¡“µ√∞“π§ÿ≥¿“æ ‚√ßæ¬“∫“≈‰∑¬ (Thai Hospital Accreditation › HA) πÕ°®“°π’∫È √‘…∑— œ ¡’∞“πºŸªâ «É ¬∑’Ë‰¥â√∫— §”·π–π”®“°·æ∑¬å ‚√ßæ¬“∫“≈Õ◊πË „Àâ¡“√—∫°“√√—°…“‡©æ“–∑“ß (Referral Patients) ®“°∑—ßÈ „πª√–‡∑»·≈–µà“ßª√–‡∑» ®÷ß‡ªìπ°“√µÕ°¬È”∂÷ß™◊ÕË ‡ ’¬ß¢Õß°“√‡ªìπºŸπâ ” ∑—ßÈ „πª√–‡∑»·≈–µà“ßª√–‡∑»¢Õß∫√‘…∑— œ 3. °“√¢“¥·§≈π∫ÿ§≈“°√ ªí®®—¬ ”§—≠„π°“√ª√–°Õ∫∏ÿ√°‘®‚√ßæ¬“∫“≈ª√–°“√Àπ÷ßË §◊Õ °“√¡’∫§ÿ ≈“°√∑’¡Ë §’ «“¡√Ÿ§â «“¡™”π“≠‡©æ“–∑“ß ´÷ßË √«¡∂÷ßæ¬“∫“≈ «‘™“™’æ ‡¿ —™°√·≈–‡®â“Àπâ“∑’‡Ë ∑§π‘§ “¢“µà“ß Ê ∫√‘…∑— œ ®÷ß¡’§«“¡‡ ’¬Ë ß∑’®Ë –¢“¥·§≈π∫ÿ§≈“°√«‘™“™’æ‡À≈à“π’È ‡æ√“–‡»√…∞°‘® ∑’Ë‡µ‘∫‚µ¢÷Èπ∑”„ÀâÕ“®¡’°“√·¬àß™‘ß∫ÿ§≈“°√®“°‚√ßæ¬“∫“≈Õ◊Ëπ πÕ°®“°π’È ∫√‘…—∑œ ¬—ß‰¥â„Àâ§«“¡ ”§—≠°—∫∞“π≈Ÿ°§â“¢ÕßºŸâªÉ«¬ ™“«µà“ß™“µ‘ ®÷ß¡’§«“¡µâÕß°“√∫ÿ§≈“°√«‘™“™’æ∑’æË ¥Ÿ ‰¥âÀ≈“¬¿“…“Õ’°¥â«¬ ¥—ßπ—πÈ ‡æ◊ËÕ≈¥§«“¡‡ ’¬Ë ß¥—ß°≈à“« ∫√‘…∑— œ ®÷ß‰¥â°”Àπ¥§à“µÕ∫·∑π·≈–º≈ª√–‚¬™πå„π√–¥—∫∑’®Ë ßŸ „® ”À√—∫∫ÿ§≈“°√¢Õß∫√‘…∑— œ Õ’°∑—ßÈ ¬—ß®—¥„Àâ¡°’ “√»÷°…“·≈–Ωñ°Õ∫√¡Õ¬à“ßµàÕ‡π◊ÕË ß ®—¥„Àâ¡°’ ®‘ °√√¡‡ √‘¡ √â“ß§ÿ≥¿“æ™’«µ‘ ·≈–®—¥ «— ¥‘°“√„π√Ÿª·∫∫µà“ßÊ „Àâ∑¥— ‡∑’¬¡°—∫ºŸªâ √–°Õ∫°“√√“¬Õ◊πË ‡æ◊ÕË ‡ªìπ°“√√—°…“∫ÿ§≈“°√¢Õß∫√‘…∑— œ ‡Õ“‰«â µ≈Õ¥®π¡’·ºπ°≈¬ÿ∑∏å‡æ◊ÕË √â“ß§«“¡°â“«Àπâ“ „πÀπâ“∑’°Ë “√ß“π ‚¥¬ºà“π‚§√ß √â“ß°“√®—¥°“√·∫∫°“√°√–®“¬Õ”π“®

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

4. °“√≈ß∑ÿπ„πµà“ßª√–‡∑» ‡æ◊ÕË √—°…“§«“¡‡ªìπºŸπâ ”„π¥â“π°“√∫√‘À“√®—¥°“√„π∏ÿ√°‘®‚√ßæ¬“∫“≈„π¿Ÿ¡¿‘ “§ ∫√‘…∑— œ ‰¥â°”Àπ¥‚§√ß √â“ßÕß§å°√‚¥¬„Àâ∫√‘…∑— ∫”√ÿß√“…Æ√å Õ‘π‡µÕ√å‡π™—πË ·π≈ ®”°—¥ (çBILé) ∑”Àπâ“∑’≈Ë ß∑ÿπ„π‚√ßæ¬“∫“≈µà“ßª√–‡∑» ‚¥¬„πªí®®ÿ∫π— BIL ‰¥â≈ß∑ÿπ„π ‚√ßæ¬“∫“≈∑’ªË √–‡∑»øî≈ª‘ ªîπ å·≈–‰¥âµ°≈ß∑’®Ë –≈ß∑ÿπ„π‚√ßæ¬“∫“≈„πª√–‡∑» À√—∞Õ“À√—∫Õ“¡‘‡√µ å ´÷ßË °“√≈ß∑ÿπ¥—ß°≈à“«¡’§«“¡ ‡ ’¬Ë ß®“°‚§√ß°“√∑’≈Ë ß∑ÿπ·≈–§«“¡‡ ’¬Ë ß®“°°“√≈ß∑ÿπ„πµà“ßª√–‡∑» ¥—ßπ—πÈ ‡æ◊ÕË ‡ªìπ°“√≈¥§«“¡‡ ’¬Ë ß ºŸ∫â √‘À“√¢Õß BIL ´÷ßË ¡’ª√– ∫°“√≥å®“°À≈“¬ª√–‡∑» ‰¥â∑”°“√»÷°…“§«“¡‡ªìπ‰ª‰¥â¢Õß‚§√ß°“√ Õ¬à“ß≈–‡Õ’¬¥√Õ∫§Õ∫ ·≈–¡’°“√∑” due diligence ‚¥¬„™â∫√‘…∑— ∑’¡Ë §’ «“¡√Ÿ·â ≈–§«“¡™”π“≠„πª√–‡∑»π—πÈ Ê °àÕπ∑’®Ë –·π–π”°“√ ≈ß∑ÿπ πÕ°®“°π’È ∫√‘…∑— œ¡’°“√≈¥§«“¡‡ ’¬Ë ß‚¥¬¡’º√Ÿâ «à ¡≈ß∑ÿπ´÷ßË ‡ªìπ™“«∑âÕß∂‘πË „πª√–‡∑»π—πÈ Ê 5. ¢âÕæ‘æ“∑∑“ß°ÆÀ¡“¬ °“√ª√–°Õ∫∏ÿ√°‘®‚√ßæ¬“∫“≈Õ“®¡’°“√øÑÕß√âÕß‡√’¬°§à“‡ ’¬À“¬®“°°“√∫√‘°“√∑“ß°“√·æ∑¬å¢Õßæπ—°ß“πÀ√◊Õ·æ∑¬å¢Õß ‚√ßæ¬“∫“≈ ¥—ßπ—πÈ ‡æ◊ÕË ‡ªìπ°“√≈¥§«“¡‡ ’¬Ë ß∑’ÕË “®‡°‘¥¢÷πÈ ∫√‘…∑— œ ®÷ß‰¥â®¥— „Àâ¡√’ –∫∫°“√∫√‘À“√§«“¡‡ ’¬Ë ß„π°“√√—°…“æ¬“∫“≈ (Healthcare Risk Management System) ‡æ◊ÕË „Àâ¡π—Ë „®«à“§«“¡‡ ’¬Ë ß∑’ÕË “®‡°‘¥¢÷πÈ ®“°°“√¥”‡π‘π°“√‚¥¬∫ÿ§≈“°√¢Õß∫√‘…∑— œ ®–‰¥â√∫— °“√ ªÑÕß°—π·≈–·°â‰¢„π√–¥—∫Àπ÷ßË πÕ°®“°π’È ∫√‘…∑— œ ¬—ß‰¥â∑”ª√–°—π¿—¬§«“¡‡ ’¬Ë ßµà“ß Ê ∑’ÕË “®‡°‘¥¢÷πÈ ‰¥â‡æ◊ÕË √Õß√—∫§«“¡‡ ’¬À“¬∑’ÕË “®‡°‘¥¢÷πÈ ®“°°“√∂Ÿ°øÑÕß√âÕß¥—ß°≈à“«Õ’°¥â«¬ 5. ‚§√ß √â“ß°“√∂◊ÕÀÿπâ ·≈–°“√®—¥°“√ 5.1 ºŸ∂â Õ◊ Àÿπâ √“¬™◊ÕË ºŸ∂â Õ◊ Àÿπâ √“¬„À≠à 10 √“¬¢Õß∫√‘…—∑œ ≥ «—π∑’Ë 2 °—π¬“¬π 2548 ¡’¥ß— µàÕ‰ªπ’È °≈ÿ¡à ºŸ∂â Õ◊ Àÿπâ 1. ∫√‘…∑— ∫√‘À“√ ‘π∑√—æ¬å∑«’ ®”°—¥ 2. ∫√‘…∑— °√ÿß‡∑æª√–°—π¿—¬ ®”°—¥ (¡À“™π) 3. HSBC (Singapore) Nominees Ptl Ltd 4. ∏π“§“√ °√ÿß‡∑æ ®”°—¥ (¡À“™π) 5. ∫√‘…∑— «—≤π‚ ¿≥æπ‘™ ®”°—¥ 6. Morgan Stanley & Co International Limited 7. Chase Nominees Ltd.1 8. State Street Bank and Trust Company 9. Somer (U.K.) Limited 10. UOB Kay Hian Private Limited √«¡ * ®”π«πÀÿπâ √«¡∑—ßÈ Àÿπâ ∫ÿ√¡‘ ‘∑∏‘·≈–Àÿπâ “¡—≠ ** °“√§‘¥ —¥ à«π°“√∂◊ÕÀÿâπ √«¡∑—ÈßÀÿâπ∫ÿ√¡‘ ‘∑∏‘·≈–Àÿâπ “¡—≠ 70

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

®”π«πÀÿπâ * 175,000,000 96,286,402 56,642,700 47,899,765 25,121,875 16,408,700 12,236,600 11,650,000 11,252,000 10,032,390 462,530,432

—¥ à«π°“√∂◊ÕÀÿπâ ** (√âÕ¬≈–) 23.97 13.19 7.76 6.56 3.44 2.25 1.68 1.60 1.54 1.37 63.36

√“¬ß“πª√–®”ªï 2548

5.2 °“√®—¥°“√ (1) °“√®—¥°“√ ‚§√ß √â“ß°“√®—¥°“√ ∫√‘…∑— œ¡’§≥–°√√¡°“√ 2 ™ÿ¥ §◊Õ §≥–°√√¡°“√∫√‘…∑— ·≈–§≥–°√√¡°“√µ√«® Õ∫ ‚¥¬√“¬≈–‡Õ’¬¥¢Õß§≥–°√√¡°“√·µà≈–™ÿ¥ ¡’¥ß— µàÕ‰ªπ’È §≥–°√√¡°“√∫√‘…∑— √“¬™◊ÕË §≥–°√√¡°“√∫√‘…∑— ≥ «—π∑’Ë 31 ∏—π«“§¡ 2548 ¡’¥ß— µàÕ‰ªπ’È 1. π“¬™—¬ ‚ ¿≥æπ‘™ ª√–∏“π°√√¡°“√ 2. π“¬·æ∑¬å™“≠«‘∑¬å µ—πµ‘æÏ æ‘ ≤— πå √Õßª√–∏“π°√√¡°“√ 3. π“ß≈‘π¥“ ’ À–ªí≠≠“ °√√¡°“√, °√√¡°“√ºŸ®â ¥— °“√ 4. π“ß “«‚ ¿“«¥’ Õÿµµ‚¡∫≈ °√√¡°“√Õ‘ √–, ª√–∏“π°√√¡°“√µ√«® Õ∫ 5. π“¬ √¥‘… «‘≠≠√—µπå °√√¡°“√Õ‘ √–, °√√¡°“√µ√«® Õ∫ 6. π“¬∫ÿ≠ª°√≥å ‚™§«—≤π“ °√√¡°“√Õ‘ √–, °√√¡°“√µ√«® Õ∫ 7. π“¬™“µ√’ ‚ ¿≥æπ‘™ °√√¡°“√ 8. π“¬·æ∑¬å∏π‘µ ‡∏’¬√∏πŸ °√√¡°“√, ª√–∏“π°√√¡°“√·æ∑¬å 9. π“¬·æ∑¬åÕπ—πµå ‡µ™–‡«™ °√√¡°“√ 10. π“¬·æ∑¬å®Õπ ¬—ßæ‘™µ‘ °√√¡°“√ 11. ·æ∑¬åÀ≠‘ß§ÿ≥ «√√¬“ ‡¥™Õÿ¥¡ °√√¡°“√ 12. π“ß°ÿ≈∏‘¥“ »‘«¬“∏√ °√√¡°“√ 13. π“¬™Õß ‚∑ °√√¡°“√ 14. π“¬§Õ√åµ ‘ ‡® ™‚√‡¥Õ√å °√√¡°“√, ºŸÕâ ”π«¬°“√¥â“π∫√‘À“√ - °≈ÿ¡à ¿Ÿ¡¿‘ “§ ‚¥¬¡’π“ß “«»ÿ∑∏‘π’ ‡µ«‘∑¬å ‡ªìπ‡≈¢“πÿ°“√§≥–°√√¡°“√∫√‘…∑— «‘∏°’ “√≈ßπ“¡ºŸ°æ—π∫√‘…∑— ¢Õß°√√¡°“√ °√√¡°“√ Õß§π πÕ°®“° π“¬™“µ√’ ‚ ¿≥æπ‘™ π“ß°ÿ≈∏‘¥“ »‘«¬“∏√ ·≈– π“¬™Õß ‚∑ ≈ß≈“¬¡◊Õ™◊ÕË √à«¡°—π·≈–ª√–∑—∫µ√“ ”§—≠ ¢Õß∫√‘…∑— œ Õ”π“®Àπâ“∑’¢Ë Õß§≥–°√√¡°“√∫√‘…∑— 1. ªØ‘∫µ— À‘ πâ“∑’Ë„Àâ‡ªìπ‰ªµ“¡°ØÀ¡“¬ «—µ∂ÿª√– ß§å ·≈–¢âÕ∫—ß§—∫¢Õß∫√‘…—∑œ µ≈Õ¥®π¡µ‘∑ª’Ë √–™ÿ¡¢ÕßºŸ∂â Õ◊ Àÿπâ 2. ¡’Õ”π“®„π°“√¥”‡π‘π°“√∑”π‘µ°‘ √√¡ºŸ°æ—π∫√‘…∑— œ §◊Õ°√√¡°“√ Õß§π≈ß≈“¬¡◊Õ™◊ÕË √à«¡°—π·≈–ª√–∑—∫µ√“ ”§—≠¢Õß∫√‘…∑— œ 3. æ‘®“√≥“°”Àπ¥·≈–·°â ‰¢‡ª≈’Ë¬π·ª≈ß™◊ËÕ°√√¡°“√ ´÷Ëß¡’Õ”π“®≈ß≈“¬¡◊Õ™◊ËÕºŸ°æ—π∫√‘…—∑œ„π°“√∑”π‘µ‘°√√¡µà“ßÊ·∑π∫√‘…—∑œ æ√âÕ¡∑—ßÈ °”Àπ¥‡ß◊ÕË π‰¢„π°“√≈ß≈“¬¡◊Õ™◊ÕË ºŸ°æ—π∫√‘…∑— œ¢Õß°√√¡°“√¥—ß°≈à“« 4. ¡’Àπâ“∑’¥Ë ”‡π‘π°“√„Àâ∫√‘…∑— œ¡’√–∫∫°“√§«∫§ÿ¡¿“¬„π·≈–°“√µ√«® Õ∫¿“¬„π∑’¡Ë ª’ √– ‘∑∏‘º≈ ∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

§≥–°√√¡°“√µ√«® Õ∫ √“¬™◊ÕË §≥–°√√¡°“√µ√«® Õ∫ ≥ «—π∑’Ë 31 ∏—π«“§¡ 2548 ¡’¥ß— µàÕ‰ªπ’È 1. π. . ‚ ¿“«¥’ Õÿµµ‚¡∫≈ ª√–∏“π°√√¡°“√µ√«® Õ∫ 2. π“¬ √¥‘… «‘≠≠√—µπå °√√¡°“√µ√«® Õ∫ 3. π“¬∫ÿ≠ª°√≥å ‚™§«—≤π“ °√√¡°“√µ√«® Õ∫ ‚¥¬¡’ π“ß∑«‘™“ µ—≥ ∂‘µ¬å ‡ªìπ‡≈¢“πÿ°“√§≥–°√√¡°“√µ√«® Õ∫ Õ”π“®Àπâ“∑’¢Ë Õß§≥–°√√¡°“√µ√«® Õ∫ §≥–°√√¡°“√µ√«® Õ∫¢Õß∫√‘…∑— œ ¡’¢Õ∫‡¢µ Àπâ“∑’Ë §«“¡√—∫º‘¥™Õ∫ ‡æ◊ÕË √“¬ß“πµàÕ§≥–°√√¡°“√∫√‘…—∑ ¥—ßµàÕ‰ªπ’È 1. ¥Ÿ·≈√“¬ß“π∑“ß°“√‡ß‘π¢Õß∫√‘…∑— œ„Àâ‡ªìπ‰ªµ“¡¡“µ√∞“π∫—≠™’ ‡æ’¬ßæÕ·≈–‡™◊ÕË ∂◊Õ‰¥â °àÕππ”‡ πÕµàÕ§≥–°√√¡°“√∫√‘…—∑ 2. æ‘®“√≥“§—¥‡≈◊Õ° ·≈–‡ πÕ·µàßµ—ßÈ ºŸ â Õ∫∫—≠™’¢Õß∫√‘…—∑œ æ√âÕ¡∑—Èß§à“∏√√¡‡π’¬¡°“√ Õ∫∫—≠™’ 3. ¥Ÿ·≈„Àâ∫√‘…∑— œ¡’√–∫∫°“√§«∫§ÿ¡¿“¬„π∑’‡Ë À¡“– ¡·≈–¡’ª√– ‘∑∏‘¿“æ 4. ¥Ÿ·≈„Àâ∫√‘…∑— œªØ‘∫µ— µ‘ “¡¢âÕ°”Àπ¥·≈–°ÆÀ¡“¬∑’‡Ë °’¬Ë «¢âÕß 5. ¥Ÿ·≈‰¡à„Àâ‡°‘¥§«“¡¢—¥·¬âß∑“ßº≈ª√–‚¬™πå √–À«à“ß∫ÿ§§≈∑’‡Ë °’¬Ë «‚¬ß°—π 6. ®—¥∑”√“¬ß“π°“√°”°—∫¥Ÿ·≈°‘®°“√¢Õß§≥–°√√¡°“√µ√«® Õ∫„π√“¬ß“πª√–®”ªï¢Õß∫√‘…—∑œ´÷Ëß√“¬ß“π¥—ß°≈à“«µâÕß≈ßπ“¡‚¥¬ ª√–∏“π°√√¡°“√µ√«® Õ∫ 7. ªØ‘∫µ— °‘ “√Õ◊πË „¥µ“¡∑’§Ë ≥–°√√¡°“√∫√‘…∑— œ¡Õ∫À¡“¬ Àπâ“∑’ÕË π◊Ë Ê 1. æ‘®“√≥“ß∫ª√–¡“≥ ·≈–°”≈—ß§π¢Õß ”π—°ß“πµ√«® Õ∫¿“¬„π 2. ª√– “πß“π°—∫ΩÉ“¬µ√«® Õ∫¿“¬„π¢Õß∫√‘…∑— œ ‡°’¬Ë «°—∫√–∫∫°“√§«∫§ÿ¡¿“¬„π ·ºπß“π·π«∑“ßµ√«® Õ∫ √«¡∑—ßÈ ª√–‡¡‘πº≈ °“√µ√«® Õ∫°“√¥”‡π‘πß“π¥â“πµà“ßÊ ¢Õß∫√‘…∑— œ µ“¡«‘∏°’ “√ ·≈–¡“µ√∞“π∑’¬Ë Õ¡√—∫‚¥¬∑—«Ë ‰ª 3. ·µàßµ—ßÈ ∂Õ¥∂Õπ ‚¬°¬â“¬ À√◊Õ‡≈‘°®â“ß ºŸÕâ ”π«¬°“√ (À—«Àπâ“·ºπ°) µ√«® Õ∫¿“¬„π

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

ºŸ∫â √‘À“√ √“¬™◊ÕË ºŸâ∫√‘À“√¢Õß∫√‘…—∑œ ≥ «—π∑’Ë 31 ∏—π«“§¡ 2548 ¡’¥—ßµàÕ‰ªπ’È 1. 2. 3. 4. 5. 6. 7.

π“ß≈‘π¥“ ≈’ À–ªí≠≠“ π.æ.∏π‘µ ‡∏’¬√∏πŸ π“¬‡§Õ√åµ ‘ ®ÕÀåπ ™‚√‡¥Õ√å π.æ. ‘π Õπÿ√“…Æ√å π.æ. °“√ÿ≥ ‡¡¶“ππ∑å™¬— æ.≠. ®“¡√’ ‡™◊ÕÈ ‡æ™√–‚ ¿≥ π“¬§“√å≈ ·µππ‘‡øÕ√å

°√√¡°“√ºŸ®â ¥— °“√ ª√–∏“π°√√¡°“√·æ∑¬å ºŸÕâ ”π«¬°“√¥â“π∫√‘À“√ - °≈ÿ¡à ¿Ÿ¡¿‘ “§ ºŸÕâ ”π«¬°“√¥â“π°“√·æ∑¬å - °≈ÿ¡à ¿Ÿ¡¿‘ “§ ºŸÕâ ”π«¬°“√¥â“π°“√·æ∑¬å √ÕßºŸÕâ ”π«¬°“√¥â“π°“√·æ∑¬åÕ“«ÿ‚ ºŸÕâ ”π«¬°“√¥â“π°“√‡ß‘π - °≈ÿ¡à ¿Ÿ¡¿‘ “§ ·≈–ºŸÕâ ”π«¬°“√¥â“πæ—≤π“‚§√ß°“√√–À«à“ßª√–‡∑» 8. π“¬‡¥π‘ ∫√“«πå ºŸÕâ ”π«¬°“√¥â“πªØ‘∫µ— °‘ “√ - °≈ÿ¡à ¿Ÿ¡¿‘ “§ 9. π“¬ ‡®¡ å ·¡∑∏‘« ·∫π‡πÕ√å* ºŸÕâ ”π«¬°“√¥â“π∫√‘À“√ 10. π“ß§Õ√å ≈’ ™“π ºŸÕâ ”π«¬°“√¥â“π°“√‡ß‘π 11. π“ß “«‡®ππ‘ ™“π¡—π¬’ ºŸÕâ ”π«¬°“√¥â“π°“√ªØ‘∫µ— °‘ “√ * π“¬ ‡®¡ å ·¡∑∏‘« ·∫π‡πÕ√å √—∫µ”·ÀπàßºŸÕâ ”π«¬°“√¥â“π∫√‘À“√‡¡◊ÕË «—π∑’Ë 25 °√°Æ“§¡ 2548 √“¬≈–‡Õ’¬¥‡°’¬Ë «°—∫ºŸ∫â √‘À“√·≈–ºŸ¡â Õ’ ”π“®§«∫§ÿ¡∫√‘…∑— °√√¡°“√∫√‘…∑— ™◊ÕË / µ”·Àπàß

1. π“¬™—¬ ‚ ¿≥æπ‘™ ª√–∏“π°√√¡°“√

Õ“¬ÿ

§ÿ≥«ÿ≤∑‘ “ß °“√»÷°…“ Ÿß ÿ¥

—¥ à«π °“√∂◊ÕÀÿπâ * (%)

- ª√‘≠≠“µ√’ University of Colorado, USA - ºà“π Director Certification Program √ÿπà 116/2002 ®“° ¡“§¡ àß‡ √‘¡ ∂“∫—π°√√¡°“√ ∫√‘…∑— ‰∑¬ - ºà“π Chairman 2000 √ÿπà 10/2004 ®“° ¡“§¡ àß‡ √‘¡ ∂“∫—π°√√¡°“√ ∫√‘…∑— ‰∑¬

1.09

§«“¡ —¡æ—π∏å ∑“ß§√Õ∫§√—« √–À«à“ßºŸ∫â √‘À“√

ª√– ∫°“√≥å∑”ß“π

- §Ÿ à ¡√ ¢Õßæ’Ë “« - ª√–∏“π°√√¡°“√ π“ß≈‘π¥“ ·≈–°√√¡°“√ ≈’ À–ªí≠≠“ ºŸÕâ ”π«¬°“√„À≠à - πâÕß™“¬¢Õßπ“¬™“µ√’ ∫¡®. °√ÿß‡∑æª√–°—π¿—¬ ‚ ¿≥æπ‘™ - ª√–∏“π°√√¡°“√ ∫¡®. ®√ÿß‰∑¬‰«√å·Õπ¥å‡§‡∫‘≈È - ª√–∏“π°√√¡°“√ ∫¡®. øŸ√°Ÿ “«“‡¡Á∑∑—≈ (‰∑¬·≈π¥å) - √Õßª√–∏“π°√√¡°“√ ∫¡®. Õ¡µ– §Õ√åªÕ‡√™—πË - °√√¡°“√ ∫¡®. ¬Ÿ‡π’¬Ë πæ≈“ µ‘° - °√√¡°“√ ∫¡®. °√ÿß‡∑æª√–°—π™’«µ‘

* —¥ à«π°“√∂◊ÕÀÿπâ ≥ «—π∑’Ë 2 °—π¬“¬π 2548 π—∫√«¡°“√∂◊ÕÀÿπâ ¢Õß§Ÿ à ¡√ ·≈–∫ÿµ√∑’¬Ë ß— ‰¡à∫√√≈ÿπµ‘ ¿‘ “«–

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548 ™◊ÕË / µ”·Àπàß

Õ“¬ÿ

§ÿ≥«ÿ≤∑‘ “ß °“√»÷°…“ Ÿß ÿ¥

2. π.æ. ™“≠«‘∑¬å µ—πµ‘æÏ æ‘ ≤— πå √Õßª√–∏“π°√√¡°“√

- MB. CHB., Leeds University «ÿ≤∫‘ —µ√ F.R.C.S ª√–‡∑»Õ—ß°ƒ…

3. π“ß≈‘π¥“ ≈’ À–ªí≠≠“ °√√¡°“√ºŸ®â ¥— °“√

4. π“ß°ÿ≈∏‘¥“ »‘«¬“∏√ °√√¡°“√

§«“¡ —¡æ—π∏å ∑“ß§√Õ∫§√—« √–À«à“ßºŸ∫â √‘À“√

ª√– ∫°“√≥å∑”ß“π

0.07

- »“ µ√“®“√¬å ¿“§«‘™“»—≈¬»“ µ√å §≥–·æ∑¬å»“ µ√å ®ÿÃ“≈ß°√≥å¡À“«‘∑¬“≈—¬

- ª√‘≠≠“‚∑ ∑“ß°“√‡ß‘π University of llinois USA

0.18

- πâÕß “«¢Õß §Ÿ à ¡√ ¢Õß π“¬™—¬ ‚ ¿≥æπ‘™

- °√√¡°“√ºŸ®â ¥— °“√ ‚√ßæ¬“∫“≈∫”√ÿß√“…Ø√å

- B.Sc (Chemistry) Stetson University - ºà“π Director Certification Program √ÿπà 3/2000 ®“° ¡“§¡ àß‡ √‘¡ ∂“∫—π°√√¡°“√∫√‘…∑— ‰∑¬

0.01

- 2519- ªí®®ÿ∫π— ºŸ™â «à ¬ºŸ®â ¥— °“√„À≠à ∫¡®. ∏π“§“√°√ÿß‡∑æ

5. π.æ. ®Õπ ¬—ßæ‘™µ‘ °√√¡°“√

- Queens University «ÿ≤∫‘ µ— √ MRCOG, FRCOG

0.02

- ·æ∑¬åÕ ‘ √– √à«¡ƒ¥’§≈’π§‘

6. π.æ. ∏π‘µ ‡∏’¬√∏πŸ °√√¡°“√

- æ.∫ ¡À“«‘∑¬“≈—¬¡À‘¥≈ - «ÿ≤‘∫µ— √ »—≈¬»“ µ√å√–∫∫ ª√– “∑ª√–‡∑…Õ—ß°ƒ…

0.04

- √Õß»“ µ√“®“√¬å‡°’¬√µ‘§≥ÿ À—«Àπâ“Àπà«¬ ª√– “∑»—≈¬»“ µ√å ¿“§«‘™“»—≈¬»“ µ√å §≥–·æ∑¬å»“ µ√å ‚√ßæ¬“∫“≈√“¡“∏‘∫¥’

7. æ.≠. §ÿ≥ «√√¬“ ‡¥™Õÿ¥¡ °√√¡°“√

- æ.∫ ¡À“«‘∑¬“≈—¬¡À‘¥≈ 0.05 - «ÿ≤∫‘ µ— √ - Õ“¬ÿ√»“ µ√å - Õ“¬ÿ√°√√¡‚√§À—«„® - ºà“π Director Accreditation Program √ÿπà 47/2005 ®“° ¡“§¡ àß‡ √‘¡ ∂“∫—π°√√¡°“√∫√‘…∑— ‰∑¬

- 2535-ªí®®ÿ∫π— Õ“¬ÿ√·æ∑¬å ‚√§À—«„® ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å - 2535-ªí®®ÿ∫π— Õ“¬ÿ√·æ∑¬å ‚√§À—«„® §≈’π°‘ »Ÿπ¬å·æ∑¬åæ≤— π“ - ª√–∏“πΩÉ“¬«‘™“°“√ ¡Ÿ≈π‘∏À‘ «— „®·Ààßª√–‡∑»‰∑¬ „πæ√–∫√¡√“™Ÿª∂—¡¿å

- Edinburgh University «ÿ≤∫‘ µ— √ °ÿ¡“√‡«™ - DCH (ª√–‡∑»Õ—ß°ƒ…) FRCP (Edinburgh) - ºà“π Director Accreditation Program √ÿπà 47/2005 ®“° ¡“§¡ àß‡ √‘¡ ∂“∫—π°√√¡°“√∫√‘…∑— ‰∑¬

- »“ µ√“®“√¬å‡°’¬√µ‘§≥ÿ ¿“§«‘™“°ÿ¡“√‡«™»“ µ√å §≥–·æ∑¬å»“ µ√å ¡À“«‘∑¬“≈—¬¡À‘¥≈

8. π.æ. Õπ—πµå ‡µ™–‡«™ °√√¡°“√

—¥ à«π °“√∂◊ÕÀÿπâ * (%)

0.14

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548 ™◊ÕË / µ”·Àπàß

9. π“¬™Õß ‚∑ °√√¡°“√

Õ“¬ÿ

§ÿ≥«ÿ≤∑‘ “ß °“√»÷°…“ Ÿß ÿ¥

—¥ à«π °“√∂◊ÕÀÿπâ * (%) - ª√‘≠≠“‚∑ ∑“ß∫√‘À“√∏ÿ√°‘® Massachusetts Institute of Technology - BA Hons (Oxon) in Philosophy, Politics and Economics-Oxford University

10. π. . ‚ ¿“«¥’ Õÿµµ‚¡∫≈ °√√¡°“√

- ∫√‘À“√∏ÿ√°‘®¡À“∫—≥±‘µ ®ÿÃ“≈ß°√≥å¡À“«‘∑¬“≈—¬ - ºà“π Director Accreditation Program ®“° ¡“§¡ àß‡ √‘¡ ∂“∫—π°√√¡°“√∫√‘…∑— ‰∑¬

11. π“¬ √¥‘… «‘≠≠√—µπå °√√¡°“√

- Õ∫√¡°“√∏π“§“√ 0.02 ®“°ª√–‡∑»Õ—ß°ƒ… - ºà“π Director Accreditation Program √ÿπà CP «—π∑’Ë 4 æ.§. 2548 ®“° ¡“§¡ àß‡ √‘¡ ∂“∫—π°√√¡°“√∫√‘…∑— ‰∑¬

12. π“¬∫ÿ≠ª°√≥å ‚™§«—≤π“ °√√¡°“√

§«“¡ —¡æ—π∏å ∑“ß§√Õ∫§√—« √–À«à“ßºŸ∫â √‘À“√ -

- ª√‘≠≠“µ√’∑“ß‡»√…∞»“ µ√å 0.04 University of Nottingham, United Kingdom - ºà“π Director Accreditation Program √ÿπà 3/2003 ®“° ¡“§¡ àß‡ √‘¡ ∂“∫—π°√√¡°“√∫√‘…∑— ‰∑¬ - ºà“π Director Certification Program √ÿπà 68/2005 ®“° ¡“§¡ àß‡ √‘¡ ∂“∫—π°√√¡°“√∫√‘…∑— ‰∑¬ * —¥ à«π°“√∂◊ÕÀÿπâ ≥ «—π∑’Ë 2 °—π¬“¬π 2548 π—∫√«¡°“√∂◊ÕÀÿπâ ¢Õß§Ÿ à ¡√ ·≈–∫ÿµ√∑’¬Ë ß— ‰¡à∫√√≈ÿπµ‘ ¿‘ “«–

ª√– ∫°“√≥å∑”ß“π

- 2548-ªí®®ÿ∫π— ºŸ™â «à ¬ºŸ®â ¥— °“√„À≠à ∫¡®. ∏π“§“√°√ÿß‡∑æ - 2548-ªí®®ÿ∫π— ª√–∏“π°√√¡°“√ ∫√‘À“√ ∫¡®. À≈—°∑√—æ¬å∫«— À≈«ß - 2543-2548 °√√¡°“√ºŸ®â ¥— °“√ ∫¡®. À≈—°∑√—æ¬å∫«— À≈«ß - 2541-2543 Vice President, Investment banking ∫¡®.∏π“§“√°√ÿß‡∑æ - 2536-2539 Analyst, Investment Banking Morgan Stanley - 2534 -2536 Economist, Government of Singapore Investment Corporation - 2534-ªí®®ÿ∫π— ∑’ªË √÷°…“°ÆÀ¡“¬ ”π—°ß“π°ÆÀ¡“¬ ¥”√ß∏√√¡ - 2530-2534 ‡®â“Àπâ“∑’ÕË “«ÿ‚ ∏π“§“√‡Õ‡™’¬ ®”°—¥ (¡À“™π) - 2527-2530 À—«Àπâ“ΩÉ“¬π‘µ°‘ “√ ∫√‘…∑— ‡ß‘π∑ÿπ æ√ª√–¿“ ®”°—¥ - °√√¡°“√ ∫¡®.‡¥Õ–‚æ ∑å æ—∫∫≈‘™™‘Ëß - ºŸ™â «à ¬ºŸ®â ¥— °“√„À≠à ∫¡®.∏π“§“√°√ÿß‡∑æ - √Õßª√–∏“π°√√¡°“√ °≈ÿ¡à ∫√‘…∑— ·≈π¥å¡“√å§ - °√√¡°“√ºŸ®â ¥— °“√ ∫√‘…∑— √™—¬«‘«≤— πå ®”°—¥ - ª√–∏“π°√√¡°“√ ∫¡®. π‘«´‘µ’È - ª√–∏“π¡Ÿ≈π‘∏‘ ¥√. ‡∑’¬¡ ‚™§«—≤π“ - √Õßª√–∏“π°√√¡°“√ ∫¡®. Àæ—≤πæ‘∫≈Ÿ ¬å - √Õßª√–∏“π°√√¡°“√ ∫¡®. Àæ—≤π“ Õ‘π‡µÕ√å ‚Œ≈¥‘ß§å ®”°—¥ (¡À“™π) - °√√¡°“√ ∫¡®. ‰Õ∑’ ´‘µ’È

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548 ™◊ËÕ / µ”·Àπàß

Õ“¬ÿ

13. π“¬™“µ√’ ‚ ¿≥æπ‘™ °√√¡°“√

§ÿ≥«ÿ≤∑‘ “ß °“√»÷°…“ Ÿß ÿ¥

—¥ à«π °“√∂◊ÕÀÿπâ * (%)

- Õ“™’«»÷°…“™—πÈ Ÿß 0.3 ®“°«‘∑¬“≈—¬ Kwang Tai High Accountancy College, Hong Kong - Õÿ¥¡»÷°…“®“° London Regent Street Polytechnic, United Kingdom - ºà“π Director Accreditation

§«“¡ —¡æ—π∏å ∑“ß§√Õ∫§√—« √–À«à“ßºŸ∫â √‘À“√ - æ’™Ë “¬¢Õßπ“¬™—¬ ‚ ¿≥æπ‘™

ª√– ∫°“√≥å∑”ß“π

- 2542-ªí®®ÿ∫π— √Õßª√–∏“π §≥–∑’ªË √÷°…“ ∫¡®. ∏π“§“√°√ÿß‡∑æ - 2542-ªí®®ÿ∫π— ∑’ªË √÷°…“ §≥–°√√¡°“√∫√‘À“√ ∫¡®. ∏π“§“√°√ÿß‡∑æ - 2542-ªí®®ÿ∫π— ª√–∏“π°√√¡°“√ ∫¡®.∏π“§“√°√ÿß‡∑æ

Program √ÿπà CP «—π∑’Ë 4 æ.§. 2548 ®“° ¡“§¡ àß‡ √‘¡ ∂“∫—π°√√¡°“√∫√‘…∑— ‰∑¬ 14. π“¬‡§Õ√åµ ‘ ®ÕÀåπ ™‚√‡¥Õ√å °√√¡°“√

- ª√‘≠≠“‚∑ Health Services Administration, University of Southern California

0.01

- 2530-2536 ºŸÕâ ”π«¬°“√ USC University Hospital, Los Angeles, California

ºŸ∫â √‘À“√∫√‘…∑— œ ™◊ÕË / µ”·Àπàß

Õ“¬ÿ

§ÿ≥«ÿ≤∑‘ “ß °“√»÷°…“ Ÿß ÿ¥

—¥ à«π °“√∂◊ÕÀÿπâ * (%)

§«“¡ —¡æ—π∏å ∑“ß§√Õ∫§√—« √–À«à“ßºŸ∫â √‘À“√

1. π“ß≈‘π¥“ ≈’ À–ªí≠≠“ °√√¡°“√ºŸ®â ¥— °“√

- ª√‘≠≠“‚∑ ∑“ß°“√‡ß‘π University of l inois, USA

0.18

- πâÕß “«¢Õß§Ÿ à ¡√ ¢Õßπ“¬™—¬ ‚ ¿≥æπ‘™

2. π.æ.∏π‘µ ‡∏’¬√∏πŸ ª√–∏“π°√√¡°“√·æ∑¬å

- æ.∫ ¡À“«‘∑¬“≈—¬¡À‘¥≈ - «ÿ≤‘∫µ— √ »—≈¬»“ µ√å √–∫∫ª√– “∑ ª√–‡∑»Õ—ß°ƒ…

0.04

- √Õß»“ µ√“®“√¬å‡°’¬√µ‘§≥ÿ À—«Àπâ“Àπà«¬ª√– “∑ »—≈¬»“ µ√å¿“§«‘™“ »—≈¬»“ µ√å §≥–·æ∑¬å»“ µ√å ‚√ßæ¬“∫“≈√“¡“∏‘∫¥’

3. π“¬‡§Õ√åµ ‘ ®ÕÀåπ ™‚√‡¥Õ√å ºŸÕâ ”π«¬°“√¥â“π∫√‘À“√°≈ÿ¡à ¿Ÿ¡¿‘ “§

- ª√‘≠≠“‚∑ Health Services Administration, University of Southern California

0.01

- 2530-2536 ºŸÕâ ”π«¬°“√ USC University Hospital, Los Angeles, California

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

ª√– ∫°“√≥å∑”ß“π

- °√√¡°“√ºŸ®â ¥— °“√ ‚√ßæ¬“∫“≈∫”√ÿß√“…Ø√å

√“¬ß“πª√–®”ªï 2548 ™◊ÕË / µ”·Àπàß

Õ“¬ÿ

§ÿ≥«ÿ≤∑‘ “ß °“√»÷°…“ Ÿß ÿ¥

—¥ à«π °“√∂◊ÕÀÿπâ * (%)

§«“¡ —¡æ—π∏å ∑“ß§√Õ∫§√—« √–À«à“ßºŸ∫â √‘À“√

ª√– ∫°“√≥å∑”ß“π

4. π.æ. ‘π Õπÿ√“…Ø√å ºŸÕâ ”π«¬°“√¥â“π°“√·æ∑¬å°≈ÿ¡à ¿Ÿ¡¿‘ “§

- æ.∫ ®ÿÃ“≈ß°√≥å ¡À“«‘∑¬“≈—¬ - «ÿ≤∫‘ µ— √ - Õ“¬ÿ√»“ µ√å ‚√§√–∫∫ ∑“ß‡¥‘πÕ“À“√ ª√–‡∑» À√—∞Õ‡¡√‘°“

0.05

- 2530-2537 Vice Chairman for Medical Affair University Medical Center Lubbook, Texas

5. π.æ.°“√ÿ≥ ‡¡¶“ππ∑å™¬— ºŸÕâ ”π«¬°“√¥â“π°“√·æ∑¬å

- æ.∫ ¡À“«‘∑¬“≈—¬¡À‘¥≈ - «ÿ≤∫‘ µ— √: »—≈¬»“ µ√åÕÕ√å ‚∏ªî¥°‘ å

0.03

- 2532 ·æ∑¬å∑ª’Ë √÷°…“ ÕÕ√å ‚∏ªî¥°‘ å ‚√ßæ¬“∫“≈∫”√ÿß√“…Ø√å - 2526-2531 Õ“®“√¬å¿“§«‘™“ÕÕ√å ‚∏ªî¥°‘ å ·≈–‡«™»“ µ√åøπóô øŸ §≥–·æ∑¬å»“ µ√å √“¡“∏‘∫¥’ - 2521-2526 ·æ∑¬åª√–®” ‚√ßæ¬“∫“≈»Ÿπ¬å ®—ßÀ«—¥ √–∫ÿ√’

6. æ.≠. ®“¡√’ ‡™◊ÕÈ ‡æ™√–‚ ¿≥ √ÕßºŸÕâ ”π«¬°“√ ¥â“π°“√·æ∑¬åÕ“«ÿ‚

- ¡À“«‘∑¬“≈—¬¡À‘¥≈ ‚√ßæ¬“∫“≈√“¡“∏‘∫¥’ - «ÿ≤∫‘ µ— √: General Radiology, ª√–‡∑»‰∑¬ - °“√»÷°…“À≈—ßª√‘≠≠“: - Vascular and Interventional Radiology, ª√–‡∑» À√—∞Õ‡¡√‘°“ - Body Imaging, ª√–‡∑» À√—∞Õ‡¡√‘°“

- 2541-ªí®®ÿ∫π— °√√¡°“√, √“™«‘∑¬“≈—¬√—ß ’·æ∑¬å ·Ààßª√–‡∑»‰∑¬ - 2541-ªí®®ÿ∫π— ∑’ªË √÷°…“√—ß ’«∑‘ ¬“ »Ÿπ¬å¡–‡√Áß·Ààß™“µ‘ - 2533-2538 Õ“®“√¬å ·ºπ°√—ß ’«∑‘ ¬“ ‚√ßæ¬“∫“≈√“¡“∏‘∫¥’ ¡À“«‘∑¬“≈—¬¡À‘¥≈

7. π“¬§“√å≈ ·µππ‘‡øÕ√å ºŸÕâ ”π«¬°“√¥â“π°“√‡ß‘π°≈ÿ¡à ¿Ÿ¡¿‘ “§·≈–ºŸÕâ ”π«¬°“√ ¥â“π°“√æ—≤π“‚§√ß°“√ √–À«à“ßª√–‡∑»

- ª√‘≠≠“‚∑ Health Planning and Administration, University of Cincinnati - ª√‘≠≠“µ√’ Accounting and Finance, Cumberland College

0.02

- Chairman and President of VISTA Healthcare, Singapore - Senior Vice President, Operations of International Healthcare Division, Tenet Healthcare Corporation - ª√– ∫°“√≥å„π ª√–‡∑»´“Õÿ¥Õ‘ “‡√‡∫’¬ ÕÕ ‡µ√‡≈’¬ ·≈–¡“‡≈‡´’¬

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548 ™◊ÕË / µ”·Àπàß

Õ“¬ÿ

§ÿ≥«ÿ≤∑‘ “ß °“√»÷°…“ Ÿß ÿ¥

—¥ à«π °“√∂◊ÕÀÿπâ * (%)

§«“¡ —¡æ—π∏å ∑“ß§√Õ∫§√—« √–À«à“ßºŸ∫â √‘À“√

ª√– ∫°“√≥å∑”ß“π

8. π“¬‡¥π‘ ∫√“«πå ºŸÕâ ”π«¬°“√¥â“πªØ‘∫µ— °‘ “√ - °≈ÿ¡à ¿Ÿ¡¿‘ “§

- Executive Program, Graduate School of Business, Stanford University - Company Directorûs Diploma, University of New England, Australia - Master of Business Administration in Health and Hospital Administration, University of Florida

- 2546-2547 Chief Executive Officer, BFT Investment, LLC. - 2523-2527, 2528-2546 Senior Vice President, Operations Northern Region, Tenet Healthcare Corporation - Chief Executive Officer, Australian Medical Enterprises, Australia - Chief Executive Officer, Mount Elizabeth Hospital, Ltd.

9. π“¬ ‡®¡ å ·¡∑∏‘« ·∫π‡πÕ√å ºŸÕâ ”π«¬°“√¥â“π∫√‘À“√ * √—∫µ”·Àπàß‡¡◊ÕË 25/7/2548

- Master of Hospital Administration, Medical College of Virginia, USA

- BUPA Health Care Asia (previously VISTA) - Director and CEO of Subang Jaya Medical Center, Kuala Lumpur

10. π“ß§Õ√å ≈’™“π ºŸÕâ ”π«¬°“√¥â“π°“√‡ß‘π

- ª√‘≠≠“µ√’ Victoria University of Wellington, New Zealand

0.01

11. π“ß “«‡®ππ‘ ™“π¡—π¬’ ºŸÕâ ”π«¬°“√¥â“πªØ‘∫µ— °‘ “√

- ª√‘≠≠“‚∑ George Washington University

- 2530-2537 Chief Financial Officer Mount Elizabeth Hospital Ltd. - 2527-2529 Chief Accountant Scotts Holding (S) Pte. Ltd. - 2525-2526 Internal Audit Manager Diethelm Singapore Pte. Ltd. ∫√‘…∑— ∫”√ÿß√“…Æ√å ‡¡¥‘§Õ≈ ‡´Áπ‡µÕ√å ®”°—¥ - 2546-2548 √ÕßºŸÕâ ”π«¬°“√ ¥â“πªØ‘∫µ— °‘ “√ - 2543-2546 ºŸÕâ ”π«¬°“√ ΩÉ“¬ —ß°—¥ ”π—°ºŸ∫â √‘À“√

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

√“¬≈–‡Õ’¬¥‡°’¬Ë «°—∫°√√¡°“√∫√‘…∑— ¬àÕ¬ √“¬™◊ÕË ∫√‘…∑— ¬àÕ¬ √“¬™◊ÕË °√√¡°“√ BMC VITALLIFE BIL 1 π“¬™—¬ ‚ ¿≥æπ‘™ X X 2. π.æ. ™“≠«‘∑¬å µ—πµ‘æÏ æ‘ ≤— πå / / 3. π“ß≈‘π¥“ ≈’ À–ªí≠≠“ // / X 4. π“ß°ÿ≈∏‘¥“ »‘«¬“∏√ / 5. π.æ. ∏π‘µ ‡∏’¬√∏πŸ // / 6. π“¬™Õß ‚∑ / 7. π“¬∫ÿ≠ª°√≥å ‚™§«—≤π“ / 8. π“¬‡§Õ√åµ ‘ ‡®. ™‚√‡¥Õ√å // / // 9. π.æ. ‘π Õπÿ√“…Æ√å // / 10. π“ß§Õ√å ≈’ ™“π / 11. π.æ. °“√ÿ≥ ‡¡¶“ππ∑™—¬ / 12. π“¬§“√å≈ ·µππ‘‡øÕ√å // À¡“¬‡Àµÿ 1. / = °√√¡°“√ X = ª√–∏“π°√√¡°“√ // = °√√¡°“√∫√‘À“√ 2. LS Cleaning ‰¡àª√“°Ø„πµ“√“ß¢â“ßµâπ ‡π◊ÕË ß®“°‰¡à‰¥â‡ªìπ∫√‘…∑— ¬àÕ¬∑’¡Ë π’ ¬— ”§—≠ ·≈–‰¡à‰¥â¡√’ “¬‰¥â„Àâ°∫— ∫√‘…∑— œ 3. GSC ‰¡àª√“°Ø„πµ“√“ß¢â“ßµâπ ‡π◊ÕË ß®“°‰¡à¡°’ √√¡°“√À√◊ÕºŸ∫â √‘À“√¢Õß∫√‘…∑— œ‡ªìπ°√√¡°“√ ª√–∏“π°√√¡°“√ À√◊Õ°√√¡°“√∫√‘À“√ „π GCS (2) °“√ √√À“°√√¡°“√·≈–ºŸ∫â √‘À“√ ∫√‘…∑— œ¬—ß‰¡à¡§’ ≥–°√√¡°“√ √√À“‡æ◊ÕË §—¥‡≈◊Õ°§≥–°√√¡°“√·≈–ºŸ∫â √‘À“√ Õ¬à“ß‰√°Áµ“¡ °“√‡≈◊Õ°µ—ßÈ °√√¡°“√¢Õß∫√‘…∑— œ ®–µâÕß‰¥â √—∫Õπÿ¡µ— ®‘ “°∑’ªË √–™ÿ¡ºŸ∂â Õ◊ Àÿπâ µ“¡À≈—°‡°≥±å·≈–«‘∏°’ “√¥—ßµàÕ‰ªπ’È 1. ºŸ∂â Õ◊ Àÿπâ §πÀπ÷ßË ¡’§–·ππ‡ ’¬ß‡∑à“°—∫Àπ÷ßË Àÿπâ µàÕÀπ÷ßË ‡ ’¬ß 2 „π°“√‡≈◊Õ°°√√¡°“√ Õ“®„™â«‘∏’‡ ’¬ß≈ß§–·ππ‡≈◊Õ°°√√¡°“√‡ªìπ√“¬∫ÿ§§≈§√“«≈–§π À√◊Õ§√“«≈–À≈“¬§π√«¡°—π‡ªìπ§≥– µ“¡·µà∑’Ëª√–™ÿ¡ºŸ∂â ◊ÕÀÿâπ®–‡ÀÁπ ¡§«√ ·µà„π°“√≈ß¡µ‘·µà≈–§√—ßÈ ºŸ∂â Õ◊ Àÿπâ µâÕßÕÕ°‡ ’¬ß¥â«¬§–·ππ∑’¡Ë Õ’ ¬Ÿ∑à —ÈßÀ¡¥ ®–·∫àß§–·ππ ‡ ’¬ß·°à§π„¥ À√◊Õ§≥–„¥¡“°πâÕ¬‡æ’¬ß„¥‰¡à‰¥â 3. °“√ÕÕ°‡ ’¬ß≈ß§–·ππ‡≈◊Õ°µ—Èß°√√¡°“√„Àâ„™â‡ ’¬ß¢â“ß¡“° À“°¡’§–·ππ‡ ’¬ß‡∑à“°—π „ÀâºŸâ‡ªìπª√–∏“π∑’Ëª√–™ÿ¡‡ªìπºŸâÕÕ°‡ ’¬ß ™’¢È “¥ ∏π“§“√°√ÿß‡∑æ ®”°—¥ (¡À“™π) ´÷ßË ‡ªìπºŸ∂â Õ◊ Àÿπâ √“¬„À≠à¢Õß∫√‘…∑— œ ‚¥¬∂◊ÕÀÿπâ „π —¥ à«π 30.53%* ¡’µ«— ·∑π¢Õß∏π“§“√‡ªìπ °√√¡°“√¢Õß∫√‘…—∑œ 2 ∑à“π §◊Õ π“¬™“µ√’ ‚ ¿≥æπ‘™ ·≈– π“ß°ÿ≈∏‘¥“ »‘«¬“∏√ * ¢âÕ¡Ÿ≈ ≥ «—π∑’Ë 2 °—π¬“¬π 2548 √«¡°“√∂◊ÕÀÿπâ ‚¥¬∫√‘…∑— ∫√‘À“√ ‘π∑√—æ¬å∑«’ ®”°—¥ ·≈–∏π“§“√°√ÿß‡∑æ ®”°—¥ (¡À“™π)

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

Õπ÷Ëß°√–∫«π°“√„π°“√ √√À“°√√¡°“√Õ‘ √–¢Õß∫√‘…—∑œ „™â«‘∏’‡¥’¬«°—π°—∫°√–∫«π°“√„π°“√ √√À“°√√¡°“√·≈–ºŸâ∫√‘À“√ ‚¥¬§ÿ≥ ¡∫—µ‘‡∫◊ÕÈ ßµâπ¢Õß°√√¡°“√Õ‘ √–¢Õß∫√‘…∑— œ ¡’¥ß— µàÕ‰ªπ’È 1. ‡ªìπ°√√¡°“√®“°¿“¬πÕ°∑’Ë‰¡à‰¥â¡µ’ ”·Àπàß‡ªìπºŸ∫â √‘À“√À√◊Õæπ—°ß“πª√–®”¢Õß∫√‘…∑— œ, ∫√‘…∑— „π‡§√◊Õ, ∫√‘…∑— √à«¡À√◊Õ∫√‘…∑— ∑’‡Ë °’¬Ë «¢âÕß 2. ‰¡à‰¥â‡ªìπ°√√¡°“√∫√‘À“√¢Õß∫√‘…∑— œ, ∫√‘…∑— „π‡§√◊Õ, ∫√‘…∑— √à«¡À√◊Õ∫√‘…∑— ∑’‡Ë °’¬Ë «¢âÕß 3. ‡ªìπºŸ∑â ’Ë‰¡à¡º’ ≈ª√–‚¬™πåÀ√◊Õ à«π‰¥â‡ ’¬ ‰¡à«“à ∑“ßµ√ßÀ√◊Õ∑“ßÕâÕ¡ ∑—ßÈ „π¥â“π°“√‡ß‘π·≈–°“√∫√‘À“√‡ß‘π¢Õß∫√‘…∑— œ, ∫√‘…∑— „π ‡§√◊Õ, ∫√‘…∑— √à«¡À√◊Õ∫√‘…∑— ∑’‡Ë °’¬Ë «¢âÕß 4. ‡ªìπÕ‘ √–®“°ºŸ∂â Õ◊ Àÿπâ √“¬„À≠à, ºŸ∫â √‘À“√·≈–ºŸ∑â ‡’Ë °’¬Ë «¢âÕß 5. ‡ªìπºŸ∑â ’Ë “¡“√∂∑”Àπâ“∑’§Ë ¡ÿâ §√Õßº≈ª√–‚¬™πå¢ÕßºŸ∂â Õ◊ Àÿπâ ∑ÿ°√“¬Õ¬à“ß‡∑à“‡∑’¬¡°—π 6. ‡ªìπºŸ∑â ’Ë “¡“√∂™à«¬¥Ÿ·≈‰¡à„Àâ‡°‘¥√“¬°“√∑’¡Ë §’ «“¡¢—¥·¬âß∑“ßº≈ª√–‚¬™πå√–À«à“ß∫√‘…∑— œ °—∫∫ÿ§§≈∑’‡Ë °’¬Ë «¢âÕß 7. ‡ªìπºŸ∑â ∂’Ë ◊ÕÀÿâπ‰¡à‡°‘π√âÕ¬≈– 5 ¢Õß∑ÿπ™”√–·≈â«¢Õß∫√‘…∑— œ, ∫√‘…∑— „π‡§√◊Õ, ∫√‘…∑— √à«¡ À√◊Õ∫√‘…∑— ∑’‡Ë °’¬Ë «¢âÕß (∑—ßÈ π’Èπ∫— √«¡Àÿâπ∑’Ë ∂◊Õ‚¥¬ºŸ∑â ‡’Ë °’¬Ë «¢âÕß¥â«¬)

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

(3) §à“µÕ∫·∑π°√√¡°“√ §≥–°√√¡°“√µ√«® Õ∫·≈–ºŸ∫â √‘À“√ §à“µÕ∫·∑π°√√¡°“√·≈–§≥–°√√¡°“√µ√«® Õ∫ ∫√‘…∑— œ‰¥â®“à ¬§à“µÕ∫·∑π°√√¡°“√·≈–§≥–°√√¡°“√µ√«® Õ∫ ”À√—∫ß«¥ ‘πÈ ÿ¥«—π∑’Ë 31 ∏—π«“§¡ 2548 ”À√—∫°√√¡°“√ 15 ∑à“π ¥—ßµàÕ‰ªπ’È

√“¬™◊ÕË

1. π“¬ ™—¬ ‚ ¿≥æπ‘™ 2. π.æ. ™“≠«‘∑¬å µ—πµ‘æÏ æ‘ ≤— πå 3. π.æ. ∏π‘µ ‡∏’¬√∏πŸ 4. π“¬ ∫ÿ≠ª°√≥å ‚™§«—≤π“ 5. π“¬ √¥‘… «‘≠≠√—µπå 6. æ.≠. §ÿ≥ «√√¬“ ‡¥™Õÿ¥¡ 7. π.æ. Õπ—πµå ‡µ™–‡«™ 8. π.æ.®Õπ ¬—ßæ‘™µ‘ 9. π“ß °ÿ≈∏‘¥“ »‘«¬“∏√ 10. π“ß “« ‚ ¿“«¥’ Õÿµµ‚¡∫≈ 11 π“¬ ™Õß ‚∑ 12. π“ß ≈‘π¥“ ≈’ À–ªí≠≠“ 13. π“¬ ‡°’¬√µ‘ π‘µ¬å∏√’ “ππ∑å* 14. π“¬ ‡§Õ√åµ ‘ ®ÕÀåπ ™‚√‡¥Õ√å 15. π“¬ ™“µ√’ ‚ ¿≥æπ‘™

®”π«π§√—ßÈ ∑’Ë ‡¢â“ª√–™ÿ¡/ ®”π«π§√—ßÈ ∑’Ë ‡™‘≠ª√–™ÿ¡ 5/5 4/5 5/5 5/5 4/5 5/5 5/5 4/5 3/5 5/5 5/5 5/5 1/1 3/5 1/5

‡∫’¬È ª√–™ÿ¡§≥–°√√¡°“√ §à“µÕ∫·∑π ‡∫’¬È ª√–™ÿ¡ √“¬ªï √“¬§√—ßÈ

280,000 240,000 200,000 200,000 200,000 200,000 200,000 200,000 200,000 200,000 200,000 200,000 0 200,000 200,000 2,920,000

150,000 100,000 100,000 100,000 80,000 100,000 100,000 80,000 60,000 100,000 100,000 100,000 20,000 60,000 20,000 1,270,000

√«¡

430,000 340,000 300,000 300,000 280,000 300,000 300,000 280,000 260,000 300,000 300,000 300,000 20,000 260,000 220,000 4,190,000

‡∫’¬È ª√–™ÿ¡§≥–°√√¡°“√µ√«® Õ∫ ®”π«π§√—ßÈ ∑’Ë ‡∫’¬È ª√–™ÿ¡ √«¡§à“ ‡¢â“ª√–™ÿ¡/ µÕ∫·∑π ®”π«π§√—ßÈ ∑’Ë ‡™‘≠ª√–™ÿ¡

4/4 4/4

80,000 80,000

4/4

120,000

280,000

430,000 340,000 300,000 380,000 360,000 300,000 300,000 280,000 260,000 420,000 300,000 300,000 20,000 260,000 220,000 4,470,000

* π“¬‡°’¬√µ‘ π‘µ¬å∏√’ “ππ∑å‰¥â≈“ÕÕ°®“°°“√‡ªìπ°√√¡°“√∫√‘…∑— œ ‡¡◊ÕË «—π∑’Ë 28 ‡¡…“¬π 2548

§à“µÕ∫·∑π°√√¡°“√ §◊Õ§à“µÕ∫·∑π∑’®Ë “à ¬„Àâ·°à°√√¡°“√¢Õß∫√‘…∑— œ ‚¥¬‰¡à√«¡‡ß‘π‡¥◊Õπ·≈–º≈ª√–‚¬™πå∑‡’Ë °’¬Ë «¢âÕß∑’®Ë “à ¬„Àâ·°àº∫Ÿâ √‘À“√ ·≈–§à“µÕ∫·∑π°√√¡°“√¥—ß°≈à“« ‰¥â√∫— Õπÿ¡µ— ®‘ “°ºŸ∂â Õ◊ Àÿπâ ·≈â«

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

§à“µÕ∫·∑π¢Õß°√√¡°“√∫√‘À“√·≈–ºŸ∫â √‘À“√ §à“µÕ∫·∑π√«¡¢Õß°√√¡°“√∫√‘À“√·≈–ºŸâ∫√‘À“√¢Õß∫√‘…—∑œ ·≈–∫√‘…—∑¬àÕ¬ ®”π«π 11 ∑à“π ª√–®”ªï 2548 ‡ªìπ®”π«π‡ß‘π 89,677,027 ∫“∑ ‚¥¬∑’§Ë “à µÕ∫·∑π¥—ß°≈à“« √«¡∂÷ß‡ß‘π‡¥◊Õπ·≈–º≈ª√–‚¬™πå∑’Ë‡°’Ë¬«¢âÕß¢ÕßºŸ∫â √‘À“√ (4) °“√°”°—∫¥Ÿ·≈°‘®°“√ ∫√‘…—∑œ ‰¥âµ√–Àπ—°∂÷ß§«“¡ ”§—≠¢Õß°“√°”°—∫¥Ÿ·≈°‘®°“√∑’Ë¥’ ·≈–¡’§«“¡µ—Èß„®∑’Ë®–ªØ‘∫—µ‘µ“¡À≈—°°“√°”°—∫¥Ÿ·≈°‘®°“√∑’Ë¥’¢Õß µ≈“¥À≈—°∑√—æ¬å·Ààßª√–‡∑»‰∑¬¥—ßµàÕ‰ªπ’È 1. π‚¬∫“¬‡°’¬Ë «°—∫°“√¥Ÿ·≈°‘®°“√ §≥–°√√¡°“√∫√‘…∑— ‡ÀÁπ«à“°“√°”°—∫¥Ÿ·≈°‘®°“√∑’¥Ë ‡’ ªìπ ‘ßË ∑’¡Ë §’ «“¡ ”§—≠ ·≈–¡’§«“¡¡ÿßà ¡—πË µ—ßÈ „®∑’®Ë –ªØ‘∫µ— µ‘ “¡À≈—°°“√¥—ß°≈à“« §≥–°√√¡°“√∫√‘…—∑„Àâ§«“¡ ”§—≠°—∫√–∫∫°“√§«∫§ÿ¡¿“¬„π·≈–°“√µ√«® Õ∫¿“¬„π ·≈–°”°—∫¥Ÿ·≈ΩÉ“¬∫√‘À“√„Àâ¥”‡π‘π µ“¡π‚¬∫“¬¢Õß∫√‘…—∑œÕ¬à“ß¡’ª√– ‘∑∏‘¿“æ ‡æ◊ËÕª√–‚¬™πå „π√–¬–¬“«µàÕºŸâ∂◊ÕÀÿâπ ¿“¬„µâ°√Õ∫¢âÕ°”Àπ¥¢Õß°ÆÀ¡“¬·≈– ®√‘¬∏√√¡∑“ß∏ÿ√°‘® 2. ‘∑∏‘¢ÕßºŸ∂â ◊ÕÀÿâπ ∫√‘…∑— œ‡≈Áß‡ÀÁπ∂÷ß§«“¡ ”§—≠¢Õß ‘∑∏‘¢ÕßºŸ∂â Õ◊ Àÿπâ ∑ÿ°√“¬ ´÷ßË √«¡∑—ßÈ ºŸ∂â Õ◊ Àÿπâ √“¬„À≠à ·≈–ºŸ∂â ◊ÕÀÿπâ √“¬¬àÕ¬ ·≈–¡ÿßà ‡πâπ„π°“√„Àâ ¢âÕ¡Ÿ≈·°àº∂Ÿâ Õ◊ Àÿπâ ∑ÿ°√“¬Õ¬à“ß∂Ÿ°µâÕß ∑—π‡«≈“ ‡∑à“‡∑’¬¡°—π ·≈–‚ª√àß„ „π°“√ª√–™ÿ¡ºŸâ∂Õ◊ Àÿπâ ∑ÿ°§√—Èß ∫√‘…∑— œ‰¥â®—¥ àßÀπ—ß ◊Õ‡™‘≠ ª√–™ÿ¡‡æ◊ÕË ·®âß«“√–°“√ª√–™ÿ¡ æ√âÕ¡§«“¡§‘¥‡ÀÁπ¢Õß§≥–°√√¡°“√„π·µà≈–«“√– √«¡∂÷ß‡Õ° “√ª√–°Õ∫µà“ßÊ ‡æ◊ÕË „Àâº∂Ÿâ Õ◊ Àÿπâ ¡’ ¢âÕ¡Ÿ≈‡æ’¬ßæÕ„π°“√µ—¥ ‘π„® ·≈–∫√‘…∑— œ¡’°“√∫—π∑÷°°“√ª√–™ÿ¡∑’∂Ë °Ÿ µâÕß §√∫∂â«π ‡æ◊ÕË „Àâº∂Ÿâ Õ◊ Àÿπâ “¡“√∂µ√«® Õ∫‰¥â 3. ‘∑∏‘¢ÕßºŸ¡â ’ «à π‰¥â‡ ’¬ ∫√‘…—∑œ‰¥â„Àâ§«“¡ ”§—≠µàÕ ‘∑∏‘¢ÕßºŸâ¡’ à«π‰¥â‡ ’¬∑ÿ°°≈ÿà¡ ·≈–¡’§«“¡µ—Èß„®∑’Ë®–ªØ‘∫—µ‘µàÕºŸâ¡’ à«π‰¥â‡ ’¬·µà≈–°≈ÿà¡Õ¬à“ß¬ÿµ‘∏√√¡ ºŸ¡â ’ «à π‰¥â‡ ’¬∑’Ë ”§—≠¢Õß∫√‘…—∑œ ¡’¥ß— µàÕ‰ªπ’È ≈Ÿ°§â“ / §π‰¢â

§Ÿ§à “â / §Ÿ à ≠— ≠“ æπ—°ß“π §Ÿ·à ¢àß

∫√‘…∑— œ„Àâ∫√‘°“√·°àºªŸâ «É ¬Õ¬à“ß¡’®√‘¬∏√√¡·≈–„π√–¥—∫§ÿ≥¿“æ∑’ Ë ßŸ ÿ¥ §≥–°√√¡°“√ Medical Ethics Committee ¢Õß‚√ßæ¬“∫“≈®–™à«¬¥Ÿ·≈æ‘∑°— …å ∑‘ ∏‘ºªŸâ «É ¬ πÕ°®“°π’È ‚√ßæ¬“∫“≈¡’·ºπ°∑’¥Ë ·Ÿ ≈·≈– æ—≤π“§ÿ≥¿“æ¢Õß°“√∫√‘°“√ºŸâªÉ«¬Õ¬à“ßµàÕ‡π◊ËÕß ‚¥¬æ‘®“√≥“∂÷ß§«“¡µâÕß°“√·≈–§«“¡§‘¥‡ÀÁπ ¢Õß§π‰¢â ∫√‘…∑— œªØ‘∫µ— µ‘ “¡‡ß◊ÕË π‰¢∑’µË °≈ß‰«â°∫— §Ÿ§à “â ·≈–§Ÿ à ≠— ≠“ ∫√‘…—∑œ‡™◊ËÕ¡—Ëπ«à“æπ—°ß“π§◊Õ∑√—æ¬“°√∑’Ë¡’§ÿ≥§à“ ¥—ßπ—Èπ∫√‘…—∑œ®÷ß¡’¡“µ√°“√∑’Ë®–„Àâº≈µÕ∫·∑π∑’Ë ‡À¡“– ¡ √«¡∑—ßÈ ¡’°“√æ—≤π“∫ÿ§≈“°√‚¥¬„Àâ°“√Ωñ°Õ∫√¡‡ √‘¡ √â“ß§«“¡√Ÿâ„À¡àÊÕ¬à“ß ¡Ë”‡ ¡Õ ∫√‘…∑— œª√–æƒµ‘µ“¡°√Õ∫°µ‘°“°“√·¢àß¢—π∑’¥Ë ’ ¿“¬„µâ°√Õ∫¢Õß°ÆÀ¡“¬

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

—ß§¡

∫√‘…∑— œ¡’§«“¡√—∫º‘¥™Õ∫µàÕ “∏“√≥– √«¡∂÷ß ‘ßË ·«¥≈âÕ¡ ‚¥¬∫√‘…∑— œ¡’π‚¬∫“¬ ‘ßË ·«¥≈âÕ¡ ´÷ßË ¡’°“√ ◊ËÕ “√„Àâæπ—°ß“π∑ÿ°§π™à«¬°—πÕπÿ√—°…å ‘Ëß·«¥≈âÕ¡·≈–∑√—æ¬“°√∏√√¡™“µ‘ Õ’°∑—Èß¡ÿàß‡πâπ π—∫ πÿπ °‘®°√√¡µà“ßÊ ‡æ◊ËÕ√—°…“‰«â´÷Ëß§«“¡ª≈Õ¥¿—¬¢ÕßÕß§å°√·≈–™ÿ¡™π ·≈–¡’°“√„™â∑√—æ¬“°√Õ¬à“ß ¡’ª√– ‘∑∏‘¿“æ πÕ°®“°π’È ∫√‘…∑— œ¡’°®‘ °√√¡µà“ßÊ ‡æ◊ÕË ™ÿ¡™πÕ¬à“ß ¡Ë”‡ ¡Õ ‚¥¬ºà“π¡Ÿ≈π‘∏‘ ‚√ßæ¬“∫“≈ ∫”√ÿß√“…Æ√å

4. °“√ª√–™ÿ¡ºŸ∂â Õ◊ Àÿπâ „π°“√ª√–™ÿ¡ºŸ∂â ◊ÕÀÿπâ ª√–®”ªï 2548 ¡’°√√¡°“√‡¢â“√à«¡ª√–™ÿ¡∑—ßÈ ‘πÈ 10 ∑à“π ‡æ◊ÕË „Àâ¢âÕ¡Ÿ≈·≈–™’·È ®ß√“¬≈–‡Õ’¬¥∑’ºË Ÿâ∂Õ◊ ÀÿâπµâÕß°“√ ∑√“∫‡æ‘Ë¡‡µ‘¡ ‚¥¬ª√–∏“π„π∑’Ëª√–™ÿ¡‰¥â‡ªî¥‚Õ°“ „ÀâºŸâ∂◊ÕÀÿâπ¡’ ‘∑∏‘‡∑à“‡∑’¬¡°—π„π°“√ Õ∫∂“¡ ·≈–· ¥ß§«“¡§‘¥‡ÀÁπ·≈–¢âÕ ‡ πÕ·π–µà“ßÊ √«¡∑—ßÈ ‰¥â¡°’ “√∫—π∑÷°ª√–‡¥Áπ´—°∂“¡·≈–¢âÕ§‘¥‡ÀÁπ∑’ Ë ”§—≠‰«â„π√“¬ß“π°“√ª√–™ÿ¡·≈â« 5. ¿“«–ºŸπâ ”·≈–«‘ ¬— ∑—»πå §≥–°√√¡°“√‰¥â„Àâ§«“¡‡ÀÁπ™Õ∫„π°“√°”Àπ¥ «‘ ¬— ∑—»πå ¿“√°‘® °≈¬ÿ∑∏å ‡ªÑ“À¡“¬ ·ºπ∏ÿ√°‘® ·≈–ß∫ª√–¡“≥¢Õß∫√‘…∑— œ µ≈Õ¥®π°”°—∫¥Ÿ·≈„ÀâΩ“É ¬∫√‘À“√¥”‡π‘π°“√„Àâ‡ªìπ‰ªµ“¡·ºπ∑’°Ë ”Àπ¥‰«âÕ¬à“ß¡’ª√– ‘∑∏‘¿“æ·≈–ª√– ‘∑∏‘º≈ ‡æ◊ÕË ‡æ‘¡Ë ¡Ÿ≈§à“ Ÿß ÿ¥ „Àâ°—∫°‘®°“√·≈–§«“¡¡—Ëπ§ß Ÿß ÿ¥„Àâ°—∫ºŸâ∂◊ÕÀÿâπ §≥–°√√¡°“√¡’°“√ª√–™ÿ¡∑ÿ°‰µ√¡“ ‡æ◊ËÕª√–‡¡‘πº≈ª√–°Õ∫°“√¢Õß∫√‘…—∑œ ‡ª√’¬∫‡∑’¬∫°—∫·ºπ∑’°Ë ”Àπ¥‰«â πÕ°®“°π’È§≥–°√√¡°“√∫√‘…—∑œ¬—ß‡ªìπºŸâ∑’Ë°”Àπ¥Õ”π“®Àπâ“∑’Ë§«“¡√—∫º‘¥™Õ∫¢Õß§≥–°√√¡°“√µà“ßÊ √«¡∂÷ß√–∫∫§«∫§ÿ¡ ¿“¬„π °“√µ√«® Õ∫¿“¬„π ·≈–‰¥â¡°’ “√ ◊ÕË “√∫∑∫“∑ Àπâ“∑’Ë ·≈–§«“¡√—∫º‘¥™Õ∫¥—ß°≈à“«µàÕºŸ∫â √‘À“√ ·≈–æπ—°ß“π‚¥¬∑—«Ë ∂÷ß 6. §«“¡¢—¥·¬âß∑“ßº≈ª√–‚¬™πå ‡æ◊ËÕªÑÕß°—πªí≠À“§«“¡¢—¥·¬âß¢Õßº≈ª√–‚¬™πå §≥–°√√¡°“√¡’°“√æ‘®“√≥“√“¬°“√∑’ËÕ“®¡’§«“¡¢—¥·¬âß∑“ßº≈ª√–‚¬™πå ·≈– √“¬°“√∑’‡Ë °’¬Ë «‚¬ß°—πÕ¬à“ß√Õ∫§Õ∫ ·≈–¡’°“√ªØ‘∫µ— µ‘ “¡À≈—°‡°≥±å¢Õßµ≈“¥À≈—°∑√—æ¬å·Ààßª√–‡∑»‰∑¬ ‚¥¬¡’√“§“·≈–‡ß◊ÕË π‰¢ ‡ ¡◊Õπ°“√∑”√“§“°—∫∫ÿ§§≈¿“¬πÕ° ·≈–‰¥â‡ªî¥‡º¬√“¬≈–‡Õ’¬¥ ¡Ÿ≈§à“√“¬°“√ §Ÿ à ≠— ≠“ ‡Àµÿº≈§«“¡®”‡ªìπ ‰«â„πß∫°“√‡ß‘π √“¬ ß“πª√–®”ªï ·≈–·∫∫ 56-1 ·≈â« µ“¡¢âÕ°”Àπ¥¢Õßµ≈“¥À≈—°∑√—æ¬å·Ààßª√–‡∑»‰∑¬ 7. ®√‘¬∏√√¡∑“ß∏ÿ√°‘® ∫√‘…∑— œ¡’æπ— ∏°‘® (Mission Statement) §◊Õ ç‡√“„Àâ∫√‘°“√∑“ß¥â“π°“√√—°…“æ¬“∫“≈Õ¬à“ß‡Õ◊ÕÈ Õ“∑√ ‡Õ“„®„ à ·≈–‰¥â¡“µ√∞“π √–¥—∫‚≈°é ·≈–∫√‘…∑— œ¡’À≈—°°“√ªØ‘∫µ— ‘ ´÷ßË ‰¥â¡°’ “√ ◊ÕË “√‰ª Ÿæà π—°ß“π∑ÿ°§π¥—ßµàÕ‰ªπ’È 1. ‡√“„Àâ∫√‘°“√ºŸªâ «É ¬ ‡ ¡◊ÕπÀπ÷ßË ∫ÿ§§≈„π§√Õ∫§√—«¢Õß‡√“ 2. ‡√“„Àâ∫√‘°“√ºŸªâ «É ¬ ∑ÿ°™“µ‘ ¿“…“ ·≈–«—≤π∏√√¡Õ¬à“ß‡∑à“‡∑’¬¡°—π 3. ‡√“ªØ‘∫µ— µ‘ Õà ºŸªâ «É ¬¥â«¬§«“¡´◊ÕË —µ¬å ¡’§«“¡‰«â«“ß„®´÷ßË °—π·≈–°—π·≈–§ß‰«â´ß÷Ë ®√‘¬∏√√¡ 4. ‡√“∑”ß“π√à«¡°—π‡ªìπ∑’¡ 5. ‡√“ª√—∫ª√ÿß§ÿ≥¿“æ¢Õßß“πÕ¬à“ßµàÕ‡π◊ÕË ß 6. ‡√“¡ÿßà ¡—πË ∑’®Ë – √â“ß‰«â´ß÷Ë ∫√√¬“°“»„π°“√∑”ß“π∑’ÕË ∫Õÿπà ‚¥¬„Àâ‡°’¬√µ‘·≈–‰«â«“ß„®´÷ßË °—π·≈–°—π ∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

7. ‡√“ àß‡ √‘¡°“√æ—≤π“»—°¬¿“æ¢Õß∫ÿ§§≈ ·≈–§«“¡§‘¥√‘‡√‘¡Ë ‚¥¬„Àâ¡°’ “√»÷°…“Õ¬Ÿ‡à ¡Õ 8. ‡√“„Àâ°“√√—°…“æ¬“∫“≈Õ¬à“ß¡’ª√– ‘∑∏‘¿“æ ‡æ◊ÕË ‡æ‘¡Ë §ÿ≥§à“„Àâ°∫— ≈Ÿ°§â“¿“¬πÕ° ·≈–≈Ÿ°§â“¿“¬„π¢Õß‡√“ 9. ‡√“ªØ‘∫—µ‘µπ‡ªìπæ≈‡¡◊Õß¥’¢Õß™“µ‘ æπ—°ß“π∑ÿ°§π®–µâÕß√—∫∑√“∫·≈–ªØ‘∫µ— µ‘ “¡À≈—°ªØ‘∫µ— ¢‘ Õß∫√‘…∑— œ 8. °“√∂à«ß¥ÿ≈¢Õß°√√¡°“√∑’Ë‰¡à‡ªìπºŸ∫â √‘À“√ ∫√‘…∑— œ¡’°√√¡°“√®”π«π 3 ∑à“π∑’‡Ë ªìπºŸâ∫√‘À“√ ¥—ßµàÕ‰ªπ’È 1. π“ß≈‘π¥“ ≈’ À–ªí≠≠“ 2. π.æ. ∏π‘µ ‡∏’¬√∏πŸ 3. π“¬‡§Õ√åµ ‘ ®ÕÀåπ ™‚√‡¥Õ√å °√√¡°“√®”π«π 8 ∑à“π∑’Ë‰¡à‰¥â‡ªìπºŸ∫â √‘À“√¡’¥ß— µàÕ‰ªπ’È 1. π“¬™—¬ ‚ ¿≥æπ‘™ 2. π.æ. ™“≠«‘∑¬å µ—πµ‘æÏ ‘æ≤— πå 3. π“ß°ÿ≈∏‘¥“ »‘«¬“∏√ 4. π.æ. ®Õπ ¬—ßæ‘™µ‘ 5. æ.≠. §ÿ≥ «√√¬“ ‡¥™Õÿ¥¡ 6. π.æ. Õπ—πµå ‡µ™–‡«™ 7. π“¬™Õß ‚∑ 8. π“¬™“µ√’ ‚ ¿≥æπ‘™ ∫√‘…∑— œ¡’°√√¡°“√®”π«π 3 ∑à“π∑’‡Ë ªìπ°√√¡°“√Õ‘ √–·≈–‡ªìπ°√√¡°“√µ√«® Õ∫¥—ßµàÕ‰ªπ’È 1. π. . ‚ ¿“«¥’ Õÿµµ‚¡∫≈ 2. π“¬ √¥‘… «‘≠≠√—µπå 3. π“¬∫ÿ≠ª°√≥å ‚™§«—≤π“ °√√¡°“√∑’‡Ë ªìπÕ‘ √– 3 ∑à“π §‘¥‡ªìπ 21.4% ¢Õß°√√¡°“√∑—ßÈ §≥– ∫√‘…∑— œ¡’π‚¬∫“¬∑’®Ë –ª√—∫®”π«π°√√¡°“√∑’‡Ë ªìπÕ‘ √–„Àâ‰¡àπÕâ ¬ °«à“ 1 „π 3 ¢Õß°√√¡°“√∑—ßÈ §≥–„πÕπ“§µ 9. °“√√«¡À√◊Õ·¬°µ”·Àπàß ª√–∏“π°√√¡°“√‰¡à‡ªìπ∫ÿ§§≈‡¥’¬«°—π°—∫°√√¡°“√ºŸâ®—¥°“√‡æ◊ËÕ‡ªìπ°“√·∫àß·¬°Àπâ“∑’Ë „π°“√°”Àπ¥π‚¬∫“¬°“√°”°—∫¥Ÿ·≈·≈– °“√∫√‘À“√ß“πª√–®”

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

10. §à“µÕ∫·∑π°√√¡°“√·≈–ºŸ∫â √‘À“√ ∫√‘…∑— œ¬—ß‰¡à¡§’ ≥–Õπÿ°√√¡°“√°”Àπ¥§à“µÕ∫·∑π Õ¬à“ß‰√°Áµ“¡ º≈µÕ∫·∑π¢Õß§≥–°√√¡°“√Õ¬Ÿà„π√Ÿª¢Õß§à“µÕ∫·∑πª√–®”ªï ·≈–§à“‡∫’¬È ª√–™ÿ¡ ´÷ßË ‰¥â√∫— Õπÿ¡µ— ®‘ “°ºŸ∂â ◊ÕÀÿπâ ·≈â« º≈µÕ∫·∑π¢ÕßºŸ∫â √‘À“√Õ¬Ÿà„π√Ÿª¢Õß‡ß‘π‡¥◊Õπ·≈–‚∫π— ·≈–¢÷ÈπÕ¬Ÿà°∫— º≈ß“π¢Õß∫√‘…∑— œ·≈–º≈ªØ‘∫µ— ß‘ “π¢ÕßºŸ∫â √‘À“√·µà≈–∑à“π √“¬≈–‡Õ’¬¥º≈µÕ∫·∑π¢Õß§≥–°√√¡°“√·≈–ºŸ∫â √‘À“√ Õ¬Ÿà„πÀ—«¢âÕ §à“µÕ∫·∑π°√√¡°“√, °√√¡°“√µ√«® Õ∫·≈–ºŸ∫â √‘À“√ 11. °“√ª√–™ÿ¡§≥–°√√¡°“√ §≥–°√√¡°“√¡’°”Àπ¥°“√ª√–™ÿ¡‚¥¬ª°µ‘‡ªìπª√–®”∑ÿ°‰µ√¡“ ·≈–¡’°“√ª√–™ÿ¡æ‘‡»…‡æ‘Ë¡µ“¡§«“¡®”‡ªìπ ‚¥¬¡’°“√°”Àπ¥ «“√–™—¥‡®π≈à«ßÀπâ“ ‡≈¢“πÿ°“√∫√‘…∑— œ‰¥â®¥— Àπ—ß ◊Õ‡™‘≠ª√–™ÿ¡æ√âÕ¡«“√–°“√ª√–™ÿ¡·≈–‡Õ° “√µà“ßÊ àß„Àâ§≥–°√√¡°“√°àÕπ °“√ª√–™ÿ¡≈à«ßÀπâ“ 7 «—π ‡æ◊ÕË „Àâ°√√¡°“√‰¥â¡‡’ «≈“»÷°…“À“¢âÕ¡Ÿ≈Õ¬à“ß‡æ’¬ßæÕ°àÕπ‡¢â“√à«¡ª√–™ÿ¡ ª°µ‘°“√ª√–™ÿ¡®–„™â‡«≈“ ª√–¡“≥ 2 ™—«Ë ‚¡ß „πªï 2548 ∑’ºË “à π¡“§≥–°√√¡°“√¡’°“√ª√–™ÿ¡ ®”π«π 5 §√—ßÈ ‚¥¬°“√‡¢â“√à«¡ª√–™ÿ¡¢Õß§≥–°√√¡°“√∫√‘…∑— ·µà≈–∑à“π √ÿª‰¥âµ“¡µ“√“ß„πÀ—«¢âÕ§à“µÕ∫·∑π°√√¡°“√, §≥–°√√¡°“√µ√«® Õ∫·≈–ºŸ∫â √‘À“√ ∫√‘…∑— œ¡’°“√∫—π∑÷°√“¬ß“π°“√ª√–™ÿ¡∑ÿ°§√—ßÈ ·≈–¡’°“√√—∫√Õß√“¬ß“π„π°“√ª√–™ÿ¡§≥–°√√¡°“√§√—ßÈ ∂—¥‰ª ·≈–∫√‘…∑— œ®–®—¥‡°Á∫ √“¬ß“π°“√ª√–™ÿ¡‰«âæ√âÕ¡„Àâ§≥–°√√¡°“√·≈–ºŸ∑â ‡’Ë °’¬Ë «¢âÕßµ√«® Õ∫‰¥â 12. §≥–Õπÿ°√√¡°“√ ∫√‘…—∑œ¡’§≥–°√√¡°“√µ√«® Õ∫ √“¬≈–‡Õ’¬¥µ“¡À—«¢âÕ°“√®—¥°“√·≈–√“¬≈–‡Õ’¬¥¢Õß°√√¡°“√·≈–ºŸâ∫√‘À“√ ‚§√ß √â“ß°“√ ®—¥°“√ ∫√‘…∑— œ¬—ß‰¡à¡§’ ≥–Õπÿ°√√¡°“√°”Àπ¥§à“µÕ∫·∑π 13. √–∫∫°“√§«∫§ÿ¡·≈–°“√µ√«® Õ∫¿“¬„π ∫√‘…—∑œ‰¥â „Àâ§«“¡ ”§—≠°—∫√–∫∫°“√§«∫§ÿ¡¿“¬„π·≈–°“√µ√«® Õ∫¿“¬„π ‚¥¬‰¥â®—¥µ—ÈßÀπà«¬ß“πµ√«® Õ∫¿“¬„π ´÷Ëß¡’ «—µ∂ÿª√– ß§åÀ≈—°‡æ◊ÕË π—∫ πÿπ ·≈– àß‡ √‘¡„Àâ¡√’ –∫∫°“√§«∫§ÿ¡¿“¬„π∑’¥Ë ¿’ “¬„πÕß§å°√ ‡æ◊ÕË ≈¥§«“¡‡ ’¬Ë ß„π°“√¥”‡π‘πß“π ·≈– ‡æ◊ÕË „Àâ¡§’ ≥ÿ ¿“æ„π√–∫∫ß“π·≈–„π°“√ªØ‘∫µ— ß‘ “π ‚¥¬¡ÿßà ‡πâπ∂÷ß§«“¡¡’ª√– ‘∑∏‘¿“æ ª√– ‘∑∏‘º≈ ·≈–¡’°“√„™â®“à ¬Õ¬à“ß√–¡—¥√–«—ß ¡ª√–‚¬™πå ·≈–√«¡∂÷ß°“√ªØ‘∫µ— ß‘ “π‡æ◊ÕË „Àâ‡ªìπ‰ªµ“¡π‚¬∫“¬·≈–/À√◊Õ§«“¡µâÕß°“√¢ÕßºŸ∫â √‘À“√ ‡æ◊ÕË „Àâ·πà„®«à“Àπà«¬ß“πµ√«® Õ∫¿“¬„π¡’°“√∑”ß“π∑’‡Ë ªìπÕ‘ √– ·≈–¡’°“√∂à«ß¥ÿ≈Õ”π“® Àπà«¬ß“πµ√«® Õ∫¿“¬„π¡’Àπâ“∑’√Ë “¬ ß“πº≈°“√¥”‡π‘πß“π‚¥¬µ√ßµàÕ§≥–°√√¡°“√µ√«® Õ∫

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

14. √“¬ß“π¢Õß§≥–°√√¡°“√ √“¬ß“π§«“¡√—∫º‘¥™Õ∫¢Õß§≥–°√√¡°“√µàÕ√“¬ß“π°“√‡ß‘π §≥–°√√¡°“√∫√‘…—∑‡ªìπºŸâ√—∫º‘¥™Õ∫µàÕß∫°“√‡ß‘π√«¡¢Õß∫√‘…—∑œ·≈–∫√‘…—∑¬àÕ¬ ·≈– “√ π‡∑»∑’Ëª√“°Ø„π√“¬ß“πª√–®”ªï ß∫°“√‡ß‘π¥—ß°≈à“«®–®—¥∑”¢÷Èπµ“¡¡“µ√∞“π°“√∫—≠™’∑’Ë√—∫√Õß∑—Ë«‰ª‚¥¬‡≈◊Õ°„™âπ‚¬∫“¬°“√∫—≠™’∑’Ë‡À¡“– ¡·≈–∂◊ÕªØ‘∫—µ‘Õ¬à“ß ¡Ë”‡ ¡Õ ‚¥¬®—¥∑”¢÷ÈπÕ¬à“ß√–¡—¥√–«—ßµ≈Õ¥®πª√–‡¡‘π∂÷ß§«“¡‡À¡“– ¡¢Õß°“√· ¥ß√“¬°“√∑’Ëπ”‡ πÕ„πß∫°“√‡ß‘π‚¥¬√«¡ √«¡∑—ßÈ ¡’°“√‡ªî¥‡º¬¢âÕ¡Ÿ≈Õ¬à“ß‡æ’¬ßæÕ„πÀ¡“¬‡Àµÿª√–°Õ∫ß∫°“√‡ß‘π §≥–°√√¡°“√∫√‘…∑— ‰¥â®¥— „Àâ¡√’ –∫∫°“√§«∫§ÿ¡¿“¬„π∑’¡Ë ª’ √– ‘∑∏‘¿“æ·≈–ª√– ‘∑∏‘º≈ ‡æ◊ÕË „Àâ¡π—Ë „®«à“¢âÕ¡Ÿ≈∑“ß∫—≠™’¡°’ “√∫—π∑÷° Õ¬à“ß§√∫∂â«π ∂Ÿ°µâÕß ·≈–¡’√–∫∫°“√®—¥‡°Á∫√—°…“∑√—æ¬å π‘ ‡æ◊ÕË ªÑÕß°—π°“√∑ÿ®√‘µÀ√◊Õ‡ ’¬À“¬Õ¬à“ß¡’ “√– ”§—≠ §≥–°√√¡°“√¡’§«“¡‡ÀÁπ«à“ √–∫∫§«∫§ÿ¡¿“¬„π¢Õß∫√‘…∑— œ‚¥¬√«¡Õ¬Ÿà„π√–¥—∫∑’πË “à æÕ„® ·≈– “¡“√∂ √â“ß§«“¡‡™◊ÕË ¡—πË µàÕ§«“¡ ‡™◊ÕË ∂◊Õ‰¥â¢Õßß∫°“√‡ß‘π¢Õß∫√‘…∑— œ·≈–∫√‘…∑— ¬àÕ¬ ≥ «—π∑’Ë 31 ∏—π«“§¡ 2548 15. §«“¡ —¡æ—π∏å°∫— ºŸ≈â ß∑ÿπ §≥–°√√¡°“√‰¥â„Àâ§«“¡ ”§—≠µàÕ°“√‡ªî¥‡º¬¢âÕ¡Ÿ≈∑’¡Ë §’ «“¡∂Ÿ°µâÕß §√∫∂â«π ‡™◊ÕË ∂◊Õ‰¥â ∑—π‡«≈“ ‚ª√àß„ ·≈–∑—«Ë ∂÷ß ∑—ßÈ √“¬ß“π ∑“ß°“√‡ß‘π·≈–¢âÕ¡Ÿ≈∑—«Ë ‰ª ´÷ßË ®–‡ªìπª√–‚¬™πåµÕà °“√µ—¥ ‘π„®¢ÕßºŸ≈â ß∑ÿπ ·≈–‡ªìπ‰ªµ“¡·π«∑“ßÀ√◊Õ°Æ‡°≥±å∑ ’Ë ”π—°ß“π°”°—∫ À≈—°∑√—æ¬å·≈–µ≈“¥À≈—°∑√—æ¬å ·≈–µ≈“¥À≈—°∑√—æ¬å·Ààßª√–‡∑»‰∑¬°”Àπ¥ ·≈–®—¥„Àâ¡º’ ¥Ÿâ ·Ÿ ≈ß“ππ—°≈ß∑ÿπ —¡æ—π∏å ‡æ◊ÕË Õ”π«¬ §«“¡ –¥«°·°àπ—°≈ß∑ÿπ·≈–ºŸ∂â Õ◊ Àÿπâ ºŸ∑â ’Ë π„® “¡“√∂µ‘¥µàÕ¢Õ¢âÕ¡Ÿ≈‰¥â∑’Ë ·ºπ°π—°≈ß∑ÿπ —¡æ—π∏å ‚∑√»—æ∑å 0-2667-2010 E-mail address: ir@bumrungrad.com Website: www.bumrungrad.com (5) °“√¥Ÿ·≈–‡√◊ÕË ß°“√„™â¢Õâ ¡Ÿ≈¿“¬„π ∫√‘…∑— œ¡’π‚¬∫“¬·≈–«‘∏°’ “√¥Ÿ·≈ºŸ∫â √‘À“√„π°“√π”¢âÕ¡Ÿ≈‰ª„™â‡æ◊ÕË ª√–‚¬™πå «à πµπ¥—ßπ’È 1. ¢âÕ∫—ß§—∫¢Õß∫√‘…∑— œ °”Àπ¥„Àâ°√√¡°“√µâÕß·®âß„Àâ∫√‘…∑— œ∑√“∫‚¥¬‰¡à™°— ™â“ À“°¡’ «à π‰¥â‡ ’¬„π —≠≠“∑’∑Ë ”°—∫∫√‘…∑— œÀ√◊Õ∂◊ÕÀÿπâ À√◊ÕÀÿπâ °Ÿ‡â æ‘¡Ë ¢÷πÈ À√◊Õ≈¥≈ß„π∫√‘…∑— œÀ√◊Õ∫√‘…∑— „π‡§√◊Õ 2. °√√¡°“√·≈–ºŸâ∫√‘À“√µâÕß®—¥∑”·≈–‡ªî¥‡º¬√“¬ß“π°“√∂◊ÕÀ≈—°∑√—æ¬å µàÕ§≥–°√√¡°“√°”°—∫À≈—°∑√—æ¬å·≈–µ≈“¥À≈—°∑√—æ¬å ¿“¬„π‡«≈“∑’°Ë ”Àπ¥ ¡“µ√°“√≈ß‚∑… À“°°√√¡°“√∑à“π„¥ΩÉ“Ωóπ¡’¥ß— π’È 1. ·®âß¥â«¬«“®“‡æ◊ÕË ·°â‰¢ 2. √“¬ß“πºŸ∂â Õ◊ Àÿπâ ‡æ◊ÕË æ‘®“√≥“ 3. ™¥„™â§“à ‘π‰À¡∑¥·∑π°√≥’‡°‘¥§«“¡‡ ’¬À“¬ 4. ‡ªî¥‡º¬„Àâ ”π—°ß“π§≥–°√√¡°“√°”°—∫À≈—°∑√—æ¬å·≈–µ≈“¥À≈—°∑√—æ¬å ·≈–µ≈“¥À≈—°∑√—æ¬å·Ààßª√–‡∑»‰∑¬∑√“∫ 86

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

(6) °“√§«∫§ÿ¡¿“¬„π √“¬ß“π¢Õß§≥–°√√¡°“√µ√«® Õ∫ (Àπâ“ 22) (7) π‚¬∫“¬°“√®à“¬‡ß‘πªíπº≈ 1. π‚¬∫“¬°“√®à“¬‡ß‘πªíπº≈¢Õß∫√‘…∑— œ ¡’¥ß— π’È 1.1

1.2 1.3 1.4

‡¡◊ÕË ∫√‘…∑— œ¡’°”‰√ ÿ∑∏‘∑®’Ë –®à“¬„Àâ·°àº∂Ÿâ Õ◊ Àÿπâ ‰¥â ∫√‘…∑— œ®–®à“¬„Àâ·°àº∂Ÿâ Õ◊ Àÿπâ µ“¡ ‘∑∏‘¢ÕßÀÿπâ ∫ÿ√¡‘ ‘∑∏‘°Õà π ∂â“ªï„¥ºŸ∂â Õ◊ Àÿπâ ∫ÿ√¡‘ ‘∑∏‘‰¥â√∫— ·®°‡ß‘πªíπº≈∂÷ß√âÕ¬≈– 15 ¢Õß∑ÿπ¢Õß∫√‘…∑— œ∑’‡Ë ªìπÀÿπâ ∫ÿ√¡‘ ‘∑∏‘·≈â« °”‰√ à«π∑’‡Ë À≈◊Õ®–·®°„Àâ·°àº∂Ÿâ Õ◊ Àÿπâ “¡—≠‡ªìπ®”π«π‡∑à“„¥°Á‰¥âµ“¡¡µ‘∑ª’Ë √–™ÿ¡„À≠à ∂â“ªï„¥∫√‘…—∑œ “¡“√∂·®°‡ß‘πªíπº≈‰¥â‡°‘π°«à“√âÕ¬≈– 15 ¢Õß∑ÿπ¢Õß∫√‘…—∑œ „ÀâºŸâ∂◊ÕÀÿâπ∑—Èß Õß™π‘¥‰¥â√—∫·®°‡ß‘πªíπ º≈‡∑à“°—π °“√®à“¬‡ß‘πªíπº≈ „Àâ°√√¡°“√ªØ‘∫—µµ‘ “¡¡µ‘¢Õß∑’ªË √–™ÿ¡„À≠àº∂Ÿâ Õ◊ Àÿπâ ∑ÿ°§√“«∑’∫Ë √‘…∑— œ®à“¬‡ß‘πªíπº≈ ∫√‘…∑— œ®–®—¥ √√‡ß‘π‰«â‡æ◊ÕË ‡ªìπ∑ÿπ ”√ÕßÕ¬à“ßπâÕ¬√âÕ¬≈– 5 ¢Õß®”π«πº≈°”‰√ ®π°«à“ ∑ÿπ ”√Õß¡’∂ß÷ √âÕ¬≈– 10 ¢Õß®”π«π∑ÿπ¢Õß∫√‘…∑— œ ‡ß‘πªíπº≈§â“ß®à“¬∫√‘…∑— œ®–‰¡à§¥‘ ¥Õ°‡∫’¬È „Àâ

2. π‚¬∫“¬°“√®à“¬‡ß‘πªíπº≈¢Õß∫√‘…∑— ¬àÕ¬ ¡’¥ß— π’È 2.1 2.2

‡¡◊ÕË ∫√‘…∑— ¡’°”‰√ ÿ∑∏‘∑®’Ë –®à“¬„Àâ·°àº∂Ÿâ Õ◊ Àÿπâ ‰¥â ∫√‘…∑— ®–®à“¬„Àâ·°àº∂Ÿâ Õ◊ Àÿπâ ‡ªìπ®”π«π‡∑à“„¥°Á‰¥âµ“¡¡µ‘∑ª’Ë √–™ÿ¡„À≠à ‡ß‘πªíπº≈§â“ß®à“¬∫√‘…∑— ®–‰¡à§¥‘ ¥Õ°‡∫’¬È „Àâ

”À√—∫º≈°“√¥”‡π‘πß“πªï 2548 ∫√‘…∑— œ‰¥â®“à ¬‡ß‘πªíπº≈√–À«à“ß°“≈„Àâ·°àºŸâ∂Õ◊ Àÿπâ ®“°º≈°“√¥”‡π‘πß“πµ—ßÈ ·µà«—π∑’Ë 1 ¡°√“§¡ 2548 ∂÷ß«—π∑’Ë 30 ¡‘∂ÿπ“¬π 2548 „πÕ—µ√“Àÿâπ≈– 0.30 ∫“∑ √«¡‡ªìπ‡ß‘π 219 ≈â“π∫“∑ ·≈–„π«—π∑’Ë 28 °ÿ¡¿“æ—π∏å 2549 §≥– °√√¡°“√∫√‘…∑— ‰¥âÕπÿ¡µ— °‘ “√®à“¬‡ß‘πªíπº≈ª√–®”ªï „πÕ—µ√“Àÿπâ ≈– 0.45 ∫“∑µàÕÀÿâπ √«¡‡ªìπ‡ß‘π 329 ≈â“π∫“∑ ´÷ßË ®”π«π‡ß‘πªíπº≈ ¥—ß°≈à“« µâÕß‰¥â√∫— Õπÿ¡µ— ®‘ “°∑’Ëª√–™ÿ¡ºŸ∂â Õ◊ Àÿπâ „π‡¥◊Õπ‡¡…“¬π 2549 ‡ªìπº≈„Àâ∫√‘…∑— œ§“¥«à“®–®à“¬‡ß‘πªíπº≈ ”À√—∫º≈°“√¥”‡π‘π ß“πªï 2548 ∑—ßÈ ‘πÈ 0.75 ∫“∑ ´÷ßË §‘¥‡ªìπ√âÕ¬≈– 52.0 ¢Õß°”‰√ ÿ∑∏‘¢Õß∫√‘…∑— œ

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

6. √“¬°“√√–À«à“ß°—π 1. ≈—°…≥–¢Õß√“¬°“√√–À«à“ß°—π ∫√‘…∑— œ¡’∏√ÿ °‘®°—∫∫√‘…∑— ¬àÕ¬ ∫√‘…∑— √à«¡ ·≈–∫√‘…∑— ∑’‡Ë °’¬Ë «¢âÕß°—π ¥—ß√“¬≈–‡Õ’¬¥„πÀ¡“¬‡Àµÿª√–°Õ∫ß∫°“√‡ß‘π ¢âÕ 6 πÕ°®“°π’È ∫√‘…∑— œ¡’°“√‡¢â“∑”√“¬°“√°—∫°‘®°“√∑’‡Ë °’¬Ë «¢âÕß°—π°—∫∫√‘…∑— œ ´÷ßË ‡ªìπ√“¬°“√‚¥¬ª°µ‘¢Õß°“√ª√–°Õ∫∏ÿ√°‘® √«¡∂÷ß√“¬‰¥â ®“°∫√‘…∑— §Ÿ à ≠— ≠“ ´÷ßË ¡’‡ß◊ÕË π‰¢∑“ß§â“∑’‡Ë ªìπ¡“µ√∞“π∑—«Ë ‰ª¢Õß∫√‘…—∑œ √“¬°“√

∫√‘…∑— ∑’‡Ë °’¬Ë «¢âÕß

§«“¡ —¡æ—π∏å

√“¬°“√°—∫∫√‘…∑— ¬àÕ¬ ∫√‘…∑— √à«¡ ·≈–°‘®°“√∑’‡Ë °’¬Ë «¢âÕß°—π √“¬‰¥â®“°∫√‘…∑— §Ÿ à ≠— ≠“

√“¬≈–‡Õ’¬¥„πÀ¡“¬‡Àµÿ ª√–°Õ∫ß∫°“√‡ß‘π¢âÕ 6 ∫√‘…∑— °√ÿß‡∑æª√–°—π¿—¬ ®”°—¥ (¡À“™π) ∏π“§“√°√ÿß‡∑æ ®”°—¥ (¡À“™π)

2548 ®”π«π‡ß‘π (≈â“π∫“∑) -

°√√¡°“√√à«¡

22.1

ºŸ∂â Õ◊ Àÿπâ √“¬„À≠à

22.8

√“¬‰¥â®“°∫√‘…∑— §Ÿ à ≠— ≠“

2. §«“¡®”‡ªìπ·≈–§«“¡ ¡‡Àµÿ ¡º≈¢Õß√“¬°“√√–À«à“ß°—π ∫√‘…∑— œ¡’√“¬°“√°—∫°‘®°“√∑’‡Ë °’¬Ë «¢âÕß°—π ‡æ◊ÕË ™à«¬ π—∫ πÿπ°“√¥”‡π‘πß“π¢Õß∫√‘…∑— œ °“√‡™à“Õ“§“√®“°∏π“§“√°√ÿß‡∑æ ®”°—¥ (¡À“™π) (√“¬≈–‡Õ’¬¥µ“¡À¡“¬‡Àµÿª√–°Õ∫ß∫°“√‡ß‘π¢âÕ 6) ™à«¬„Àâ∫√‘…∑— œ “¡“√∂√—°…“·≈–¢¬“¬∞“π≈Ÿ°§â“µà“ßª√–‡∑»‰¥â ¢≥–‡¥’¬«°—π ∫√‘…∑— §Ÿ à ≠— ≠“ ·≈–∫√‘…∑— ª√–°—π ™à«¬¢¬“¬∞“π≈Ÿ°§â“¢Õß∫√‘…∑— œ 3. ¢—πÈ µÕπ°“√Õπÿ¡µ— °‘ “√∑”√“¬°“√√–À«à“ß°—π °“√∑”√“¬°“√√–À«à“ß°—π ´÷Ëß‡ªìπ‰ªµ“¡∏ÿ√°‘®ª°µ‘¢Õß∫√‘…—∑œ µâÕß‰¥â√—∫°“√Õπÿ¡—µ‘®“°ºŸâ¡’Õ”π“®µ“¡¢—ÈπµÕπª°µ‘µ“¡π‚¬∫“¬ ¢Õß∫√‘…∑— œ ”À√—∫√“¬°“√Õ◊πË Ê ´÷ßË ¡’¡≈Ÿ §à“ Ÿßµ“¡π‘¬“¡¢Õßµ≈“¥À≈—°∑√—æ¬å·Ààßª√–‡∑»‰∑¬ ®–µâÕß‰¥â√∫— °“√Õπÿ¡µ— ®‘ “°§≥– °√√¡°“√ ·≈–/À√◊Õ ºŸ∂â Õ◊ Àÿπâ µ“¡°Æ√–‡∫’¬∫ ‚¥¬∑’ºË ∫Ÿâ √‘À“√ ·≈–/À√◊Õ°√√¡°“√∑’¡Ë ’ «à π‰¥â «à π‡ ’¬‰¡à¡ ’ ∑‘ ∏‘ÕÕ°‡ ’¬ß 4. π‚¬∫“¬°“√∑”√“¬°“√√–À«à“ß°—π„πÕπ“§µ ∫√‘…—∑œ¬—ß¡’π‚¬∫“¬∑’Ë®–¡’√“¬°“√°—∫°‘®°“√∑’Ë‡°’Ë¬«¢âÕß°—πµàÕ‰ª„πÕπ“§µ ‡π◊ËÕß®“°‡ªìπ√“¬°“√∑’Ë¡’º≈¥’µàÕ∫√‘…—∑œ ¥—ß∑’Ë°≈à“«‰«â ¢â“ßµâπ Õ¬à“ß‰√°Áµ“¡ ∫√‘…∑— œ®–ªØ‘∫µ— µ‘ “¡π‚¬∫“¬¢Õß∫√‘…∑— œ·≈–°Ø√–‡∫’¬∫¢Õßµ≈“¥À≈—°∑√—æ¬å·Ààßª√–‡∑»‰∑¬Õ¬à“ß‡§√àß§√—¥ πÕ°®“°π’È ∫√‘…∑— œ®–¡ÿßà ‡πâπ§«“¡‚ª√àß„ ¢Õß√“¬°“√∑’‡Ë °’¬Ë «‚¬ß°—π ·≈–®–√—°…“ª√–‚¬™πå ßŸ ÿ¥¢Õß∫√‘…∑— œ‡ªìπ ”§—≠ 7. §”Õ∏‘∫“¬·≈–°“√«‘‡§√“–Àå∞“π–°“√‡ß‘π·≈–º≈°“√¥”‡π‘πß“π Àπâ“ 20-21

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

√“¬ß“πª√–®”ªï 2548

8. ß∫°“√‡ß‘π 8.1 ß∫°“√‡ß‘π Àπâ“ 24-60 8.2 §à“µÕ∫·∑π¢ÕßºŸ â Õ∫∫—≠™’ (Audit fee) (°) §à“µÕ∫·∑π®“°°“√ Õ∫∫—≠™’ ∫√‘…∑— œ·≈–∫√‘…∑— ¬àÕ¬ ¡’§“à µÕ∫·∑π®“°°“√ Õ∫∫—≠™’„πªï 2548 ‡ªìπ®”π«π‡ß‘π 1,762,480 ∫“∑ Õπ÷ßË §à“ Õ∫∫—≠™’ªï 2548 ‰¥â√∫— °“√Õπÿ¡µ— ®‘ “°∑’ªË √–™ÿ¡ºŸ∂â Õ◊ Àÿπâ ·≈â« (¢) §à“∫√‘°“√Õ◊πË ‰¡à¡’

∫√‘…—∑ ‚√ßæ¬“∫“≈∫”√ÿß√“…Æ√å ®”°—¥ (¡À“™π)

Financial Information

Annual Report 2005

Financial Highlights 2005

2004

2003

Total Current Assets

1,103,842

1,503,740

1,635,878

Total Assets

5,727,518

5,021,086

4,456,285

Total Current Liabilities

1,580,758

1,181,395

824,743

Total Liabilities

3,031,729

2,960,888

3,196,780

Total Shareholders’ Equity

2,695,789

2,060,198

1,259,505

Total Revenues

6,806,775

5,809,299

4,620,311

Net Earnings for the Year

1,052,739

934,547

666,488

Basic Earnings Per Share

1.45

1.36

1.34

Earnings Per Share – Fully Diluted

1.21

1.08

0.78

Book Value Per Share

3.59

3.00

2.48

Book Value Per Share – Fully Diluted

3.01

2.39

1.44

Dividend Per Share

0.75

0.70

1.27

1.98

Average Collection Period (days)

13.99

16.36

16.34

Average Inventory Period (days)

11.04

9.73

10.04

Average Payable Period (days)

38.98

39.88

41.49

Gross Profit Margin (%)

37.6%

35.6%

34.6%

EBITDA Margin (%)

24.5%

23.4%

22.3%

Net Profit Margin (%)

15.5%

16.1%

14.4%

Growth on Sales from Hospital Operations (%)

16.9%

26.6%

25.4%

Growth on Net Profit (%)

12.6%

40.2%

194.5%

Return on Assets (%)

19.6%

19.7%

16.6%

1.16

1.44

2.58

12.94

9.54

6.66

3.72

3.03

5.47

Financial Performance (Bt ‘000)

Financial Ratios Current Ratio (x)

Debt to Equity Ratio (x) Interest Coverage Ratio (x) Debt Service Coverage Ratio (Cash Basis) (x)

Basic earnings per share and diluted earnings per share for the year ended 31 December 2003 have been adjusted as though the share split had been effective since the beginning of the reported period

Bumrungrad Hospital Public Company Limited

Annual Report 2005

Management Discussion and Analysis 1. Revenues and Expenses For the year ended 2005, the Company has total revenues of Bt 6,807 million, an increase of Bt 998 million (17%) from 2004 (excluding extraordinary income in 2004 of Bt 64 million).The increase is mainly the result of the continuous growth in hospital operations, where inpatient revenues increased by 13% while outpatient revenues increased by 17%. In 2005, the Company has total expenses of Bt 5,760 million, an increase of Bt 829 million (17%) from 2004.This is a result of the growth of hospital operations. Cost of service and other operating expenses were in line with the increase in revenues. In 2005, income tax expense has increased by Bt 89 million or an increase of 69% as the Company has used up its tax loss carried forward and has started paying corporate income tax in 2005. 2. Net Profits and Extraordinary Item The Company reported net profit for the year-ended 2005 of Bt 1,053 million representing a 21% growth compared to Bt 871 million in 2004 (excluding extraordinary income of Bt 64 million in 2004). This is mainly a result of continuous growth in hospital revenue. Basic EPS stood at Bt 1.45 per share, an increase of 14% from Bt 1.27 per share in 2004 (excluding extraordinary items). Similarly, fully diluted EPS was up by 20% from Bt 1.01 per share in 2004 to Bt 1.21 per share in 2005. In year 2004, the Company reported a gain from the conversion of convertible bonds to ordinary shares by BKI amounting to Bt 64 million. Of the bond’s 12 years accrued interest of Bt 96 million, the Company recorded a write back of interest expense amounting to Bt 64 million as “Gain from bond conversion” when BKI exercised its right to convert all of its bonds on 25 August 2004 and was presented as an extraordinary item in 2004 statement of earnings.

2005

Unit: Bt million 2004

Total Revenues

6,807

5,809

Gross Profit

2,501

2,020

Net Profit (Before extra. Item)

1,053

870

1,053

935

Extraordinary Item Net Profit

3. Balance Sheet Total assets increased to Bt 5,728 million as at 31 December 2005 compared to Bt 5,021 million as at 31 December 2004, primarily because of increase in fixed assets mainly attributable to construction of new hospital building and international investment in the Asian Hospital Inc in the Philippines. Net Debt to equity remained constant at 0.37x as at 31 December 2005. Shareholders’ equity increased to Bt 2,615 million as at 31 December 2005 from Bt 2,060 million as at 31 December 2004, primarily as a result of net profit for the year. Total liability was Bt 3,032 million as at 31 December 2005, which was constant compared to Bt 2,960 million as at 31 December 2004. 4. Liquidity The Company’s cash flow from operating activities in 2005 was at Bt 1,513 million, compared to Bt 1,238 million in 2004. The increase was primarily attributable to improved pre-tax profits from operation. Net cash used in investment activities decreased to Bt 859 million in 2005 from Bt 1,268 million in 2004 because of the decrease in deposits at financial institutions with maturity of more than 3 months. Net cash used in financing activities increased to Bt 857 million in 2005 from Bt 273 million in 2004 as the Company paid down its long term loan and made dividend payments in 2005. As a result, cash and cash equivalents at the end of the year decreased to Bt 544 million in 2005 from Bt 723 million in 2004. Liquidity ratio stood at 0.70x in 2005 compared to 1.27x in 2004, primarily due to decrease in cash on hand and current investments, coupled with increase in current liabilities, mainly in corporate income tax payable. Consequently, quick ratio was at 0.65x in 2005, a decrease from 1.15x in 2004.

Bumrungrad Hospital Public Company Limited

Annual Report 2005

Report of the Audit Committee To the Shareholders of Bumrungrad Hospital Public Company Limited On 28 February 2005, the Audit Committee, whose term has expired, was re-appointed by a board resolution for another 3-year term from 2005 - 2007.The Committee comprises of three independent directors of the Company with Miss Sophavadee Uttamobol as the Chairperson and Dr. Boonpakorn Chokwatana and Mr. Soradis Vinyaratn as Members of the Audit Committee. The Audit Committee had 4 meetings in year 2005. The following major areas were discussed: 1.

Reviewed the Company and subsidiariesâ&#x20AC;&#x2122; financial statements prior to submission to the Board of Directors. After due considerations with the external auditors and the management, it is the opinion of the committee that the financial statements are presented with sufficient and accurate disclosure of material information.

Considered and recommended an appointment of external auditor and the yearly audit fee to the Board of Directors and Shareholders.

Reviewed and acknowledge the reports from internal auditors on the adequacy and the effectiveness of risk assessment for each Department of the Company. The committee is of the opinion that the internal control systems are adequate and appropriate to prevent risks in the Companyâ&#x20AC;&#x2122;s operation.

The Audit Committee has performed its assigned duties with care and at its fullest ability for the benefit of the Company, the shareholders and stakeholders.

Miss Sophavadee Uttamobol Chairperson of Audit Committee 3 March 2006

Bumrungrad Hospital Public Company Limited

Annual Report 2005

Report of the Accountability of the Board of Directors to the Companyâ&#x20AC;&#x2122;s Financial Reports The board of directors is responsible for the consolidated financial statements of the Company and its subsidiaries and information as appears in the annual report. The financial statements have been prepared in accordance with the generally accepted accounting principles, using appropriate and consistent accounting policies.The financial statements have been prepared with caution and have been evaluated for appropriateness of the overall presentation of the financial statement.There was sufficient information disclosure in the notes to the financial statements. The board of directors has set up an efficient and effective internal control system to ensure that all accounting transactions have been recorded correctly and comprehensively, and that there has been a record-keeping system of assets to protect the Company from any material fraud or damage. The board of directors has the opinion that the overall internal control system of the Company was at a satisfactory level, which resulted in confidence in the reliability of the financial statements of the Company and its subsidiaries as at 31 December 2005.

Mr. Chai Sophonpanich Chairperson

Bumrungrad Hospital Public Company Limited

Mrs. Linda Lisahapanya Managing Director

Annual Report 2005

Report of Independent Auditor To The Board of Directors and Shareholders of Bumrungrad Hospital Public Company Limited

I have audited the consolidated balance sheets of Bumrungrad Hospital Public Company Limited and subsidiaries as at 31 December 2005 and 2004, and the related consolidated statements of earnings, changes in shareholdersâ&#x20AC;&#x2122;equity, and cash flows for the years then ended, and the separate financial statements of Bumrungrad Hospital Public Company Limited for the same periods. These financial statements are the responsibility of the management of the Company and subsidiaries as to their correctness and the completeness of the presentation. My responsibility is to express an opinion on these financial statements based on my audits. I conducted my audits in accordance with generally accepted auditing standards. Those standards require that I plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. I believe that my audits provide a reasonable basis for my opinion. In my opinion, the financial statements referred to above present fairly, in all material respects, the financial position of Bumrungrad Hospital Public Company Limited and subsidiaries and of Bumrungrad Hospital Public Company Limited as at 31 December 2005 and 2004, and the results of their operations and cash flows for the years then ended, in accordance with generally accepted accounting principles.

Sumalee Reewarabandith Certified Public Accountant (Thailand) No. 3970 Ernst & Young Office Limited Bangkok: 28 February 2006

Bumrungrad Hospital Public Company Limited

Annual Report 2005

BUMRUNGRAD HOSPITAL PUBLIC COMPANY LIMITED AND SUBSIDIARIES BALANCE SHEETS AS AT 31 DECEMBER 2005 AND 2004 (Unit: Baht) CONSOLIDATED Note

2005

2004

THE COMPANY ONLY 2005

2004

ASSETS CURRENT ASSETS Cash and cash equivalents

523,506,119

652,881,941

362,385,685

516,300,167

20,000,000

470,000,000

20,000,000

339,475,021

234,958,035

314,651,484

233,885,989

10,014,019

5,533,291

9,523,442

5,436,879

1,383,764

430,028

21,039,663

25,172,581

149,895,896

104,451,057

147,181,909

102,027,734

49,969,718

30,277,597

26,073,426

29,378,850

Current investments - fixed deposits at financial institutions Trade accounts receivable - net

5, 6

Advances to employees and directors

Short-term loans and interest receivable related parties Inventories Prepaid expenses Other current assets

9,597,054

5,208,217

1,245,248

765,330

TOTAL CURRENT ASSETS

1,103,841,591

1,503,740,166

902,100,857

912,967,530

229,883,845

229,827,772

221,250,972

221,250,880

Investments accounted for under equity method

481,415,370

209,354

1,492,256,552

885,171,148

Other long-term investments - net

2,047,213

22,603,851

25,022,369

NON-CURRENT ASSETS Pledged fixed deposits at financial institutions

Long-term loans and interest receivable related parties

Property, plant and equipment - net

3,269,654,875

2,801,618,198

2,153,355,063

1,618,024,805

Intangible assets - net

624,219,061

476,127,798

692,026,413

661,016,711

16,456,303

7,515,561

19,456,303

7,515,561

TOTAL NON-CURRENT ASSETS

Other non-current assets

4,623,676,667

3,517,345,896

4,602,996,367

3,420,048,687

TOTAL ASSETS

5,727,518,258

5,021,086,062

5,505,097,224

4,333,016,217

The accompanying notes are an integral part of the financial statements.

Bumrungrad Hospital Public Company Limited

Annual Report 2005

BUMRUNGRAD HOSPITAL PUBLIC COMPANY LIMITED AND SUBSIDIARIES BALANCE SHEETS (Continued) AS AT 31 DECEMBER 2005 AND 2004 (Unit: Baht) CONSOLIDATED 2004

THE COMPANY ONLY

Note

2005

2004

484,362,198

413,412,878

482,523,293

412,139,998

328,521,802

1,704,315,348

1,470,826,509

213,240,714

167,001,668

213,049,372

166,377,045

LIABILITIES AND SHAREHOLDERS' EQUITY CURRENT LIABILITIES Trae accounts payable Current portion of long-term loan Short-term loans and interest payable a related party Accrued physician's fee Interest payable

585,039

Interest payable - convertible bonds treated as equity securities

6,232,877

Corporate income tax payable

205,622,400

60,893,372

204,543,949

Accrued expenses

203,357,059

136,153,589

171,015,278

134,068,672

47,862,449

67,173,381

40,064,828

Accounts payable - others

71,126,079

Unearned income

34,131,272

Other current liabilities

33,578,559

21,316,501

32,445,898

19,994,446

1,580,757,999

1,181,395,136

2,881,299,396

2,249,704,375

1,450,971,293

1,779,493,095

TOTAL CURRENT LIABILITIES NON-CURRENT LIABILITIES Long-term loan Provision for loss in excess of cost of investments in subsidiaries

8,561,836

23,114,011

TOTAL NON-CURRENT LIABILITIES

1,450,971,293

1,779,493,095

8,561,836

23,114,011

TOTAL LIABILITIES

3,031,729,292

2,960,888,231

2,889,861,232

2,272,818,386

The accompanying notes are an integral part of the financial statements.

Bumrungrad Hospital Public Company Limited

Annual Report 2005

BUMRUNGRAD HOSPITAL PUBLIC COMPANY LIMITED AND SUBSIDIARIES BALANCE SHEETS (Continued) AS AT 31 DECEMBER 2005 AND 2004 (Unit: Baht) CONSOLIDATED Note

2005

2004

THE COMPANY ONLY 2005

2004

SHAREHOLDERS' EQUITY Share capital

Registered 920,341,835 ordinary shares of Baht 1 each (2004: 920,009,835 ordinary shares of Baht 1 each)

920,341,835

920,009,835

920,341,835

920,009,835

2,360,850

2,692,850

2,360,850

2,692,850

727,691,372

727,359,372

727,691,372

727,359,372

2,360,850 preference shares of Baht 1 each 2004: 2,692,850 preference shares of Baht 1 each) Issued and paid-up 727,691,372 ordinary shares of Baht 1 each (2004: 727,359,372 ordinary shares of Baht 1 each) 2,360,850 preference shares of Baht 1 each (2004: 2,692,850 preference shares of Baht 1 each) Premium on ordinary shares Translation adjustment Convertible bonds treated as equity securities

2,360,850

2,692,850

2,360,850

2,692,850

285,568,300

30,828,437

550,000,000

(192,661,558)

92,275,000

46,500,000

92,275,000

46,500,000

1,119,173,591

640,738,867

1,119,173,591

640,738,867

Excess of investment over book value of a susidiary Retained earnings Appropriated - statutory reserve Unappropriated TOTAL EQUITY ATTRIBUTABLE TO COMPANY'S SHAREHOLDERS

2,615,235,992 2,060,197,831

MINORITY INTEREST - Equity attributable to minority shareholders of subsidiaries

80,552,974

TOTAL SHAREHOLDERS' EQUITY

2,695,788,966 2,060,197,831

2,615,235,992 2,060,197,831

TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY

5,727,518,258 5,021,086,062

5,505,097,224 4,333,016,217

The accompanying notes are an integral part of the financial statements.

100

Bumrungrad Hospital Public Company Limited

Annual Report 2005

BUMRUNGRAD HOSPITAL PUBLIC COMPANY LIMITED AND SUBSIDIARIES STATEMENTS OF EARNINGS FOR THE YEARS ENDED 31 DECEMBER 2005 AND 2004 (Unit: Baht) CONSOLIDATED Note

THE COMPANY ONLY

2005

2004

2005

2004

6,646,518,382

5,686,055,350

6,595,730,218

2,482,255,106

89,087,699

53,074,334

114,204,008

85,599,024

REVENUES Revenues from hospital operations Rental income

Non-competition fee income

Interest income

8,414,581 25,216,037

16,099,062

24,467,416

6,718,329

34,378,394

28,636,062

36,903,233

57,489,213

29,804,599

328,668,699

Gain on exchange rate Other income

25,434,212

8,402,714

25,500,000 15,524,216

Share of profit from investments accounted for under equity method

3,160,025

TOTAL REVENUES

6,806,775,118

5,809,299,020

6,809,512,188

3,001,754,587

EXPENSES Cost of hospital operations

4,145,590,150

3,665,606,435

4,127,593,520

1,591,582,497

10, 11

291,816,213

242,004,565

251,605,807

80,313,675

Administrative expenses

981,990,496

763,153,919

1,002,171,837

409,534,019

Directors' remuneration

4,105,000

4,365,000

4,105,000

4,365,000

Amortisation of goodwill

2.3

Loss on impairment of fixed assets

Depreciation and amortisation

(1,366,162)

11,430,248

9,000,000

11,430,248

9,000,000

37,995,459

10,334,336 2,105,129,527

Share of loss from investments accounted for under equity method TOTAL EXPENSES

5,434,932,107

4,682,763,757

5,434,901,871

1,371,843,011

1,126,535,263

1,374,610,317

896,625,060

(106,867,549)

(118,886,083)

(101,549,396)

(26,056,027)

(217,907,995)

(128,636,071)

(220,321,642)

1,047,067,467

879,013,109

1,052,739,279

EARNINGS BEFORE INTEREST EXPENSE AND INCOME TAX INTEREST EXPENSE

CORPORATE INCOME TAX

EARNINGS BEFORE MINORITY INTEREST MINORITY INTEREST EARNINGS FROM ORDINARY OPERATIONS

870,569,033

5,671,812

(8,444,076)

1,052,739,279

870,569,033

1,052,739,279

870,569,033

63,978,082

1,052,739,279

934,547,115

1,052,739,279

934,547,115

EXTRAORDINARY ITEM - Gain from conversion of convertible bonds to ordinary shares NET EARNINGS FOR THE YEAR

The accompanying notes are an integral part of the financial statements.

Bumrungrad Hospital Public Company Limited

101

Annual Report 2005

BUMRUNGRAD HOSPITAL PUBLIC COMPANY LIMITED AND SUBSIDIARIES STATEMENTS OF EARNINGS (Continued) FOR THE YEARS ENDED 31 DECEMBER 2005 AND 2004 (Unit: Baht) CONSOLIDATED Note BASIC EARNINGS PER SHARE

2005

1.45

Extraordinary item

Net earnings Weighted average number of ordinary shares (shares)

1.27 0.09

1.45 -

1.27 0.09

1.36

1.45

1.36

686,003,287

727,630,430

686,003,287

18 1.21 -

Net earnings

1.01 0.07

1.21 -

1.01 0.07

1.21

1.08

1.21

1.08

867,414,859

863,080,160

867,414,859

863,080,160

The accompanying notes are an integral part of the financial statements.

Bumrungrad Hospital Public Company Limited

2004

1.45

Extraordinary item

102

2005

727,630,430

Earnings from ordinary operations

Weighted average number of ordinary shares (shares)

2004

Earnings from ordinary operations

DILUTED EARNINGS PER SHARE

THE COMPANY ONLY

equity securities

Bumrungrad Hospital Public Company Limited

727,691,372

The accompanying notes are an integral part of the financial statements.

Balance - end of year 2005

Minority interest for the year 2005

Dividend paid

332,000

727,359,372

Net earnings for the year 2005

Transferred to statutory reserve

equity securities

Interest paid for convertible bonds treated as

Translation adjustment

of investment in a subsidiary

Investment of minority interest as at purchase date

Preference shares converted to ordinary shares

Balance - end of year 2004

from minority

Purchase of investment in a subsidiary

Minority interest for the year 2004

57,142,857

9,500,000

(205,000)

2,360,850

(332,000)

2,692,850

(660,716,515) (2,692,850)

205,000

Dividend paid

shares 5,590,700

1,321,228,030

285,568,300

184,456,627

101,111,673

Convertible

30,828,437

(41,599,484)

41,599,484

option

550,000,000

equity securities

Translation Conversion bonds treated as

ordinary shares adjustment

Premium on

(192,661,558)

a subsidiary

book value of

investment over

Preference

up share capital

Ordinary

Net earnings for the year 2004

Transferred to statutory reserve

Convertible bonds converted to ordinary shares

Interest paid for convertible bonds treated as

Ordinary shares issued during the year

to deduct deficit

Reduction the par value of the shares

Preference shares converted to ordinary shares

Balance - beginning of year 2004

Note

Excess of

Issued and paid-

CONSOLIDATED

FOR THE YEARS ENDED 31 DECEMBER 2005 AND 2004

STATEMENTS OF CHANGES IN SHAREHOLDERSâ&#x20AC;&#x2DC; EQUITY

BUMRUNGRAD HOSPITAL PUBLIC COMPANY LIMITED AND SUBSIDIARIES

Retained earnings

92,275,000

45,775,000

46,500,000

statutory reserve

interest

Minority Total

8,444,076

(219,015,667)

934,547,115

(12,671,233)

200,000,000

110,611,673

(5,671,812)

7,901,275

78,323,511

(5,671,812)

(511,029,555)

1,052,739,279

(17,500,000)

38,729,712

78,323,511

2,060,197,831

(28,561,788) (221,223,346)

8,444,076

1,119,173,591 80,552,974 2,695,788,966

(511,029,555)

1,052,739,279

(45,775,000)

(17,500,000)

640,738,867

(219,015,667)

934,547,115

(46,500,000)

(12,671,233)

663,409,365

(679,030,713) 20,117,712 1,259,505,213

(deficit)

Appropriated- Unappropriated

(Unit: Baht)

Annual Report 2005

103

104

Bumrungrad Hospital Public Company Limited

The accompanying notes are an integral part of the financial statements.

727,691,372

Balance - end of year 2005

332,000

727,359,372

Dividend paid

Net earnings for the year 2005

Transferred to statutory reserve

equity securities

Interest paid for convertible bonds treated as

Translation adjustment

Preference shares converted to ordinary shares

Balance - end of year 2004

Purchase of investment in a subsidiary from minority

Dividend paid

57,142,857

9,500,000

(660,716,515)

205,000

1,321,228,030

2,360,850

(332,000)

2,692,850

(2,692,850)

(205,000)

5,590,700

285,568,300

184,456,627

101,111,673

ordinary

Premium on

30,828,437

adjustment

Translation

(41,599,484)

41,599,484

option

Conversion

Convertible

550,000,000

equity securities

(192,661,558)

a subsidiary

bonds treated as book value of

investment over

Preference

up share capital Ordinary

Net earnings for the year 2004

Transferred to statutory reserve

equity securities

Interest paid for convertible bonds treated as

Convertible bonds converted to ordinary shares

Ordinary shares issued during the year

deduct deficit

Reduction the par value of the shares to

Preference shares converted to ordinary shares

Balance - beginning of year 2004

Note

Excess of

Issued and paid-

THE COMPANY ONLY

BUMRUNGRAD HOSPITAL PUBLIC COMPANY LIMITED AND SUBSIDIARIES STATEMENTS OF CHANGES IN SHAREHOLDERSâ&#x20AC;&#x2122; EQUITY FOR THE YEARS ENDED 31 DECEMBER 2005 AND 2004

92,275,000

45,775,000

46,500,000

statutory reserve

Total

(192,661,558)

(219,015,667)

934,547,115

(12,671,233)

200,000,000

110,611,673

(17,500,000)

30,828,437

(511,029,555) 1,119,173,591 2,615,235,992

(511,029,555)

1,052,739,279 1,052,739,279

(45,775,000)

(17,500,000)

640,738,867 2,060,197,831

(219,015,667)

934,547,115

(46,500,000)

(12,671,233)

663,409,365

(679,030,713) 1,239,387,501

(deficit)

Unappropriated

Retained earnings Appropriated-

(Unit: Baht)

Annual Report 2005

BUMRUNGRAD HOSPITAL PUBLIC COMPANY LIMITED AND SUBSIDIARIES STATEMENTS OF CASH FLOWS FOR THE YEARS ENDED 31 DECEMBER 2005 AND 2004 (Unit: Baht) CONSOLIDATED 2005 Cash flows from (used in) operating activities Net earnings Adjustments to reconcile net earnings to net cash provided by (paid from) operating activities: Depreciation and amortisation Loss on impairment of fixed assets Bad debts and allowance for doubtful accounts Amortisation of goodwill Share of loss (profit) from investments accounted for under equity method Earnings attributed to minority interest for the year Loss on disposal of fixed assets

2004

THE COMPANY ONLY 2005

2004

1,052,739,279

934,547,115

1,052,739,279

934,547,115

291,816,213 11,430,248 14,264,748 -

242,005,565 9,000,000 25,401,693 (1,366,162)

251,605,807 11,430,248 12,776,194 -

80,313,675 9,000,000 20,629,906 -

(3,160,025) (5,671,812) 2,694,621 1,364,113,272

8,444,076 12,634,832 1,230,667,119

8,190,860 3,073,072 1,339,815,460

(318,334,363) 75,989 726,232,322

Decrease (increase) in operating assets Trade accounts receivable Inventories Other current assets

(118,781,734) (45,444,839) (24,080,958)

(27,367,348) (10,937,761) (24,080,633)

(93,541,690) (45,154,175) 2,825,506

(233,476,034) (102,027,734) (29,108,734)

Increase (decrease) in operating liabilities Trade accounts payable Accrued physicians' fee Interest payable Corporate income tax payable Accrued expenses Accounts payable - others Unearned income Other current liabilities Net cash from operating activities

8,523,531 46,239,046 585,039 144,729,028 67,203,470 23,263,630 34,131,272 12,262,058 1,512,742,815

(29,705,824) 23,109,224 60,893,372 (1,400,477) 2,359,624 15,337,486 1,238,074,782

7,957,506 46,672,327 204,543,949 36,946,606 27,108,553 12,451,452 1,539,625,494

366,589,082 166,377,045 127,974,511 785,282 18,668,832 1,042,014,572

The accompanying notes are an integral part of the financial statements.

Bumrungrad Hospital Public Company Limited

105

Annual Report 2005

BUMRUNGRAD HOSPITAL PUBLIC COMPANY LIMITED AND SUBSIDIARIES STATEMENTS OF CASH FLOWS (Continued) FOR THE YEARS ENDED 31 DECEMBER 2005 AND 2004 (Unit: Baht) CONSOLIDATED Note

2005

2004

THE COMPANY ONLY 2005

2004

Cash flows from (used in) investing activities Decrease (increase) in deposits at financial institutions with maturity of more than 3 months and those pledged Decrease (increase) in advances to employees and directors

399,943,927

(390,029,286)

(92)

(219,944,991)

(4,480,728)

4,271,126

(4,086,563)

(5,357,699)

(135,412,365)

4,132,918

(250,334,202)

7,791,506

2,418,518

6,285,039

(221,223,346)

(599,000,000)

(221,223,346)

Decrease (increase) in short-term loans and interest receivable related parties

(953,736)

Decrease in long-term loans and interest receivable - related parties

Purchase of investments in a subsidiary and associated companies

(385,002,855)

Purchase of other investment

Dividend received

(347,213) -

(347,213)

239,738,300

Increase in plant and equipment

(653,109,053)

(508,207,993)

(665,176,119)

(1,140,670,600)

Increase in other non-current assets

(215,474,922)

(25,072,229)

(116,787,922)

(28,990,053)

Net cash used in investing activities

(859,077,367)

(1,268,229,800) (1,378,499,260)

(1,620,844,765)

Cash flows from (used in) financing activities Increase in short-term loans and interest payable a related party

Decrease in long-term loan

(328,521,802)

Cash received from issued ordinary shares Dividend paid

(82,130,450)

233,488,839 -

1,214,280,376 -

110,611,673

(511,029,555)

(219,015,667)

(511,029,555)

(219,015,667)

Decrease in liabilities under debt restructuring agreement from interest payment

(8,043,836)

(17,500,000)

(10,000,000)

(17,500,000)

(10,000,000)

(857,051,357)

(208,578,280)

(295,040,716)

1,087,832,546

(63,978,082)

(857,051,357)

(272,556,362)

(295,040,716)

1,023,854,464

(203,385,909)

(302,711,380)

(133,914,482)

445,024,271

Interest paid for convertible bonds treated as equity securities Net cash from (used in) financing activities before extraordinary item Extraordinary item - gain from conversion of convertible bonds to ordinary shares Net cash from (used in) financing activities Net increase (decrease) in cash and cash equivalents Translation adjustment

24,010,087

Cash and cash equivalents at beginning of year Cash and cash equivalents at end of year

Bumrungrad Hospital Public Company Limited

722,881,941

1,025,594,321

516,300,167

71,275,896

543,506,119

722,882,941

382,385,685

516,300,167

The accompanying notes are an integral part of the financial statements

106

(63,978,082)

Annual Report 2005

BUMRUNGRAD HOSPITAL PUBLIC COMPANY LIMITED AND SUBSIDIARIES STATEMENTS OF CASH FLOWS (Continued) FOR THE YEARS ENDED 31 DECEMBER 2005 AND 2004 (Unit: Baht) CONSOLIDATED Note

THE COMPANY ONLY

2005

2004

2005

2004

106,270,888

126,959,087

106,930,038

28,719,220

73,178,967

78,214,628

15,777,693

10,471,929

Supplemental cash flows information Cash paid during the year for: Interest expense Corporate income tax Non-cash transaction: Convertible bonds converted to ordinary shares

200,000,000

Asset acquisition from off-set debts

390,900,014

Net assets from transfer of business not yet paid

772,236,429

The accompanying notes are an integral part of the financial statements.

Bumrungrad Hospital Public Company Limited

107

Annual Report 2005

BUMRUNGRAD HOSPITAL PUBLIC COMPANY LIMITED AND SUBSIDIARIES NOTES TO FINANCIAL STATEMENTS FOR THE YEARS ENDED 31 DECEMBER 2005 AND 2004 1. GENERAL INFORMATION Bumrungrad Hospital Public Company Limited is registered as a public limited company under Thai laws and operates its business in Thailand. Its principal activities are hospital business, investment in other companies and rental of properties service. On 8 June 2004, the meeting of the Company’s Board of Directors passed a resolution approving the relocation of the Company’s office from 210 Soi 1 (Soi Ruen Rudee) Sukhumvit Road, Klongtoey Nua Sub District, Wattana District, Bangkok to 33 Sukhumvit Soi 3 (Nana Nua) Sukhumvit Road, Klongtoey Nua Sub District, Wattana District, Bangkok. The Company registered this relocation with the Ministry of Commerce and the Revenue Department on 1 July 2004 and 11 June 2004, respectively. On 15 June 2004, the extraordinary general meeting of the Company’s shareholders passed a resolution approving the purchase of the hospital business from a subsidiary, Bumrungrad Medical Center Ltd., and approving the Board of Directors to consider the remuneration. The Company acquired the movable assets, relevant licenses and permits, rights under various contracts and all employees involved in the hospital business. The purchase of the business was completed and relevant transactions were recorded. Total remuneration on purchase was Baht 772.2 million. In addition, the Company leases the hospital building from Bumrungrad Medical Center Ltd., for use in carrying on the hospital operations. The meeting of the Company’s Board of Directors No. 2/2548 dated 28 February 2005 has approved an investment of 49% of shares in a new company to be incorporated in Dubai, United Arab Emirates for operating hospital business, with investment value amounting to Baht 388 million. The initial investment is expected to be made in 2006 - 2007. On 16 March 2005, a subsidiary (Bumrungrad International Ltd.) entered into a Memorandum of Understanding with the counterparty. On 21 September 2005, the extraordinary meeting of the Company’s shareholders No. 1/2005 approved the issue and offer of up to Baht 2,500 million of bonds with a period not exceeding 10 years from the issue date in order to refinancing existing loans, fund the business operations and expansion.The Company’s investment committee or any persons assigned by the investment committee are authorised to determine the issue date and also other information and conditions of the issue and offer of the bonds. On 25 November 2005, the Office of the Securities and Exchange Commission, Thailand allowed the bonds to be generally offered for a period of 1 year.

2. BASIS OF CONSOLIDATION 2.1

The consolidated financial statements included the financial statements for the years ended 31 December 2005 and 2004 of Bumrungrad Hospital Public Company Limited (“the Company”) and the following subsidiaries: -

Subsidiaries

Percentage of total

Percentage own

Type of

assets included

revenues included

by the Company

business

in the consolidated

2005

2004

100.00

2005

2004

2005

2004

Held by the Company Bumrungrad Medical Center Ltd.

Building lease

Bumrungrad International Ltd.

100.00

Holding company

Vitallife Corporation Ltd.

100.00

Health care center

Held by a subsidiary Bumrungrad International Philippines Inc. 100.00

Hospital management 7

Neptune Stroika Holdings, Inc.

40.00

Holding company

100.00

Holding company

100.00

Hospital management

Bumrungrad International Holdings (Hong Kong) Limited Bumrungrad International Management (Hong Kong) Limited

108

Bumrungrad Hospital Public Company Limited

Annual Report 2005

2.2

Significant intercompany balances and transactions, investments in subsidiaries in the Company’s accounts and shareholders’ equity of the subsidiaries are eliminated from the consolidated financial statements.

2.3

The differences between cost of investments and the value ascribed to the equity in subsidiaries at the time of acquisition are shown under the caption of “Goodwill on consolidation” in the consolidated balance sheets and subject to amortisation over the period of 5 years and 10 years.

2.4

In February 2005, a subsidiary (Bumrungrad International Ltd.) invested in Bumrungrad International Philippines Inc. (BIPI, formerly known as “Vista Medical Management, Inc.”), incorporated in Philippines, in which it holds 100% of equity.

2.5

In February 2005, a subsidiary (Bumrungrad International Ltd.) invested in Neptune Stroika Holdings, Inc. (Neptune), incorporated in Philippines, in which it holds 40% of equity. Although the subsidiary holds only a 40% shareholding in Neptune, this company’s financial statements have nevertheless been consolidated since the subsidiary has controlled over its management. In December 2005, a subsidiary (Bumrungrad International Ltd.) invested in Bumrungrad International Holdings (Hong Kong) Limited (BIH (HK)), incorporated in Hong Kong, in which it holds 100% of equity.

2.6

2.7

In December 2005, a subsidiary (Bumrungrad International Ltd.) invested in Bumrungrad International Management (Hong Kong) Limited (BIM (HK)), incorporated in Hong Kong, in which it holds 100% of equity.

2.8

In June 2004, the Company purchased additional investment in Bumrungrad Medical Center Ltd. from former shareholder. As a result, the Company’s shareholding in this subsidiary increased from 97.45% to 100%.

2.9

In November 2004, Bumrungrad International Ltd. increased its share capital and the Company purchased all increased shares. As a result, the Company’s shareholding in this subsidiary increased from 99.94% to 100%.

2.10 The financial statements of subsidiaries incorporated overseas are translated into Thai Baht at the closing exchange rate for assets and liabilities, and at the average exchange rate for revenues and expenses. The resultant difference is shown under the caption of “Translation adjustment” in shareholders’ equity.

3. SIGNIFICANT ACCOUNTING POLICIES The financial statements have been prepared in accordance with accounting standards enunciated under the Accounting Profession Act B.E. 2547. The Company’s and its subsidiaries’ financial statements have been prepared on the basis of historical cost. Significant accounting policies adopted by the Company and subsidiaries are summarised below: 3.1

Revenue and expense recognition Revenues from hospital operations, mainly consisting of medical fees, hospital room sales, and medicine sales, are recognised as income when services have been rendered or medicine delivered. Rental income, consulting and management fee income, interest income and expenses are recognised on an accrual basis.

3.2

Cash and cash equivalents Cash and cash equivalents consist of cash in hand and at financial institutions with an original maturity of three months or less and not subject to restriction.

3.3

Trade accounts receivable and allowance for doubtful accounts Trade accounts receivable are stated at the net realisable value. Allowance for doubtful accounts is provided to cover the estimated losses that may incur in collection.The adequacy of the allowance is reviewed and evaluated in relation to the current status of the receivables. Bad debt will be written off for the accounts considered uncollectible.

3.4

Inventories Inventories are valued at the lower of cost (weighted average basis) and net realisable value.

Bumrungrad Hospital Public Company Limited

109

Annual Report 2005

3.5

Property, plant and equipment/Depreciation Land is stated at cost, plant and equipment are stated at cost less accumulated depreciation. Depreciation of plant and equipment is calculated, by reference to their costs, on a straight-line basis over the following estimated useful lives: Leasehold right Land improvement Buildings and construction Facility systems Medical accessory equipment Hospital equipment Equipment and furniture Vehicles

lease period (30 years) 3 years and 30 years 8 - 30 years 5 - 20 years 5 - 15 years 3 - 15 years 5 - 15 years 5 - 10 years

No depreciation is provided for land and construction in progress and under installation 3.6

Impairment of assets The Company and the subsidiaries review the impairment of assets whenever events indicate that the carrying value of an asset exceeds its recoverable amount. The recoverable value of the assets are arrived at based on the management’s valuation. The Company and the subsidiaries recognise an impairment loss in the earnings statements whenever the carrying value of an asset exceeds its recoverable amount. The Company and the subsidiaries will reverse the impairment loss to other income whenever there is any indication that the impairment loss recognised may no longer exist or may have decreased.

3.7

Amortisation Intangible assets are amortised on a straight-line method over the period of 5 years and 10 years.

3.8

Investments Investments in subsidiaries (in the Company’s financial statements) and an associated company are valued at the equity method, whereby the investments are recorded at cost at the acquisition date and, for each subsequent period, adjusted to incorporate the Company’s proportionate shares of the operating results in the subsidiaries and associated company. Loss in excess of cost of investments in subsidiaries have been shown as non-current liabilities under the caption of “Provision for loss in excess of cost of investments in subsidiaries”. Long-term investments in non-marketable equity securities, which are held as other investments, are valued at cost. The Company recognises loss on impairment of investment (if any) in the earnings statement.

3.9

Foreign currencies Foreign currency transactions during the year are translated into Baht at the rates ruling on the transaction dates. Monetary assets and liabilities in foreign currency outstanding on the balance sheet date are translated into Baht at the rates ruling on the balance sheet date. Exchange gains and losses are included in determining earnings.

3.10 Financial instruments The Company and its subsidiaries have no policy to speculate in or engage in the trading of any derivative financial instruments. Financial instruments carried in the balance sheets include cash and deposits at financial institutions, investments, trade accounts receivable, trade accounts payable, loans and borrowings. The particular recognition methods adopted are disclosed in the individual policy statements associated with each item. 3.11 Use of accounting estimates Preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates for certain accounting transactions, affecting amounts reported in the financial statements and notes related thereto. Subsequent actual results may differ from these estimates.

110

Bumrungrad Hospital Public Company Limited

Annual Report 2005

3.12 Employeesâ&#x20AC;&#x2122; benefits The Company and subsidiaries and their employees have jointly established a provident fund scheme under the Provident Fund Act B.E. 2530. The fund is contributed to by both employees and the Company or subsidiaries at the rate of 5% and 5 - 7% of the employeesâ&#x20AC;&#x2122; basic salaries, respectively. The fund is managed by Finansa Asset Management Limited and will be paid to employees upon termination in accordance with the rules of the provident fund. During the year 2005, the contributions of the Company and subsidiaries to the fund totaled Baht 21.9 million (2004: Baht 17.1 million) which was recorded as expense. 3.13 Corporate income tax Corporate income tax has been calculated on the net earnings, after adding back certain provisions for expenses which are disallowable for tax computation purposes, deducting accumulated tax loss brought forward from previous year (if any) and excluding share of profit and loss from investments accounted for under equity method and dividend received from subsidiaries. 3.14 Earnings per share Basic earnings per share is calculated by dividing net earnings for the year by the weighted average number of ordinary shares in issue during the year. Diluted earnings per share is calculated by dividing net earnings for the year, after adjusting the effect of transactions relating to dilutive potential ordinary shares, by the total sum of the weighted average number of ordinary shares in issue during the year and the weighted average number of ordinary shares to be issued for conversion of all dilutive potential ordinary shares into ordinary shares.

4. PLEDGED FIXED DEPOSITS AT FINANCIAL INSTITUTIONS As at 31 December 2005, deposits at financial institutions of Baht 9.9 million (2004: Baht 9.8 million) have been pledged with banks to secure bank guarantees issued by banks on behalf of the Company and a subsidiary (Bumrungrad Medical Center Ltd.), and Baht 220 million (2004: Baht 220 million) has been pledged to secure long-term loan of that subsidiary as described in Note 12.

5. TRADE ACCOUNTS RECEIVABLE The agings of the trade accounts receivable balances as at 31 December 2005 and 2004 are as

follows: (Unit: Baht)

CONSOLIDATED Outstanding period Current Overdue 1 - 30 days 31 - 60 days 61 - 90 days 91 - 180 days 181 - 365 days More than 365 days Total Less: Allowance for doubtful accounts Net

2005

2004

THE COMPANY ONLY 2005

2004

209,272,336

136,767,440

186,997,648

136,417,029

67,190,268 24,610,224 15,250,749 22,180,489 15,347,076 28,688,726 382,539,868 (43,064,847) 339,475,021

64,123,228 20,727,678 6,726,545 8,740,767 11,208,297 17,035,150 265,329,105 (30,371,070) 234,958,035

65,560,381 24,016,496 14,244,873 22,038,206 14,690,543 28,679,631 356,227,778 (41,576,294) 314,651,484

63,970,698 20,454,501 6,623,260 8,618,016 11,138,405 17,035,150 264,257,059 (30,371,070) 233,885,989

Bumrungrad Hospital Public Company Limited

111

Annual Report 2005

6. RELATED PARTY TRANSACTIONS During the years, the Company had significant business transactions with subsidiaries and related companies, which are related through shareholding or through having certain common shareholders or directors. Such transactions, which have been presented on the terms and basis agreed between the Company and those companies, are summarised below: (Unit: Million Baht) THE COMPANY ONLY

Pricing policy

2005

2004

25.1

40.6

As per contracts a)

Non-competition fee income

25.5

As per contract b)

Interest income

2.4

2.0

10.6

3.3

Transactions with subsidiaries Rental income

MLR less 0.5% p.a. (2004: 11% p.a. and MLR less 0.5% p.a.)

Medical service income

Cost plus margin

Consulting fee income

24.8

As per contract c)

Dividend received

239.7

Baht 2 per share

Other income

9.9

Rental expense

84.0

35.0

As per contract d)

Actual charge

Interest expense

101.5

26.0

MLR less 0.45% p.a.

Net remuneration on purchase of -

772.2

Book value plus margin

Purchase of equipment

hospital business

8.5

Book value plus margin

Sales of equipment

0.7

Book value

Transactions with related companies Medical service income Rental income

12.4

1.0

Cost plus margin

1.3

1.9

As per contract e)

Interest income

12.9

MLR p.a.

Rental expense

20.1

19.6

As per contract f )

Donation expense

11.6

0.6

Purchase of computer software

64.2

415.2

Insurance expense

15.6

0.9

As per contract g) As per insurance policies (Unit: Million Baht)

CONSOLIDATED 2005

2004

1.9

12.4

13.8

Pricing policy

Transactions with subsidiaries (eliminated from consolidated financial statements) Interest income

10% p.a.

Transactions with related companies Medical service income

Cost plus margin

System implementation income

6.8

As per contract h)

Software license fee income

5.7

As per contract i)

1.3

1.9

As per contract e)

23.1

As per contract j)

Rental income Management fee income Interest income

17.5

MLR p.a.

Rental expense

20.1

19.6

As per contract f )

Donation expense

11.6

8.2

7.7

Maintenance fee expense Purchase of computer software Sales of equipment System implementation expense Insurance expense 112

Bumrungrad Hospital Public Company Limited

164.2 7.7

415.2

As g) As per contract g)

As g)

4.1

As per contract h)

15.7

7.4

As per insurance policies

Annual Report 2005

a) A subsidiary (Bumrungrad Medical Center Ltd.) has leased a plot of land, building and nursing dormitory from the Company for its hospital operations. The lease agreements cover a period of 30 years, commencing from the year 1996. The rental fees are Baht 40.1 million per annum, not including the rental fee for B.H. Residence. On 1 August 2004, the subsidiary terminated the lease agreements of building, nursing dormitory and B.H. Residence with the Company, the subsidiary has no obligation to pay such rental fees. Another subsidiary (Vitallife Corporation Ltd.) has leased building spaces from the Company for use in its operations. The lease agreement covers a period of 11 years, commencing from the year 2001, and rental fees are Baht 3 million per annum. On 1 July 2004, the Company and subsidiary made an addendum to lease agreement. The subsidiary has to pay rental fee equal to 5% of gross revenue inclusive of value added tax, but not less than Baht 238,200 per month. b) A subsidiary (Bumrungrad Medical Center Ltd.) entered into a non-competition agreement with the Company, for a period of 30 years commencing from the year 1997. Under this agreement, the subsidiary was obliged to pay a non-competition fee totaling Baht 255 million over nine years. The obligation for 1997 was Baht 51 million, and for each of the next eight years the fee obligation was Baht 25.5 million. In addition, the Company charged interest on the unpaid portion of the fee at a rate of 11% per annum. As a result of the sale of the subsidiary’s hospital business, the subsidiary has no obligation to pay such non-competition fee. c) The Company and Vitallife Corporation Ltd. entered into a management service agreement under which Vitallife Corporation Ltd. had to pay the Company an amount equal to 3.5% of its turnover. In September 2004, both companies agreed to cancel such agreement. The Company and Bumrungrad Medical Center Ltd. entered into a consulting service agreement which Bumrungrad Medical Center Ltd. was obliged to pay Baht 24 million for consulting service rendered from August to December 2004. d) The Company has leased hospital building from Bumrungrad Medical Center Ltd. for use in its hospital business. The lease agreement covers a period of 3 years, commencing from August 2004, and the rental fees are Baht 84 million per annum. e) Global Care Solutions (Thailand) Co., Ltd. has leased building spaces from the Company for use in its operations. The lease agreement covers a period of 3 years, commencing from the year 2001, and shall be extended for a further period of 3 years. The rental fees are Baht 1 million per annum, not including rental fees for room at B.H. Residence. f ) The Company has entered into an agreement to lease land and a building (B.H. Tower) from Bangkok Bank Plc. for a period of 3 years, commencing from August 2000. The rental fee is calculated at the rate of 75% of net income (total revenues minus total expenses) from the sub-lease, with a minimum rental of Baht 8 million per annum. On 11 November 2005, the bank approved renewal of agreement, commencing on 29 August 2005 to 28 August 2006. The rate of rental and other conditions shall be in accordance with the initial agreement. Rental payable as at 31 December 2005, amounting to Baht 3.3 million (2004: Baht 4.3 million), was shown in the balance sheet under the caption of “Accounts payable - others”. g) In December 2004, the Company entered into a license agreement with Global Care Solutions (Thailand) Co., Ltd. to purchase computer software, totaling USD 10.3 million (exclusive of value added tax) which the Company paid in full. In January 2005, the Company entered into a license agreement with Global Care Solutions (Thailand) Co., Ltd. to purchase additional computer software, totaling USD 1.5 million (exclusive of value added tax). The Company paid for such software in the first quarter of 2005. A subsidiary (Bumrungrad International Ltd.) has entered into a license agreement with Global Care Solutions (Thailand) Co., Ltd. in January 2005 to purchase computer software for use in its international hospital management service business. The subsidiary paid a minimum license fee of USD 2.5 million in the second quarter of 2005. In January 2005, a subsidiary (Bumrungrad Medical Center Ltd.) sold its equipment to Global Care Solutions (Thailand) Co., Ltd., amounting to Baht 7.7 million (book value plus margin) and fully received the proceeds. Bumrungrad Medical Center Ltd. was obliged to pay a software maintenance fee to Global Care Solutions (Thailand) Co., Ltd. As at 31 December 2004, the outstanding balance of Baht 7.7 million of the fee was recorded in “Accounts payable - others” in consolidated financial statements and paid during the year 2005.

Bumrungrad Hospital Public Company Limited

113

Annual Report 2005

h) A subsidiary (Bumrungrad International Ltd.) has entered into the provision of services under system implementation agreement with Global Care Solutions (Thailand) Co., Ltd. in April 2005 to provide computer system implementation services to Asian Hospital, Inc. (AHI) for the use in its hospital business. The subsidiary is obliged to pay such fee totaling USD 200,000. During the year 2005, the subsidiary recorded for such fee amounting to USD 103,000. The subsidiary has also entered into computer system implementation agreement with AHI, totaling USD 350,000. During the year 2005, the subsidiary received such fee amounting to USD 175,000. i)

A subsidiary (Bumrungrad International Ltd.) and Asian Hospoital, Inc. (AHI) have entered into a software site license agreement. AHI paid all license fee of 52,676,342 pesos in 2005.The license fee will be recognised as income in accordance with the period as stipulated in the agreement. Unrecognised license fee as at 31 December 2005, amounting to Baht 32.6 million, was shown in the balance sheet under the caption of “Unearned income”.

A subsidiary (Bumrungrad International Philippines Inc. (BIPI) and Asian Hospital, Inc. (AHI) have entered into a management service agreement under which AHI has to pay the subsidiary a percentage of its net revenue and earnings before interest, tax, depreciation and amortisation. The management fee shall be paid in form of cash up to a certain amount, the excess of which will be paid in form of AHI’s shares, up to maximum 10% of total issued and outstanding capital stock of AHI (fully diluted basis).The agreement covered a period of 5 years, expiring in the year 2010, and shall be renewed. Management fee receivable as at 31 December 2005, amounting to Baht 22.8 million, was recorded in “Trade accounts receivable” in consolidated financial statements.

The outstanding balances of the above transactions (except f ), g), i) and j)) were separately presented in the balance sheets as follows: (Unit: Baht) CONSOLIDATED

THE COMPANY ONLY

2005

2004

2005

2004

39,431,842

Short-term loans and interest receivable - related parties Former subsidiary The Bumrungrad Hospital Rayong Co., Ltd. Less: Allowance for doubtful accounts

(39,431,842)

Bumrungrad International Ltd.

5,878

Vitallife Corporation Ltd.

20,744,994

Subsidiary 24,742,553

Associated companies Asian Hospital, Inc. L.S. Cleaning Co., Ltd.

1,094,973

105

150

105

150

138,547

217,648

138,547

217,648

Related companies Global Care Solutions (Thailand) Co., Ltd. The Bumrungrad Hospital Foundation Total

114

Bumrungrad Hospital Public Company Limited

150,139

212,230

150,139

212,230

1,383,764

430,028

21,039,663

25,172,581

Annual Report 2005

(Unit: Baht) CONSOLIDATED 2005

2004

THE COMPANY ONLY 2005

2004

Long-term loans and interest receivable - related parties Subsidiaries Bumrungrad International Ltd.

Vitallife Corporation Ltd.

22,603,851

24,289,265

733,104

Total

22,603,851

25,022,369

Short-term loans and interest payable - a related party Subsidiary Bumrungrad Medical Center Ltd.

1,704,315,348 1,470,826,509

The short-term and long-term loans to Vitallife Corporation Ltd. carry interest at the rate of MLR less 0.5% per annum. No interest has been charged on short-term loans to other related parties. Bumrungrad International Ltd. granted long-term loan to Neptune Stroika Holdings, Inc. of 30 million pesos, carrying interest at the rate of 10% per annum, for a period of 7 years (within the year 2012). The loan has been secured by a pledge of shares in Neptune Stroika Holdings, Inc., which are held by Mr. Auqusto G. Gan. The short-term loans from Bumrungrad Medical Center Ltd. carry interest at the rate of MLR less 0.45% per annum.

Bumrungrad Hospital Public Company Limited

115

Annual Report 2005

Movement of loans to and loans from during the year are summarised below: (Unit: Baht) 31 December

31 December

2004

Increase

Decrease

2005

16,685,753

16,679,875

5,878

23,572,320

29,440,842

32,365,839

20,647,323

1,170,233

1,051,870

2,124,432

97,671

9,779,374

8,684,401

1,094,973

150

605

650

105

Global Care Solutions (Thailand) Co., Ltd.

217,648

10,541,377

10,620,478

138,547

The Bumrungrad Hospital Foundation

212,230

1,937,365

1,999,456

150,139

Short-term loans and interest receivable - related parties Subsidiary Bumrungrad International Ltd. Vitallife Corporation Ltd. Principal Interest receivable Associated companies Asian Hospital, Inc.

L.S. Cleaning Co., Ltd. Related companies

Long-term loans and interest receivable - related parties Subsidiaries Bumrungrad International Ltd. Principal

538,300

Interest receivable

194,804

Vitallife Corporation Ltd. Principal Interest receivable

22,494,000

1,795,265

1,210,054

2,895,468

109,851

1,465,445,867

705,742,675

466,873,194

1,704,315,348

5,380,642

101,641,785

107,022,427

Short-term loans and interest payable - a related party Subsidiary Bumrungrad Medical Center Ltd. Principal Interest receivable

7. INVENTORIES (Unit: Baht) CONSOLIDATED 2005

THE COMPANY ONLY

2004

2005

2004

Medicine

90,825,694

72,896,227

88,111,707

70,472,904

Medical supplies

25,784,871

19,874,000

25,784,871

19,874,000

Other supplies

33,285,331

11,680,830

33,285,331

11,680,830

149,895,896

104,451,057

147,181,909

102,027,734

Total

116

Bumrungrad Hospital Public Company Limited

Annual Report 2005

8. INVESTMENTS ACCOUNTED FOR UNDER EQUITY METHOD/PROVISION FOR LOSS IN EXCESS OF COST OF INVESTMENTS IN SUBSIDIARIES Investments accounted for under equity method comprise of investments in ordinary shares of the following companies: CONSOLIDATED (Unit: Baht) Investment Percentage of Paid-up capital Companies

2005

shareholding

2004

2005

2004

25.00

35.19

Cost method 2005

Equity method

2004

2005

Dividend

2004

2005

2004

Associated company L.S. Cleaning Co., Ltd. Asian Hospital, Inc.

1,250,000

1,250,000 -

1,409,179,552 Peso

Total investments

312,500

385,759,564

386,072,064

312,500

209,354

481,206,016

481,415,370

209,354

THE COMPABY ONLY (Unit: Baht) Investment Percentage of Paid-up capital Companies

2005

2004

shareholding 2005

2004

Cost method 2005

Equity method

2004

2005

Dividend

2004

2005

2004

1,077,599,756

239,738,300

Subsidiaries Bumrungrad Medical Center Ltd.

958,953,608

100.00 100.00 1,691,902,972

1,691,902,972 1,092,852,182

Bumrungrad International Ltd. 600,000,000

1,000,000

100.00 100.00

599,999,400

999,400

591,856,574

23,596

Vitallife Corporation Ltd.

31,500,000

100.00 100.00

25,610,000

(8,561,836)

(23,114,011)

1,718,512,372 1,676,146,920

1,054,509,341

31,500,000

Total investments in subsidiaries

2,317,512,372

Associated company L.S. Cleaning Co., Ltd.

1,250,000

25.00

312,500

209,354

312,500

209,354

1,718,824,872 1,676,356,274

1,054,718,695

Total investment in associated company Total investments

2,317,824,872

(Unit: Baht) THE COMPANY ONLY 2005

2004

Net investments Investments accounted for under equity method Excess of investment over book value of a subsidiary

1,492,256,552

885,171,148

192,661,558

Provision for loss in excess of cost of investment in subsidiary Total

(8,561,836) 1,676,356,274

(23,114,011) 1,054,718,695

Bumrungrad Hospital Public Company Limited

117

Annual Report 2005

On 16 June 2004, the Company purchased 3,060,623 ordinary shares of Bumrungrad Medical Center Ltd. from International Finance Corporation at the price of Baht 72.28050 per share (market price, based on opinion of the Company’s financial advisor), totaling Baht 221,223,346. As a result, the Company’s shareholding in this subsidiary increased from 97.45% to 100%. The difference between cost of investment and the value ascribed to the equity in the subsidiary at the time of acquisition amounting to Baht 192.7 million is presented in shareholders’ equity in the consolidated and the separate financial statements. On 18 August 2004, the Board of Directors of Bumrungrad Medical Center Ltd. approved the payment of an interim dividend of Baht 2 per share to the shareholders from that company’s earnings from 1 January 2004 to 30 June 2004. The Company received dividend totaling Baht 239.7 million. In November 2004, Bumrungrad International Ltd. increased its share capital by issuing 5,990,000 new ordinary shares at a par value of Baht 100 each which caused the increase in subsidiary’s registered capital from Baht 1 million to Baht 600 million. The Company purchased all increased shares therefore the Company’s shareholding in this subsidiary increased from 99.94% to 100%.The Company paid for such share subscription in the first quarter of 2005. On 24 February 2005, a subsidiary (Bumrungrad International Ltd.) invested Baht 131,949,605.69 (Peso 185 million) in Neptune Stroika Holdings, Inc. (Neptune) to acquire 66,667 preferred shares at a par value of 1,000 pesos each (40% ownership) and also invested Baht 59,155,653.07 in Bumrungrad International Philippines Inc. (BIPI) to acquire 7,000,000 shares at a par value of 1 peso each (a 100% holding) and further inject Capital in the form of loans to BIPI amounted to Baht 179,386,827.26 (253,856,573.29 pesos). Neptune and BIPI acquired investments in the ordinary shares of Asian Hospital, Inc. (AHI) for Peso 215 million (190,265,487 shares) and Peso 283 million (423,238,004 shares), respectively, representing respective shareholdings of 13.41% and 29.83%. AHI is incorporated in Philippines and operates the hospital business. The share of the profit/loss of L.S. Cleaning Co., Ltd. has been calculated from the management accounts of that company. The share of the profit/loss of AHI has been calculated from the management accounts which are audited by its auditor.

9. OTHER LONG-TERM INVESTMENTS (Unit: Baht) PERCENTAGE OF COMPANIES

SHAREHOLDING 2005

2004

Chantaburi Country Club Co., Ltd.

0.5

Global Care Solutions S.A.

14.0

Total Less: Provision for impairment loss Net

CONSOLIDATED

THE COMPANY ONLY

2005

2004

2005

2004

4,500,000

347,213

4,847,213

(2,800,000)

2,047,213

The Company estimated provision for loss on impairment of investments by considering the latest financial statements of invested companies.

118

Bumrungrad Hospital Public Company Limited

Transfer

Depreciation for the year

Depreciation â&#x20AC;&#x201C; disposals

31 December 2005

Increase during the year

31 December 2005

290,861,482

31 December 2005

23,311,077

24,414,097

11,569,832

1,103,020

10,466,812

34,880,909

1,401,016,277

1,318,719,249

557,246,549

(356,836)

70,081,480

487,521,905

1,958,262,826

121,824,040

(5,991,383)

36,189,015

1,806,241,154

Bumrungrad Hospital Public Company Limited

(15,031,373)

241,043,269

968,732,746

130,873,745

130,725,141

167,165,714

(307,135)

15,016,801

152,456,048

19,494,228

26,221,167

30,945,859

(1,151,528)

5,813,931

26,283,456

50,440,087

(4,684,536)

2,620,000

52,504,623

564,476,715

304,866,725

564,476,715

(121,824,040)

381,434,030

304,866,725

3,269,654,875

2,801,618,198

20,430,248

11,430,248

9,000,000

1,751,906,521

(8,139,391)

233,373,296

1,526,672,616

5,041,991,644

(32,905,305)

737,606,135

4,337,290,814

Total

233,373,296

191,402,522

185,030,677

334,833,558

(954,160)

47,948,195

287,839,523

298,039,459

(1,555,855)

16,414,125

283,181,189

Vehicles

Construction in progress under installation

2005

572,986,030

439,428,697

20,430,248

11,430,248

9,000,000

601,328,364

(5,343,071)

86,367,386

520,304,049

526,236,080

(5,530,878)

58,896,758

472,870,200

Hospital equipment

Equipment and furniture

(Unit:Baht)

213,967,124

75,232,799

81,350,963

48,816,645

(26,661)

7,042,483

41,800,823

124,049,444 1,194,744,642

(111,280)

1,008,938

123,151,786

Facility systems

Medical accessory equipment

CONSOLIDATED

2004

Depreciation included in the earnings statement for the year

290,861,482

31 December 2004

Net book value

31 December 2004

Provision for impairment of assets

31 December 2004

Accumulated depreciation

290,861,482

Disposals

31 December 2005

290,861,482

Purchase

31 December 2004

Cost

Land

Leasehold right and land Building and improvement construction

10. PROPERTY, PLANT AND EQUIPMENT

Annual Report 2005

119

120

Transfer

Bumrungrad Hospital Public Company Limited

Depreciation for the year

Depreciation â&#x20AC;&#x201C; disposals

31 December 2005

Increase during the year

31 December 2005

290,861,482

31 December 2005

8,710,100

9,169,201

6,853,240

459,101

6,394,139

15,563,340

293,358,601

153,176,108

59,677,436

(143,156)

15,265,924

44,554,668

353,036,037

121,824,040

(1,124,174)

34,605,395

197,730,776

106,318,909

105,506,187

72,035,757

(234,367)

14,432,607

57,837,517

178,354,666

(1,127,255)

16,138,217

163,343,704

19,494,219

26,221,158

8,510,111

(1,151,528)

5,813,931

3,847,708

28,004,330

(4,684,536)

2,620,000

30,068,866

564,476,714

304,866,725

564,476,714

(121,824,040)

381,434,029

304,866,725

2,153,355,063

1,618,024,805

20,430,248

11,430,248

9,000,000

409,394,543

(2,920,885)

177,768,329

234,547,099

2,583,179,854

(12,620,232)

734,228,182

1,861,571,904

Total

177,768,329

188,698,833

178,882,314

111,181,677

(509,499)

46,505,786

65,185,390

299,880,510

(1,650,146)

57,462,952

244,067,704

Vehicles

Construction in progress under installation

2005

599,312,003

461,157,151

20,430,248

11,430,248

9,000,000

134,021,932

(855,674)

88,391,003

46,486,603

753,764,183

(3,922,841)

241,043,270

516,643,754

Hospital equipment

Equipment and furniture

69,624,253

82,124,202

88,184,479

17,114,390

(26,661)

6,899,977

10,241,074

99,238,592

(111,280)

924,319

98,425,553

Facility systems

Medical accessory equipment

2004

Depreciation included in the earnings statement for the year

290,861,482

31 December 2004

Net book value

31 December 2004

Provision for impairment of assets

31 December 2004

Accumulated depreciation

290,861,482

Disposals

31 December 2005

290,861,482

Purchase

31 December 2004

Cost

Land

Leasehold right and land Building and improvement construction

THE COMPANY ONLY

(Unit:Baht)

Annual Report 2005

The Company has mortgaged all of the land with a book value of Baht 290.9 million (Baht 581 million appraisal fair value as of 12 November 2004) with a commercial bank, acting as bondholders’ trustee, as collateral for the convertible bonds of the Company as described in Notes 13 a) and 13 b). The Company and Bumrungrad Medical Center Ltd. have mortgaged their buildings and pledged medical instruments and hospital equipment, with net book value as at 31 December 2005 of Baht 1,285 million (2004: Baht 1,327 million), to secure long-term loan obtained from a local commercial bank as described in Note 12. During the year 2005, the Company recorded provision for impairment of medical instruments, amounting to Baht 11.4 million (2004: Baht 9 million) because there were indications that the carrying value of these assets exceeded their recoverable value. As at 31 December 2005, the gross carrying amounts of fully depreciated equipment of the Company and subsidiaries still in use are Baht 110 million and Baht 2.3 million (2004: Baht 6 million and Baht 4.5 million), respectively.

11. INTANGIBLE ASSETS (Unit: Baht) CONSOLIDATED

THE COMPANY ONLY

2005

2004

2005

2004

Computer software

683,625,752

478,778,572

583,625,752

478,778,572

Less: Accumulated amortisation

(61,065,496)

(2,650,774)

(57,195,496)

(2,650,774)

Computer software – net

622,560,256

476,127,798

526,430,256

476,127,798

business

192,927,561

Less: Accumulated amortisation

(27,331,404)

(8,038,648)

Goodwill on purchase of

Goodwill on purchase of business – net Other intangible asset Less: Accumulated amortisation Other intangible asset – net Total

165,596,157

184,888,913

1,687,000

(28,195)

1,658,805

624,219,061

476,127,798

692,026,413

661,016,711

58,442,917

28,037,441

73,837,478

10,689,422

Amortisation included in the earnings statement for the year

12. LONG-TERM LOAN (Unit: Baht) CONSOLIDATED Bumrungrad Medical Center Ltd. Loan from a local commercial bank Less: Current portion Long-term portion

2005

2004

1,779,493,095 (328,521,802) 1,450,971,293

2,108,014,897 (328,521,802) 1,779,493,095

On 16 September 2002, the subsidiary entered into a loan agreement in the Baht currency with a local commercial bank to obtain a Baht 2,400,000,000 credit facility. Such loan carries interest at 5.5% per annum for the first two years and then at MLR less a certain percentage per annum. Interest is payable on a monthly basis and principal is repayable in 24 quarterly installments, commencing 30 December 2004. To guarantee this loan, the subsidiary has mortgaged its building and pledged medical instruments, hospital equipment and fixed deposits as described in Notes 10 and 4. In July 2004, the Company has entered into the Amendment Agreement and the Amended and Restated Facility Agreement with that bank in order to assume joint responsibility for these liabilities. The loan agreement contains normal covenants pertaining to matters such as the maintenance of certain financial ratios, and restriction on financial indebtedness and the payment of dividends, among others.

Bumrungrad Hospital Public Company Limited

121

Annual Report 2005

13. CONVERTIBLE BONDS Convertible bonds as at 31 December 2005 and 2004 are as follows: a)

Partly secured convertible bonds in an amount of Baht 300 million, with a maturity of 12 years, and a coupon rate of 2.5% for years 1 - 4, 5% for years 5 - 8, and 10% for years 9-12, payable semi-annually. The current conversion price is Baht 4.55 per one ordinary share. The bondholders have the option to convert the bonds into ordinary shares throughout the life of the bonds. The bonds are secured by the mortgage of the Company’s land.

Partly secured convertible bonds in an amount of Baht 250 million (after conversion by the bondholder of Baht 750 million in the year 2003), with a maturity of 12 years, and a coupon rate of 1% per annum, payable semi-annually. The current conversion price is Baht 3.50 per one ordinary share. The bondholders have the option to convert the bonds into ordinary shares throughout the life of the bonds. The bonds are secured by the mortgage of the Company’s land.

On 24 November 2000, an extraordinary meeting of the Company’s shareholders passed approval of the amendment to the terms and conditions governing the rights and obligations of the issuer and the bondholders, which gives the Company the option to either redeem the convertible bonds or to convert the bonds into ordinary shares on the maturity date. According to the Thai Accounting Standard No. 48 “Financial Instruments: Disclosure and Presentation”, because the Company has the option to either redeem the convertible bonds or to convert them into ordinary shares on the maturity date, and delivery of equity securities will not be changed by fair value of such equity securities (since the Company determined a certain conversion price), so the convertible bonds are not covered by the definition of financial liabilities and are to be treated as equity securities. In addition, the Company’s management express their intention to convert these bonds into ordinary shares on the maturity date. Therefore, the whole amount of the convertible bonds are presented as part of shareholders’ equity, and future interest on the bonds will be recorded as a deduction from shareholders’ equity. The Company has reserved 178,571,433 ordinary shares to accommodate the above convertible bonds. Interest expense for the year 2005 of the convertible bonds amounted to Baht 17.5 million (2004: Baht 12.7 million), being recorded as a reduction to “retained earnings”. On 24 August 2004, the bondholder of unsecured convertible bonds without trustee in an amount of Baht 200 million, Bangkok Insurance Public Company Limited, requested to exercise its right to convert all of the bonds, effective on 25 August 2004.The results of such conversion can be summarised as follows: Total convertible bonds sold Previously converted bonds Bonds requested for conversion Outstanding bonds Ordinary shares reserved for bond conversion Previously converted - ordinary shares Requested for conversion - ordinary shares Outstanding ordinary shares reserved for conversion

20 20 75,000,000 57,142,857 17,857,143

Units Units Units Units Shares Shares shares Shares

As a result of the conversion, the Company has no future interest.The Company therefore reversed the balance of liabilities under the debt restructuring agreement, amounting to Baht 63,978,082, and presented such amount as an extraordinary item in the statement of earnings, under the caption of “Gain from conversion of convertible bonds to ordinary shares”. The Company also transferred Baht 41,599,484 from “Conversion option” to “Premium on ordinary shares”.

14. SHARE CAPITAL Preference shareholders have the same right as the ordinary shareholders except that they are entitled to receive an annual dividend at 15% of preference shares capital prior to the dividend paid to the ordinary shareholders. Preference shares can be converted into ordinary shares.

122

Bumrungrad Hospital Public Company Limited

Annual Report 2005

In the first quarter of 2005, 332,000 preference shares (2004: 20,500 shares) were converted into ordinary shares at ratio of one preference share to one ordinary share. The Company registered this conversion with the Ministry of Commerce on 8 March 2005. On 18 December 2003, the extraordinary general meeting of the Company’s shareholders passed a resolution approving the reduction of registered share capital of Baht 922,702,685 by reducing the par value of the shares from Baht 10 to Baht 5, which affect to the decrease in paid-up share capital of Baht 663,409,365. All reduced paid-up share capital will be used to settle against the deficit. The Company registered this change with the Ministry of Commerce on 8 March 2004. On 28 April 2004, the annual general meeting of the Company’s shareholders passed a resolution approving the change of the par value of the shares from Baht 5 to Baht 1 and the amendment of number of registered shares from 184,540,537 shares of Baht 5 each to 922,702,685 shares of Baht 1 each. The Company registered this change with the Ministry of Commerce on 17 May 2004. On 16 June 2004, the Company issued 9,500,000 ordinary shares with par value of Baht 1 to Internation Finance Corporation at the price of Baht 11.643334 per share (the price was based on the average market price of the Company traded on the Stock Exchange of Thailand), totaling Baht 110,611,673. As a result, the Company had increment in paid-up share capital from Baht 663,409,365 to Baht 672,909,365 and premium on ordinary shares in amount of Baht 101,111,673. The Company registered this change with the Ministry of Commerce on 18 June 2004. As a result of the conversion of Baht 200 million convertible bonds on 25 August 2004, the Company’s paid up capital has increased from Baht 672,909,365 to Baht 730,052,222 and its premium on ordinary shares had increased from Baht 101,111,673 to Baht 285,568,300. The Company registered this conversion with the Ministry of Commerce on 26 August 2004 and the Stock Exchange of Thailand (SET) allowed the common shares increased to be listed on the SET.

15. STATUTORY RESERVE Under the Public Company Limited Act B.E. 2535, the Company is required to set aside as a statutory reserve at least 5 percent of its net profit, after deducting accumulated deficit brought forward (if any), until the reserve reaches 10 percent of its registered share capital. The statutory reserve could not use for dividend payment. During the year 2005, the Company allocated Baht 45.8 million (2004: Baht 46.5 million) from its net earnings for the year to statutory reserve.

16. DIRECTORS’ REMUNERATION Directors’ remuneration represents the benefits paid to the Company’s executive directors in accordance with Section 90 of the Public Limited Companies Act, exclusive of salaries and related benefits payable to executive directors.

17. CORPORATE INCOME TAX The Company’s corporate income tax for the year 2005 has been calculated at the rate of 25% of net earnings not exceed Baht 300 million and 30% for the rest. The tax rates applied are in compliance with the provisions of Royal Decree 387 (B.E. 2544) dated 28 August 2001, issued under the Revenue Code, regarding the reduction of income tax rates. Corporate income tax for the years 2005 and 2004 of a subsidiary (Bumrungrad Medical Center Ltd.) has been calculated at the rate of 30% of net tax earnings. No Corporate income tax was payable by the Company for the year 2004 since tax losses brought forward from previous years exceed net earnings for the year.

Bumrungrad Hospital Public Company Limited

123

Annual Report 2005

18. RECONCILIATION OF DILUTED EARNINGS PER SHARE (Unit: Baht) For the years ended 31 December Weighted average Net earnings 2005

number of ordinary shares

2004

2005

2004

Earnings per share 2005

2004

1.45

1.36

1.21

1.08

Basic earnings per share Net earnings

1,052,739,279 934,547,115

727,630,430

686,003,287

Effect of dilutive potential ordinary shares Preference shares 2,360,850 shares (2004: 2,692,850 shares)

2,421,792

2,711,894

Convertible bonds 55 units

137,362,637

174,364,979

867,414,859

863,080,160

Diluted earnings per share Net earnings of ordinary shareholders assuming the conversion of dilutive potential ordinary shares

1,052,739,279 934,547,115

19. DIVIDEND PAID On 17 August 2005, the Company’s Board of Directors approved the payment of an interim dividend of Baht 0.30 per share to the Company’s shareholders from the Company’s earnings from 1 January 2005 to 30 June 2005. This constitutes a total dividend of Baht 219 million On 27 April 2005, the Company’s Annual General Meeting of shareholders approved the payment of a dividend of Baht 0.40 per share to the Company’s shareholders from the Company’s earnings for the year ended 31 December 2004. This constitutes a total dividend of Baht 292 million. The meeting also acknowledged payment of interim dividend of Baht 0.30 per share. On 18 August 2004, the Company’s Board of Directors approved the payment of an interim dividend of Baht 0.30 per share to the Company’s shareholders from the Company’s earnings from 1 January 2004 to 30 June 2004. This constitutes a total dividend of Baht 219 million.

20.STATEMENTS OF CASH FLOWS Cash and cash equivalents as reflected in the statements of cash flows consist of the following: (Unit: Baht)

Cash on hand and at financial institutions Fixed deposits at financial institutions

CONSOLIDATED

THE COMPANY ONLY

31 December

2005

2004

2005

2004

523,506,119

652,881,941

362,385,685

516,300,167

249,883,845

699,827,772

241,250,972

221,250,880

773,389,964

1,352,709,713

603,636,657

737,551,047

(229,883,845)

(629,827,772)

(221,250,972)

(221,250,880)

543,506,119

722,881,941

382,385,685

516,300,167

Less: Amounts with maturities of more than 3 months or those pledged Cash and cash equivalents

124

Bumrungrad Hospital Public Company Limited

Annual Report 2005

21. EMPLOYEES AND RELATED COSTS (Unit: Baht) CONSOLIDATED 2005 Number of employees at end of year Employee costs for the year (Thousand Baht)

2004

THE COMPANY ONLY 2005

2004

2,841

2,762

2,809

2,729

928,897

777,783

916,257

333,575

22. FINANCIAL INSTRUMENTS 22.1 Interest rate risk The interest rate risk is the risk whereby future movement in market interest rates will have an effect to the result of operations and cash flows of the Company and subsidiaries. The exposure to the interest rate risk relates primarily to their deposits at financial institutions, loans to related parties, loans from a related party, long-term loan and convertible bonds. The Company and subsidiaries do not use derivative financial instruments to hedge this risk. The details of long-term loan and convertible bonds were included in Notes 12 and 13, respectively. 22.2 Foreign currency risk As at 31 December 2005, the Company and subsidiaries had assets and liabilities denominated in foreign currencies which are not hedged against exchange rate risk as summarised below. Currencies USD Peso

Assets 32,818 29,380,522

Liabilities 4,601,749

22.3 Credit risk The Company and subsidiaries are exposed to credit risk primarily with respect to trade accounts receivable. However, due to the large number of entities comprising the customer base of the Company and subsidiaries, they do not anticipate material losses from their debt collection. 22.4 Fair value Since the majority of the financial assets are short-term and loans carry interest at rates close to current market rates, the management believes that the fair value of the Companyâ&#x20AC;&#x2122;s financial assets and liabilities does not materially differ from their carrying value.

23. COMMITMENTS As at 31 December 2005, the Company and its subsidiaries have the following outstanding commitments: a) The Company has a commitment of Baht 1.7 million (2004: Baht 1.9 million) to pay fee to a bank which is bondholdersâ&#x20AC;&#x2122; representative. The agreement will be terminated in year 2012. b) The Company has future commitments to pay a total of Baht 79.5 million (2004: Baht 263.6 million) in relation to the construction of a new building and Baht 150.1 million (2004: Baht 71.5 million) in respect of purchase of medical instrument and hospital equipment. c) The Company has a commitment of Baht 91.7 million in respect of land rental for construction of nursing dormitory. The agreement covered a period of 30 years, expiring in the year 2035, and shall be extended for a further period of 20 years. d) The Company has a commitment of Baht 16.6 million (2004: Baht 36.6 million) in respect of the lease of medical instrument under a 5-year agreement expiring in the year 2006.

Bumrungrad Hospital Public Company Limited

125

Annual Report 2005

e) The Company has a commitment of Baht 48 million in respect of the lease of land and building for operating in service apartment. The agreement covered a period of 3 years, expiring in the year 2008, and shall be extended for a further period of 2 years. f ) The Company has a commitment of Baht 10.1 million (2004: Baht 17.4 million) in respect of the lease of building for nursing dormitory and related services. The agreement covered a period of 3 years, expiring in the year 2007, and shall be renewed automatically. g) The Company has a commitment to pay maintenance service fee for medical instrument. Service fee of Baht 2.8 million is payable on a monthly basis. The agreement covered a period of 5 years, expiring in the year 2008, and shall be renewed automatically. h) The Company has a commitment to pay security service fee. Service fee of Baht 0.8 million is payable on a monthly basis. The agreement covered a period of 3 years, expiring in the year 2005, and shall be renewed automatically. i)

The Company has a commitment to pay cleaning service fee of Baht 1.9 million per month.

The Company has a commitment to pay rental and maintenance service fee for cars of Baht 24.9 million. The agreements covered a period of 5 years, expiring in the year 2009.

k) A subsidiary, Bumrungrad International Ltd., has a commitment to pay consulting fee of USD 20,000 per annum. The agreement covered a period of 7 years, expiring in the year 2012.

24. BANK GUARANTEES As at 31 December 2005, there were outstanding bank guarantees of Baht 1.9 million (2004: Baht 1.9 million) issued by a bank on behalf of the Company, and of Baht 8.4 million (2004: Baht 8.4 million) issued on behalf of a subsidiary. All were required in the normal course of business.

25. CONTINGENT LIABILITIES On 4 October 2005, Asian Hospital, Inc. (AHI), an associated company, received a preliminary deficiency tax findings for the year ended 31 December 2002 from the Revenue Department of Philippines. AHI’s management strongly believes that the finding was made without grounds and vigorously challenged it. AHI has therefore not set aside allowance for the assessment in its accounts.

26. FINANCIAL INFORMATION BY SEGMENT The operations of the Company and subsidiaries mainly involve the single industry segment of the hospital business and health care center, and most of them are carried on in the single geographic area in Thailand. As a result, all of the revenues, operating profits and assets as reflected in these financial statements pertain to the aforementioned industry segment and geographic area. In 2005, the Company and a subsidiary had income of Baht 43.0 million (2004: Baht 17.1 million) from hospital business in foreign countries.

27. PRESENTATION The presentation of the financial statements has been made in compliance with the stipulations of the Notification of the Department of Business Development dated 14 September 2001 as empowered under the Accounting Act B.E. 2543. Certain amounts in the financial statements for the year ended 31 December 2004 have been reclassified to conform to the current year’s classification, with no effect on previously reported net earnings or shareholders’ equity.

126

Bumrungrad Hospital Public Company Limited

Annual Report 2005

28. SUBSEQUENT EVENT On 28 February 2006, the Company’s Board of Directors approved the payment of Baht 0.45 per share to the Company’s shareholders from the Company’s earnings for the year ended 31 December 2005. This constitutes a total dividend of Baht 329 million. The meeting also acknowledged payment of interim dividend of Baht 0.30 per share according to the Company’s Board of Directors dated 17 August 2005. Dividend payment for the year 2005 total to Baht 0.75 per share.

29. APPROVAL OF FINANCIAL STATEMENTS These financial statements were authorised for issue by Board of Directors on 28 February 2006.

Bumrungrad Hospital Public Company Limited

127

Other Important Information

Annual Report 2005

Other Important Information 1. General Information 1.1

Company Information Name : Type of Business : Head Office Address : Registration No. : Home page : E-mail address : Telephone : Fax : Registered Capital :

Issued and Paid up Capital:

1.2

Bumrungrad Hospital Public Company Limited (â&#x20AC;&#x153;the Companyâ&#x20AC;?) Private hospital 33 Sukhumvit Soi 3 (Nana Nua) Sukhumvit Road Klong Toey Nua, Wattana, Bangkok 10110 Public Company Limited 173 http://www.bumrungrad.com info@bumrungrad.com 0 2667 1000 0 2667 2525 Bt 922,702,685 Divided into Ordinary shares of 920,341,835 shares, par value at Bt 1 per share Preferred shares of 2,360,850 shares, par value at Bt 1 per share Bt 730,052,222 Divided into Ordinary shares of 727,691,372 shares, par value at Bt 1 per share Preferred shares of 2,360,850 shares, par value at Bt 1 per share

Entities in which the Company has more than 10% shareholding Company

Type of Business

Address

Telephone

Fax

Issued and paid up ordinary shares

Shareholding (%)

1. Bumrungrad Medical Center Limited

Property Lease

33/3 Sukhumvit 3 (Nana Nua) Sukhumvit Road, Klong Toey Nua, Wattana, Bangkok 10110

0 2667 1000

0 2667 2525

119,869,201 shares

100%

2. Vitallife Corporation Limited

Wellness Center

210 Sukhumvit Soi 1 Sukhumvit Road North Klong Toey, Wattana, Bangkok 10110

0 2667 2340

0 2667 2341

315,000 shares

100%

International

33 Sukhumvit Soi 3

0 2667 1000

0 2667 2525

6,000,000

100%

Investment

(Nana Nua) Sukhumvit Road, Klong Toey Nua, Wattana, Bangkok 10110

3. Bumrungrad International Limited

4. L.S. Cleaning Company Limited

Laundry

68 Sukhumvit Soi 1

Services; currently a dormant

Sukhumvit Road Klong Toey Nua, Wattana, Bangkok 10110

0 2667 1000

0 2667 2525

12,500

25%

company 5. Global Care Solutions S.A.

Healthcare

9 Rue Schiller,

software development

L-2519 Luxembourg

41 (76) 565 1533

41 (44) 496 6319

31,426

14%

Bumrungrad Hospital Public Company Limited

131

Annual Report 2005

1.3 Reference Persons Company 1. Auditor

Ernst & Young Office Limited

Address 33rd Floor, Lake Rajada Office Complex, 193/136-137 New Rajadapisek Road

Telephone

Fax

0 2264 0777

0 2264 0789-90

0 2255 2552

0 2653 1133

0 2229 2800

0 2359 1259

Bangkok 10110 2. Legal Consultant

Thai Consultant Limited

63 Soi 8 (Soi Preeda), Sukhumvit Road, Bangkok 10110

3. Share Registrar

Thailand Securities Depository Co., Ltd.

62 The Stock Exchange of Thailand Building, 4th and 6th-7th Floor, Rachadapisek Road, Bangkok 10110

4. Convertible Bonds Registrar

Bumrungrad Hospital Public Company Limited

33 Sukhumvit Soi 3 (Nana Nua) Sukhumvit Road, Klong Toey Nua, Wattana, Bangkok 10110

0 2667 2025

0 2667 2031

5. Bondholders’ Representative

Thai Military Bank Public Company Limited

3000 Paholyothin Road, Jatujak, Bangkok 10900

0 2299 1111, 0 2617 9111

02 299 1784

2. Financial Highlights 2.1 Information from Financial Statements (Page 93) 2.2 Financial Ratios (Page 93) 3. Company Profile 3.1 Executive Summary Bumrungrad Hospital Public Company Limited (“the Company”) operates private hospital business in Bangkok with 554 beds and is one of the leaders in healthcare provider in Thailand and in the Southeast Asia region. The Company provides complete healthcare services including both outpatient and inpatient. The Company has always emphasized the importance of quality healthcare and experienced physicians. The Company is the first hospital in Asia and the only hospital in Thailand to receive the US standard accreditation from Joint Commission International Accreditation (JCIA).

132

Bumrungrad Hospital Public Company Limited

Annual Report 2005

In addition, the Company is a holding company, holding 100% in Bumrungrad Medical Center Limited, Vitallife Corporation Limited and Bumrungrad International Limited, holding 25% in LS Cleaning Company Limited and 14% in Global Care Solutions S.A. The corporate structure of the Company is as follows:

Bumrungrad Hospital Public Company Limited

- Operates private hospital in Bangkok - A holding company

100%

25%

14%

Bumrungrad Medical

Bumrungrad

Vitalife Corporation

LS Cleaning

Global Care Solutions

Center Limited

International Limited

Limited

Company Limited

S.A.

- Owner of main

- International

- Comprehensive

- Dormant Company

- Healthcare software

hospital building and

investment and

wellness center

development

lesser of the building

business

specializing in

company

to the Company

development

preventive care

Details of subsidiaries, affiliates and related companies are as follows: 1. Bumrungrad Medical Center Limited (“BMC”) is the owner of the existing hospital building, which is leased to the Company. 2. Bumrungrad International Limited (“BIL”) is the Company’s international investment arm and is also the representative to enter into consulting and management contracts with foreign hospitals. BIL has entered into consulting and management contracts with hospitals in Myanmar and Bangladesh, both of which contracts have been completed in 2005 and 2006 respectively. In addition, in 2005, BIL invested 35% in Asian Hospital, Inc. in the Philippines and has also entered into consulting and management contract with the hospital. In 2005, BIL entered into a memorandum of understanding to build a hospital in Dubai with Istithmar of the United Arab Emirates, and will be responsible for the management of the hospital.The hospital in Dubai is expected to be operational in the year 2008. 3. Vitallife Corporation Limited is the pioneer wellness center which provides preventive care services targeted at health-conscious individuals. The Vitallife program brings together experienced medical professionals and world-class technologies to provide customers with a customized exercise programs and nutrition plans, and food and vitamin supplements for healthy living. 4. LS Cleaning Co., Ltd. (“LS”) is currently a dormant company. 5. Global Care Solutions S.A. (“GCS”) is a healthcare software development company headquartered in Luxemburg.

Bumrungrad Hospital Public Company Limited

133

Annual Report 2005

3.2

Revenue Structure Unit: Bt Million Product line /

Operate by

% Shareholding

Business Group Healthcare

Bumrungrad

2005

2004

by Company

Revenue

6,586

96.8

Revenue

2003 %

Revenue

2,482

42.7

Hospital Pcl. Healthcare

Bumrungrad Medical Center Ltd 100.00

Healthcare

Vitallife Corporation

Total Healthcare Rental

Bumrungrad

3,167

54.5

4,473

96.8

0.8

0.7

0.4

6,647

97.6

5,686

97.9

4,491

97.2

1.3

0.7

0.6

0.2

0.5

1.3

0.9

1.1

0.9

0.6

0.8

0.6

0.9

100.00

Hospital Pcl. Rental

Bumrungrad Medical

100.00

Center Ltd Total Rental Others

Bumrungrad

Hospital Pcl. Others

Bumrungrad Medical

100.00

Center Ltd Others

Bumrungrad

100.00

0.2

International Ltd Total Others Total

1.1

1.2

1.7

6,807

100.0

5,809

100.0

4,620

100.0

3.3 Business Characteristics and Competition Bumrungrad Hospital Public Company Limited is the operator of Bumrungrad Hospital in Bangkok, and is the main revenue contributor of 97.6% of total revenues. The hospital, which is run by the advanced Hospital 2000 Medical Information System, has services which can be detailed as follows: 1. Outpatient service has 135 examination rooms in 33 outpatient clinics, with the capacity to service 3,500 patients per day 2. Inpatient service has 554 beds. As at 31 December 2005, the hospital has 457 beds in operation 3. Emergency facilities and operating theaters: The Company has emergency center open 24 hours, equipped with specialized physicians. In addition, the Company has 19 operating theaters fully equipped with modern medical equipment. The Company has the plan to expand the capacity in order to accommodate the increase in patient volume for the next 5-7 years and is in the process of building a new 22-storey outpatient facility. At full capacity, the new facility will be able to service 5,500 patients per day. At the same time, the Company will be able to convert the current outpatient clinics in the existing building into inpatient beds. This will ultimately increase the inpatient service capacity to 700 beds. The Company will open the space in the new building as needed according to the increased demand, starting in 2006.

134

Bumrungrad Hospital Public Company Limited

Annual Report 2005

In 2005, the Company has treated a total of over one million patients. The client base of the hospital can be segmented in 2 ways as follows: 1. Inpatient and outpatient (% of total revenue) Inpatient 53%

Outpatient 47% Data as at 31 December 2005 2. Domestic and international patients In 2005, Bumrungrad Hospital in Thailand treated 400,000 international patients from over 190 countries.The Company’s revenue can be divided as follows (% of total revenue): Thai 47%

International 53% Data as at 31 December 2005 Industry and Competition As at end of 2003, there are 346 private hospitals in Thailand, of which 100 are in Bangkok. The supply of private healthcare facilities in Thailand remains in excess of demand though a robust economy is fueling increased healthcare demand. Competition for Thai patients remains intense with improvements seen from private hospitals in all fronts including quality of service and building improvements. In any case, private healthcare industry in Thailand is a fragmented market and there are only a few private hospitals that have the technology and sophistication to address the needs of international patients. In addition, since international patients contribute about half of the Company’s revenue, the Company is not only competing with Thai hospitals, but also with regional hospitals in countries such as Singapore, Malaysia and India, where these hospitals are also becoming more competitive. The Company’s strategy is to maintain quality superiority through a differentiated product that includes Bumrungrad as Thailand’s only internationally accredited hospital. Also, pricing is targeted within the top tier of Thai hospitals while remaining price competitive in the region. For regional competition, in addition to maintaining the quality and the pricing strategy, the Company also seeks to maintain as the dominant player by operating hospitals in key markets through investments in hospitals abroad, which at present includes the Philippines and the Middle East. The Company operates overseas representative offices and has an international patient center to accommodate the needs of international patients. The Company is also a tertiary referral center for both domestic and international hospitals.

Bumrungrad Hospital Public Company Limited

135

Annual Report 2005

4. Risk Factors 1. Slow down of the tourism industry In the past, Thailand’s tourism industry has been affected by many issues, including the spread of SARS, bird flu epidemics, the international terrorism, the unrest in the Middle East, and the tsunami catastrophe in the south of Thailand. These events could cause a reduction in the number of tourists visiting Thailand and could in turn affect revenues from international patients. In order to minimize the possible risk, the Company maintains a balanced portfolio of international and Thai patients so that the Company does not rely excessively on revenue from international patients. 2. Intensified competition in the premium healthcare sector With the current environment where purchasing power is quite high, the need for high quality private healthcare also increases. As a result, the competition in the private healthcare sector continues to intensify, and therefore the risk of the Company losing its clients to other competitors also increases. In order to maintain its leading position in Thailand and Asia and to mitigate the risk, the Company has invested in up-to-date technology and has continuously improved its quality of care. The Company was the first hospital in Asia to receive US standard accreditation from Joint Commission International Accreditation (JCIA), and was the first private hospital in Thailand to receive Thai Hospital Accreditation (HA). In addition, the Company has a strong client base of referral patients both from within Thailand and internationally. This signifies the reputation of the Company as the leader both within Thailand and in the region. 3. Shortage of professional staff The hospital business requires personnel with specific technical expertise and knowledge, including nurses, pharmacists and various technicians. A shortage of these professionals is possible due to the increase in demand as a result of economic growth. In addition, because the Company sees the importance of its international client base, multi-lingual professionals are also required. In order to minimize the risk, the Company offers competitive compensation and benefits for its staff.The Company also provides education and training, recreation and staff welfare activities to all staff members, on par with other competitors. Through a decentralized management structure, the Company also offers excellent career paths to various categories of staff members. 4. International investments To maintain its status as a leader in management of regional private healthcare, the Company has assigned Bumrungrad International Limited (“BIL”) to conduct investments in overseas hospitals. At present, BIL has made investment in a hospital in the Philippines and has agreed to invest in a hospital in the United Arab Emirates. Such investments carry the inherent risk of investment and expose the Company to country risk outside Thailand. To mitigate this risk, BIL’s experienced international management team conducts extensive feasibility studies and carries out detailed due diligence using firms with local knowledge before recommending Company’s investment. Risk is also reduced by engaging local equity partners in most overseas investments. 5. Legal disputes Hospital business is subject to litigation risk attended to the provision of healthcare services by hospital staff and physicians. Therefore, in order to minimize the risk, the Company has implemented a healthcare risk management system to ensure that the risk of mistakes by the Company’s personnel is minimized and corrected. In addition, the Company has various insurance policies in place against possible legal lawsuits.

136

Bumrungrad Hospital Public Company Limited

Annual Report 2005

5. Shareholding Structure and Management 5.1 Major Shareholders List of Company’s 10 major shareholders as at 2 September 2005 is as follows: Shareholder

Number of shares*

Shareholding** (%)

1. Sinsuptawee Asset Management Co., Ltd. 2. Bangkok Insurance Pcl.

175,000,000

23.97

96,286,402

13.19

3. HSBC (Singapore) Nominees Ptl Ltd.

56,642,700

7.76

4. Bangkok Bank Pcl.

47,899,765

6.56

5. Wattanasophonpanich Co., Ltd.

25,121,875

3.44

6. Morgan Stanley & Co International Limited

16,408,700

2.25

7. Chase Nominees Ltd.1

12,236,600

1.68

8. State Street Bank and Trust Company

11,650,000

1.60

9. Somer (U.K.) Limited

11,252,000

1.54

10. UOB Kay Hian Private Limited

10,032,390

1.37

462,530,432

63.36

Total *

Number of shares includes both preferred shares and common shares

The calculation of holding percentage includes both preferred shares and ordinary shares

5.2 Management (1) Management Management Structure The Company has 2 sets of committees; i.e. the Company’s Board of Directors and the Audit Committee. Details of each committee are as follows: Board of Directors The Company’s Board of Directors as at 31 December 2005 consists of the following: 1.

Mr. Chai Sophonpanich

Chairperson

Dr. Chanvit Tanphiphat, MD

Vice Chairperson

Mrs. Linda Lisahapanya

Director, Managing Director

Ms. Sophavadee Uttamobol

Director, Chairperson of Audit Committee

Mr. Soradis Vinyaratn

Director, Member of Audit Committee

Mr. Boonpakorn Chokwatana

Director, Member of Audit Committee

Mr. Chatri Sophonpanich

Director

Dr. Dhanit Dheandhanoo, MD

Director, Chairperson of the Medical Director

Dr. Anant Tejavej, MD

10. Dr. John Yangpichitt, MD

Director Director

11. Dr. Sawanya Dej-Udom, MD

Director

12. Mrs. Kultida Sivayathorn

Director

13. Mr. Chong Toh

Director

14. Mr. Curtis John Schroeder

Director, Group Chief Executive Officer

Ms. Suthinee Tevidhaya is the secretary of the Board of Directors.

Bumrungrad Hospital Public Company Limited

137

Annual Report 2005

Legal Binding of the Company Any two authorized directors, except Mr. Chatri Sophonpanich, Mrs. Kultida Sivayathorn and Mr. Chong Toh, sign and affix the Company’s seal. Duties and Responsibilities of Board of Directors: 1. To perform duties in accordance with the laws, the Company’s objectives and regulations, and resolutions of the shareholders’ meetings 2. To have the authority to enter into any transaction on behalf of the Company, which requires two signatures of any authorized directors and affixing of the Company’s seal 3. To consider the stipulation and amendments of the list of authorized directors, including specifying any conditions to legally bind the Company by such authorized directors’ signatures 4. To ensure that the Company has an effective internal control and internal audit system. Audit Committee The Company’s Audit Committee as at 31 December 2005 comprises the following: 1. Miss Sophavadee Uttamobol

Chairperson of the Audit Committee

2. Mr. Soradis Vinyaratn

Member of the Audit Committee

3. Mr. Boonpakorn Chokwatana

Member of the Audit Committee

Mrs. Tawichar Tansathit is the secretary of the Audit Committee. Duties and Responsibilities of the Audit Committee The Company’s Audit Committee has the scope of duties and responsibilities to report to the Board of the Directors as follows: 1. To review the financial report of the Company to be in accordance with the accounting standards, and ensure that the financial reporting is sufficient and reliable, before being presented to the Board of Directors 2. To consider and recommend the appointment of external auditors and audit fees 3. To ensure that the Company has adequate and effective internal control system 4. To ensure the Company’s compliance with regulations and other relevant laws 5. To ensure that there is no conflict of interest arising from connected parties 6. To prepare the report of the Audit Committee to be disclosed in the Company’s annual report; the report must be signed by the Chairperson of the Audit Committee 7. To be responsible for any other matters assigned by the Board of Directors. Other responsibilities: 1. To consider the budget and human resources of the internal audit office 2. To coordinate with the Company’s internal auditors regarding the internal control system, audit plans and audit programs, and to evaluate the results of the internal auditing of various operations of the Company, according to the generally accepted methods and standards 3. To appoint, dismiss, transfer or terminate the employment of director (chief ) of internal audit.

138

Bumrungrad Hospital Public Company Limited

Annual Report 2005

Management The Company’s Management as at 31 December 2005 consists of the following: 1. Mrs. Linda Lisahapanya

Managing Director

2. Dr. Dhanit Dheandhanoo, MD

Chairperson of the Medical Director

3. Mr. Curtis J. Schroeder

Group Chief Executive Officer

4. Dr. Sinn Anuras, MD

Group Medical Director

5. Dr. Karoon Mekanontchai, MD

Medical Director

6. Dr. Chamaree Chuapetcharasopon, MD

Senior Associate Medical Director

7. Mr. Carl Stanifer

Group Chief Financial Officer and Director of International Development

8. Mr. Dennis Brown

Group Chief Operating Officer

9. Mr. James Matthew Banner

Chief Executive Officer

10. Mrs. Khor Yow Lee Chan

Chief Financial Officer

11. Ms. Janice Chan Mun Yee

Chief Operating Officer

* Mr. James Matthew Banner joined the Company as Chief Executive Officer on 25 July 2005.

Details of Management and Controlling Parties Directors Name / Position

1. Mr. Chai Sophonpanich

Age

Chairperson

Education

Shareholding*

Family Relationship

(%)

between Management

- Bachelor’s degree

1.09

Husband of sister

Work Experience

- President and

University of

of Mrs. Linda

Managing

Colorado, USA

Lisahapanya

Director, Bangkok

- Director Certification

Program # 116/2002,

Brother of Mr. Chatri Sophonpanich

Thai Corporate

Insurance Pcl. - Chairman of Charoong Thai Wire & Cable Pcl.

Directors Institution

- Chairman of Furukawa

Association

Metal (Thailand) Pcl.

- Chairman 2000 # 10/2004

- Vice Chairman of

Thai Corporate Director

Amata Corporation Pcl.

Institution Association

- Director of Union Plastic Pcl. - Director of Bangkok Life Insurance Co., Ltd.

2. Dr. Chanvit Tanphiphat, MD

Vice Chairperson

3. Mrs. Linda Lisahapanya

Managing Director

4. Mrs. Kultida Sivayathon

Director

- MB. CHB., Leeds

0.07

- Professor, Faculty of Medical

University

Science, Surgery Department,

F.R.C.S. England

Chulalongkorn University

- Master‘s Degree

0.18

Sister of Mr. Chai

University of llinois

Sophonpanich’s

USA

wife

- B.Sc (Chemistry)

0.01

Stetson University

- Managing Director, Bumrungrad Hospital Pcl.

- 1976-Present, Executive Vice President,

- Director Certification

Bangkok Bank Pcl.

Program # 3/2000 Thai Corporate Directors Institution Association 5. Dr. John Yangpichitt, MD Director

- MRCOG, FRCOG, Queens University

0.02

- Independent physician Ruam Rudee Clinic

* Shareholding as at 2 September 2005, including shares held by spouses and minors

Bumrungrad Hospital Public Company Limited

139

Annual Report 2005

Name / Position

6. Dr. Dhanit

Age

Education

Shareholding*

Family Relationship

(%)

between Management

- M.D, Mahidol University

Dheandhanoo, MD

0.04

- Board Certification:

Director

Work Experience

- Emeritus Professor, Director, Neurology

Neurosurgery, UK

Surgery Department of Ramathibodi University

7. Dr. Swanya Dej-Udom,

- M.D, Mahidol University

MD Au

- Board Certifications

Director

- Internal Medicine

0.05

- 1980-present cardiologist Bumrungrad Hospital - 1992-present cardiologist

- Cardiology

Paat Pattana Medical Center

- Director Accreditation

- Academic Director, the Heart

Program # 47/2005, Thai

Foundation of Thailand

Corporate Directors Institution Association 8. Dr. Anant Tejavej, MD

- MBChB (Edinburgh

Director

0.14

University)

- Emeritus Professor, Medical Science Faculty,

- DCH (England) FRCP

Ramathibodi,

Edinburgh)

Mahidol University

- Director Accreditation Program # 47/2005, Thai Corporate Directors Institution Association 9.

Mr. Chong Toh

- Master of Science

Director

in Management –

- 2005-present Executive Vice President,

Massachusetts

Bangkok Bank Pcl.

Institute of

- 2005-present

Technology

Executive Chairman,

- BA Hons (Oxon) in

Bualuang Securities Pcl.

Philosophy,

- 2000-2005 President,

Politics and

Bualuang Securities Pcl.

Economics-Oxford

- 1998-2000 Vice

University

President, Investment Banking – Bangkok Bank Pcl. - 1993-1996 Analyst, Investment Banking – Morgans Stanley - 1991-1993 Economist, Government of Singapore Investment Corporation

10. Ms. Sophavadee

- MBA Chulalongkorn

Uttamobol

University

Director

- 1991-present Legal Consultant,

- Director Accreditation

Dhamrongtham Law Office

Program, Thai

- 1987-1991 Supervisor

Corporate Directors

Officer, Bank of Asia Pcl.

Institution Association

- 1984-1987 Head of Legal Department, Pornprapa Finance Corporation

11. Mr. Soradis Vinyaratn Director

- Attended City of London

0.02

College of Banking, London - Director Accreditation Program CP on 4 May 2005 from Thai Corporate Directors Institution Association

- Executive Director, The Post Publishing Pcl. - Executive Vice President, Bangkok Bank Pcl. - Vice Chairperson, Landmark Hotel Group - Managing Director, Sorachai Wiwat Co., Ltd.

* Shareholding as at 2 September 2005, including shares held by spouses and minors

140

Bumrungrad Hospital Public Company Limited

Annual Report 2005

Name / Position

12. Mr. Boonpakorn

Age

Education

Shareholding*

Family Relationship

(%)

between Management

- Bachelor‘s degree

Chokwatana

0.04

- Chairperson, New City

of Economics

Director

Work Experience

(Bangkok ) Pcl.

- The University of

- Chairperson Dr. Tiem

Nottingham, United Kingdom

Chokwatana Foundation

- Director Accreditation

- Vice Chairperson

Program # 3/2003, Thai

Saha Pathanapibul Pcl.

Corporate Directors

- Vice Chairperson

Institution Association

Saha Pathana Interholding Pcl.

- Director Certification

- Director IT City Pcl.

Program # 63/2005 Thai Corporate Directors Institution Association 13. Mr. Chatri

- High Level Vocational

0.3

- Brother of

- 1999 – present

Sophonpanich

Education, Kwang Tai

Mr. Chai

Vice Chairman of

Director

High Accountancy

Sophonpanich

the Advisory Committee,

College, Hong Kong

Bangkok Bank Pcl.

- Higher Education,

- 1999 – present Advisor

London Regent Street

of the Executive

Polytechnic, United Kingdom

Committee of Bangkok Bank Pcl. - 1999 – present Chiarman Bangkok Bank Pcl.

14. Mr. Curtis John Schroeder

- Master‘s degree in

Director

0.01

- 1987-1993 Director,

Health Services

of USC University

Administration,

Hospital, Los Angeles,

University of Southern

California

California * Shareholding as at 2 September 2005, including shares held by spouses and minors

Management Name / Position

1. Mrs. Linda Lisahapanya

Age

Managing Director

2. Dr. Dhanit Dheandhanoo,

MD Chairman of the Medical

Education

Shareholding* (%)

- Master‘s degree

0.18

Family Relationship between Management - Sister of Mr. Chai

Work Experience

- Managing Director,

in Finance University

Sophonpanich‘s

Bumrungrad

of llinois USA

wife

Hospital Pcl.

- M.D, Mahidol University

0.04

- Emeritus Professor,

- Board Certifications:

Director Neurology

Neurosurgery, UK

Surgery Department

Director

of Ramathibodi University

3. Mr. Curtis John Schroeder

Group Chief Executive Officer

4. Dr. Sinn Anuras, MD Group Medical Director

- Master’s degree

0.01

- 1987-1993 Director of

in Health Services

USC University

Administration, University

Hospital, Los Angeles,

of Southern California

California

- M.D Chulalongkorn University - Board Certifications: - American Board of Internal Medicine - American Board of

0.05

- 1987-1994 Vice Chairperson for Medical Affair University Medical Center Lubbook, Texas

Gastroenterology * Shareholding as at 2 September 2005, including shares held by spouses and minors

Bumrungrad Hospital Public Company Limited

141

Annual Report 2005

Name / Position

5. Dr. Karoon Mekanontchai,

Age

Education

Shareholding*

Family Relationship

(%)

between Management

- MD, Mahidol

0.03

University

Medical Director

Work Experience

- 1989 Orthopedics Consultant, Bumrungrad Hospital

- Board Certification:

- 1983-1998 Orthopedics

Orthopedic Surgery

and Rehabilitation Medical School, Mahidol University - 1978-1993 Full time physician, Saraburi Province Hospital

6. Dr. Chamaree

Chuapetcharasopon

- Mahidol University,

Ramathibodi Hospital

Senior Associate Medical

committee, Royal College

- Board Certification:

Director

- 1998-present Executive of Radiologists of Thailand

General Radiology, Thailand

- 1994-present Consultant

- Fellowships:

Radiologist, National

- Vascular and Interventional

Cancer Institute

Radiology, USA

- 1990-1995 Instructor,

- Body Imaging, USA

Department of Radiology, Ramathibodi Hospital, Mahidol University

7. Mr. Carl Stanifer

- Graduate studies in

Group Chief Financial

Health Planning and

Officer and Director

Administration at the

of International Development

0.02

- Chairperson and President of VISTA Healthcare, Singapore - Senior Vice President,

University of Cincinnati

Operations of International

- Bachelor’s Degree in

Healthcare Division,

Accounting and Finance,

Tenet Healthcare Corporation

Cumberland College

- Experience in Saudi Arabia, Australia and Malaysia

8. Mr. Dennis Brown

- Executive Program,

Group Chief

Graduate School of

Operating Officer

Business, Stanford

- 2003-2004 Chief Executive Officer, BFT Investments, LLC. - 1980-1984, 1985-2003

University

Senior Vice President,

- Company Director’s

Operations Northern Region,

Diploma, University

Tenet Healthcare

of New England, Australia

Corporation

- Master of Business

- Chief Executive Officer,

Administration in Health

Australian Medical

and Hospital Administration,

Enterprises, Australia

University of Florida

- Chief Executive Officer, Mount Elizabeth Hospital, Ltd.

9. Mr. James Matthew

- Master of Hospital

- BUPA Health Care Asia

Banner

Administration, Medical

(previously VISTA)

Chief Executive Officer

College of Virginia, USA

- Director and CEO of

* Appointed CEO

Subang Jaya Medical

effective on 25/7/2005

Center, Kuala Lumpur

10 Mrs. Khor Lee Chan

Chief Financial Officer

- Bachelor’s degree,

0.01

Victoria University

- 1987-1994 Chief Financial Officer, Mount Elizabeth

of Wellington,

Hospital Ltd.

New Zealand

- 1984-1986 Chief Accountant, Scotts Holding (S) Pte. Ltd - 1982-1983 Internal Manager, Diethelm Singapore Pte. Ltd.

11. Ms. Janice Chan Mun Yee

- Master Degree, George Washington University

Chief Operating Officer

Bumrungrad Medical Center - 2003 – 2005 Director of Operations - 2000 – 2003 Division Director Hospital administrative

* Shareholding as at 2 September 2005, including shares held by spouses and minors

142

Bumrungrad Hospital Public Company Limited

Annual Report 2005

Details of Directorship in Subsidiaries and Related Companies Subsidiaries Directors 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12.

Mr. Chai Sophonpanich Dr. Chanvit Tanphiphat, MD Mrs. Linda Lisahapanya Mrs. Kultida Sivayathorn Dr. Dhanit Dheandhanoo, MD Mr. Chong Toh Mr. Boonpakorn Chokwatana Mr. Curtis John Schroeder Dr. Sinn Anuras, MD Mrs. Khor Yow Lee Chan Dr. Karoon Mekanontchai, MD Mr. Carl Stanifer

BMC

VITALLIFE

X / // / // / / // //

X /

BIL

/ X /

/ / /

/ //

Notes 1. / = Director X = Chairperson // = Management 2. LS Cleaning does not appear in this table since it is not considered a significant part of the operation and does not contribute any revenue to the company. 3. GCS does not appear in this table as no director, chairperson or management of the Company holds a directorship position in GCS. (2) Election of Directors and Management The Company does not have a nominating committee for the selection of directors and management. The election of any members of the Board of Directors must be approved by the shareholdersâ&#x20AC;&#x2122; meeting, in accordance with the following rules and principles: 1. Each shareholder has one vote for one share. 2. The election of directors may be either by voting for each individual director, or by voting for a group of directors, whichever way the shareholdersâ&#x20AC;&#x2122; meeting deems appropriate. For each resolution, each shareholder must exercise all of his/her votes for one individual director or for one group of directors. Votes by each shareholder may not be split between any directors or any groups of directors. 3. The election passes with the majority of the votes. If the number of votes is equal, the chairperson of the meeting has the final vote. Bangkok Bank Pcl, the major shareholder of the Company with 30.53* percent shareholding, has 2 representatives on the Board of Directors, which are Mr. Chatri Sophonpanich and Mrs. Kultida Sivayathorn. * The data as of at 2 September 2005; the shareholding includes that of Sinsuptawee Asset Management Co., Ltd. and Bangkok Bank Pcl.

The process for selection of independent directors is the same as the selection of directors and management. The fundamental qualifications of independent directors are as follows: 1. Is an external director with no management or employment position in the Company, subsidiaries, affiliates or related companies 2. Is not a management of the Company, subsidiaries, affiliates or related companies 3. Does not have direct or indirect benefits or interests, either financially or managerially, in the Company, subsidiaries, affiliates or related companies 4. Is independent from the major shareholders, management and related parties 5. Is able to protect the interest of every shareholder fairly 6. Is able to prevent transactions with conflict of interest between the Company and related parties 7. Holds shares accounting for not more than 5 percent of paid-up capital of the Company, subsidiaries, affiliates or related companies (Including shares held by related parties).

Bumrungrad Hospital Public Company Limited

143

Annual Report 2005

(3) Remuneration of Directors, Audit Committee and Management Directors’ Remunerations and Audit Committee’s Remuneration Directors’ remunerations and Audit Committee’s remunerations for the year ended 31 December 2005 for 15 directors are as follows: Director’s Remuneration Name

Audit Committee’s Remuneration

Number of

Annual

Meeting

Meetings

Remuneration

Total

Number of

Meeting

Total

Meetings

Remuneration

Remureation

Attending/

Invitation

1. Mr. Chai Sophonpanich

5/5

280,000

150,000

430,000

2. Dr. Chanvit Tanphiphat, MD

4/5

240,000

100,000

340,000

3. Dr. Dhanit Dheandhanoo, MD

5/5

200,000

100,000

300,000

4. Mr. Boonpakorn Chokwatana

5/5

200,000

100,000

300,000

4/4

80,000

4/4

80,000

5. Mr. Soradis Vinyaratn

4/5

200,000

80,000

280,000

6. Dr. Sawanya Dejudom, MD

5/5

200,000

100,000

300,000

300,000 380,000 360,000 300,000

7. Dr. Anant Tejavej, MD

5/5

200,000

100,000

300,000

8. Dr. John Yangpichitt, MD

4/5

200,000

80,000

280,000

9. Mrs. Kultida Sivayathorn

3/5

200,000

60,000

260,000

10. Ms. Sophavadee Uttamobol

5/5

200,000

100,000

300,000

260,000 4/4

120,000

420,000

11. Mr Chong Toh

5/5

200,000

100,000

300,000

12. Mrs. Linda Lisahapanya

5/5

200,000

100,000

300,000

13. Mr. Kiat Nitthiranondh

1/1

20,000

14. Mr. Curtis Schroeder

3/5

200,000

60,000

260,000

15. Mr. Chatri Sophonpanich

1/5

200,000

20,000

220,000

2,920,000

1,270,000

4,190,000

280,000

4,470,000

Mr. Kiat Nitthiranondh resigned from the position of Company’s director on 28 April 2005 Director remunerations represent the benefits paid to the Company’s directors, exclusive of salaries and related benefits payable to the management. The above remunerations have been approved by the shareholders.

Remunerations of Management In 2004, the total remuneration of the 10 executives of the Company and its subsidiaries is amounted to Bt 89,677,027. The remuneration represent the salaries and benefits paid to the management. (4) Corporate Governance The Company realizes the importance of good corporate governance, and is committed to follow the Principles of Good Corporate Governance Guidelines provided by the Stock Exchange of Thailand as follows: 1. Corporate governance policy The Board of Directors sees the importance of good corporate governance, and has the intention to follow such policies. The Board of Directors emphasizes the internal control and internal audit system, and oversees that the management runs the Company in accordance with the Company’s policies efficiently, for the long-term benefits of shareholders, under the regulations and laws and business ethics.

144

Bumrungrad Hospital Public Company Limited

Annual Report 2005

2. Shareholders’ rights The Company acknowledges the importance of all shareholders’ rights, including both major shareholders and minority shareholders, as well as emphasizes on providing correct, timely, equal and transparent information to all shareholders. For every shareholder meeting, the Company sends invitation letters to shareholders to inform of the meeting agenda and Board of Directors’ opinion on each agenda, with supporting documents and information sufficient to facilitate shareholders in making their decisions.The Company also has minutes of the shareholders meeting which are correct and complete available for shareholders to verify. 3. Stakeholders’ rights The Company recognizes the importance of the rights of each stakeholder, and intends to interact with each party fairly. The important stakeholders are as follows: Customers / Patients

The Company provides patient care in an ethical manner, and at the best quality possible. The hospital’s Medical Ethics Committee protects patients’ rights. In addition, the Company has a department to monitor and improve the quality of the care provided to all patients, taking into consideration patients’ needs and suggestions.

Suppliers / Contractors The Company abides by the contracts with all suppliers and contractors. Employees

The Company believes that its employees are valuable resources and therefore has the policy to provide employees with appropriate compensation and to develop human resources through continuous education and regular training programs.

Competitors

The Company competes with competitors fairly and in accordance with the rules and regulations.

Community

The Company has social responsibilities, including environmental responsibilities, and has set up an environmental policy to communicate to employees its views on environment preservation and encourages employees to help protect global environment. The Company is committed to controlling environmental impact to neighboring communities and efficiently utilizing natural resources. In addition, the Company has various activities to support the community through its Bumrungrad Hospital Foundation.

4. Shareholders’ meetings In the 2005 annual general shareholders’ meeting, 10 directors attended the meeting to provide information and details to shareholders. The Chairperson of the meeting gave all shareholders equal opportunity to ask questions, express their views, and make suggestions. The Company has recorded the important issues raised in the minutes of the meeting. 5. Leadership and vision The Board or Directors approves the setting of the Company’s vision, mission, strategies, goals, business plans and budgets. The Board of Directors also ensures that the plans are carried out efficiently and effectively, to ensure the maximization of the Company’s value and stability to shareholders. The Board of Directors meets quarterly to review the Company’s performance against the plan. Moreover, the Board of Directors has set roles and responsibilities for various committees, including internal control system and internal audit, as well as has communicated such roles and responsibilities to all levels of management and employees. 6. Conflict of interest To prevent any conflicts of interest, the Board of Directors pays special attention to the consideration of transactions which conflicts of interest may arise, and to related parties transaction, as well as strictly follows the Stock Exchange of Thailand rules and regulations, with pricing and other conditions on an arms-length basis. Details of the transactions, including amount, contracting party, and reasons for entering into the transactions are disclosed in financial statements, annual report, and the 56-1 filing.

Bumrungrad Hospital Public Company Limited

145

Annual Report 2005

Business ethics The Company’s mission statement is “We provide world class healthcare with care and compassion”. In addition, the Company has guiding principles, which are communicated to all employees as follows: 1. 2. 3. 4. 5. 6. 7. 8. 9.

We treat our patients as we would our family members. We embrace cultural diversity. We are trusted, honest and ethical in all our dealings. We work as a team. We continually improve the quality of everything we do. We strive for a happy working environment with respect and mutual trust. We encourage professional development and innovation through a constant process of learning. We provide efficient healthcare to bring value to our external and internal customers. We are a good corporate citizen.

All employees are expected to observe and follow these guiding principles. 8. Balance of power in the Board of Directors The Company has 3 directors who are management: 1. Mrs. Linda Lisahapanya 2. Dr. Dhanit Dheandhanoo, MD 3. Mr. Curtis John Schroeder There are 8 directors who are not management: 1. Mr. Chai Sophonpanich 2. Dr. Chanvit Tanphiphat, MD 3. Mrs. Kultida Sivayathorn 4. Dr. John Yangpichitt, MD 5. Dr. Swanya Dej-Udom, MD 6. Dr. Anant Tejavej, MD 7. Mr. Chong Toh 8. Mr. Chatri Sophonpanich The Company has 3 directors who are independent directors and members of the Audit Committee: 1. Miss Sophavadee Uttamobol 2. Mr. Soradis Vinyaratn 3. Mr. Boonpakorn Chokwatana The 3 independent directors account for 21.4% of total Board of Directors. The Company plans to increase the number of independent directors to not less than 1/3 of all directors in the future. 9

Aggregation and segregation of positions Chairperson of the Board of Directors is not the same person as the Managing Director, in order to segregate the duties of policy setting and control from the day-to-day management.

10. Directors and management remuneration The Company does not have a compensation committee. The directors’ remunerations are in the form of annual remunerations and meeting fees, which have already been approved by the shareholders. Management’s remunerations are in the form of salaries and bonus, and are based upon both the Company’s performance and individual performance. The details of remunerations for directors and management are in Section Remuneration of Directors, Audit Committee and Management.

146

Bumrungrad Hospital Public Company Limited

Annual Report 2005

11. Board of Directors’ meetings The Board of Directors has a regular meeting every quarter, and has extraordinary meetings as necessary. The agendas of the meeting are set in advance and are sent together with invitation letters and other necessary documents to directors 7 days prior to the meeting so that the directors will have sufficient time to study the information. Normally, each meeting takes approximately 2 hours. In 2005, there were 5 meetings, with details of the attendance of each director in the table in Section Remuneration of Directors, Audit Committee and Management. The Company has documented minutes for every board meeting, which are approved at the next board meeting. The Company keeps the minutes available for directors and relevant persons’ verification. 12. Committees The Company has Audit Committee, as detailed in Management Structure Section. The Company does not have a compensation committee. 13. Internal control and internal audit systems The Company has given importance to internal control and internal audit systems, by establishing an internal audit unit, with the primary objective to support and develop effective internal control of the organization, in order to minimize operational risks, and to ensure quality of the work process and operations. Emphasis is on effectiveness and efficiency, and appropriateness of expenses and costs, including operations in accordance to the policy and/or requirements of the management. To ensure the independence of the internal audit unit and the balance of power, the internal audit unit reports directly to the Audit Committee. 14. Directors’ report Report of the Accountability of the Board of Directors to the Company’s Financial Reports The Board of Directors is responsible for the consolidated financial statements of the Company and its subsidiaries and information as appears in the annual report. The financial statements have been prepared in accordance with generally accepted accounting principles, using appropriate and consistent accounting policies. The financial statements have been prepared with caution and have been evaluated for appropriateness of the overall presentation of the financial statement. There was sufficient information disclosure in the notes to the financial statements. The Board of Directors has set up an efficient and effective internal control system to ensure that all accounting transactions have been recorded correctly and comprehensively, and that there has been a record-keeping system of assets to protect the Company from any material fraud or damage. The Board of Directors has the opinion that the overall internal control system of the Company was at a satisfactory level, which resulted in confidence in the reliability of the financial statements of the Company and its subsidiaries as at 31 December 2005. 15. Relations with investors The Board of Directors sees the importance of the disclosure which is correct, complete, reliable, timely, transparent and dispersed, including the disclosure of financial information and general information which are important to investors’ decision making process. The Company also ensures that the disclosures are in accordance with the Securities and Exchange Commission, Thailand and Stock Exchange of Thailand’s rules and regulations. The Company has assigned personnel to be responsible for investor relations activities to facilitate interested investors and shareholders in this regard. Interested investors or shareholders can inquire regarding the Company’s information at the following: Investor Relations Telephone: 0-2667-2010 Email address: ir@bumrungrad.com Website: www.bumrungrad.com

Bumrungrad Hospital Public Company Limited

147

Annual Report 2005

(5) Internal Control of Information The Company has the policy regarding management using internal information for personal benefits as follows: 1. According to Company’s rules and regulations, directors are required to inform the Company immediately in the event that they may have any interests in any transactions being entered into by the Company, or that there is an increase or decrease in their holding of shares or bonds of the Company or subsidiaries. 2. Directors and management must prepare and disclose securities holding report to the Securities Exchange Commission within the required time. Penalties for violation include the following: 1. 2. 3. 4.

Verbal warning for corrective action Report to shareholders’ meeting for consideration Compensation for any damages Disclosure to Securities and Exchange Commission and The Stock Exchange of Thailand

(6) Internal Control See Report of Audit Committee (Page 95) (7) Dividend Policy 1. The Company’s dividend policy is as follows: 1.1

When the Company has net profit which can be distributed to shareholders, the preferred shareholders will receive dividends before the ordinary shareholders. In any year that dividends distributed to the preferred shareholders reaches 15% of the capital represented by the preferred shares, the balance of the profit shall be distributed to the ordinary shareholders at any amount as determined by the shareholders meeting. In any year that the Company is able to distribute dividends of more than 15% of its capital, the shareholders of both types shall receive the dividends equally.

1.2

For the payment of dividends, the Board of Directors is to follow the resolution of the shareholders’ meeting.

1.3

For every dividend payment, the Company shall reserve at least 5% of the profit as appropriated statutory reserve, until the reserve accounts for 10% of the Company’s capital.

1.4

Accrued dividends are not entitled to any interest payment.

2. Subsidiaries’ dividend policy is as follows: 2.1

When the company has profit which can be distributed to shareholders, the company is eligible to pay dividends to its shareholders at any amount in accordance with the resolution of shareholders’ meeting.

2.2

Accrued dividends are not entitled to any interest payment.

For the year 2005, the Company paid an interim dividend from the net profit of 1 January 2005 until 30 June 2005 of Bt 0.30 per share, totaling to an amount of Bt 219 million. In addition, on 28 February 2006, the Board of Directors has approved dividend payment of Bt 0.45 per share, amounting to Bt 329 million. Such amount is subject to shareholders’ approval in shareholders’ meeting to be held in April 2006. Therefore, the total dividend payment for the operation of the year 2005 is expected to be Bt 0.75 per share, which is 52.0% dividend pay-out ratio. 6. Related Parties Transactions 1. Characteristics of Related Parties Transactions The Company has transactions with its subsidiaries, affiliates and related companies as detailed in note to financial statement no. 6.

148

Bumrungrad Hospital Public Company Limited

Annual Report 2005

In addition, the Company has also entered into related parties transactions, which are the Company’s normal courses of business, including revenues from corporate contracts, charged at market rate. Transaction

Related Parties

Relationship

2005 Amount (Bt million)

Transactions with the Company’s subsidiaries and affiliates

Details in notes to financial statement no. 6

Revenues from corporate contract

Bangkok Insurance Pcl.

Common director

22.1

Revenues from corporate contract

Bangkok Bank Pcl.

Major shareholder

22.8

2. The Necessity and Rationale of the Related Parties Transactions The Company has entered into related parties transactions to support the normal business of the Company.The rental of building from Bangkok Bank Pcl (as detailed in notes to financial statements no. 6) has helped the Company to maintain and expand its international patient base. The corporate contracts and insurance contracts have helped expand the Company’s client base. 3. Approval Process for Entering into Related Parties Transactions For contracts which were entered into as part of normal courses of business, the transactions are approved through the normal process in accordance with the Company’s policy. For other transactions which are significant in size as per the definition of the Stock Exchange of Thailand, Board of Directors’ and/or shareholders’ approvals are obtained in accordance with rules and regulations, where management and/or directors with vested interests are not allowed to vote. 4. Policy on Related Parties Transactions in the Future The Company will continue to have related parties’ transactions, as these transactions are beneficial to the Company as explained earlier. The Company will strictly abide by the Company’s policy, as well as the rules and regulations of the Stock Exchange of Thailand. In addition, the Company will emphasize the transparency of the related parties transactions, and will protect the highest benefit of the Company. 7

Management Discussion and Analysis Page 94

8. Financial Statements 8.1 Financial Statements Page 97-127 8.2 Audit Fees (a) Audit Fees For the year 2005, the Company and subsidiaries have paid the audit fee in the amount of Bt 1,762,480. The 2005 audit fee has been approved by the shareholders’ meeting. (b) Non-Audit Fees None

Bumrungrad Hospital Public Company Limited

149